"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT02275104","Multimodal Image Processing Software to Guide Cardiac Ablation Therapy","MIGAT","Completed","No Results Available","Ventricular Arrhythmias|Persistent Atrial Fibrillation","Device: Contrast-enhanced ECG-gated multi-detector computed tomography|Device: Magnetic resonance imaging|Device: Positron emission tomography|Device: Body surface mapping|Procedure: Cardiac ablation procedure","To build MIGAT software|To test MIGAT for real-time guidance during cardiac ablation procedures.|To improve the compatibility of MIGAT with daily clinical use|Correlations between MIGAT predictions from non-invasive data, and ablation targets observed during invasive procedures","University Hospital, Bordeaux","All","18 Years and older   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","CHUBX 2013/35","September 1, 2014","July 21, 2016","July 21, 2016","October 27, 2014",,"February 17, 2017","Hôpital cardiologique du Haut-Lévêque, Pessac, France",,"https://ClinicalTrials.gov/show/NCT02275104"
2,"NCT03151512","UNDISTORT Correction of Distortions in Diffusion MRI V1.0","UNDISTORT","Unknown status","No Results Available","MR Image Distortion Correction|Prostate Cancer",,"Dice similarity score to assess distortions|Radiological scoring of image quality|Diffusion coefficient consistency","University College, London","All","18 Years to 120 Years   (Adult, Older Adult)",,"155","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","16/0128","March 29, 2017","January 2020","March 2020","May 12, 2017",,"May 12, 2017","University College London Hospital, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03151512"
3,"NCT03790930","Deep-learning Based Classification of Spine CT","DETECT","Recruiting","No Results Available","Surgical Procedure, Unspecified","Diagnostic Test: deep learning","classification accuracy|segmentation accuracy","Shanghai 10th People's Hospital|Third Affiliated Hospital, Sun Yat-Sen University","All","18 Years to 65 Years   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","SHSY180624","February 22, 2019","May 2020","May 2020","January 2, 2019",,"May 12, 2020","Shanghai Tenth People's Hospital, Shanghai, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT03790930"
4,"NCT03894254","Predictive Factors of Autonomy Loss in Real-life Cohort","MEM-AURA","Not yet recruiting","No Results Available","Memory Disorders","Other: no intervention","Functional autonomy level","Hospices Civils de Lyon","All","18 Years and older   (Adult, Older Adult)","Not Applicable","5250","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","69HCL18_0613","April 1, 2019","March 1, 2024","March 1, 2032","March 28, 2019",,"March 28, 2019",,,"https://ClinicalTrials.gov/show/NCT03894254"
5,"NCT02302482","Predictive Factors and Autonomy Level Change","MEMORA","Recruiting","No Results Available","Memory Impairment","Other: The Lawton Instrumental Activities of Daily Living score (IADL), and the disability assessment of dementia score (DAD-6","Functional autonomy level|Cognitive function level","Hospices Civils de Lyon","All","65 Years and older   (Older Adult)","Not Applicable","6780","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","2014.868","November 2014","November 2023","November 2023","November 27, 2014",,"May 23, 2017","Hôpital Dugoujon, Caluire-et-Cuire, France|Hospices Civils de Lyon - Hôpital des Charpennes, Lyon, France",,"https://ClinicalTrials.gov/show/NCT02302482"
6,"NCT04368481","MRI Incidental Finding Deep Learning Identification","MIDI","Recruiting","No Results Available","Neurological Disorder","Diagnostic Test: Deep Learning Algorithm","Sensitivity and specificity of a deep learning computer algorithm (termed a convolutional neural network) to recognise abnormalities on cranial MRI scans.|Sensitivity and specificity of a deep learning computer algorithm to broadly categorise abnormalities on cranial MRI scans.","King's College Hospital NHS Trust","All","18 Years and older   (Adult, Older Adult)",,"30000","Other","Observational","Observational Model: Other|Time Perspective: Other","KCH18-197","April 1, 2019","October 20, 2023","November 20, 2023","April 29, 2020",,"April 29, 2020","Guy's Hospital, London, United Kingdom|King's College Hospital, London, United Kingdom|St George's Hospital, London, United Kingdom|St Thomas' Hospital, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04368481"
7,"NCT04056650","Assessing the Effectiveness of an N-of-1 Platform Using Study of Cognitive Enhancers",,"Recruiting","No Results Available","Cognitive Performance","Drug: L-theanine|Dietary Supplement: Caffeine supplement|Device: N1 app","Percent of individuals who reach study completion|Percent of completed n-of-1 trials that yield statistically meaningful results.|Study adherence.","Icahn School of Medicine at Mount Sinai","All","18 Years and older   (Adult, Older Adult)","Phase 4","640","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","GCO 18-0756","October 18, 2019","September 2, 2020","September 2, 2020","August 14, 2019",,"February 21, 2020","Icahn School of Medicine at Mount Sinai, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04056650"
8,"NCT03706664","Small Bowel Deep Learning Algorithm Project",,"Active, not recruiting","No Results Available","Crohn Disease","Other: Machine learning algorithm","Machine learning algorithm's ability to accurately localize the terminal ileum.|Data processing time until a diagnosis reported by algorithm.|Machine learning algorithm's ability to accurately distinguish abnormal and normal terminal ileum.","London North West Healthcare NHS Trust|Imperial College London","All","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","226","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","IRAS No:238924","March 1, 2019","November 2020","January 2021","October 16, 2018",,"February 27, 2020","St Mark's Hospital, London, Harrow, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03706664"
9,"NCT02492971","Function-oriented Assistive Technology Indexing System Development and Promotion",,"Completed","No Results Available","Multiple Disability",,"user satisfaction (by using System Usability Scale)","Chang Gung Memorial Hospital","All","20 Years to 60 Years   (Adult)",,"175","Other","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","kcheng","September 2016","November 2017","November 2017","July 9, 2015",,"January 25, 2018","Chang Gung Univ., Taoyuan, Taiwan",,"https://ClinicalTrials.gov/show/NCT02492971"
10,"NCT03222375","SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism","SQUED™","Recruiting","No Results Available","Autistic Disorder|Autism Spectrum Disorder|Child Development Disorders, Pervasive|Neurodevelopmental Disorders|Mental Disorders|Asperger's Syndrome|Neurobehavioral Manifestations|Nervous System Diseases","Device: SQUED™ series 28.1 home-use","SQUED™ software of patient","American Federation of Medical Synergetics|Clinic of Synergetics, Department of Neurology/Neuropsychology WOMS|Institute of Medical Synergetics, Department of Cognitive Neurology WOMS|Laboratory of Neurocomputational Active Media WOMS|SQUED, Inc., USA|Center of Synergetics, Universität Stuttgart, Germany|Ivan Franko National University of Lviv, Ukraine|Danylo Halytsky Lviv National Medical University|World Organization of Medical Synergetics|World Autism Center, American Federation of Medical Synergetics","All","1 Month to 21 Years   (Child, Adult)",,"80","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","SQUED™ series 28.1 home-use","September 26, 2017","September 2022","December 2027","July 19, 2017",,"November 28, 2017","World Autism Center, American Federation of Medical Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology WOMS, Louisville, Kentucky, United States|Clinic of Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology of the World Organization of Medical Synergetics, Lviv, Solonka Village, Urozayna Street 41, Ukraine",,"https://ClinicalTrials.gov/show/NCT03222375"
11,"NCT03309787","Health Coaching & Technology in a Weight Loss Center",,"Completed","Has Results","Obesity|Technology|Videoconferencing|mHealth|Behavior, Health","Behavioral: eHealth","Completion Rate: Number of Participants Completing the Intervention|Acceptability|Change in Weight|Change in 6 Minute Walk|Diet Change|Subjective Health|Readiness to Change|Willingness to Pay","Dartmouth-Hitchcock Medical Center","All","18 Years to 65 Years   (Adult, Older Adult)",,"37","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","D17123","November 29, 2017","October 1, 2018","December 1, 2019","October 16, 2017","July 8, 2020","July 8, 2020","Dartmouth-Hitchcock, Lebanon, New Hampshire, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/87/NCT03309787/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03309787"
12,"NCT02781714","Evaluation of an mHealth SMS Dialogue Strategy to Meet Women's and Couples' Postpartum Contraceptive Needs in Kenya","Mobile WACh XY","Completed","No Results Available","Contraception|Postpartum Period","Behavioral: Two-way SMS","Highly-effective contraceptive use|Time to contraceptive use|Dual contraceptive use|Any contraceptive use|Family planning satisfaction questionnaire|Exclusive breastfeeding questionnaire","University of Washington|Kenyatta National Hospital|University of Nairobi","Female","14 Years to 50 Years   (Child, Adult)","Not Applicable","260","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","51125","July 2016","September 2017","September 2017","May 24, 2016",,"May 3, 2018","Ahero sub-County Hospital, Ahero, Kisumu County, Kenya|Bondo County Hospital, Bondo, Siaya County, Kenya",,"https://ClinicalTrials.gov/show/NCT02781714"
13,"NCT03109366","Electronic Tool for Interaction Between Patients and Health Professionals",,"Completed","No Results Available","Chronic Illness","Behavioral: Online patient-provider communication service","Patterns of intervention use","Oslo University Hospital|University of Oslo|University Hospital of North Norway|Balsfjord Municipality|Marshfield Clinic Research Foundation|Columbia University|Norwegian Centre for Integrated Care and Telemedicine","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","201512/S10","May 2011","October 2015","October 2015","April 12, 2017",,"April 12, 2017","Oslo University Hospital, Rikshospitalet,, Oslo, Norway",,"https://ClinicalTrials.gov/show/NCT03109366"
14,"NCT00154947","Develop Biomarkers for Assessing RA Joint Erosion",,"Unknown status","No Results Available","Rheumatoid Arthritis",,,"National Taiwan University Hospital|Palo Alto Medical Foundation","All","18 Years to 65 Years   (Adult, Older Adult)",,"60","Other","Observational","Observational Model: Case Control|Primary Purpose: Screening|Time Perspective: Longitudinal|Time Perspective: Prospective","9361700330","May 2004",,"May 2006","September 12, 2005",,"July 20, 2006","Liang-In Lin, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT00154947"
15,"NCT02175823","Health Status Evaluation for Cancer Survivors by Non-intrusive Sensing System",,"Unknown status","No Results Available","Cancer",,"Quality of Life","National Taiwan University Hospital","All","65 Years and older   (Older Adult)",,"40","Other","Observational","Observational Model: Ecologic or Community|Time Perspective: Prospective","201401056RIND","July 2014","July 2015","July 2015","June 26, 2014",,"July 8, 2014","National Taiwan University Hospital, Taipei, Da'an Dist, Taiwan",,"https://ClinicalTrials.gov/show/NCT02175823"
16,"NCT00138073","Effectiveness of a Computer Application in Improving Pulmonary Artery Catheter Waveform Interpretation",,"Terminated","Has Results","Pulmonary Artery Catheter Waveform Interpretation","Device: Web-based waveform interpretation guide","Score on a Computer-based Test on Pulmonary Artery Catheter Waveform Interpretation|Individual and Collective Frequency of Use and Usage Patterns of the Web-based Waveform Interpretation Guide","Massachusetts General Hospital","All","Child, Adult, Older Adult","Not Applicable","55","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)","2005-P-001381/1; MGH","December 2005","April 2012","April 2012","August 30, 2005","June 30, 2014","June 30, 2014","Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT00138073"
17,"NCT01232686","Snow Disease Surveillance System Study","Snow","Completed","No Results Available","Communicable Diseases","Other: Online disease surveillance data access","Earlier diagnosis and treatment for communicable diseases|Earlier detection of local disease outbreaks|Lower number of infected during disease outbreaks|Impact on health service costs","University Hospital of North Norway|University of Tromso|The Royal Norwegian Ministry of Health|Norwegian Health Network (state owned enterprise)","All","Child, Adult, Older Adult","Not Applicable","200","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","ID 3746/ HST954-10","October 2010","December 2012","December 2012","November 2, 2010",,"February 16, 2017",,,"https://ClinicalTrials.gov/show/NCT01232686"
18,"NCT01786044","The Impact of a ""Serious Game"" on Improving Patient's Medication Knowledge",,"Completed","No Results Available","Health Knowledge, Attitudes, Practice","Behavioral: MasterMed|Behavioral: Usual Care","medication knowledge|medication adherence","Massachusetts General Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","850","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Supportive Care","MGH 2012-P-002093/1|PCHI MGH 2012-P-002093/1","March 2014","June 2015","June 2015","February 7, 2013",,"March 22, 2017","Massachusetts General Hospital, Internal Medicine Associates, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT01786044"
19,"NCT03120741","Dementia Patient's Behavior Evaluation Using Noninvasive Ambient Sensor",,"Unknown status","No Results Available","Mild Cognitive Impairment, Dementia",,"The relationship between moving pattern change and dementia.|The relationship between daily routine change and dementia.|The relationship between sleeping time change and dementia.","National Taiwan University Hospital","All","65 Years to 100 Years   (Older Adult)",,"35","Other","Observational","Observational Model: Case-Control|Time Perspective: Other","201608004RINB","May 2017","August 2018","August 2018","April 19, 2017",,"April 19, 2017","National Taiwan University Hospital, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT03120741"
20,"NCT03306082","Image-guided Cochlear Implant Programming (IGCIP)",,"Enrolling by invitation","No Results Available","Cochlear Implant","Other: Image-Guided Cochlear Implant Programming","AzBio Sentence Scores at +5 Signal to Noise Ratio (SNR)|Minimum Speech Test Battery","Vanderbilt University Medical Center|National Institute on Deafness and Other Communication Disorders (NIDCD)","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","150","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","150417|R01DC014037","June 23, 2015","May 2021","May 2022","October 10, 2017",,"January 22, 2020","Vanderbilt University Medical Center, Nashville, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT03306082"
21,"NCT04320251","Tissue Growth Characterization for Cochlear Implant Users",,"Enrolling by invitation","No Results Available","Cochlear Implant","Procedure: cochlear implant revision surgery","Tissue growth","Vanderbilt University Medical Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","24","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","192257","June 1, 2020","January 9, 2023","January 9, 2023","March 24, 2020",,"May 5, 2020","Vanderbilt University Medical Center, Nashville, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT04320251"
22,"NCT04036903","D-Lung: An Analytics Platform for Lung Cancer Based on Deep Learning Technology",,"Recruiting","No Results Available","Lung Cancer","Radiation: computed tomography","accuracy|sensitivity|specificity|area under curve (AUC)|average number of false positives per scan (FPs/scan)|competition performance metric (CPM)","Chinese University of Hong Kong|Department of Computer Science & Engineering, CUHK","All","Child, Adult, Older Adult",,"500","Other","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","2019.316","August 16, 2019","June 2020","December 2021","July 30, 2019",,"October 23, 2019","The Chinese University of Hong Kong, Prince of Wale Hospital, Hong Kong, Shatin, Hong Kong",,"https://ClinicalTrials.gov/show/NCT04036903"
23,"NCT03336411","A Personalized Diet Study to Reduce Glycemic Exposure",,"Recruiting","No Results Available","Pre-diabetes|Overweight and Obesity","Behavioral: mHealth|Behavioral: Personalized mHealth","Body weight, percent change|Body Composition|Metabolic Adaptation|Weight regain","NYU Langone Health|American Heart Association|Weizmann Institute of Science","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","17-00741","December 12, 2017","October 2020","May 2021","November 8, 2017",,"May 29, 2020","New York University School of Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03336411"
24,"NCT04322487","Simple, Safe, Same: Lung Ultrasound for COVID-19","LUSCOVID19","Recruiting","No Results Available","Coronavirus|Epidemic Disease|Pneumonia, Viral","Diagnostic Test: Lung ultrasound","Lung ultrasound grading system for COVID-19 pneumonia","Catholic University of the Sacred Heart|Valle del Serchio General Hospital, Lucca, Italy|University of Trento, Trento, Italy|Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy|Bresciamed, Brescia, Italy|118 USL Nordovest Toscana, Lucca, Italy|General Hospital, Voghera, Italy|Lodi General Hospital, Lodi, Italy","All","Child, Adult, Older Adult",,"100","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","0013226/20","April 8, 2020","December 31, 2020","January 15, 2021","March 26, 2020",,"April 17, 2020","Bresciamed, Brescia, Italy|Pulmonary Medicine Unit, Lodi General Hospital, Lodi, Italy|118 USL Nordovest Toscana, Lucca, Italy|Diagnostic and Interventional Ultrasound Unit, Valle del Serchio General Hospital, Lucca, Italy|Emergency Department, Fondazione IRCCS Policlinico San Matteo, and Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy|Department of woman and child health and public health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy|Pulmonary Medicine Unit, Dept. Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy|Department of Information Engineering and Computer Science, Ultrasound Laboratory Trento, University of Trento, Trento, Italy|Emergency Medicine Unit, General Hospital, Voghera, Italy",,"https://ClinicalTrials.gov/show/NCT04322487"
25,"NCT03266224","Digital Analysis of Ultrasonographic Images in Children With Wry Neck",,"Completed","No Results Available","Torticollis Congenital|Wryneck",,"cervical passive range of motion|Area in cm^2|Brightness of echogenicity in %|max Feret's diameter in cm|min Feret's diameter in cm","Chang Gung Memorial Hospital","All","up to 12 Months   (Child)",,"29","Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","100-3793A3","April 30, 2013","August 15, 2015","August 15, 2015","August 30, 2017",,"August 31, 2017",,,"https://ClinicalTrials.gov/show/NCT03266224"
26,"NCT02385643","The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients",,"Unknown status","No Results Available","Alcohol Dependence","Behavioral: SmartPhone Support System","Time to first lapse|Time to first relapse|Cumulative abstinence days|Number of drinks per drinking days|VAS craving measurement|complete abstinence rate|Drop-out rate","Ming-Chyi Huang|Taipei City Hospital","All","20 Years to 65 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","MOST 103-2628-B-532 -001 -MY3","September 2013","July 2017","July 2017","March 11, 2015",,"March 11, 2015","Ming-Chyi, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT02385643"
27,"NCT04342234","Neural Network to Calculate Morphology of the Cleft Palate to Reduce Cleft Lip and Palate Treatment Burden.",,"Recruiting","No Results Available","Cleft Palate|Orofacial Cleft","Other: data collection of palatal casts and palatal images of cleft patients routinely treated at the institution","3D palatal geometry","University Hospital, Basel, Switzerland|Botnar Research Centre for Child Health (BRCCH)|sciCORE Basel|Department of Computer Science, Computer Graphics Laboratory, ETH Zurich","All","Child, Adult, Older Adult",,"450","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2020-00388; ch19Mueller2","March 5, 2020","December 2025","December 2025","April 10, 2020",,"April 15, 2020","Mund-, Kiefer- und Gesichtschirurgie, Universitätsspital Basel, Basel, Switzerland",,"https://ClinicalTrials.gov/show/NCT04342234"
28,"NCT03549806","Stanford Cardiac Invasive Electrophysiology Novel Computer Experience","SCIENCE","Recruiting","No Results Available","Atrial Fibrillation|Atrial Tachycardia|Atrial Flutter|Arrhythmias, Cardiac","Diagnostic Test: No Intervention. Test is computer algorithm.","Reduction in AF burden on follow-up|Freedom from arrhythmia on follow-up|Clinical status as measured by the EQ5D","Stanford University","All","21 Years to 80 Years   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","SCIENCE","June 21, 2018","June 30, 2020","June 30, 2021","June 8, 2018",,"September 19, 2019","Stanford Hospital, Stanford, California, United States",,"https://ClinicalTrials.gov/show/NCT03549806"
29,"NCT02404194","Targeted Cognitive Training in Clinical High Risk (CHR) for Psychosis",,"Recruiting","No Results Available","Clinical High Risk for Psychosis","Behavioral: Targeted Cognitive Training|Behavioral: Computer Games","Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery|Global Function: Social and Role Scales","Rush University Medical Center|Harvard Medical School|Beth Israel Deaconess Medical Center|National Institute of Mental Health (NIMH)","All","15 Years to 30 Years   (Child, Adult)","Not Applicable","76","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","MH105246|R01MH105246","March 2015","September 2019",,"March 31, 2015",,"March 19, 2019","Rush University Medical Center, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT02404194"
30,"NCT02734550","(1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis","CandiSep","Completed","No Results Available","Severe Sepsis|Septic Shock","Other: Standard of care|Other: (1,3)-β-D-glucan guided therapy","28 day mortality|28 day antifungal-free survival|Candida Colonization|Time to antifungal therapy|Duration of organ support|Mean total SOFA score|ICU and hospital length of stay|ICU and hospital mortality|Adverse events|Diagnostic performance of (1,3)-β-D-glucan in comparison to PCR and other experimental diagnostics|Pharmacoeconomics","Center for Sepsis Control and Care, Germany|Center for Clinical Studies, University Hospital Jena, Germany|Dept. of Microbiology, University Hospital Erlangen, Germany|Institute of Medical Statistics, Computer Sciences and Documentation, University Hospital Jena, Germany|Federal Ministry of Education and Research, Berlin, Germany|Associates of Cape Cod, Inc., East Falmouth, MA, USA","All","18 Years and older   (Adult, Older Adult)","Not Applicable","342","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","ZKSJ0087|01EO1502|U1111-1181-8724|DRKS00010285","September 12, 2016","August 22, 2019","September 17, 2019","April 12, 2016",,"December 20, 2019","Hospital Augsburg, Augsburg, Germany|HELIOS Klinikum Bad Saarow, Bad Saarow, Germany|University Hospital Bonn, Bonn, Germany|Hospital Emden, Emden, Germany|University Hospital Erlangen, Erlangen, Germany|University Hospital Frankfurt, Frankfurt, Germany|University Hospital Göttingen, Gottingen, Germany|University Hospital Greifswald, Greifswald, Germany|University Hospital Halle, Halle, Germany|University Hospital Hamburg-Eppendorf, Hamburg, Germany|University Hospital Heidelberg, Heidelberg, Germany|Jena University Hospital, Jena, Germany|University Hospital Schleswig-Holstein, Kiel, Germany|University Hospital Leipzig, Leipzig, Germany|University Hospital Münster, Münster, Germany|Hospital Oldenburg, Oldenburg, Germany|Diakonie Klinikum, Siegen, Germany|University Hospital Würzburg, Würzburg, Germany",,"https://ClinicalTrials.gov/show/NCT02734550"
31,"NCT01269775","Comparison of Face to Face Lecture, Interactive Internet Based and Computer Based Teaching",,"Completed","No Results Available","3rd Year Medical School's Students","Other: Teaching Methods",,"Tehran University of Medical Sciences","All","Child, Adult, Older Adult","Early Phase 1","84","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)","10764","June 2010","July 2010","July 2010","January 4, 2011",,"January 4, 2011","Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of",,"https://ClinicalTrials.gov/show/NCT01269775"
32,"NCT01406106","Effect of Plant Sterols on the Lipid Profile of Patients With Hypercholesterolaemia",,"Unknown status","No Results Available","Hypercholesterolemia","Dietary Supplement: Plant stanol esters","Change in lipid profile|Change in cardiovascular risk|Adherence to the dairy product (liquid yoghurt)|Adverse events|Adherence to the dietary recommendations|Frequency of food intake|Occurrence of cardiovascular events|Weight, height, body mass index (BMI)|Physical activity|Smoking habit|Systolic and diastolic blood pressure (two measurements):|Health problems|Lipid-lowering pharmacological treatment.|Socio-demographic data","Gerencia de Atención Primaria, Albacete|Fundación para la Investigación Sanitaria en Castilla-La Mancha (FISCAM)|Castilla-La Mancha Health Research Foundation.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","182","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","2009/001","January 2010","December 2011","December 2012","July 29, 2011",,"July 29, 2011",,,"https://ClinicalTrials.gov/show/NCT01406106"
33,"NCT03996083","Multicomponent Exercise vs Walking Intervention in Nursing Home Residents","MCvsW","Completed","No Results Available","Aging","Other: Multicomponent exercise intervention|Other: Walking intervention","Short Physical Performance Battery|Senior Fitness Test: strength of the upper extremities|Senior Fitness Test: strength of the lower extremities|Senior Fitness Test: flexibility|Senior Fitness Test: dynamic balance|Senior Fitness Test: aerobic capacity|The Berg Balance Scale|Usual gait speed (4m)|The instrumented Timed Up and Go test|Objectively measured habitual physical activity|Montreal Cognitive Assessment test|Rey Auditory Verbal Learning Test|Anxiety and Depression Goldberg Scale|Quality of Life Alzheimer´s disease scale|de Jong Gierveld loneliness scale|Handgrip strength|Anthropometric measurements: Height|Anthropometric measurements: weight|Anthropometric measurements: perimeters|Frailty Tilburg|Frailty Fried|Falls|Deaths","Basque Country University","All","70 Years and older   (Older Adult)","Not Applicable","81","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","2019","February 1, 2018","April 1, 2019","May 1, 2019","June 24, 2019",,"June 24, 2019","Basque Country, Leioa, Bizkaia, Spain",,"https://ClinicalTrials.gov/show/NCT03996083"
34,"NCT03388918","Future Patient - Telerehabilitation of Heart Failure Patients",,"Unknown status","No Results Available","Heart Failure NYHA Class I|Heart Failure NYHA Class II|Heart Failure NYHA Class III|Heart Failure NYHA Class IV|Acute Decompensated Heart Failure","Device: Telerehabilitation","Increased quality of life|Time from baseline to optimized medical treatment|All cause hospitalization|Steps taken|Development of bloodpressure|Development of pulse|Development of weight|Sleep|Illness perception|Motivation|Anxiety and depression|Health- literacy|eHealth literacy|Experiences of using the Heart portal|Costs of healthcare and rehabilitation services","Aalborg University|Aage og Johanne Louis-Hansens Fond|Viewcare A/S|Laboratory of Welfare Technologies – Telehealth & Telerehabilitation, SMI, Department of Health Science and Technology, Aalborg University|Regionshospitalet Viborg, Skive|Technical University of Denmark|University of Aarhus|Danish Heart Foundation|Viborg Healthcare Center|Skive Healthcare Center|CIMT, Odense University Hospital, Odense|Department of Computer Science, AAU","All","18 Years and older   (Adult, Older Adult)","Not Applicable","140","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","N-20160055","December 21, 2016","July 1, 2019","July 1, 2019","January 3, 2018",,"January 3, 2018","Cardiology Ward, Viborg Hospital, Viborg, Denmark",,"https://ClinicalTrials.gov/show/NCT03388918"
35,"NCT04214210","The DIALOGUE Study: Swiss-Korean Billateral Collaboration","DIALOGUE","Not yet recruiting","No Results Available","Hereditary Cancer|Breast Cancer|Ovarian Cancer","Other: Adapted Family Gene Toolkit|Other: Targeted intervention","Profile of Mood States (POMS)|Change in proportion of informed relatives|Informing Relatives Inventory|Intention to have genetic testing|Reach|Effectiveness|Adoption|Implementation|Maintenance|Acceptability - investigator developed|K-CASCADE|Cancer diagnoses|Cancer surveillance|Breast cancer risk factors and genetics knowledge index|Brief Cope|Decision regret|Decision conflict","University of Basel|Yonsei University|University Hospital, Basel, Switzerland|Hopital du Jura, Delemont, Switzerland|Department of Computer Science Yonsei University, Seoul, Korea|National Cancer Center, Korea|Chungnam National University|Ente Ospedaliero Cantonale, Ticino, Switzerland|Swiss National Science Foundation|University Hospital Inselspital, Berne|University Hospital, Geneva","All","19 Years to 99 Years   (Adult, Older Adult)","Not Applicable","228","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Screening","IZKSZ3_188408 / 1","March 1, 2020","February 28, 2023","October 31, 2023","January 2, 2020",,"January 6, 2020","University Hospital Basel, Basel, Switzerland|Istituto Oncologico della Zvizzera Italiana, Bellinzona, Switzerland|Universitatklinik fur Medizinische Onkologie, Inselspital, Bern, Switzerland|Unite d'Oncogenetique et de Prevention des Cancers, Geneva, Switzerland",,"https://ClinicalTrials.gov/show/NCT04214210"
36,"NCT03359343","Computer-assisted Diagnosis System Based on Linked Colour Imaging",,"Unknown status","No Results Available","Colorectal Polyp|Linked Color Imaging|Computer-aided Diagnosis",,"LCI accuracy|the short learning curve|the correlation","Affiliated Hospital to Academy of Military Medical Sciences","All","16 Years to 80 Years   (Child, Adult, Older Adult)",,"250","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","307-LCI-CAD","October 1, 2017","February 1, 2018","February 1, 2018","December 2, 2017",,"January 12, 2018","Affiliated Hospital to Academy of Military Medical Sciences, Beijing, Beijing, China|Department of Gastroenterology, Affilited Hospital to Academy of Military Medical Sciences, Beijing, China",,"https://ClinicalTrials.gov/show/NCT03359343"
37,"NCT00337974","Computer-Based Training for Cognitive Enhancement: In Home Study",,"Completed","No Results Available","Aging","Other: Computerized Plasticity-Based Adaptive Cognitive Training|Other: Educational DVDs","Evaluation of training effects.|Safety effects of computer-based training.","Posit Science Corporation","All","60 Years and older   (Adult, Older Adult)","Not Applicable","182","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","OUT-106-2005","March 2005","January 2006","January 2006","June 20, 2006",,"November 2, 2015","Posit Science Corporation, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT00337974"
38,"NCT00387062","Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment",,"Completed","No Results Available","Breast Cancer|Cognitive Symptoms|Memory Disorders","Device: Computer-based Cognitive Training","Examination of the quantitative training program progression data|Safety|Quality of life health assessments|Functional outcomes assessments|Perceived stress assessments","Posit Science Corporation","All","21 Years and older   (Adult, Older Adult)","Phase 1","50","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","OUT-113-2005; 06140-01","October 2006","June 2008","June 2008","October 12, 2006",,"June 24, 2008","Posit Science Corporation, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT00387062"
39,"NCT02810366","Physician Versus Computer Coding of Verbal Autopsies",,"Unknown status","No Results Available","Fatal Outcome","Other: Physician versus Computer Coded Verbal Autopsy","Equivalence (CSMF Accuracy) of cause of death distribution between physician versus computer coded verbal autopsies|Equivalence of cause of death assignment at the population (CSMF Accuracy) and individual (sensitivity) levels of physician versus lay surveyor collected verbal autopsies","Centre for Global Health Research, Toronto|International Institute for Population Sciences|Tata Memorial Hospital|HM Patel Center for Medical Care and Education","All","18 Years and older   (Adult, Older Adult)","Not Applicable","12500","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","PCVA vs CCVA","September 2015","September 2016","December 2016","June 23, 2016",,"June 23, 2016","HM Patel Center for Medical Care and Education, Karamsad, Gujarat, India|Tata Memorial Centre, Mumbai, Maharashtra, India|International Institute of Population Sciences, Mumbai, Maharashtra, India",,"https://ClinicalTrials.gov/show/NCT02810366"
40,"NCT00337909","Computer-Based Training for Cognitive Enhancement: Classroom Study",,"Completed","No Results Available","Aging","Other: Computerized Plasticity-Based Adaptive Cognitive Training|Other: Educational DVDs","Evaluation of training program.|Evaluation of training effects.","Posit Science Corporation","All","60 Years and older   (Adult, Older Adult)","Not Applicable","94","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","OUT-107-2005","September 2005","March 2006","March 2006","June 20, 2006",,"November 2, 2015","Posit Science Corporation, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT00337909"
41,"NCT02459873","Modeling and Testing Change in Mental Abilities in Childhood",,"Completed","No Results Available","Low Executive Function in Children","Behavioral: Computer games to assess change in executive function skills","Change in working memory skills assessed through Executive Function Battery and NIH ToolBox|Change in processing speed skills assessed through Executive Function Battery and NIH ToolBox|Change in school grades in science, reading and math.|Change in parent reported behavior as assessed through BRIEF and CBCL questionnaires","University of Southern California","All","84 Months to 132 Months   (Child)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","15-01767","June 2015","August 31, 2016","August 31, 2016","June 2, 2015",,"April 18, 2017","University of Southern California, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT02459873"
42,"NCT02126163","Promoting Responsible Drinking: An Internet-based, Interactive Computer Tailored Intervention",,"Completed","No Results Available","Regular Heavy AOD Use|Excessive Drinking","Behavioral: Treatment Group","Proportion of participants who reach criteria for limiting drinking according to low-risk drinking guidelines|Quantity of alcohol use (number of drinks per week, number of drinks per drinking day)|Frequency of alcohol use (days drinking above recommended limits during the past month, number of drinking days in the past month)|Ratings of alcohol-related problems|Well-being related to productivity","Pro-Change Behavior Systems","All","21 Years and older   (Adult, Older Adult)","Not Applicable","1000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","2R44AA01733-02","April 2014","March 2016","March 2016","April 29, 2014",,"March 24, 2016","Pro-Change Behavior Systems, Inc., South Kingstown, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT02126163"
43,"NCT01891656","Motivational Assessment Program to Initiate Treatment","MAPIT","Completed","No Results Available","Substance-Related Disorders","Behavioral: Motivational Interviewing|Behavioral: Motivational Computer","Treatment Progress|Drug and Alcohol Use|Probation Progress|Criminal Behavior","University of North Texas Health Science Center|National Institute on Drug Abuse (NIDA)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","380","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","R01DA029010-01|5R01DA029010-06","June 2012","June 2015","February 2016","July 3, 2013",,"April 13, 2016","University of North Texas Health Science Center, Fort Worth, Texas, United States|George Mason University, Fairfax, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT01891656"
44,"NCT03391024","Non-Contact Intraoperative Optical Imaging During Instrumentation Procedure",,"Completed","No Results Available","Computer-assisted Surgery","Device: BBL Experimental Navigation System","Pilot hole and screw trajectory accuracy as compared between post-operative CT and intraoperative images","Sunnybrook Health Sciences Centre","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","177-2013","September 24, 2013","August 1, 2015","August 1, 2015","January 5, 2018",,"January 5, 2018","Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03391024"
45,"NCT01781364","Neuroplasticity-oriented Cognitive Intervention in Early Onset and First Admission Schizophrenia",,"Completed","No Results Available","Psychosis","Behavioral: Brain Fitness Training, Posit Science SF","change from baseline at post-training and at 3-months and at 7-months follow-up in each of the following outcome measures: neuropsychological test performance (MCCCB), GAF, PANSS, MEG event-related potentials (M50), alpha activity|change from baseline in GAF score at 3-months and 7-moths follow-up","University of Konstanz","All","17 Years to 37 Years   (Child, Adult)","Not Applicable","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","FP16963311","January 2012","December 2014","December 2014","February 1, 2013",,"December 16, 2014","University Konstanz, Konstanz, Baden Wuerttemberg, Germany",,"https://ClinicalTrials.gov/show/NCT01781364"
46,"NCT01183078","Distal Locking Using an Electromagnetic Field Guided Computer Based Real Time System for Orthopaedic Trauma Patients","Sure Shot","Completed","No Results Available","Tibial Fractures|Femoral Fractures","Procedure: free-hand|Procedure: Wand technique","Reduced operative time.|Reduced C-arm exposure|Reduces inadvertent nail misses.|No complications","Wake Forest University Health Sciences|Smith & Nephew, Inc.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","55","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRB00012034","August 2010","September 2013","September 2013","August 17, 2010",,"August 1, 2018","Wake Forest University Health Sciences - CompRehab, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT01183078"
47,"NCT03391089","Non-contact Intraoperative Optical Imaging During Spinal Procedures",,"Unknown status","No Results Available","Computer-assisted Surgery","Device: BBL Experimental Navigation System","Pilot hole and screw trajectory accuracy as compared between post-operative CT and intraoperative images","Sunnybrook Health Sciences Centre","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","406-2015","January 21, 2016","January 21, 2019","January 21, 2019","January 5, 2018",,"January 5, 2018",,,"https://ClinicalTrials.gov/show/NCT03391089"
48,"NCT03391011","Non-contact Intraoperative Optical Imaging During Neurosurgical Procedures",,"Enrolling by invitation","No Results Available","Computer-assisted Surgery","Device: BBL Experimental Navigation System","Pilot hole and screw trajectory accuracy as compared between post-operative CT and intraoperative images","Sunnybrook Health Sciences Centre","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","086-2015","March 13, 2015","March 13, 2019","March 13, 2019","January 5, 2018",,"September 5, 2018",,,"https://ClinicalTrials.gov/show/NCT03391011"
49,"NCT01773239","Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia","TARA","Completed","No Results Available","Schizophrenia","Behavioral: TARA computer-based exercises","Source Memory Test|Temporal Experience of Pleasure Scale|Quality of Life Scale|Social Functioning Scale|Global Social and Role Functioning Scale|Theories of Intelligence|Faux Pas test|Behavioral Inhibition/Behavioral Activation Scale|Wechsler Test of Adult Reading|Penn Facial Memory Test|Measure of Insight into Cognition|Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT)","Posit Science Corporation|National Institute for Health Research, United Kingdom","All","18 Years to 35 Years   (Adult)","Not Applicable","16","Industry|Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","1R43MH091793-01A1","May 2012","July 2013","July 2013","January 23, 2013",,"September 30, 2016","San Francisco Veterans Affairs Medical Center, San Francisco, California, United States|Langley Porter Psychiatric Institute, UCSF, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT01773239"
50,"NCT03285347","Effect of Computer-based Cognitive Training on Attention and Executive Functions in Patients With Parkinson's Disease",,"Recruiting","No Results Available","Parkinson Disease|Executive Dysfunction","Device: Computer-based cognitive training","SDMT|PDQ-39|HADS|Digit span|Verbal fluency|Stroop colour/word test|Trail Making A and B","Bispebjerg Hospital","All","Child, Adult, Older Adult","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","H-17000220","October 1, 2017","February 29, 2020","June 30, 2020","September 18, 2017",,"June 23, 2020","Bispebjerg Hospital, Copenhagen, Region Hovedstaden, Denmark",,"https://ClinicalTrials.gov/show/NCT03285347"
51,"NCT02529280","Choices for Latinas and Clinical Trials",,"Completed","No Results Available","Breast Cancer","Behavioral: Intervention","Attitudes towards clinical trials|Self-efficacy|Enrollment in a Clinical Trial","The University of Texas Health Science Center at San Antonio","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","77","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","HSC20090165H","February 2012","December 2015","December 2015","August 20, 2015",,"July 21, 2016","Cancer Therapy and Research Center - CTRC, San Antonio, Texas, United States",,"https://ClinicalTrials.gov/show/NCT02529280"
52,"NCT00182585","Computer-Assisted HIV Prevention for Young Drug Users",,"Unknown status","No Results Available","HIV","Procedure: computer-based HIV, STD & Hepatitis Education|Procedure: educator-delivered HIV, STD and Hepatitis education","HIV risk behavior|knowledge related to HIV, Hepatitis, STDs|behavioral intentions|attitudes toward risk-reduction behavior|feedback on intervention","National Development and Research Institutes, Inc.|Daytop (adolescent treament program)|St. Luke's-Roosevelt Hospital Center","All","13 Years to 18 Years   (Child, Adult)","Not Applicable","56","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","R01DA015964","August 2004",,,"September 16, 2005",,"August 13, 2008","Daytop, Brooklyn, New York, United States|St. Luke's-Hospital, CAPA Program, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT00182585"
53,"NCT00526942","Behavioral and Physiological Effects of Visual Training",,"Unknown status","No Results Available","Healthy","Behavioral: SAAGE-designed, visual memory-based cognitive training","Improvement in visual memory assessment after training or no-contact period.|Improvement on at least 1 of the Computerized Visual Attention, Speed and Memory Tests conducted.|Improvement on the computerized cognitive assessments.|Improvement on exercise-based assessments.","Posit Science Corporation|University of San Francisco","All","60 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","54","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","RES-203-2007","August 2007",,"August 2008","September 10, 2007",,"September 11, 2007","Posit Science Corporation, San Francisco Bay Area, California, United States",,"https://ClinicalTrials.gov/show/NCT00526942"
54,"NCT01795157","Computer Based Assessment and Treatment","COMBAT","Completed","No Results Available","Neoplasms|Pain","Device: CCADSS|Device: pen-paper","average and worst pain during the last 24 hours|symptoms","Norwegian University of Science and Technology|St. Olavs Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","255","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","2009/859","September 2009","February 2013","February 2013","February 20, 2013",,"September 25, 2017","Department of Oncology outpatient clinic, St Olavs Hospital, Trondheim, Norway",,"https://ClinicalTrials.gov/show/NCT01795157"
55,"NCT02737696","Computer-based Prescription Opioid Abuse Prevention for Adolescents",,"Completed","No Results Available","Opioid Related Disorders","Behavioral: Web-based prescription opioid prevention for adolescents|Behavioral: JustThinkTwice.gov website (DEA)","Negative attitudes and perceived risk associated with their misuse|Intentions to use prescription opioids|Rates of prescription opioid use.|Knowledge about key issues relevant to prescription opioid abuse among youth|Skill acquisition relevant to preventing misuse of prescription opioids (decision making/refusal skills)","Dartmouth-Hitchcock Medical Center","All","12 Years to 17 Years   (Child)","Not Applicable","431","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","00028283","May 15, 2017","March 18, 2018","September 18, 2018","April 14, 2016",,"September 26, 2018","Center for Technology and Behavioral Health, Lebanon, New Hampshire, United States",,"https://ClinicalTrials.gov/show/NCT02737696"
56,"NCT00505349","Blood Neurotrophic Factors in Adults",,"Withdrawn","No Results Available","Healthy","Behavioral: Computer-based cognitive training","The primary outcome of this study will be the evaluation of blood derived neurotrophic factors in both young adults and in mature adults undergoing cognitive training.|To obtain information on the levels of growth factors in health adults","Posit Science Corporation|University of California, San Francisco|Case Western Reserve University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","0","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","OUT-117-2005","June 2007","June 2009","June 2009","July 23, 2007",,"February 5, 2016","Posit Science Corporation, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT00505349"
57,"NCT01781923","Cognitive Remediation in 22q11DS",,"Completed","No Results Available","22q11.2 Deletion Syndrome|Velo-Cardio-Facial Syndrome","Behavioral: Cognitive remediation program|Behavioral: Small group social skills training","Change in sustained attention|Change in executive function.|Change in verbal memory.|Social skills|Change in brain function and white matter structure.","Duke University|National Institute of Mental Health (NIMH)|Harvard University|University of Pittsburgh","All","11 Years to 17 Years   (Child)","Not Applicable","38","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)","Pro00025985|R34MH091314","October 2010","June 2015","June 2015","February 1, 2013",,"August 10, 2015","Duke University Health Systems, Durham, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT01781923"
58,"NCT01027962","Intensive Computerized Brain Training (ICBT) in Youth With Early Onset Psychosis (EOP)",,"Completed","No Results Available","Psychosis","Other: ICBT Program","Feasibility, Tolerability and Acceptability of Intensive Computerized Brain Training (ICBT) in youth with EOP.","University of North Carolina, Chapel Hill|Foundation of Hope, North Carolina|National Institute of Mental Health (NIMH)","All","10 Years to 19 Years   (Child, Adult)","Not Applicable","35","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","UNC # 09-0637; Maine #3589|R34MH085888-01","October 2009","January 2013","January 2013","December 9, 2009",,"January 15, 2013","University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT01027962"
59,"NCT01550796","Treatment of Chronic Bothersome Tinnitus Using Cognitive Training and D-cycloserine",,"Completed","No Results Available","Tinnitus","Behavioral: Cognitive Training","Change from baseline in Tinnitus Handicap Inventory (THI)|Change in Neurocognitive assessment score","Washington University School of Medicine","All","35 Years to 65 Years   (Adult, Older Adult)","Phase 2","37","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","201110105","January 2012","April 2012","June 2012","March 12, 2012",,"May 23, 2013","Washington University School of Medicine, St. Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT01550796"
60,"NCT02325947","Efficacy of Hand Exoskeleton Controlled by BCI in Post Stroke Patients","iMove","Completed","No Results Available","Poststroke/CVA Paresis","Device: hand exoskeleton, brain-computer interface (BCI),|Device: hand exoskeleton, sham BCI","Change from Baseline in hand paresis level and hand muscle spasticity|Long-term changes from Baseline in hand paresis level and hand muscle spasticity","Russian Academy of Medical Sciences|Pirogov Russian National Research Medical University","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","75","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research","iMove","January 2015","September 2017","September 2017","December 25, 2014",,"September 29, 2017","Research Center of Neurology of RAMS, Moscow, Russian Federation",,"https://ClinicalTrials.gov/show/NCT02325947"
61,"NCT00558233","Effectiveness Study of a Computer-Based Colorectal Cancer Screening Decision Aid","InfoPC","Completed","No Results Available","Colorectal Cancer|Health Literacy","Behavioral: CHOICE decision aid|Behavioral: YourMeds patient education program","Receipt of colorectal cancer screening|Change in participants' readiness to be screened (Stage of Change)|Self-reported intent to discuss colorectal cancer screening with healthcare provider|Provider ordering a colorectal cancer screening test|Participant completion of computer program without assistance|Participant acceptance of computer program|Number of polyps and cancers found by screening tests performed","Wake Forest University Health Sciences|American Cancer Society, Inc.|University of North Carolina, Chapel Hill","All","50 Years to 75 Years   (Adult, Older Adult)","Not Applicable","264","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","CCCDA-05-162-01","November 2007","March 2009","March 2009","November 14, 2007",,"August 9, 2018","Wake Forest University Baptist Medical Center; Downtown Health Plaza, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT00558233"
62,"NCT03482687","It's Your Game: An Innovative Approach to Preventing Teen Dating Violence",,"Completed","No Results Available","Adolescent Behavior|Interpersonal Relationships|Domestic Violence|Physical Violence","Behavioral: Me & You: Building Healthy Relationships","Percent of youth who perpetrated any type of teen dating violence as indicated by the Conflict in Adolescent Dating Relationships Inventory|Percent of youth who were victimized by any type of teen dating violence as indicated by the Conflict in Adolescent Dating Relationships Inventory|Percent of youth who perpetrated psychological teen dating violence as indicated by the Conflict in Adolescent Dating Relationships Inventory|Percent of youth who were victimized by psychological teen dating violence as indicated by the Conflict in Adolescent Dating Relationships Inventory|Percent of youth who perpetrated physical teen dating violence as indicated by the Conflict in Adolescent Dating Relationships Inventory|Percent of youth who were victimized by physical teen dating violence as indicated by the Conflict in Adolescent Dating Relationships Inventory|Percent of youth who perpetrated sexual teen dating violence as indicated by the Conflict in Adolescent Dating Relationships Inventory|Percent of youth who were victimized by sexual teen dating violence as indicated by the Conflict in Adolescent Dating Relationships Inventory|Percent of youth who perpetrated electronic teen dating violence as indicated measures adapted from Picard and Zweig|Percent of youth who were victimized by electronic teen dating violence as indicated measures adapted from Picard and Zweig|Mean score reflecting student norms toward violence for boys and girls as indicated byt the Acceptance of Dating Abuse Survey|Mean score for self-efficacy to resolve conflict as indicated by the Teen Conflict Survey|Percent of youth reported one or more positive coping strategies as indicated by the Kidcope-Child Survey Form|Mean score of constructive and destructive conflict resolution skills as indicated by valid scales developed by Foshee et al.|Mean score for attitudes towards sexting as indicated by a scale developed by Strassberg et al.|Mean score related to a student's belief in the need for help for dating violence victimization as indicated by measures developed by Foshee et al.|Mean score for perceived peer dating violence perpetration (from the perspective of student) - newly developed|Mean score for parental communication about drugs, sex, and relationships as indicated by measures developed by Tharp et al.|Percent of youth who indicated social support from source as indicated by measures adapted from the Social Support Rating Scale|Percent of youth who perpetrated bullying as indicated by measures developed by Wang et al.|Percent of youth who were victimized by bullying as indicated by measures developed from Wang et al.","The University of Texas Health Science Center, Houston","All","11 Years to 14 Years   (Child)","Not Applicable","834","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","HSC-SPH-12-0593","September 2012","May 2015","May 2015","March 29, 2018",,"March 29, 2018","Melissa Fleschler Peskin, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03482687"
63,"NCT04189939","Computational Psychiatric Approach to Depression",,"Active, not recruiting","No Results Available","Depression","Other: clinical assessments","Functional Brain scanning - Neural activation|Sensation Seeking Scale|Perceived Control of Internal States Scale (PCISS)|Montreal Cognitive Assessment|Physical Risk Assessment Inventory|Patient Health Questionnaire-9|Hamilton Depression Inventory","Wake Forest University Health Sciences","All","18 Years to 70 Years   (Adult, Older Adult)",,"96","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IRB00056131","March 9, 2020","July 2021","July 2021","December 6, 2019",,"April 24, 2020","Wake Forest School of Medicine, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT04189939"
64,"NCT00283010","Improvement in Memory With Plasticity-Based Adaptive Cognitive Training (IMPACT)","IMPACT","Completed","No Results Available","Aging","Other: Computerized Plasticity-Based Adaptive Cognitive Training|Other: Educational DVDs","Cognitive effects of training|Safety effects of computer-based training","Posit Science Corporation|Mayo Clinic|University of Southern California","All","65 Years and older   (Older Adult)","Not Applicable","487","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","OUT-105-2005","January 2006","April 2008","April 2008","January 27, 2006",,"November 2, 2015","Posit Science Corporation, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT00283010"
65,"NCT00972634","Computerized Questionnaires in Assessing Symptoms, Pain, Depression, and Physical Function in Patients With Metastatic and/or Advanced Locoregional Cancer",,"Completed","No Results Available","Cachexia|Depression|Pain|Unspecified Adult Solid Tumor, Protocol Specific","Other: computer-assisted intervention|Other: questionnaire administration|Procedure: assessment of therapy complications|Procedure: quality-of-life assessment","Feasibility of applying a computer based system for symptom assessment and classification in palliative cancer care|Differences across groups related to acceptance of computers (i.e., age, culture, stage of disease, cognitive and physical function, etc.)|General user-friendliness of the tool|Performance of selected domains and items for classification and assessment of pain and cachexia|Validity of domains and items for depression","Norwegian University of Science and Technology","All","18 Years and older   (Adult, Older Adult)",,"1051","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","CDR0000648077|NUST-EPCRC-CSA|EU-20962","October 2008","November 2009","December 2009","September 7, 2009",,"January 18, 2017","Norwegian University of Science and Technology, Trondheim, Norway",,"https://ClinicalTrials.gov/show/NCT00972634"
66,"NCT01964664","Mindfulness Meditation for Subjects With Severe Speech and Physical Impairments","MSPi","Completed","No Results Available","Physical Impairments|Cerebral Palsy|Cerebral Ataxia|locked-in Syndrome","Behavioral: Mindfulness Meditation Training|Behavioral: Audio Group","Change from Baseline in Working Memory at 8 weeks (post intervention)|Change from Baseline in Perceived Stress Scale at 8 weeks (post intervention)|Change from Baseline in performance on BCI spelling task at 8 weeks (post intervention)","Oregon Health and Science University","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","8","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","8912","January 2013","October 2016","October 2016","October 17, 2013",,"April 13, 2017","Participant Homes, Portland Metropolitan Area, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT01964664"
67,"NCT00286299","Treatment Effects From Aerobic Endurance Training and Maximal Strength Training in Patients Suffering From Schizophrenia",,"Completed","No Results Available","Schizophrenia|Cardiovascular Disease","Other: Aerobic high-intensity interval training (AIT)|Other: Computer game training (CG)|Other: Maximal strength training","peak aerobic capacity (VO2peak)|Positive and Negative Syndrome Scale (PANSS)|Calgary Depression Scale for Schizophrenia (CDSS)|The 36-item short form (SF-36)|60 Watt walking efficiency, Net efficiency|Maximal strength, measured as one repetition maximum (1RM) in a incline leg press machine (Technogym)|Fasting blood samples, systolic and diastolic blood pressure.","Norwegian University of Science and Technology|St. Olavs Hospital|Central Norway Regional Health Authority","All","20 Years to 65 Years   (Adult, Older Adult)","Not Applicable","33","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","4.2005.1507","October 2005","July 2008","July 2008","February 3, 2006",,"March 29, 2017","St. Olavs Hospital, Department of Psychiatry, Trondheim, Norway",,"https://ClinicalTrials.gov/show/NCT00286299"
68,"NCT00923078","Neurophysiological Targets for Cognitive Training in Schizophrenia",,"Completed","Has Results","Schizophrenia","Behavioral: Auditory Cognitive Training|Behavioral: Visual Cognitive Training","Visual Target Detection (P300 Event-related Potential Amplitude) Change|Auditory Mismatch Negativity (MMN) Amplitude Change|MCCB Cognitive Composite Score Change|Visual Learning (BVMT-R) Change|Verbal Learning (HVLT-R) Change|Visual Working Memory (Spatial Span) Change|Auditory Working Memory (LNS) Change","VA Office of Research and Development","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","60","U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","D7008-W","November 2010","October 2014","October 2014","June 18, 2009","December 20, 2017","December 22, 2017","VA Connecticut Health Care System (West Haven), West Haven, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT00923078"
69,"NCT00589589","Computer Decision Support to Achieve Glycemic Control in the ICU","EndoTool","Completed","No Results Available","Burns|Hypoglycemia","Device: Endo Tool","Time spent in target glucose range of 80-110 mg/dL.|Time to achieve target glucose of 80-110 mg/dL and number of hypoglycemic events less than 80 and 50 mg/dL.","United States Army Institute of Surgical Research","All","18 Years to 80 Years   (Adult, Older Adult)","Phase 1","24","U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","H-07-040","January 2008","September 2010","January 2011","January 9, 2008",,"September 3, 2015","US Army Institute of Surgical Research, Fort Sam Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT00589589"
70,"NCT01280136","Web-Based Middle School HIV Prevention Curricula: Aspiring for Reach and Impact",,"Completed","No Results Available","HIV|Sexually Transmitted Diseases","Behavioral: It's Your Game Tech","sexual initiation|sexual activity in past 3 months|unprotected sexual intercourse|number of sexual partners","The University of Texas Health Science Center, Houston|National Institute of Mental Health (NIMH)","All","12 Years to 16 Years   (Child)","Not Applicable","1700","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","R01MH085594","December 2009","June 2013","June 2013","January 20, 2011",,"June 13, 2014","University of Texas Houston School of Public Health, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT01280136"
71,"NCT00319891","Computer-Based Training for Mild Alzheimer's Disease",,"Completed","No Results Available","Alzheimer's Disease","Procedure: Computer-based Cognitive Training","The primary objective of this trial will be to assess the feasibility of using computer-based|cognitive training in an a population with early Alzheimer's Disease.|A standardized set of neuropsychological assessments will be conducted pre- and post-|compuer-based training.","Posit Science Corporation|University of California, San Francisco","All","60 Years to 90 Years   (Adult, Older Adult)","Phase 1","6","Industry|Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","OUT-109-2005","September 2004","October 2006","October 2006","April 27, 2006",,"May 15, 2013","University of California, San Francisco, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT00319891"
72,"NCT02233946","Computerized Alcohol Screening for Children and Adolescents (cASCA) in Primary Care","cASCA","Completed","No Results Available","Prevention Harmful Effects","Behavioral: computer-facilitated brief intervention","Sensitivity/Specificity of screener to detect frequency of past-12-months drinking and any problematic alcohol use, abuse, or dependence|Number of self-reported days of past-12-months drinking|Any self-reported past-3-months drinking|Any self-reported past-3-months cannabis use","Boston Children’s Hospital|National Institute on Alcohol Abuse and Alcoholism (NIAAA)","All","9 Years to 18 Years   (Child, Adult)","Not Applicable","1457","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","P00004862|1R01AA021904-01","January 2015","May 31, 2018","May 31, 2018","September 9, 2014",,"July 20, 2018","Tufts Medical Center, Boston, Massachusetts, United States|Boston Childrens Primary Care Center, Boston, Massachusetts, United States|Longwood Pediatrics, Boston, Massachusetts, United States|East Boston Neighborhood Health Center, East Boston, Massachusetts, United States|Lexington Pediatrics, Lexington, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02233946"
73,"NCT01640158","Broad-spectrum Cognitive Remediation: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury","BRAVE","Completed","No Results Available","Traumatic Brain Injury","Other: Computerized Plasticity-based Adaptive Cognitive Training|Other: Commercially available computerized training","Change in Cognitive Function|Change in Functional Performance|Change in Mental Health-Related Quality of Life|Change in Physical Health-Related Quality of Life|Change in Depressive Symptoms|Change in PTSD Symptoms|Change in Executive Function Symptoms|Change in Cognitive Symptoms|Change in Neurobehavioral Symptoms|Change in TBI Functional Status|Change in Immediate Verbal Memory|Change in Delayed Verbal Memory|Change in Immediate Visual Memory|Change in Delayed Visual Memory|Change in Short-Term Verbal Memory Span|Change in Short-Term Visual Memory Span|Change in Inhibition of Reflexive Saccade|Change in Response Inhibition|Change in Cognitive Flexibility","Posit Science Corporation|Congressionally Directed Medical Research Programs|Walter Reed National Military Medical Center|Tripler Army Medical Center|VA Connecticut Healthcare System|VA Boston Healthcare System|Michael Debakey Veterans Affairs Medical Center","All","18 Years to 50 Years   (Adult)","Not Applicable","86","Industry|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","BPI-1002-11","September 2013","March 2, 2017","March 2, 2017","July 13, 2012",,"April 16, 2019","Posit Science Corporation, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT01640158"
74,"NCT00694889","Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia",,"Completed","No Results Available","Schizophrenia","Behavioral: Neuroadaptive cognitive training|Behavioral: Computer games","Cognitive Performance, as measured by a neuropsychological battery|Symptom profile, as measured by clinical interviews","University of California, San Francisco|Stanley Medical Research Institute","All","12 Years to 35 Years   (Child, Adult)","Phase 1|Phase 2","144","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Prevention","06TAF-972","August 2007","February 2015","February 2015","June 11, 2008",,"May 16, 2016","University of California, Davis, Sacramento, California, United States|University of California, San Francisco, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT00694889"
75,"NCT00319943","Computer-Based Therapy for Mild Cognitive Impairment",,"Completed","No Results Available","Mild Cognitive Impairment","Procedure: Computer-based training for Mild Cognitive Impairment (MCI)","The study investigates changes in a neuropsychological assessment battery pre-randomization|and upon the completion of training.|Early evaluations will be conducted from brain imaging; specifically, date|obtained via positron emission tomography (PET), magnetoencephalography (MEG),|electroencephalography (EEG), and functional magnetic resonance imaging (fMRI)|studies.","Posit Science Corporation|University of California, San Francisco|University of California, Davis|Stanford University","All","65 Years to 90 Years   (Older Adult)","Phase 1","48","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Treatment","OUT-108-2005","September 2004",,"July 2006","April 27, 2006",,"April 27, 2006","University of California, San Francisco, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT00319943"
76,"NCT03730792","Success & Health Impacts For Transit Drivers During Onboarding","SHIFTOnboard","Recruiting","No Results Available","Obesity","Behavioral: SHIFT Onboard Intervention","Change from baseline in body weight at 12 and 24 months|Body Mass Index|Change from baseline in percent body fat|Change from baseline in self-reported fruit and vegetable intake at 12 and 24 months|Change from baseline in self-reported consumption of high fat foods at 12 and 24 months.|Change from baseline in self-reported sugary food and drink consumption at 12 and 24 months|Change from baseline in self-reported fast food consumption.|Change from baseline in self-reported physical activity at 12 and 24 months|Change from baseline in actigraphically measured physical activity at 12 and 24 months|Change from baseline in self-reported sleep quality at 12 and 24 months|Change from baseline in self-reported sleep quantity at 12 and 24 months|Change from baseline in actigraphically measured sleep quality at 12 and 24 months|Change from baseline in actigraphically measured sleep quantity at 12 and 24 months|Changes in job role conflict|Changes in perceived acceptance by others|Changes in job-related self-efficacy|Changes in job satisfaction|Changes in intention to remain at job|Economic cost-benefit factors|Absenteeism|Job turnover|Bus collisions|Injuries","Oregon Health and Science University|National Heart, Lung, and Blood Institute (NHLBI)","All","21 Years and older   (Adult, Older Adult)","Not Applicable","284","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","3061|2R01HL105495-06A1","July 15, 2019","January 31, 2023","January 31, 2023","November 5, 2018",,"February 6, 2020","Oregon Health & Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT03730792"
77,"NCT01612949","Facial Analysis to Classify Difficult Intubation",,"Recruiting","No Results Available","Difficult Intubation","Other: photographing head and neck","Computer algorithm to predict difficulty of endotracheal intubation","Wake Forest University Health Sciences","All","18 Years to 99 Years   (Adult, Older Adult)",,"3500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IRB00036442","May 2012","December 2021","December 2021","June 6, 2012",,"June 2, 2020","Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT01612949"
78,"NCT01781000","Cerebral Reorganization in Schizophrenia",,"Completed","No Results Available","Schizophrenia","Behavioral: Brain Fitness & Brain Training- Posit Science|Behavioral: Facial Affect Training- FAT|Behavioral: Treatment as usual","change from baseline at post-intervention (4-weeks) and 3-months in each to the primary outcome measures: neuropsychological test scores (MCCB), MEG alpha oscillations|change from baseline in global functioning (GAF score) at 4 weeks and 3 months","University of Konstanz","All","18 Years to 60 Years   (Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","RO805/142","December 2011","April 2014","April 2014","January 31, 2013",,"November 4, 2014","University of Konstanz, Konstanz, Baden Württemberg, Germany",,"https://ClinicalTrials.gov/show/NCT01781000"
79,"NCT01303575","Internet-Based Sexual Health Education for Middle School Native American Youth","IYG-AI/AN","Completed","No Results Available","Sexually Transmitted Diseases|Pregnancy|HIV Infections","Behavioral: HIV, STI and Pregnancy Prevention Curriculum|Behavioral: Control Curricula","Delay onset of sexual activity|Reduce alcohol/drug use|Reduce instances of sexual activity|Decrease the number of sexual partners|Condom use during sexual activity|Contraceptive use while sexually active|Prevalence of sexually transmitted infections|Increase sexual knowledge|Changes in sexual beliefs|Changes in attitudes toward sexual activity|Changes in perception of sexual beliefs among peers|Increased self-efficacy for refusal skills|Increased self-efficacy for condom use|Increased avoidance of risky situations|Changes in perceived norms about sexual activity|Changes in reasons for or against having sex|Changes in intentions to have/abstain from sex","The University of Texas Health Science Center, Houston|Alaska Native Tribal Health Consortium|Inter Tribal Council of Arizona|Northwest Portland Area Indian Health Board","All","12 Years to 14 Years   (Child)","Not Applicable","574","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","5U48DP001949","September 2010","January 2015","January 2015","February 24, 2011",,"June 23, 2015","Alaska Native Tribal Health Consortium, Anchorage, Alaska, United States|Inter Tribal Council of Arizona, Inc., Phoenix, Arizona, United States|Northwest Portland Area Indian Health Board, Portland, Oregon, United States|University of Texas Health Science Center, Houston, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT01303575"
80,"NCT00782444","Computer Navigation vs Conventional Technique in Knee Arthroplasty","CAOS","Active, not recruiting","No Results Available","Knee Osteoarthritis|Rheumatoid Arthritis","Procedure: Computer navigated knee replacement|Procedure: Conventional knee replacement","longevity of the implant|Function of the knee|Bleeding|complications","Haukeland University Hospital|The Research Council of Norway","All","50 Years to 85 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","2007/12587","January 2009","December 2020","December 2020","October 31, 2008",,"April 7, 2020","Haukeland university hospital, Bergen, Norway|Haugesund hospital, Haugesund, Norway|Haugesund sanitetsforenings revmatismesykehus, Haugesund, Norway|Lovisenberg diakonale sykehus, Oslo, Norway",,"https://ClinicalTrials.gov/show/NCT00782444"
81,"NCT00549406","Visual Training Program to Improve Balance and Prevent Falls in Older Adults",,"Completed","No Results Available","Accidental Falls|Musculoskeletal Equilibrium","Procedure: computerized visual training|Procedure: computerized word puzzles|Procedure: video-game based visual training","ability to use peripheral vision to recover balance by grasping a handhold|natural gaze and balance-recovery behavior (in responding to a sudden unpredictable balance perturbation while walking in an unfamiliar environment); clinical balance measures; visual-processing measures","Sunnybrook Health Sciences Centre|Ontario Neurotrauma Foundation|Canadian Institutes of Health Research (CIHR)","All","64 Years to 80 Years   (Adult, Older Adult)","Phase 1","33","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","2007-PREV-INT-452|CIHR grant# MOP-13355","June 2008","July 2011","February 2012","October 25, 2007",,"December 23, 2014","Centre for Studies in Aging, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT00549406"
82,"NCT02058966","Pilot Study of Entacapone for Methamphetamine Abuse",,"Completed","Has Results","Methamphetamine Dependence","Drug: Entacapone|Drug: Methamphetamine|Drug: Placebo","Effect of Entacapone on Methamphetamine-induced Mood|Effect of Entacapone on Subjective Effects of Methamphetamine|Effect of Entacapone on Methamphetamine-induced Stimulation|Cognitive Function","Oregon Health and Science University|Portland VA Medical Center","All","18 Years to 45 Years   (Adult)","Early Phase 1","29","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research","8874|1004805|3986","June 2014","June 2016","June 2016","February 11, 2014","September 12, 2019","September 12, 2019","Oregon Health & Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT02058966"
83,"NCT02444715","Computer-Aided Prevention System","CAPSYS","Completed","Has Results","Cerebrovascular Diseases|Stroke|Cardiovascular Diseases|CVD Risk Factors","Behavioral: Standard care|Behavioral: CAPSYS","Change in Systolic Blood Pressure|Change in HDL Level|Change in LDL Level|Change in Triglyceride Level|Change in HbA1c Level|Change in Glycaemia Level|Change in BMI Value|Change in Fruits and Vegetables Consumption|Change in Whole Grain Food Consumption|Change in Sweets Consumption|Change in Duration of Physical Activity|Change in Quality of Life","Lübomira Spassova|Centre Hospitalier du Luxembourg|Luxembourg Institute of Science and Technology","All","20 Years and older   (Adult, Older Adult)","Not Applicable","94","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","CAPSYS-201205/08-1","January 2013","August 2014","August 2014","May 14, 2015","August 24, 2015","February 18, 2016",,,"https://ClinicalTrials.gov/show/NCT02444715"
84,"NCT04048083","Computer-aided and Mental Trainings Induced Plasticity of Sensorimotor Cortex in Patients Born Without Upper Limbs",,"Recruiting","No Results Available","Amelia of Upper Limb","Behavioral: Mental trainings|Behavioral: Computer-aided trainings|Behavioral: Computer-aided and mental trainings|Other: No trainings","Magnetic Resonance Imaging (MRI)|Functional Magnetic Resonance Imaging (fMRI)|Transcranial magnetic stimulation (TMS)|Electroencephalography (EEG)|Near-infrared spectroscopy (NIRS)|Electromyography (EMG)|Mechanomyography (MMG)|Temperature measurements (Temp)","University School of Physical Education in Wroclaw|Wrocław University of Science and Technology|Kessler Foundation|Nencki Institute of Experimental Biology, Warsaw, Poland|Hospital of St. Hedwig in Trzebnica","All","18 Years to 25 Years   (Adult)","Not Applicable","18","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science","DEC-2011/03/B/NZ7/00588","March 11, 2014","September 9, 2016","December 2019","August 7, 2019",,"August 7, 2019","University School of Physical Education in Wroclaw, Wroclaw, Lower Silesia, Poland",,"https://ClinicalTrials.gov/show/NCT04048083"
85,"NCT04421365","Brain-Computer Interface in Laryngeal Dystonia",,"Not yet recruiting","No Results Available","Laryngeal Dystonia","Device: neurofeedback brain-computer interface (BCI)","Changes in voice symptoms","Massachusetts Eye and Ear Infirmary","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","2019P001547","April 2021","March 2026","March 2026","June 9, 2020",,"June 9, 2020","Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04421365"
86,"NCT02119364","Working Memory Training for Children With Cerebral Palsy",,"Unknown status","No Results Available","Cerebral Palsy","Other: Working memory training","Spatial span|Verbal working memory","Sorlandet Hospital HF|Helse Sor-Ost","All","7 Years to 15 Years   (Child)","Not Applicable","115","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","2012/2/00 14","October 2013","December 2016","December 2016","April 21, 2014",,"April 21, 2014","Sorlandet Hospital, Arendal, Aust-Agder, Norway",,"https://ClinicalTrials.gov/show/NCT02119364"
87,"NCT03232996","Evaluation of a Computer Game Based Rehabilitation System for Assessment and Treatment of Balance and Gait Impairments in Individuals With Parkinson's Disease.",,"Completed","No Results Available","Parkinson Disease|Parkinson","Other: Computer game based balance and walking rehabilitation for individuals with Parkinson's Disease","Dynamic Standing Balance|Gait Assessment|Unified Parkinson Disease Rating Scale (UPDRS)","University of Manitoba","All","55 Years to 70 Years   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","H2017:225","November 1, 2017","April 30, 2019","August 1, 2019","July 28, 2017",,"March 25, 2020","College of Rehabilitation Sciences, University of Manitoba, Winnipeg, Manitoba, Canada",,"https://ClinicalTrials.gov/show/NCT03232996"
88,"NCT02284022","Clinical Validation Protocol for BCI for the Communication of Patients Suffering From Neuromuscular Disorders.","PVCAFM","Completed","No Results Available","Communication|Neuromuscular Disease","Device: Brain computer interface","Bit rate (BR) the amount fo information that flows from the patient to the computer during the spelling session. This criterion is a combination of the number of symbols selected, the accuracy, and the time.|patient satisfaction (visual analogic scale)","Centre d'Investigation Clinique et Technologique 805|Association Française contre les Myopathies (AFM), Paris","All","18 Years and older   (Adult, Older Adult)",,"15","Other","Observational","Observational Model: Ecologic or Community|Time Perspective: Prospective","14055","October 2014","February 2017","February 2017","November 5, 2014",,"April 20, 2017","Hôpital R. Poincaré, Garches, France",,"https://ClinicalTrials.gov/show/NCT02284022"
89,"NCT01002131","Exact Localisation of Impacted and Supernumerary Teeth by Cone Beam Computer Tomography",,"Completed","No Results Available","Impacted Teeth","Device: CBCT","exact localisation of impacted teeth","Norwegian University of Science and Technology|St. Olavs Hospital","All","Child, Adult, Older Adult",,"61","Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","19236","May 2007","April 2009","September 2009","October 27, 2009",,"February 28, 2017","St Olavs Hospital, Trondheim, Norway",,"https://ClinicalTrials.gov/show/NCT01002131"
90,"NCT02861703","Pilot Feasibility Study of an Online Lifestyle Intervention for Overweight Breast Cancer Survivors",,"Completed","No Results Available","Obesity","Behavioral: Online lifestyle intervention","Change in Body Mass Index|Change in Waist Circumference|Change in Quality of Life|Change in Subjective Health|Change in Life Satisfaction|Change in Symptoms of Anxiety and Depression|Change in Body Image|Change in Objectified Body Consciousness|Change in Dietary Intake|Change in 'Intuitive Eating' Habits|Change in Exercise Habits|Change in Self-Efficacy","Sunnybrook Health Sciences Centre|Canadian Breast Cancer Foundation","Female","21 Years and older   (Adult, Older Adult)","Not Applicable","15","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CBCF-092014","July 2015","July 2018","July 2018","August 10, 2016",,"December 21, 2018","Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02861703"
91,"NCT01422902","Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults","e-CAeSAR","Completed","No Results Available","Schizophrenia","Other: Plasticity-based Cognitive Training|Other: Non-plasticity-based Training","Evaluation of the effects of plasticity-based, adaptive cognitive remediation on cognitive abilities, functional status and quality of life.|Demonstration of equivalency in safety effects reported between treatment groups.","Posit Science Corporation|National Institute of Mental Health (NIMH)","All","18 Years and older   (Adult, Older Adult)","Phase 2","150","Industry|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","BPI-1001-11|IRC2MH909833-01","April 2012","March 2015","June 2015","August 25, 2011",,"February 8, 2016","Palo Alto Veteran's Affairs Medical Center, Palo Alto, California, United States|Posit Science Corporation, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT01422902"
92,"NCT02105571","Evaluation of Safety and Health Involvement For Truck Drivers","SHIFT","Completed","No Results Available","Obesity","Behavioral: Intervention","Change from baseline in body weight at 6 and 18 months|Change from baseline in dietary behaviors at 6 and 18 months|Change from baseline in physical activity at 6 and 18 months|Change from baseline in blood pressure at 6 and 18 months|Change from baseline in percent body fat at 6 and 18 months|Change from baseline in blood lipids and lipoproteins at 6 and 18 months|Change from baseline in blood glucose at 6 and 18 months|Change from baseline in sleep and fatigue at 6 and 18 months|Change from baseline in anthropometric measurements at 6 and 18 months|Change from baseline in stress at 6 and 18 months|Change from baseline in social support at 6 and 18 months|Change from baseline in self-efficacy at 6 and 18 months|Change from baseline in strength and fitness at 6 and 18 months|Change from baseline in safety outcomes (injuries, crashes, moving violations) at 6 and 18 months|Change from baseline in driving measures (sudden decelerations, driving over the speed limit, fuel efficiency, safety belt use) at 6 and 18 months","Oregon Health and Science University|National Heart, Lung, and Blood Institute (NHLBI)","All","21 Years and older   (Adult, Older Adult)","Not Applicable","472","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","e3061|R01HL105495","April 2011","April 2015","March 2017","April 7, 2014",,"May 16, 2018","Oregon Health and Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT02105571"
93,"NCT03647865","Evaluation of The Accuracy of CAD-CAM Custom Made Titanium Miniplates In Positioning of the Genial Segment in Computer Guided Genioplasty",,"Recruiting","No Results Available","Macrogenia|Microgenia|Miniplate","Procedure: Osseous Genioplasty","Accuracy Of the Custom Made Miniplate|Patient Satisfaction (Esthetics)","Cairo University","All","18 Years to 60 Years   (Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2018","September 2018","September 2019","October 2019","August 27, 2018",,"September 18, 2018","Cairo University, Cairo, Manial, Egypt",,"https://ClinicalTrials.gov/show/NCT03647865"
94,"NCT03080857","Computer Simulated Atrial Fibrillation Tool",,"Recruiting","No Results Available","Atrial Fibrillation","Other: Virtual Platform","Feasibility of using the simulated AF clinic platform|Patient satisfaction","Nova Scotia Health Authority|Cardiac Arrhythmia Network of Canada","All","18 Years and older   (Adult, Older Adult)","Not Applicable","75","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","RP-003","May 15, 2018","December 31, 2019","May 31, 2020","March 15, 2017",,"March 23, 2020","QE II Health Sciences Centre, Halifax, Nova Scotia, Canada",,"https://ClinicalTrials.gov/show/NCT03080857"
95,"NCT01584882","Computer-Assisted Tobacco Interventions in Dental Offices","CATI","Completed","No Results Available","Smoking","Behavioral: CATI Tool","Patient report","HealthPartners Institute","All","18 Years and older   (Adult, Older Adult)","Not Applicable","548","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","09-062","October 2009","April 2011","July 2012","April 25, 2012",,"July 17, 2014","HealthPartners Research Foundation, Bloomington, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT01584882"
96,"NCT01866813","Internet-Delivered Cognitive Training For Breast Cancer Survivors With Cognitive Complaints",,"Completed","No Results Available","Breast Cancer","Behavioral: Cognitive training intervention group","Paced auditory serial addition test|Cognitive failures questionnaire|cognitive failures questionnaire","University of Aarhus","Female","40 Years and older   (Adult, Older Adult)","Not Applicable","160","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","1-10-72-52-1|1-10-72-52-13","May 2013","January 2015","January 2015","May 31, 2013",,"January 12, 2015","Unit for Psychooncology and Health Psychology Dept. of Oncology, Aarhus University Hospital and Dept of Psychology, Aarhus University, Aarhus, AAarhus, Denmark",,"https://ClinicalTrials.gov/show/NCT01866813"
97,"NCT02728011","Pilot Trial Comparing Computerised Cognitive Exercises to Tetris in Adolescents With ADHD",,"Completed","No Results Available","Attention Deficit/Hyperactivity Disorder","Other: Scientific Brain Training (SBT)|Other: Tetris","Activity Perception Questionnaire|Attention Deficit/Hyperactivity Disorder-Rating Scale|Cambridge Neuropsychological Test Automated Battery (CANTAB) Rapid Visual Information Processing (RVP)(A)|CANTAB: Stockings of Cambridge (SOC) (problems solved in minimum moves)|CANTAB: DMS Delayed Matching to Sample (DMS)","Region Syddanmark|Region of Southern Denmark","All","14 Years to 17 Years   (Child)","Not Applicable","18","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","7/6/2010","October 2010","December 2010","December 2011","April 5, 2016",,"April 5, 2016","Child and Adolescent Mental Health Services Aabenraa, Aabenraa, Denmark|Child and Adolescent Mental Health Services Augustenborg, Augustenborg, Denmark",,"https://ClinicalTrials.gov/show/NCT02728011"
98,"NCT04229056","COMPuter-assisted Self-training to Improve EXecutive Function","COMPEX","Recruiting","No Results Available","Parkinson Disease|Stroke|Cardiac Arrest|Cognitive Dysfunction|Executive Dysfunction","Behavioral: Computer-based cognitive rehabilitation (CBCR)|Behavioral: General computer-based cognitive stimulation","CABPad Working Memory Test|MDS-HC-IADL|CABPad Working Memory Test - 3 months follow-up after end of intervention|Trail Making A|Trail Making B|SDMT|Fonological verbal fluency test|Categorical verbal fluency test|Fear questionnaire|mrs: Modified Rankin Scale|IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)|EuroQol-5 domain (EQ-5D-5L)|PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinson Disease)|PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinsons Disease)|Compliance|PHQ-9 (Patient health questionnaire 9)|2) visual analogue scale (1-10)","Bispebjerg Hospital|Rigshospitalet, Denmark|University of Cambridge|University of Basel","All","18 Years to 100 Years   (Adult, Older Adult)","Not Applicable","600","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","H-19039236","June 1, 2020","June 28, 2024","December 31, 2024","January 14, 2020",,"July 8, 2020","Bispebjerg Hospital, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark",,"https://ClinicalTrials.gov/show/NCT04229056"
99,"NCT02892760","Clinical Algorithm for Post-Stroke Gait Training With C-Brace",,"Active, not recruiting","No Results Available","Hemiparesis Due to Stroke|Hemiplegia Due to Stroke","Device: C-Brace","Change in gait as assessed by kinematic analysis|Change in muscle function as assessed by surface electromyography (sEMG)|Change in metabolic expenditure during walking|Change in score on the Timed Up and Go Test|Change in mental state as assessed by the Folstein Mini Mental State Examination (MMSE)|Change in hip flexors strength as assessed by dynamometry|Change in hip extensors strength as assessed by dynamometry|Change in hip abductors strength as assessed by dynamometry|Change in hip adductors strength as assessed by dynamometry|Change in knee flexors strength as assessed by dynamometry|Change in knee extensors strength as assessed by dynamometry|Change in ankle dorsiflexors strength as assessed by dynamometry|Change in ankle plantarflexors. strength as assessed by dynamometry|Change in bilateral hip range of motion as assessed by goniometry|Change in knee joints range of motion as assessed by goniometry|Change in ankle joints range of motion as assessed by goniometry|Change in motor impairment as determined by the Fugl-Meyer Assessment|Change in spasticity as assessed by the Modified Ashworth Scale (MAS)|Change in static balance as assessed by the Berg Balance Scale (BBS)|Change in gait speed as assessed by the 10 Meter Walk Test (10MWT)|Change in aerobic capacity as assessed by the Six-minute walk test (6MWT)","The University of Texas Health Science Center, Houston|Otto Bock Healthcare Products GmbH","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","14","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","HSC-MS-16-0031","February 13, 2017","January 8, 2019","December 31, 2019","September 8, 2016",,"April 17, 2019","TIRR Research Center, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT02892760"
100,"NCT00929253","Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)","CAT","Completed","No Results Available","Opiate Addiction","Drug: Suboxone|Behavioral: CRA|Behavioral: Therapy|Behavioral: CM","Abstinence defined as the longest documented period of continuous abstinence from opioids and cocaine for each participant|Delay discounting measures and other non-normal or ordinal outcomes measures will be compared across treatment groups based on nonparametric rank tests.","Virginia Polytechnic Institute and State University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","206","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRB 31695","September 2007","April 2010","April 2010","June 29, 2009",,"May 2, 2016","University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States",,"https://ClinicalTrials.gov/show/NCT00929253"
101,"NCT01875328","Stroke Therapy, Education, Prevention: Telemedicine Outpatient Initiative Trial","STEP TO IT","Completed","No Results Available","Stroke","Other: Telemedicine|Other: Clinic","Outpatient stroke follow-up after discharge using telemedicine in the home is feasible as assessed by visit and intervention adherence for patients living outside a 75 mile radius from OHSU.|Patients being followed in the telemedicine group will achieve rates of goal blood pressure similar to those being followed in clinic.","Oregon Health and Science University","All","21 Years and older   (Adult, Older Adult)","Not Applicable","64","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","9011","November 2012","September 2013","September 2016","June 11, 2013",,"October 17, 2019","Oregon Health and Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT01875328"
102,"NCT04055129","Hormone Induced Effects on Ligament Laxity and Lower Extremity Motor Control",,"Not yet recruiting","No Results Available","Hormone Influence on Ligament Laxity and Motor Control","Other: No interventions","Muscle activity for the following muscles: Quadriceps (vastus medialis and vastus lateralis), Hamstrings (semitendinosus, biceps femoris), gluteus maximus, gluteus medius, lateral gastrocnemius|Ground Reaction Force|Knee valgus, femoral internal rotation angle, knee flexion and extension angles|Laxity of ACL/ anterior tibial excursion","University of St. Augustine for Health Sciences","Female","18 Years to 35 Years   (Adult)",,"52","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","0430-018","August 2020","December 2021","December 2021","August 13, 2019",,"March 27, 2020",,,"https://ClinicalTrials.gov/show/NCT04055129"
103,"NCT00312962","Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With Schizophrenia","CRIS","Completed","No Results Available","Schizophrenia","Behavioral: Targeted cognitive training (TCT)|Behavioral: Computer games","Cognitive performance as measured by a neuropsychological battery|Symptom profile as measured by clinical interviews|Quality of life as measured by clinical interviews","University of California, San Francisco|National Institute of Mental Health (NIMH)","All","18 Years to 60 Years   (Adult)","Phase 1|Phase 2","80","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","R01MH068725|DATR A2-AISZ","April 2004","March 2012","March 2013","April 11, 2006",,"March 11, 2014","San Francisco Department of Veterans Affairs Medical Center, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT00312962"
104,"NCT02707029","Clinical and Scientific Assessment of Pain and Painful Disorders",,"Recruiting","No Results Available","Normal Physiology|Pain",,"To enable for the deep, broad, and targeted phenotyping of individuals, in particular those with rare and unusual pain disorders.|To facilitate obtaining information relevant to determining potential eligibility in IRB-approved NIH protocols, in particular those of the Clinical Investigations Branch of NCCIH.","National Center for Complementary and Integrative Health (NCCIH)|National Institutes of Health Clinical Center (CC)","All","12 Years and older   (Child, Adult, Older Adult)",,"10000","NIH","Observational","Observational Model: Cohort|Time Perspective: Prospective","160077|16-AT-0077","July 22, 2016","February 9, 2026","February 9, 2026","March 14, 2016",,"June 24, 2020","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT02707029"
105,"NCT01291485","Electronic Intervention for HIV Medication Adherence",,"Completed","No Results Available","HIV","Behavioral: Life Steps for Medication Adherence","HIV medication adherence|HIV Treatment Adherence Self-Efficacy|Quality of Life|Viral Load|CD4 cell count","Oklahoma State University Center for Health Sciences","All","18 Years and older   (Adult, Older Adult)","Not Applicable","97","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","2010022","January 2011","September 2011","November 2011","February 8, 2011",,"October 10, 2012","Internal Medicine Specialty Services, Tulsa, Oklahoma, United States",,"https://ClinicalTrials.gov/show/NCT01291485"
106,"NCT00188032","Strategies for Suspected Pulmonary Embolism in Emergency Departments",,"Completed","No Results Available","Quality of Health Care|Pulmonary Embolism","Procedure: Computer-Assisted diagnostic Decision Support|Procedure: written diagnostic guidelines|Procedure: electronic therapeutic reminders","rate of agreement between the diagnostic criteria applied in daily practice and those validated in the scientific literature|-(diagnostic intervention) Rate of strategies considered as validated or acceptable according to the opinion of international advisors.|- (diagnostic intervention) Rate of thromboembolic-events during a 3-month follow-up period in patients for whom pulmonary embolism will be ruled out|- (diagnostic intervention) Costs of the diagnostic management|- (therapeutic reminders) Delay between Emergency Department admission and the first dose of antithrombotic treatment in patients with high clinical probability of PE according to the Revised Geneva Score|- (therapeutic reminders)Rate of inappropriate treatment according to international recommendations for patients with confirmed PE.","University Hospital, Angers|Ministry of Health, France","All","Child, Adult, Older Adult","Not Applicable","1331","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)","PHRC-04-01","June 2005",,"September 2006","September 16, 2005",,"February 5, 2009","H Argenteuil, Argenteuil, France|UH Besançon, Besançon, France|H Bethune, Bethune, France|UH Ambroise Pare, Boulogne Billancourt, France|UH Caen, Caen, France|H Chalons en Champagne, Chalons-en-Champagne, France|H Chateauroux, Chateauroux, France|H Compiegne, Compiegne, France|UH Dijon, Dijon, France|H Dreux, Dreux, France|UH Grenoble, Grenoble, France|H Langres, Langres, France|H le Mans, Le Mans, France|H Lons le Saunier, Lons le Saunier, France|UH Nancy, Nancy, France|UH La Pitie Salpetriere, Paris, France|H Roanne, Roanne, France|H Saint Nazaire, Saint Nazaire, France|H Thouars, Thouars, France|UH Toulouse, Toulouse, France",,"https://ClinicalTrials.gov/show/NCT00188032"
107,"NCT00375856","Computer-Assisted Total Knee Replacement Kinematics: DePuy Sigma Posterior Cruciate Substituting Knee and the DePuy Sigma RP Rotating Platform Knee",,"Completed","No Results Available","Osteoarthritis, Knee","Device: DePuy P.F.C.® Sigma Rotating Platform Knee","Gait and radiographic parameters|Knee pain, function","Queen's University|DePuy Orthopaedics","All","45 Years to 75 Years   (Adult, Older Adult)","Phase 4","91","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","DepuyRP06","October 2006","December 2012","December 2012","September 13, 2006",,"September 27, 2016","University of Manitoba, Winnipeg, Manitoba, Canada|Kingston General Hospital, Kingston, Ontario, Canada|London Health Sciences Center, London, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT00375856"
108,"NCT02080585","Effectiveness of a Web-based, Computer-tailored, Pedometer-based Physical Activity Intervention for Adults: a Cluster-randomized Controlled Trial",,"Completed","No Results Available","Inactivity","Behavioral: Physical Activity advice.","Amount of physical activity at baseline.|Amount of Physical activity 1 month after baseline.|Amount of physical activity 3 months after baseline.|Sedentary behaviour at baseline.|Sedentary behaviour 1 month after baseline.|Sedentary behaviour 3 months after baseline.","University Ghent|Research Foundation Flanders","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","274","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","2005/027","May 2012","February 2013","June 2013","March 6, 2014",,"March 6, 2014","Ghent University - Department of Movement and Sports Sciences, Ghent, Belgium",,"https://ClinicalTrials.gov/show/NCT02080585"
109,"NCT02775396","Effects of Wearing Progressive Addition Lens on Working Distance and Refractive Status in Adult Computer Users",,"Completed","No Results Available","Video Game Play Using Handheld Computer","Device: Spectacle lens","Change in near working distance measured by an automatic ultrasound sensor|Change in refractive status measured by an automatic refractometer","The Hong Kong Polytechnic University|Carl Zeiss","All","18 Years to 40 Years   (Adult)","Not Applicable","64","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","P14-0085","September 2014","March 2015","April 2015","May 17, 2016",,"May 17, 2016",,,"https://ClinicalTrials.gov/show/NCT02775396"
110,"NCT00906789","Testing of Computer Aided Detection Software for Riverain Medical Group",,"Completed","Has Results","Lung Cancer","Behavioral: Software","Improvement in Cancer Detection as Measured by Localized Receiver Operating Characteristic) LROC Changes Under the LROC Curve.|Sensitivity and Specificity Using SoftView Software","Georgetown University|Riverain Technologies","All","Child, Adult, Older Adult",,"15","Other|Industry","Observational",,"Riverain SV 2.0.1 and OG5.0|Softview 2.0.1|OnGuard 5.0","May 2009","June 2010","June 2010","May 21, 2009","September 1, 2014","September 1, 2014","ISIS Imaging Science Research Center, Georgetown University, Washington, District of Columbia, United States",,"https://ClinicalTrials.gov/show/NCT00906789"
111,"NCT04380649","Development and Test of a Headset for BCI Until Obtaining an Efficient and Comfortable System That Can be Used in Daily Practice by ALS People","TECH-ICOPA","Not yet recruiting","No Results Available","Amyotrophic Lateral Sclerosis|Motor Neuron Disease|Spinal Cord Diseases|Alternative Communication Devices|Neurodegenerative Diseases|Nervous System Diseases|Neuromuscular Diseases","Device: New headset prototype","prototype set-up time|Quality of the impedance of each electrode|Number of errors during calibration|Patient/caregiver satisfaction","Centre Hospitalier Universitaire de Nice","All","18 Years and older   (Adult, Older Adult)","Not Applicable","5","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","19-PP-18","July 2020","December 2020","June 2021","May 8, 2020",,"July 2, 2020",,,"https://ClinicalTrials.gov/show/NCT04380649"
112,"NCT00930150","Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network",,"Completed","No Results Available","Schizophrenia","Behavioral: Targeted cognitive training|Behavioral: Computer control|Behavioral: Bridging groups|Behavioral: Health and wellness groups","Feasibility of a multisite trial using cognitive remediation|Effect of cognitive remediation on functional outcomes, including change from baseline on UCSD Performance Based Skills Assessment (UPSA) total score, Specific Levels of Functioning (SLOF) total score, and Cognitive Assessment Interview (CAI) total score","National Institute of Mental Health (NIMH)","All","18 Years to 55 Years   (Adult)","Phase 4","52","NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","N01 MH090001-07|N01-MH090001-07|PCC: DSIR AT","July 2009","February 2010","February 2010","June 30, 2009",,"April 19, 2011","Yale University/Connecticut Mental Health Center, New Haven, Connecticut, United States|Emory University, Atlanta, Georgia, United States|Medical College of Georgia, Augusta, Georgia, United States|University of Iowa Hospital, Iowa City, Iowa, United States|University of Massachusetts, Worcester, Massachusetts, United States|University of Minnesota School of Medicine, Minneapolis, Minnesota, United States|The University of North Carolina, Chapel Hill, North Carolina, United States|Philadelphia VA Medical Center-116A, Philadelphia, Pennsylvania, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States",,"https://ClinicalTrials.gov/show/NCT00930150"
113,"NCT04404348","Cognitive Rehabilitation for Opioid Abuse-related Cognitive Impairment",,"Suspended","No Results Available","Substance-Related Disorders","Behavioral: Cognitive Training|Behavioral: Placebo Control","Mean Cognitive Change from Baseline to Endpoint|Substance Abuse Program Completion Rate","Oklahoma State University Center for Health Sciences","All","18 Years to 64 Years   (Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","2018043","March 6, 2020","July 2020","July 2020","May 27, 2020",,"May 27, 2020","12&12, Inc, Tulsa, Oklahoma, United States",,"https://ClinicalTrials.gov/show/NCT04404348"
114,"NCT02621671","Communicating Multiple Disease Risks",,"Completed","No Results Available","Healthy","Behavioral: Cognitive interview|Other: Survey","Test eight images/visual displays that communicate risk estimates of five diseases associated with physical activity as measured by participants understanding of the images/visual displays|Most effective combination of strategies in communicating multiple disease risk estimates (Arm 2 only)|Time that it takes to complete the survey that accompanies the images (Arm 1 only)","Washington University School of Medicine","All","30 Years to 65 Years   (Adult, Older Adult)","Phase 1","1191","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","201501028","April 1, 2015","June 27, 2017","June 27, 2017","December 3, 2015",,"November 6, 2017","Washington University School of Medicine, Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT02621671"
115,"NCT01860287","The Effects of Buprenorphine on Responses to Verbal Tasks",,"Completed","Has Results","Basic Science","Drug: Buprenorphine 0.2 MG Sublingual Tablet|Drug: Placebo|Drug: Buprenorphine 0.4 MG Sublingual Tablet","Subjective Effects as Assessed by Score on ""Feel Drug"", ""Feel High"", ""Like Drug"", and ""Want More"" Subscales of the Drug Effects Questionnaire Subjective Responses to Stress With and Without Buprenorphine","University of Chicago","All","18 Years to 40 Years   (Adult)","Early Phase 1","48","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","UCIRB-130197","September 2013","January 2017","January 2017","May 22, 2013","August 1, 2019","August 1, 2019","University of Chicago, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT01860287"
116,"NCT03790774","Neurofeedback in Alzheimer's Disease",,"Active, not recruiting","No Results Available","Alzheimer Disease","Behavioral: Neurofeedback","EEG spectral content: within-session change in theta band activity|EEG spectral content: between-session change in theta band activity|Change in Woodcock-Johnson Tests of Achievement IV: Sentence Reading Fluency|Change in Letter Cancellation Task: speed|Change in Letter Cancellation Task: accuracy|Change in Forwards and Backwards Letter Span Task|The Reading Confidence and Emotions Questionnaire (RCEQ)|Discourse Comprehension Test|Wechsler Adult Intelligence Scale 4th Edition: Digit Span Subtest|BCI letter identification task metrics: AUC|BCI letter identification task metrics: ITR|EEG spectral content: within-session change in alpha band activity|EEG spectral content: between-session change in alpha band activity|EEG spectral content: within-session change in beta band activity|EEG spectral content: between-session change in beta band activity","Oregon Health and Science University|National Institutes of Health (NIH)|National Institute on Deafness and Other Communication Disorders (NIDCD)","All","50 Years to 89 Years   (Adult, Older Adult)","Not Applicable","5","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","STUDY00018984|R01DC009834-09S1","June 6, 2019","July 2020","July 2020","January 2, 2019",,"July 9, 2020","Oregon Health & Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT03790774"
117,"NCT03807271","Calculated and Graphically Produced Depth of Anesthesia",,"Completed","No Results Available","Anesthesia, General","Device: Calculated and graphically produced depth of anesthesia (Smart Pilot® View)","Mean Arterial Pressure (MAP)|Heart Rate (HR)|Bispectral Index (BIS)|Total dosis of Propofol in milligrams|Total dosis of Remifentanil in micrograms|Total dosis of Ephedrine in milligrams|Total dosis of Phenylephrine in micrograms|Total dosis of Atropine in micrograms|Total dosis of Norepinephrine in micrograms|Duration of surgery in minutes|Duration of anesthesia in minutes|Time until extubation in minutes|Duration of stay in postoperative ward in minutes","Norwegian University of Science and Technology|Sykehuset Innlandet HF","Female","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","114","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","2018/2176","January 14, 2019","November 13, 2019","November 13, 2019","January 16, 2019",,"December 11, 2019","Anestesiavdeling Lillehammer Sykehus, Lillehammer, Oppland, Norway",,"https://ClinicalTrials.gov/show/NCT03807271"
118,"NCT02169375","Sensorimotor Based Brain Computer Interface",,"Terminated","No Results Available","Healthy Volunteers","Other: Brain computer Interface Mu (SMR) rhythm","Accuracy of a mu rhythm BCI using adaptation versus no adaptation.","University of Michigan|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","6","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","I0004|R21HD054913","November 2010","June 2011","June 2011","June 23, 2014",,"June 23, 2014","University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT02169375"
119,"NCT03052790","Comparison of Implant Positioning With Robotic Aided Surgery and Traditional Jig Positioning in Total Knee Arthroplasty",,"Withdrawn","No Results Available","Knee Arthritis","Procedure: manually instrumented total knee arthroplasty|Device: robotic assisted total knee arthroplasty","Summation of angle differences between pre-operative plan and the final implant position as indicated by computed tomography (CT)|Pain as assessed by the PROMIS 10 measurement system|Function as assessed by the PROMIS 10 measurement system|Knee injury and Osteoarthritis as assessed by the Knee injury and Osteoarthritis Outcome Score (KOOS) measurement system|Pain as assessed by a Visual Analogue Scale (VAS)","The University of Texas Health Science Center, Houston","All","25 Years to 95 Years   (Adult, Older Adult)","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","HSC-MS-16-1096","July 1, 2018","July 1, 2019","December 1, 2019","February 14, 2017",,"April 4, 2019","The University of Texas Health Science Center at Houston, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03052790"
120,"NCT01958086","Brain Implant for Neural Control of a Computer",,"Recruiting","No Results Available","Quadriplegia","Device: Neural Communication System","Subject control of a tablet computer|Absence of infection or irritation","Richard A. Andersen, PhD|University of California, Los Angeles|Casa Colina Hospital and Centers for Healthcare|California Institute of Technology","All","22 Years to 65 Years   (Adult, Older Adult)","Not Applicable","2","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","G120287|13-000576","October 2013","September 2020","December 2020","October 8, 2013",,"July 25, 2019","University of California Los Angeles, Los Angeles, California, United States|California Institute of Technology, Pasadena, California, United States|Casa Colina Centers for Rehabilitation, Pomona, California, United States",,"https://ClinicalTrials.gov/show/NCT01958086"
121,"NCT03954847","Clinical Significance of Computer Aided Image Analysis in Treatment Response Evaluation of Lung Cancer",,"Recruiting","No Results Available","Lung Cancer",,"Overall survival|Progression free survival","Wuhan Union Hospital, China","All","18 Years and older   (Adult, Older Adult)",,"1000","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","WuhanUH-V1.2","January 1, 2012","December 31, 2020","December 31, 2020","May 17, 2019",,"May 17, 2019","Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",,"https://ClinicalTrials.gov/show/NCT03954847"
122,"NCT03389464","Computer-based Treatment of Dysfunctional Beliefs in Depressive Inpatients",,"Unknown status","No Results Available","Depression","Behavioral: computer-based confrontation with dysfunctional beliefs","change in the score on the Dysfunctional Attitude Scale|change in the conviction ratings for the dysfunctional beliefs|change in the conviction ratings for the alternative beliefs|change in the score on the Beck Depression Inventory-II","University of Regensburg|Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg am Bezirksklinikum Regensburg, Germany","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","Face","January 8, 2018","September 27, 2018","September 27, 2018","January 3, 2018",,"May 2, 2018","medbo Bezirksklinikum Regensburg, Regensburg, Germany",,"https://ClinicalTrials.gov/show/NCT03389464"
123,"NCT04404621","Computer Presented and Physical Exercises to Maintain Cognitive Function and Emotional Health in Older Adults",,"Active, not recruiting","No Results Available","Cognitive Function|Depression in Old Age","Behavioral: Physical exercise (PE) training and computer-based brain (CBB)","Composite cognition score|Sit to Stand in one-minute|Balance - stand on one foot at a time|Mood and Quality of Life|Attention and Speed of Processing|Response Inhibition|Working Memory|Verbal Memory|Speed of Processing|Cognitive Flexibility","Yale University","All","65 Years and older   (Older Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science","2000026437","November 13, 2019","September 12, 2020","September 12, 2020","May 27, 2020",,"May 27, 2020","Connecticut Mental Health Center, New Haven, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT04404621"
124,"NCT02483273","Alterations of Conjunctival Microcirculation in Brain Dead Patients",,"Completed","No Results Available","Brain Death",,"Microvascular flow index (MFI) of ocular conjunctiva.|Total vessel density (TVD) of ocular concunctiva.|Perfused vessel density (PVD) of ocular conjunctiva.|Microvascular flow index (MFI) of sublingual mucosa.|Total vessel density (TVD) of sublingual mucosa.|Perfused vessel density (PVD) of sublingual mucosa.","Lithuanian University of Health Sciences","All","18 Years and older   (Adult, Older Adult)",,"22","Other","Observational","Observational Model: Case Control|Time Perspective: Prospective","P1-BE-2-19/2011","May 2011","September 2015","March 2016","June 26, 2015",,"March 3, 2016","Lithuanian University of Health Sciences, Kaunas, Lithuania",,"https://ClinicalTrials.gov/show/NCT02483273"
125,"NCT03115788","Pain Effect on Attention Using an Ipad Game App",,"Recruiting","No Results Available","Cognitive Function","Other: Heat induced pain|Other: Cold Induced Pain|Device: iPad","Median cue duration|number correct|Premature discontinuation of game|Number of omitted responses","Wake Forest University Health Sciences","All","18 Years to 55 Years   (Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Health Services Research","IRB00037185","May 15, 2016","December 2020","December 2020","April 14, 2017",,"December 20, 2019","Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03115788"
126,"NCT01416012","Health Related Quality of Life Effects of Off-the-shelf Computer Gaming in Alzheimer and Related Disorders Populations",,"Unknown status","No Results Available","Disease Alzheimer","Behavioral: Physical Therapy (standard)|Behavioral: Balance and Gait training in Individualized sessions|Behavioral: Kinect|Behavioral: Group Xbox Kinect","questionnaires on quality of life|tests on health","Centre Hospitalier Universitaire de Nice","All","60 Years and older   (Adult, Older Adult)","Not Applicable","180","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)","11-PP-06","October 2011","October 2011","September 2013","August 12, 2011",,"April 24, 2013","The University of Queensland, St Lucia, Australia|CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez, Nice, Alpes-Maritimes, France|Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands",,"https://ClinicalTrials.gov/show/NCT01416012"
127,"NCT01085968","Cognitive Rehabilitation in Parkinson's Disease",,"Completed","Has Results","Parkinson's Disease","Behavioral: PC based training","Reaction Time and Variability for Movement Task|Neuropsychological Measures of Cognitive Function, Including Reaction Time and Time to Completion|Task Errors and Variability|Functional Dexterity Test (FDT)|Symbol Digit Modality Test (SDMT)","VA Office of Research and Development|Louisiana State University Health Sciences Center Shreveport","All","55 Years to 75 Years   (Adult, Older Adult)","Early Phase 1","54","U.S. Fed|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","E7185-R","July 2010","August 2015","August 2015","March 12, 2010","October 11, 2016","October 11, 2016",,,"https://ClinicalTrials.gov/show/NCT01085968"
128,"NCT00928941","Neural Correlates of Cognitive Rehabilitation in Post-Traumatic Stress Disorder (PTSD)",,"Terminated","No Results Available","Post-Traumatic Stress Disorder","Behavioral: cognitive training|Behavioral: video game","neuropsychological test data|MRI data","US Department of Veterans Affairs|VA Office of Research and Development","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40","U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","B7009-M","May 2010","December 2011","December 2011","June 26, 2009",,"December 10, 2014","VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT00928941"
129,"NCT01517945","Attention and Interpretation Modification (AIM) for Fear of Breast Cancer Recurrence: An Intervention Development Study",,"Recruiting","No Results Available","Breast Cancer","Behavioral: AIM materials and assessments","develop and refine materials|estimate the feasibility and acceptability|preliminary efficacy","Memorial Sloan Kettering Cancer Center|Brown University|Weill Medical College of Cornell University|Johns Hopkins University|Mclean Hospital|University of Southern California|The New School for Social Research","Female","18 Years and older   (Adult, Older Adult)",,"158","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","11-204","January 2012","January 2021","January 2021","January 25, 2012",,"February 5, 2020","Memorial Sloan-Kettering Cancer Center, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT01517945"
130,"NCT00892463","Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive Disorder",,"Completed","No Results Available","Depressive Disorder, Major","Drug: Quetiapine (Seroquel) XR","The QIDS-SR16 (Quick Inventory of Depressive Symptomatology - Self-report)|HADS (Hamilton Anxiety Depression Scale) VADIS","Sunnybrook Health Sciences Centre|AstraZeneca","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 4","26","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","D1443L00072","May 2009","December 2010","December 2010","May 4, 2009",,"July 28, 2011","Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT00892463"
131,"NCT04456192","Effects of an Indoor Cycling Program on Cardio-Metabolic Factors in Women With Obesity and Normal Body Weight",,"Completed","No Results Available","Obesity|Dyslipidemias|Hypertension|Type 2 Diabetes|Endothelial Dysfunction","Behavioral: Indoor Cycling Interval Exercise Training","Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) [mmol/l]|Human anti-oxidized low density lipoprotein antibody (OLAb) [U/L]|Blood total antioxidant capacity (TAC) [mmolCRE/l]|Thiobarbituric acid reactive substances (TBARS) [μmol/l]|Activity of endothelial nitric oxide synthase (eNOS) [ng/ml]|Vascular endothelial growth factor (VEGF) [pg/ml]|C-reactive protein concentration (CRP) [mg/l]|Body mass [kg]|Body height, waist circumference, hip circumference [cm]|Body composition|Peak oxygen uptake (VO2 peak) [ml•min-1•kg-1]|Resting heart rate [bpm], Peak heart rate [bpm], Ventilatory threshold heart rate [bpm],|Resting SBP [mmHg], Resting DBP [mmHg], Exercise SBP [mmHg], Exercise DBP [mmHg]","Poznan University of Physical Education|Poznan University of Medical Sciences","Female","30 Years to 65 Years   (Adult, Older Adult)","Not Applicable","31","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","PoznanUPhyEd no. 2","January 1, 2013","June 15, 2016","June 15, 2016","July 2, 2020",,"July 2, 2020","Poznan University of Physical Education, Poznań, Greater Poland, Poland",,"https://ClinicalTrials.gov/show/NCT04456192"
132,"NCT01736371","Analysis of Cisatracurium Consumption in Balanced Anesthesia With 1% Sevoflurane, and With Only Sevoflurane, Using a Closed-loop Computer Controlled System Infusion.",,"Completed","No Results Available","Drug Interaction Potentiation","Drug: 1% Sevoflurane|Drug: Propofol|Drug: Sevoflurane","Cisatracurium consumption rate.|Analysis of Means of Recovery Index.","Tianjin Medical University General Hospital","All","20 Years to 65 Years   (Adult, Older Adult)","Not Applicable","156","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","Cis-sevo-123","January 2012","November 2012","November 2012","November 29, 2012",,"November 29, 2012","Tianjin Medical University, Tianjin, China",,"https://ClinicalTrials.gov/show/NCT01736371"
133,"NCT01804413","Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency",,"Unknown status","No Results Available","Adults Growth Hormone Deficiency.","Drug: Pegvisomant|Drug: Regular insulin","Peak growth hormone and cortisol levels induced by the pegvisomant-glucagon test compared to those by the insulin tolerance test in assessing the growth hormone and cortisol reserve in adults suspected of adult growth hormone and cortisol deficiencies.|Correlation of peak GH and cortisol levels to BMI and fasting glucose, and effects of pegvisomant on IGF-I bioactivity.","Oregon Health and Science University|Aarhus University Hospital","All","21 Years to 55 Years   (Adult)","Not Applicable","10","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","IRB6961","March 2011","November 2013","December 2013","March 5, 2013",,"October 24, 2013","Oregon Health & Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT01804413"
134,"NCT01523444","Advancing Adolescent Screening and Brief Intervention Protocols in Primary Care Settings",,"Withdrawn","No Results Available","Substance Abuse","Behavioral: computer-assisted Screening & Brief Advice|Behavioral: computer-assisted Screening & Brief Advice Plus","Reduced substance use|Initiation of substance use","Treatment Research Institute","All","12 Years to 18 Years   (Child, Adult)","Phase 3","0","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","ASBIRT-PA-11-311","September 2013","February 2016","November 2017","February 1, 2012",,"July 16, 2015","Treatment Research Institute, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT01523444"
135,"NCT01099059","Amantadine Versus Ritalin in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)",,"Unknown status","No Results Available","Attention Deficit Hyperactivity Disorder","Drug: Amantadine|Drug: ritalin","The mean decrease in ADHD -RS-IV score from baseline will be used as the main outcome measure of response of ADHD treatment.","Tehran University of Medical Sciences","All","6 Years to 17 Years   (Child)","Phase 2","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","8630","April 2010","April 2010","June 2010","April 6, 2010",,"November 18, 2010","Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of",,"https://ClinicalTrials.gov/show/NCT01099059"
136,"NCT00267735","Measuring Preferences for Childbirth After Cesarean",,"Completed","No Results Available","Pregnancy","Behavioral: Use of Computerized Decision Aid on Childbirth","Decisional conflict scores (knowledge of options; clarity about preferences; decisional certainty; conflict) after using decision aid.","Oregon Health and Science University|Agency for Healthcare Research and Quality (AHRQ)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","131","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other","1R03HS013959-01A1","January 2006","October 2014","October 2014","December 21, 2005",,"December 11, 2019","Oregon Health & Science University Clinics, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT00267735"
137,"NCT03611855","Chronic Stroke Rehabilitation With Contralesional Brain-Computer Interface",,"Active, not recruiting","No Results Available","Chronic Stroke|Hemiparesis","Device: BCI Rehabilitation|Other: Range of Motion Therapy","Change in Fugl-Meyer (Upper Extremity) Assessment Score|Change in Corticospinal Tract Integrity|Change in Interhemispheric Somatomotor Connectivity|Change in Motricity Index|Change in Grasp Strength|Change in Arm Motor Ability Test Score","Washington University School of Medicine|Neurolutions, Inc.","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","30","Other|Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","201701021","April 26, 2018","August 2020","October 2020","August 2, 2018",,"June 11, 2020","Washington University in St. Louis, Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT03611855"
138,"NCT02864069","Impact of Combined Behavioral Interventions on Cognitive Outcomes in MCI","CBI","Completed","Has Results","Mild Cognitive Impairment","Behavioral: Walking Intervention|Behavioral: Cognitive Training Intervention|Behavioral: Combined Intervention","Rivermead Behavioral Memory Test|Everyday Cognition Scale|Older Peoples Quality of Life Questionnaire","University of California, San Diego|Alzheimer's Association","All","60 Years to 80 Years   (Adult, Older Adult)","Not Applicable","52","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","NPSASA-14-321959","September 2014","October 2018","October 2018","August 11, 2016","January 18, 2020","January 18, 2020","UCSD, La Jolla, California, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/69/NCT02864069/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02864069"
139,"NCT00655239","Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis",,"Completed","No Results Available","Schizophrenia","Behavioral: Neuroadaptive cognitive training|Behavioral: Computer games","Cognitive performance, as measured by a neuropsychological battery|Symptom profile, as measured by clinical interviews","University of California, San Francisco|National Institute of Mental Health (NIMH)","All","12 Years to 35 Years   (Child, Adult)","Not Applicable","143","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Prevention","R01MH081051","June 2008","May 2016","May 2016","April 9, 2008",,"January 8, 2019","University of California, San Francisco, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT00655239"
140,"NCT03533192","Replication of Evidence-based Programs",,"Completed","No Results Available","Sexual Behavior","Behavioral: It's Your Game...Keep it Real","Initiation of vaginal or oral sex|Initiation of vaginal intercourse|Initiation of oral sex|Participation in vaginal sex without a condom|Participation in vaginal sex without an effective method of birth control|Use of Condom at last sex|Use of effective method of birth control at last sex|Percent of youth who report having vaginal sex 2 or more times in the past 3 months|Percent of youth who report having oral sex 2 or more times in the past 3 months|Percent of youth who report having vaginal sex with 2 or more partners in the past 3 months|Percent of youth who report having oral sex with 2 or more partners in the past 3 months|Percent of youth who report using drugs or alcohol before vaginal sex at least 1 time in the past 3 months|Percent of youth who report using drugs or alcohol before oral sex at least 1 time in the past 3 months|General condom knowledge|General HIV/STI knowledge|Knowledge of signs and symptoms of STIs|General beliefs about waiting to have sex|Beliefs about waiting until marriage to have sex|Reasons to not have sex|General beliefs about condoms|Perceived friends beliefs about waiting to have sex|Perceived norms about sex (I)|Perceived norms about sex (II)|Perceived friends sexual behaviors (I)|Perceived friends sexual behaviors (II)|Perceived friends' beliefs about condoms|Perceived self-efficacy to refrain from having sex|Perceived self-efficacy to negotiate the use of condoms with a partner|Perceived self-efficacy to obtain and correctly use condoms|Personal limits regarding sex|Personal limits regarding condoms|Communication with parents about sex|Exposure to risky situations|Intentions to have sex in the next year|Intentions to remain abstinent until the end of high school|Intentions to remain abstinent until marriage|Intentions to use a condom if have sex in the next year|Intentions to use effective birth control if have sex in the next year|Intentions to get tested for HIV/STI if think at risk","The University of Texas Health Science Center, Houston|ETR Associates|The Office of Adolescent Health, HHS","All","11 Years to 14 Years   (Child)","Not Applicable","2588","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","HSC-SPH-10-0455","September 2012","July 2015","July 2015","May 23, 2018",,"May 23, 2018",,,"https://ClinicalTrials.gov/show/NCT03533192"
141,"NCT02559752","Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy",,"Recruiting","No Results Available","Central Nervous System","Other: NIH Toolbox Cognitive Battery","Feasibility of obtaining serial computer-based neurocognitive testing as measured by an acceptance rate of 60% of eligible patients.|Feasibility of obtaining serial computer-based neurocognitive testing as measured by an implementation rate of 80% among survivors","Washington University School of Medicine","All","4 Years to 21 Years   (Child, Adult)",,"80","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","201509033","October 13, 2015","March 31, 2021","March 31, 2026","September 24, 2015",,"June 11, 2020","Washington University School of Medicine, Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT02559752"
142,"NCT01099072","Carnitine as an Adjunct to Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder",,"Unknown status","No Results Available","Attention Deficit Hyperactivity Disorder","Drug: Methylphenidate+placebo|Drug: methylphenidate+carnitine","The principal measure of outcome will be the Parent and Teacher ADHD Rating Scale-IV","Tehran University of Medical Sciences","All","6 Years to 17 Years   (Child)","Phase 2","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","8642","April 2010","December 2012","December 2012","April 6, 2010",,"December 7, 2012","Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of",,"https://ClinicalTrials.gov/show/NCT01099072"
143,"NCT00394524","Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU",,"Completed","Has Results","Diabetes or With New Hyperglycemia","Device: Glucommander|Other: Standard insulin infusion algorithm","Mean Blood Glucose (BG) in mg/dl Among Glucommander Group Compared to Standard Insulin Infusion|Number of Patients With Severe Hypoglycemia Episodes Among the Glucommander Group Compared to Standard Algorithm|Mean Length of Intensive Care Unit (ICU) in Days Stay Among Glucommander Group Compared to Standard Insulin Infusion Group|Mean Hospital Length of Stay in Days Among the Glucommander Group Compared to Standard Insulin Infusion","Emory University|Sanofi|Grady Health System|Piedmont Healthcare|University of Tennessee","Female","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","160","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRB00021877|IRB 830-2005","June 2006","September 2008","September 2008","November 1, 2006","September 30, 2013","October 30, 2018","Grady Memorial Hospital, Atlanta, Georgia, United States|Piedmont Hopsital, Atlanta, Georgia, United States|University of Tennessee Health Science Center, Memphis, Memphis, Tennessee, United States|University of Washington, Seattle, Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT00394524"
144,"NCT03930654","Leveraging the Emergency Department to Engage African American Women in HIV Pre-Exposure Prophylaxis","IWPrEP","Not yet recruiting","No Results Available","HIV Infections","Behavioral: iPrEP|Behavioral: Usual Care","Number of participants with an increased willingness for pre-exposure prophylaxis (PrEP) uptake|Number of participants with decreased high risk sex|Number of participants with decrease in substance use|Number of participants with a new sexually transmitted disease diagnosis|Number of participants with HIV seroconversion|iPrEP feasibility and acceptability as assessed by the number of participants who believe that they had more information to make a better decision about being in a PrEP program after completing the survey intervention|iPrEP feasibility and acceptability as assessed by how much participant liked or disliked completing the survey|iPrEP feasibility and acceptability as assessed by how often participants relied on the survey questions being read aloud to be able to answer them|iPrEP feasibility and acceptability as assessed by number of participants who needed help from site staff in order to complete the survey|iPrEP feasibility and acceptability as assessed by the kind of help that participants needed from site staff in order to complete the survey|iPrEP feasibility and acceptability as assessed by how participants felt about the length of the survey","The University of Texas Health Science Center, Houston","Female","18 Years to 55 Years   (Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","HSC-MS-16-0892","August 2019","August 2020","August 2020","April 29, 2019",,"April 29, 2019","The University of Texas Health Science Center at Houston, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03930654"
145,"NCT03119584","Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation",,"Active, not recruiting","No Results Available","Chronic Constipation|Diabete Mellitus","Drug: linaclotide or placebo","Improvement in frequency of bowel movements","Texas Tech University Health Sciences Center, El Paso","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 4","23","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","E15025","September 1, 2015","October 30, 2020","January 30, 2021","April 18, 2017",,"February 25, 2020","Texas Tech University Health Sciences Center, El Paso, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03119584"
146,"NCT03874442","The Effectiveness of a Preoperative, Interactive Game ""SERES Pain in Children"".",,"Completed","No Results Available","Ambulatory Surgery in Children","Other: CliniPup serious game","Preoperative anxiety|Postoperative pain|User experience and satisfaction|parental anxiety","Universitaire Ziekenhuizen Leuven","All","6 Years to 10 Years   (Child)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","S58541","February 22, 2016","April 26, 2016","April 26, 2016","March 14, 2019",,"March 14, 2019",,,"https://ClinicalTrials.gov/show/NCT03874442"
147,"NCT02025140","Computer Controlled Local Anesthesia in Children","STA machine","Completed","No Results Available","Pain Perception of the New Device|The Pain Related Behavior|The Effectiveness of Anesthesia","Device: Computer controlled anesthesia|Device: conventional anesthesia syringe","The pain perception of the children to the device|The effectiveness of the anesthesia","King Abdulaziz University","All","5 Years to 9 Years   (Child)","Phase 1","91","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","3","September 2013","April 2014","April 2014","December 31, 2013",,"September 2, 2015","King Abdulaziz University, Jeddah, Saudi Arabia",,"https://ClinicalTrials.gov/show/NCT02025140"
148,"NCT02132520","A Brain Centered Neuroengineering Approach for Motor Recovery After Stroke: Combined rTMS and BCI Training",,"Completed","Has Results","Hemiparesis|Stroke","Device: rTMS|Behavioral: BCI Training","Changes in Cortical Excitability and Cortical Activation Patterns as Measured by MRI and Functional MRI|Changes in Hand Motor Function as Measured by the Box and Block Test|Changes in Paretic Hand Motor Function as Measured by the Finger Tracking Test|Changes in Inter-hemispheric Inhibition","University of Minnesota","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","3","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","1306M36401|CBET-1264562","March 2014","January 2017","June 2017","May 7, 2014","January 3, 2019","November 1, 2019","Clinical and Translational Science Institute, Minneapolis, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT02132520"
149,"NCT01222507","Processing Speed as an Objective Measure of Tinnitus","BST","Completed","Has Results","Tinnitus",,"Brain Speed Test","Washington University School of Medicine|Posit Science Corporation","All","18 Years to 80 Years   (Adult, Older Adult)",,"60","Other|Industry","Observational","Time Perspective: Prospective","10-0829","July 2010","October 2010","October 2010","October 18, 2010","October 25, 2012","October 25, 2012","Washington University School of Medicine, St. Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT01222507"
150,"NCT02445625","BCI (Brain Computer Interface) Intervention in Autism","BCIAUT","Completed","Has Results","Autism Spectrum Disorder","Device: BCI to train joint attention in ASD","JAAT_NoFace|JAAT_Face|ATEC - Autism Treatment Evaluation Checklist|VABS - Vineland Adaptive Behaviour Scale","University of Coimbra","All","16 Years to 30 Years   (Child, Adult)","Not Applicable","15","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IBILI-VB-2015-01","February 2016","November 2017","September 2018","May 15, 2015","February 18, 2019","February 18, 2019",,"""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/25/NCT02445625/SAP_000.pdf|""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/25/NCT02445625/Prot_001.pdf","https://ClinicalTrials.gov/show/NCT02445625"
151,"NCT01694303","Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being",,"Completed","No Results Available","Healthy","Behavioral: Computerized Neurobehavioral Intervention","Emotion-regulation - behavioral and fMRI|Cognition - executive function behavioral reaction time","Stanford University","All","18 Years to 30 Years   (Adult)","Not Applicable","38","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","IRB-24519","September 2012","September 2013","September 2013","September 27, 2012",,"July 17, 2015","Stanford University, Department of Psychiatry and Behavioral Sciences, Stanford, California, United States",,"https://ClinicalTrials.gov/show/NCT01694303"
152,"NCT03048656","The Postural Control in Individuals With the Structural Leg-length Discrepancy",,"Completed","No Results Available","Leg Length Inequality","Other: static posturography","Evaluation of mean COP velocity in anteroposterior and mediolateral directions during stance in subjects|Evaluation of weight distribution during stance in subjects","Poznan University of Medical Sciences","All","6 Years to 30 Years   (Child, Adult)","Not Applicable","38","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic","418/14","January 18, 2017","January 25, 2017","February 1, 2017","February 9, 2017",,"February 10, 2017","Poznan University of Medical Sciences, Poznań, Poland",,"https://ClinicalTrials.gov/show/NCT03048656"
153,"NCT01466751","Neurobehavioral Intervention as a Novel Treatment Approach for Emotion-Regulatory Deficits",,"Completed","Has Results","Anxiety|Depression","Behavioral: Computerized Neurobehavioral Intervention","Reaction Time to Facial Affect Identification During Emotional Conflict|Amygdala Blood Oxygenation-level Dependent Response (BOLD) Activation to Face Affect Identification During Emotional Conflict","Stanford University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","28","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","IRB-19338","January 2011","January 2013","December 2013","November 8, 2011","June 20, 2019","June 20, 2019","Stanford University, Department of Psychiatry and Behavioral Sciences, Stanford, California, United States",,"https://ClinicalTrials.gov/show/NCT01466751"
154,"NCT02957383","Evning Exposure to Computer Screen Disrupts Sleep, Attention and Biological Rhythms",,"Completed","No Results Available","Sleep Disorder","Other: Wavelength|Other: Intensity","Body temperature|Melatonin secretion|Epworth Sleepiness Scale (ESS) questionire- Sleepiness|Brief Symptom Inventory (BSI)- questionaire|Karolinska Sleep Questionnaire (KSS)-Subjective sleepiness|Attention|Total Sleep Time|sleep efficiency|Sleep latency to stage 1|Sleep latency to stage 2|Wake% TIB|Stage 1% TIB|Stage 2% TIB|SWS% TIB","Assuta Medical Center","All","20 Years to 65 Years   (Adult, Older Adult)","Not Applicable","19","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","2014068","July 2015","March 2016","August 2016","November 6, 2016",,"November 8, 2016",,,"https://ClinicalTrials.gov/show/NCT02957383"
155,"NCT02566239","Ambient Independence Measures for Guiding Care Transitions","AIMs","Completed","No Results Available","Aging","Other: Share activity data with care team","Self-Reported Activities of Daily Living (ADL) Assistance|Transfers to Higher Level of Care|Incidence of Adverse Events|Additional Resident Assistance","Oregon Health and Science University|National Institute on Aging (NIA)","All","70 Years and older   (Older Adult)","Not Applicable","96","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","OHSU9944|5R01AG042191-03","March 2014","August 12, 2019","August 12, 2019","October 2, 2015",,"September 13, 2019","Oregon Health & Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT02566239"
156,"NCT00875134","Testing of the Apnea Prevention Device",,"Completed","No Results Available","Respiratory Depression|Elective Surgery","Other: Verbal prompt|Other: Skin Stimulus","Efficacy in treating respiratory depression","Oregon Health and Science University","All","21 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","30","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","10-06-54","March 2009","October 2009","March 2010","April 3, 2009",,"June 18, 2019","Oregon Health and Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT00875134"
157,"NCT02929758","Speed of Processing Training in Patients With Parkinson's Disease and Healthy Older Adults",,"Completed","No Results Available","Parkinson's Disease","Behavioral: Speed of processing training (SOPT)","Time to contact|Useful Field of View (UFOV)|Executive function (MoCA, Trails, Stroop)|Vigilance","University of Alabama at Birmingham|National Institute on Aging (NIA)","All","50 Years and older   (Adult, Older Adult)","Not Applicable","88","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","X150203003|5P30AG022838","February 2015","February 2018","February 2018","October 11, 2016",,"March 26, 2018","University of Alabama at Birmingham, Birmingham, Alabama, United States",,"https://ClinicalTrials.gov/show/NCT02929758"
158,"NCT03221374","Mind-body Awareness Training and Brain-computer Interface",,"Recruiting","No Results Available","Healthy Subjects","Behavioral: Mindfulness Based Stress Reduction","BCI Learning over BCI sessions|Proportion of proficient subjects","Carnegie Mellon University","All","18 Years to 64 Years   (Adult)","Not Applicable","300","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","R01AT009263-01","September 1, 2016","May 31, 2021","May 31, 2021","July 18, 2017",,"September 11, 2019","Biomedical Engineering Department Carnegie Mellon University, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03221374"
159,"NCT01694316","Use of a Novel Neuroplasticity-based Neurobehavioral Intervention for PTSD",,"Completed","No Results Available","Anxiety|Depression","Behavioral: Computerized Neurobehavioral Intervention","WebNeuro Computerized Cognitive and Affective Assessment Battery|Clinician-assessed PTSD symptoms","Stanford University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","54","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","IRB-24890","September 2012","January 2017","January 2017","September 27, 2012",,"August 16, 2018","Stanford University, Department of Psychiatry and Behavioral Sciences, Stanford, California, United States",,"https://ClinicalTrials.gov/show/NCT01694316"
160,"NCT00167570","Long Term Clinical Evaluation of SLS Transtibial Sockets",,"Completed","No Results Available","Trauma|Diabetes","Device: Prosthetic socket fabricated using selective laser sintering","Durability during household and community mobility.|User perceptions of comfort, fit, and function.","The University of Texas Health Science Center at San Antonio","All","18 Years and older   (Adult, Older Adult)",,"11","Other","Observational",,"VA-A2755-r-UT-001-0011-267|VA-A2755-r","April 2003","July 2011","July 2011","September 14, 2005",,"April 26, 2017","South Texas Veterans Healthcare System, San Antonio, Texas, United States",,"https://ClinicalTrials.gov/show/NCT00167570"
161,"NCT00935727","Elastographic Imaging of Renal Transplants","Elastorenal","Terminated","No Results Available","Renal Transplant","Other: Elastographic imaging","Identification of features of a set of elastography images that can be characterized as those of a normally functioning transplanted kidney, or those of specific abnormalities|Assessment of the value of renal transplant imaging by elastography compared to standard ultrasound","The University of Texas Health Science Center, Houston|Memorial Hermann Hospital","All","18 Years and older   (Adult, Older Adult)","Phase 1","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","HSC-MS-06-0255","June 2006","June 2009","June 2009","July 9, 2009",,"July 9, 2009","The University of Texas health Science Center at Houston, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT00935727"
162,"NCT01571427","Conversations as a Means to Delay the Onset of Alzheimer's Disease","conversation","Completed","Has Results","Mild Cognitive Impairment|Cognitive Change","Behavioral: Active social engagement group|Behavioral: Control group","Changes in Global Cognitive Function Using Mini Mental State Examination Score (Post-study Test Score - Baseline Test Score)|Changes in Category Fluency (Animals) Test Scores (Post-study Test Score - Baseline Test Score)|Changes in Verbal Fluency Letter Test Scores (Post-study Test Score - Baseline Test Score)|Changes in the Consortium to Establish a Registry for Alzheimer's Disease Word List Immediate Recall (Post-study Test Score - Baseline Test Score)|Changes in the Consortium to Establish a Registry for Alzheimer's Disease Word List Delayed Recall (Post-study Test Score - Baseline Test Score)|Changes in Trail Making Test A Scores (Post-study Test Score - Baseline Test Score)|Changes in Trail Making Test B Scores (Post-study Test Score - Baseline Test Score)|Changes in the Stroop Color and Word Test (Stroop Test C) Scores (Post-study Test Scores - Baseline Test Scores)|Changes in Cogstate Computerized Test: Detection Test (Post-study Test Score - Baseline Test Score)|Changes in Cogstate One Back Accuracy (Post-study Test Score - Baseline Test Score)|Changes in Cogstate Two Back Accuracy (Post-study Test Score - Baseline Test Score)|Changes in CAMCI Total Score (Post-study Test Score - Baseline Test Score)","Oregon Health and Science University|National Institute on Aging (NIA)","All","70 Years and older   (Older Adult)","Early Phase 1","83","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","socialengagementR01|R01AG033581","February 2012","September 2013","September 2013","April 5, 2012","April 24, 2019","February 5, 2020","Oregon Health & Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT01571427"
163,"NCT04002583","48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease",,"Recruiting","No Results Available","Early Onset Alzheimer Disease","Diagnostic Test: Computer assisted ambulatory electroencephalogram","Electrographic seizures: Number of subjects with electrographic seizures","Mayo Clinic","All","40 Years to 64 Years   (Adult)","Not Applicable","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","19-003078","February 19, 2020","January 2021","January 2021","June 28, 2019",,"February 21, 2020","Mayo Clinic in Florida, Jacksonville, Florida, United States",,"https://ClinicalTrials.gov/show/NCT04002583"
164,"NCT02871921","Internet-based Conversational Engagement Clinical Trial","I-CONECT","Recruiting","No Results Available","Aging|Mild Cognitive Impairment","Behavioral: Conversational Engagement","Intervention Efficacy for High Dose|Intervention Efficacy for Maintenance Dose|Intervention Efficacy for High Dose: Instrumental activities of daily living (IADL)|Intervention Efficacy for Maintenance Dose: Instrumental activities of daily living (IADL) functions","Oregon Health and Science University|University of Michigan|National Institute on Aging (NIA)|Wayne State University","All","75 Years and older   (Older Adult)","Not Applicable","320","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","STUDY00015937|R56AG056102|R01AG051628|R01AG056102","June 1, 2018","April 30, 2022","May 31, 2022","August 18, 2016",,"March 4, 2020","University of Michigan, Ann Arbor, Michigan, United States|Oregon Health & Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT02871921"
165,"NCT03170492","Does Computerized Cognitive Training Improve Executive Functioning in the Older Adult?","CCT","Unknown status","No Results Available","Cognitive Impairment, Mild|Executive Dysfunction","Other: RehaCom Computerized Cognitive Training for 480 minutes|Other: Pencil-and-Paper Cognitive Training for 480 minutes","Montreal Cognitive Assessment|Delis-Kaplan Executive Functioning System (Letter Fluency)|Trail Making Test Part A|Trail Making Test Part B|Executive Function Performance Test","University of the Sciences in Philadelphia|GenesisCAREs","All","55 Years and older   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","947324","January 30, 2017","November 3, 2017","July 31, 2018","May 31, 2017",,"November 6, 2017","Mercy LIFE- West Philadelphia, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03170492"
166,"NCT02330835","Multimedia Program to Promote Positive Bus Behavior","BUS_2","Completed","No Results Available","Student Behavior","Behavioral: In the Drivers Seat|Behavioral: School bus driver training videos","Attitudes and beliefs regarding bus climate|Self-efficacy in managing misbehavior|Perceived student misbehaviors|Knowledge|Intention-behavior|Student referrals","Oregon Center for Applied Science, Inc.","All","5 Years to 65 Years   (Child, Adult, Older Adult)","Phase 2","710","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)","SBIR55-2|1R44DA015251-02","January 2007","May 2007","July 2007","January 5, 2015",,"January 5, 2015","Oregon Center for Applied Science, Eugene, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT02330835"
167,"NCT02975193","Neural Correlates of Cognition in Parkinson's Disease",,"Recruiting","No Results Available","Parkinson Disease","Behavioral: Computer task assessing cognition|Behavioral: Impulsive-Compulsive Disorders in Parkinson's Disease|Procedure: Deep Brain Stimulation Surgery","Change in behavioral performance|Change in Score on Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease - Rating Scale (QUIP-RS)|Local field potential brain signal","University of Florida|National Institute of Neurological Disorders and Stroke (NINDS)","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","75","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","IRB201601780|F30NS111841","February 1, 2017","January 2022","May 2022","November 29, 2016",,"January 9, 2020","University of Florida, Gainesville, Florida, United States",,"https://ClinicalTrials.gov/show/NCT02975193"
168,"NCT00517062","Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates",,"Completed","No Results Available","Growth Hormone Deficiency","Drug: Growth hormone (Genotropin)|Drug: Placebo","Changes in insulin sensitivity (from the hyperinsulinemic euglycemic clamp|Changes in fat IGF-I and IGF-I/insulin hybrid receptor density and body composition.","Oregon Health and Science University","All","18 Years to 75 Years   (Adult, Older Adult)","Early Phase 1","16","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","IRB1844","January 2006","January 2012","January 2012","August 16, 2007",,"May 3, 2012","Oregon Health and Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT00517062"
169,"NCT02198911","The Effects of Chewing Gum on a Computer Task and Liking Ratings of Ice Cream",,"Active, not recruiting","No Results Available","Habituation","Other: NO GUM|Other: MCC (Mint Chocolate Chip gum)|Other: C (Cinnamon gum)","Grams of ice cream eaten","The University of Tennessee, Knoxville","All","18 Years to 40 Years   (Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","9212-B","June 2013","December 31, 2018","December 2020","July 24, 2014",,"July 16, 2019","Healthy Eating and Activity Labroatory, University of Tennessee, Knoxville, Knoxville, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT02198911"
170,"NCT02331784","Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease","PACR-AD","Completed","No Results Available","Older Adults, Aging Brain","Behavioral: Computerized Plasticity-based Software|Behavioral: Commercially available Video Game","Changes in performance on global cognitive composite score|Changes in brain function|Changes in brain structure|Changes in task-related brain activation|Changes in performance on memory composite score|Changes in performance on executive function composite score|Changes in performance on processing speed composite score","Posit Science Corporation|University of Iowa","All","65 Years to 79 Years   (Older Adult)","Not Applicable","68","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","PSC-PACR-AD-01","April 2015","April 20, 2017","April 20, 2017","January 6, 2015",,"April 19, 2019","University of Iowa, Iowa City, Iowa, United States",,"https://ClinicalTrials.gov/show/NCT02331784"
171,"NCT01108991","Randomized Trial of Physical Activity Self-Management Intervention for Patients With COPD","COPD-SMART","Completed","No Results Available","Chronic Obstructive Pulmonary Disease","Behavioral: Physical activity self-management|Other: COPD education + Usual care","Chronic Respiratory Disease Questionnaire|6-minute walk|Cost-effectiveness|Self-reported adverse event reporting","The University of Texas Health Science Center at Tyler|National Heart, Lung, and Blood Institute (NHLBI)|University of Texas|University of Alabama at Birmingham","All","45 Years and older   (Adult, Older Adult)","Not Applicable","325","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care","679|R18HL092955-01A1","April 2010","April 2014","April 2014","April 22, 2010",,"December 29, 2015","University of Texas Health Science Center-Tyler, Tyler, Texas, United States",,"https://ClinicalTrials.gov/show/NCT01108991"
172,"NCT01443234","OxIGen: Oxford Imagery Generation: Investigating the Effects of an Internet Based Computer Program in Depression","OxIGen","Completed","No Results Available","Depression","Other: OxIGen|Other: OxIGen: control version","Change in score on Beck Depression Inventory - II|Change in score on Quick Inventory of Depressive Symptoms - Self Report|Change in State-Trait Anxiety Inventory (Trait scale)|Change on Beck Anxiety Inventory|Change on Scrambled Sentences Task|Change on Life Orientation Test - Revised|Change on Prospective Imagery Test|Change on Behavioural Activation in Depression Scale|Change in IAPT Toolkit|Change on EuroQol-5D|Change in Neuroticism|Change on Beck Depression Inventory - II|Change on Quick Inventory of Depressive Symptoms - Self Report|Change on State-Trait Anxiety Inventory (Trait scale)|Change on IAPT Toolkit|Change on Euroqol-5D|Change on Neuroticism|Image Generation Task","University of Oxford|Lupina Foundation","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","11/SC/0278","February 2012","April 2013","December 2013","September 29, 2011",,"January 9, 2014","MRC Cognition and Brain Sciences Unit, Cambridge, Cambridgeshire, United Kingdom|Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT01443234"
173,"NCT02755129","FRailty WAlking Patterns (FRAP) Study","FRAP","Completed","Has Results","Heart Failure","Other: Walking Exercises-Six Minute Walk (6MW) Test|Other: Walking Exercises-4 Meter Gait Speed (4MGS) Test|Other: Walking Exercises-Five Times Sit to Stand (FTSTS) Test|Other: Walking Exercises-Expanded Timed Get-Up-and-Go (ETGUG) Test|Other: Reveal LINQ accelerometer|Other: 3D accelerometer","Correlation of Gait Speed Between Reveal LINQ Accelerometer, Validation Accelerometer and/or Computer Assisted Rehabilitation System by Walking Exercises","Medtronic BRC|Medtronic Bakken Research Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","15","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","FRAP1","September 20, 2016","April 20, 2017","July 20, 2017","April 28, 2016","March 25, 2020","March 25, 2020","NUTRIM School of Nutrition and Translational Research in Metabolism of the Faculty Health, Medicine and Life Sciences, Maastricht University,, Maastricht, Netherlands","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/29/NCT02755129/Prot_000.pdf|""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/29/NCT02755129/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT02755129"
174,"NCT01291992","Seizures After Cardiac Surgery -- A Study With Continuous EEG Monitoring",,"Completed","No Results Available","Non-convulsive Seizures",,"Frequency of non-convulsive seizures in postoperative cardiac surgery patients","Lawson Health Research Institute","All","18 Years and older   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","R-10-259|17107","September 2010","October 2012","January 2013","February 9, 2011",,"March 13, 2018","London Health Sciences Centre, University Hospital, London, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT01291992"
175,"NCT03409978","Smartphone App for Analysis of General Movements in Young Infants",,"Completed","No Results Available","Cerebral Palsy","Device: in-Motion app","Percentage of recordings that movement video recordings fulfil requirements needed for observation and classification of fidgety general movements|Ease of use of the In-Motion App in score on the Software usability scale (SUS) as part of a questionnaire sent to users two weeks after received video recordings|Correlation between computer-based software estimates by smartphone videos performed by parents at home and standard videos performed at the hospital follow-up clinic","St. Olavs Hospital|Norwegian University of Science and Technology|University of Illinois at Chicago|Ann & Robert H Lurie Children's Hospital of Chicago|Christian Medical College, Vellore, India|University Ghent|Hillerod Hospital, Denmark","All","12 Weeks to 17 Weeks   (Child)",,"86","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","2017/913","March 5, 2018","December 20, 2019","December 20, 2019","January 25, 2018",,"February 19, 2020","Ghent University, Ghent, Belgium|Hillerød Hospital, Copenhagen, Denmark|St Olavs Hospital, Trondheim, Norway",,"https://ClinicalTrials.gov/show/NCT03409978"
176,"NCT02416401","Attention Training for Learning Enhancement and Resilience Trial","ALERT","Completed","No Results Available","Age-related Cognitive Decline","Other: Computerized Plasticity-Based Adaptive Cognitive Training|Other: Commercially available computerized training","Attention Measures aimed to test attention|Executive Function|Functional Capacity|Quality of Sleep","Posit Science Corporation|University of Iowa|Harvard Medical School","All","65 Years and older   (Older Adult)","Not Applicable","83","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","PSC-1006-14","November 2015","December 2017","December 2017","April 15, 2015",,"January 9, 2018","University of Iowa, Iowa City, Iowa, United States|Harvard Medical School, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02416401"
177,"NCT02035176","Novel Measure of Social Deficits in Children","OATS","Completed","No Results Available","Autism Spectrum Disorders|ADHD",,"Eye gaze in response to animated social situations|Facial expressions in response to animated social situations","Oregon Health and Science University","All","6 Years to 11 Years   (Child)",,"92","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","eIRB 9747","February 2014","December 2018","December 2018","January 14, 2014",,"August 28, 2019","OHSU, Portland, Oregon, United States|Oregon Health and Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT02035176"
178,"NCT03747276","Can Electronic Information Kiosks Enhance Patient Accrual for Cancer Clinical Trials? A Pilot and Feasibility Study",,"Recruiting","No Results Available","Malignant Neoplasm","Other: Clinical Trial Kiosk","Change in accrual rate|Proportion of patients requesting research navigator contact|Proportion of patients contacted eligible for clinical trial|Proportion of eligible patients participating in clinical trial|Satisfaction with kiosk|Proportion of patients accessing kiosk","Lawson Health Research Institute|London Health Sciences Centre","All","18 Years and older   (Adult, Older Adult)","Not Applicable","560","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","Information Kiosk","July 19, 2018","September 18, 2018","November 18, 2018","November 20, 2018",,"November 20, 2018","London Health Sciences Centre, London, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03747276"
179,"NCT01401725","Electronic Strategies to Enhance Venous Thromboemboli (VTE) Prophylaxis in Hospitalized Medical Patients","E-SENTRY","Completed","No Results Available","Venous Thromboembolism","Behavioral: Electronic Order Entry System + CDSS|Behavioral: Electronic Order Entry System Only|Other: Usual Care","Proportion of hospitalized medical patients who are appropriately managed for VTE prophylaxis|Hospital-acquired venous thromboembolism|Major bleeding","McMaster University|Hamilton Health Sciences Corporation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","600","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","HHS150411","April 2011","June 2012","June 2012","July 25, 2011",,"October 16, 2015","Hamilton General Hospital, Hamilton, Ontario, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|Juravinski Hospital, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT01401725"
180,"NCT03240003","A Novel Computer-Based Therapy for Social Anxiety",,"Recruiting","No Results Available","Social Anxiety Disorder","Behavioral: GC-MRT|Behavioral: modified GC-MRT|Behavioral: Non-GC-MRT","Liebowitz Social Anxiety Scale|Social Phobia Inventory (SPIN)|Quality of Life Enjoyment & Satisfaction Questionnaire|Revised Social Anhedonia Scale|Snaith Hamilton Pleasure Scale|Hamilton Rating Scale for Depression - 17 item version|Clinical Global Impression-Change Scale","New York State Psychiatric Institute","All","18 Years to 60 Years   (Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","7527 (SAD)","August 25, 2017","August 1, 2020","August 1, 2020","August 4, 2017",,"September 25, 2019","New York State Psychiatric Institute, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03240003"
181,"NCT01096953","Telepsychiatry in Rural Youth",,"Withdrawn","No Results Available","Attention Deficit Hyperactivity Disorder","Behavioral: Mental health care implemented by telepsychiatry|Behavioral: Face-to-face care","Equivalence|Non-inferiority","Oregon Health and Science University","All","6 Years to 17 Years   (Child)","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","1R21MH079984-01","April 2010","September 2011","September 2011","March 31, 2010",,"September 11, 2019","Douglas County Health & Social Services, Roseburg, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT01096953"
182,"NCT00850759","Using Virtual Reality to Train Children in Pedestrian Safety",,"Completed","Has Results","Street-crossing Ability|Pedestrian Safety","Device: virtual pedestrian environment|Device: computer and video|Behavioral: streetside training","Street-crossing Ability","University of Alabama at Birmingham|National Institutes of Health (NIH)","All","7 Years to 8 Years   (Child)","Phase 3","240","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","F080715010|R01HD058573-01A1","October 2009","May 2012","March 2014","February 25, 2009","November 20, 2013","December 16, 2014","UAB Youth Safety Lab, University of Alabama at Birmingham, Birmingham, Alabama, United States",,"https://ClinicalTrials.gov/show/NCT00850759"
183,"NCT01528033","Treatment Study of Vacuum Assisted Closure for Postsurgical Subcutaneous Abdominal Wound Healing Impairments","SAWHI","Completed","Has Results","Wound Healing Disorder|Impaired Wound Healing|Abdominal Wound Healing Disorder|Abdominal Wound Healing Impairment|Acute Postsurgical Subcutaneous Wound","Device: Vacuum Assisted Closure®|Other: Standard conventional wound therapy","Time to Complete Wound Closure|Incidence of Confirmed and Verified Wound Closure|Recurrence","University of Witten/Herdecke|KCI Europe Holding B.V.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","539","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","VAC2010-56|00000648","August 2, 2011","March 14, 2018","June 11, 2018","February 7, 2012","June 25, 2020","June 25, 2020","UZ Brussel, Brussel, Belgium|Department of Abdominal Surgery Gasthuisberg University Hospital, Leuven, Belgium|Sana Klinikum Lichtenberg (Berlin), Berlin, Germany|Unfallkrankenhaus Berlin Klinik für Allgemein- und Viszeralchirurgie, Berlin, Germany|St. Josef-Hospital gGmbH Universitätsklinikum der Ruhr-Universität Bochum, Bochum, Germany|Universitätsmedizin Göttingen, Göttingen, Germany|Universitätsklinikum des Saarlandes, Klinik für Allgemeine Chirurgie, Viszeral-, Gefäß- und Kinderchirurgie, Homburg, Germany|UNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität, Mainz, Germany|Universitätsmedizin Mannheim Medizinische Fakultät Mannheim der Universität Heidelberg Chirurgische Klinik, Mannheim, Germany|Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar, München, Germany|Ruppiner Kliniken GmbH, Neuruppin, Germany|Klinikum Ernst von Bergmann, Klinik für Allgemein- und Visceralchirurgie, Potsdam, Germany|Diakoniekrankenhaus Rotenburg, Rotenburg, Germany|Thüringen-Kliniken ""Georgius Agricola"" GmbH, Saalfeld, Germany|GRN-Klinik Sinsheim, Allgemein- und Viszeralchirurgie, Sinsheim, Germany","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/33/NCT01528033/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT01528033"
184,"NCT02272959","Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth Who do Not Respond to CBT",,"Recruiting","No Results Available","Anxiety Disorders","Behavioral: Attention bias modification treatment (ABMT)|Behavioral: Attention Control Condition","The Pediatric Anxiety Rating Scale (PARS)|Anxiety Related Emotional Disorders - Child/Parent Version (SCARED-C/P)","Yair Bar-Haim|United States - Israel Binational Science Foundation|Schneider Children's Hospital|Sheba Medical Center|Tel Aviv University","All","10 Years to 18 Years   (Child, Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","loe140498ctil","January 2015","July 2019","July 2019","October 23, 2014",,"September 18, 2018","Tel-Aviv University, Tel-Aviv, Israel",,"https://ClinicalTrials.gov/show/NCT02272959"
185,"NCT01174758","Development of an Instrumented System to Measure Mobility in Parkinson's Disease",,"Completed","No Results Available","Parkinson's Disease",,"iMOBILITY: the instrumented system for measuring mobility.","Oregon Health and Science University|National Institute of Neurological Disorders and Stroke (NINDS)|National Multiple Sclerosis Society","All","50 Years to 80 Years   (Adult, Older Adult)",,"160","Other|NIH","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","5029","October 2009","October 2014","October 2014","August 4, 2010",,"November 3, 2014","Oregon Clinical Translational Research Institute, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT01174758"
186,"NCT02141022","Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya",,"Completed","No Results Available","Multiple Sclerosis|Cognitive Deficits|Gilenya Modifying Therapy for MS","Other: plasticity-based computerized cognitive remediation program|Drug: Gileyna","Change from Baseline in Neuropsychological Test Results at 12weeks|Evaluate the feasibility of PACR for adults with MS on Gilenya therapy who have cognitive impairment based on Participant Adherence to Study Protocol","Stony Brook University|Novartis","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","20","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CFTY720DUS26T|IIRP-1450","August 2013","September 2014","September 2015","May 16, 2014",,"May 10, 2016","Stony Brook University, Stony Brook, New York, United States",,"https://ClinicalTrials.gov/show/NCT02141022"
187,"NCT02471976","Impact of an Early Palliative Approach","LATAREA-IV","Completed","No Results Available","Criteria of Vulnerability","Other: strategy promoting early consideration and collegiate vulnerability of patients","Number of participants dead with palliative strategy|Impact of the procedure according to ICU type|Characteristics of surgical patients concerned by a palliative strategy|Impact of an incentive approach on length of mechanical ventilation and length of stay in the ICU.|Extent of information collected concerning the collegial process|Impact of the procedure on caregivers' satisfaction|Number of identified conflicts","Assistance Publique - Hôpitaux de Paris","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1172","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","K071203","October 2012","January 2014","December 2015","June 15, 2015",,"June 20, 2017","Hôpital FOCH, Suresnes, France",,"https://ClinicalTrials.gov/show/NCT02471976"
188,"NCT01935219","Improving Performance in Drivers With Mild Cognitive Impairment",,"Completed","No Results Available","Mild Cognitive Impairment","Behavioral: Goal Management Training|Behavioral: Processing Speed Training|Behavioral: Brain Health Workshop","Driving Performance|Sustained Attention to Response Task (SART)|D-KEFs Tower Test|Useful Field of View Test (UFOV)|Cognitive Failures Questionnaire|Dysexecutive Questionnaire|Geriatric Depression Scale (GDS-15 item)|Quality of Life: AD (QOL-AD)","Baycrest|St. Michael's Hospital, Toronto|Sunnybrook Health Sciences Centre|Lakehead University|McGill University|University Health Network, Toronto|Toronto East General Hospital|Centre for Addiction and Mental Health","All","55 Years and older   (Adult, Older Adult)","Not Applicable","66","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","CIHR MOP-119580","August 2013","March 2019","March 2019","September 5, 2013",,"January 21, 2020","Baycrest Health Sciences, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT01935219"
189,"NCT01932034","Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software",,"Completed","No Results Available","Bacterial Infections","Device: BestDose Computer Software","Time to therapeutic vancomycin blood concentration|Number of blood samples sent for vancomycin concentration measurement|Incidence of nephrotoxicity","Children's Hospital Los Angeles|National Institute of General Medical Sciences (NIGMS)","All","Child, Adult, Older Adult",,"263","Other|NIH","Observational","Observational Model: Case-Only|Time Perspective: Prospective","LACUSC-Van-01|R01GM068968","September 2012","July 1, 2016","July 4, 2016","August 30, 2013",,"February 20, 2018","Los Angeles County - University of Southern California Medical Center, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT01932034"
190,"NCT04317417","MOST EMPOWER: Optimizing An Emotion Regulation Intervention","MOST EMPOWER","Not yet recruiting","No Results Available","Cancer","Behavioral: EMPOWER","Patient-Reported Outcomes Measurement Information System (PROMIS) Positive Affect Computer Adaptive Test (CAT) Questionnaire|Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Questionnaire|Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Questionnaire|Patient-Reported Outcomes Measurement Information System (PROMIS) Life Satisfaction Questionnaire","Wake Forest University Health Sciences|National Cancer Institute (NCI)","All","18 Years to 39 Years   (Adult)","Not Applicable","352","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","IRB00057993|WFBCCC 04220|R01CA242849-01","July 2020","July 2023","July 2023","March 23, 2020",,"June 16, 2020","Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States|Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT04317417"
191,"NCT03340298","Fiber and Cardiovascular Risk Factors",,"Completed","No Results Available","Cardiovascular Risk Factor","Dietary Supplement: fiber","change of weight|change of waist circumference","Isfahan University of Medical Sciences","Female","Child, Adult, Older Adult","Not Applicable","75","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","FIBER","January 2016","July 2016","July 2016","November 13, 2017",,"September 20, 2019",,,"https://ClinicalTrials.gov/show/NCT03340298"
192,"NCT01443156","The Effects of Work Schedule and Sleep Patterns on Caregivers' Health",,"Completed","No Results Available","Obesity|Diabetes|Cancer|Metabolic Syndrome|Sleep Deprivation",,"Cognitive performance|Body Composition|Diet|Work Schedule|Blood Pressure|Blood cholesterol, glucose, triglycerides|Breast, skin, and lung cancer prevention behaviors and knowledge|Preventive care habits","Oregon Health and Science University","All","18 Years and older   (Adult, Older Adult)",,"211","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","OHSU eIRB7542","January 2012","February 2013",,"September 29, 2011",,"February 18, 2013","St. Charles Medical Center, Bend, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT01443156"
193,"NCT04349852","Verbal Working Memory and Attention Remediation for Adults With Traumatic Brain Injury.",,"Not yet recruiting","No Results Available","Traumatic Brain Injury","Behavioral: BrainHQ Cognitive Training Modules|Behavioral: BrainHQ People Skills Modules","Change in participants' visual memory after participating in BrainHQ training|Change in participants' logical memory after participating in BrainHQ training|Change in participants' working memory after participating in BrainHQ training|Change in participants' vocabulary after participating in BrainHQ training|Change in participants' ability to recall information|Change in participants' abstract reasoning|Change in participants' level of reading|Change in participants' spatial memory|Change in participants' verbal memory|Change in participants' ability to visually search|Change in participants' ability to attention|Change in participants ability to assess auditory information|Change in participants' verbal attention.|Change in participants' attention and verbal memory|Changes to participants' ability to understand social cues|Change in participants' sense of depression|Change in participants' sense of anxiety|Changes to participants' mental status|Changes in participants' daily living|Changes in the pattern of participants social lifestyle|Changes in the participants' overall status","NYU Langone Health","All","18 Years to 100 Years   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","20-00130","August 2020","August 2021","January 2022","April 16, 2020",,"April 16, 2020",,,"https://ClinicalTrials.gov/show/NCT04349852"
194,"NCT01128127","Strategies for Improving Proton Pump Inhibitors (PPIs) Prescription Associated to Non-steroidal Anti-inflammatory Drugs (NSAIDs)",,"Withdrawn","No Results Available","Adverse Events","Behavioral: Group education, audit-feedback and computer support|Behavioral: Audit-feedback and computer support|Behavioral: Control","Rate of inappropriate PPI prescriptions","Servicio Canario de Salud|Fundación Canaria de Investigación y Salud","All","Child, Adult, Older Adult","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","PI 43 08","January 2013","November 2014","June 2015","May 21, 2010",,"September 14, 2012","Servicio de Evaluación. Servicio Canario de Salud, Santa Cruz de Tenerife, Spain",,"https://ClinicalTrials.gov/show/NCT01128127"
195,"NCT04190043","Womens's Experiences of Pregnancy Loss Aftercare in the Gynecological Emergency",,"Completed","No Results Available","Miscarriage",,"to evaluate womens's experiences of pregnancy loss aftercare|evaluate the discrepancy between the patient's experience and the caregivers' experience in front of diagnosis of miscarriage.","University Hospital, Montpellier","Female","18 Years to 70 Years   (Adult, Older Adult)",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","RECHMPL19_0547","January 1, 2020","May 1, 2020","May 30, 2020","December 9, 2019",,"June 5, 2020","Uhmontpellier, Montpellier, France",,"https://ClinicalTrials.gov/show/NCT04190043"
196,"NCT01428401","Astragalus Membranaceus for Brain Edema Induced by Hemorrhagic Stroke",,"Completed","No Results Available","Stroke|Hemorrhagic Transformation Due to Acute Stroke","Drug: Chinese Herb Astragalus membranaceus|Other: Placebo","patients' scores(BI,FIM,GOS,mRS) on several clinical scales|inflammatory index and Computer tomography (CT) examination","China Medical University Hospital","All","30 Years to 75 Years   (Adult, Older Adult)","Phase 2","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","DMR96-IRB-126","January 2008","December 2010","March 2011","September 5, 2011",,"September 5, 2011",,,"https://ClinicalTrials.gov/show/NCT01428401"
197,"NCT00252395","Evaluation of Electronic Prescribing in Hospital Ambulatory Care Clinics",,"Completed","No Results Available","Electronic Prescribing","Device: PDA-based Electronic Prescribing Software","Total prescribing error, as measured by the number of call backs received from pharmacists.|a) Interactions|b) Dosing and route of administration errors|c) Pack errors|d) Legibility errors","Sunnybrook Health Sciences Centre|Health Canada","All","Child, Adult, Older Adult","Phase 4","40","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Educational/Counseling/Training","S&W e-RX|6804-15-2003/5590024","August 2005",,"August 2006","November 11, 2005",,"November 11, 2005","Sunnybrook & Women's College Health Science Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT00252395"
198,"NCT01921439","OCAST Cessation Study","OCAST","Completed","No Results Available","Tobacco Smoking Behavior|Cigarette Smoking Behavior|Second Hand Tobacco Smoke|Tobacco Use Cessation","Behavioral: Personalized Feedback","Self-Reported Readiness and Motivation to Quit Smoking|Parent and Child Salivary Cotinine|Change in self-reported cigarette use","University of Oklahoma|Oklahoma Center for the Advancement of Science and Technology","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","152","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other","3262","July 2013","December 2016","December 2016","August 13, 2013",,"April 11, 2017","Oklahoma Tobacco Research Center, Oklahoma City, Oklahoma, United States",,"https://ClinicalTrials.gov/show/NCT01921439"
199,"NCT01890031","Interactive Cholesterol Advisory Tool","ICAT","Completed","Has Results","Low Risk (0-10% Chance) of Developing Cardiovascular Disease Within 10 Years Based on Risk Factors|Moderate Risk (10-20% Chance) of Developing Cardiovascular (Heart) Disease Within 10 Years Based on Risk Factors","Other: Interactive Cholesterol Advisory Tool|Other: Study physician visits","LDL-C in All ICAT Group Participants Versus Non-ICAT Group Participants|Number of Participants Who Adhered to Medication Prescribed as Self Reported at 9 Months","University of Rochester","All","18 Years and older   (Adult, Older Adult)","Phase 1","131","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)","1R44HL097506-01","January 2012","June 2013","June 2013","July 1, 2013","September 4, 2015","September 4, 2015","University of Rochester, Rochester, New York, United States",,"https://ClinicalTrials.gov/show/NCT01890031"
200,"NCT04355325","Posterior Implant-Supported Modified Monolithic Zirconia and Metal-Ceramic Single Crowns: 5 Years Study",,"Recruiting","No Results Available","Posterior Occlusion|Fracture","Device: modified monolithic zirconia crowns|Device: Metal Ceramic crowns","Screw loosing|Marginal integrity|chipping of veneering ceramic|occlusal roughness|framework fracture|Marginal bone loss:|Crown de-bonding","Jordan University of Science and Technology|ITI International Team for Implantology, Switzerland","All","21 Years to 55 Years   (Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic","Jordan","April 2, 2020","May 2, 2024","December 5, 2024","April 21, 2020",,"April 22, 2020","Jordan University of Science and Technology, Irbid, Jordan",,"https://ClinicalTrials.gov/show/NCT04355325"
201,"NCT04103775","Mechanisms of Cognitive Change","CTCS","Recruiting","No Results Available","Psychosis","Behavioral: Cognitive Remediation|Behavioral: Active Control","MATRICS Consensus Cognitive Battery (MCCB) Verbal Learning Subscale Scores|Academic Performance","Colorado State University","All","15 Years to 100 Years   (Child, Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","19-8509H","September 20, 2019","May 15, 2021","May 15, 2021","September 25, 2019",,"September 25, 2019","Colorado State University, Fort Collins, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT04103775"
202,"NCT01836094","Effects of USP Methylene Blue on Cognitive and fMRI Brain Activity",,"Completed","No Results Available","Brain Activity","Drug: Methylene Blue (USP grade, 280mg oral)|Drug: Placebo","Improvement in reaction time assessed by fMRI measurements and PVT measurements|Improvement in memory assessed by fMRI measurements and DMS measurements|Enhanced fMRI responses to visual-motor task","The University of Texas Health Science Center at San Antonio","All","18 Years to 65 Years   (Adult, Older Adult)","Early Phase 1","36","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","NS 13-208","August 2013","March 2016","March 2016","April 19, 2013",,"April 11, 2017","Research Imaging Institute, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States",,"https://ClinicalTrials.gov/show/NCT01836094"
203,"NCT04260308","A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia",,"Recruiting","No Results Available","Virus; Pneumonia",,"GHQ-12(general health questionnaire-12)|IES-R(Impact of Event Scale-Revised)","Huazhong University of Science and Technology","All","Child, Adult, Older Adult",,"30000","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","IRBID:TJ-C 20200107","February 3, 2020","April 15, 2020","April 20, 2020","February 7, 2020",,"February 7, 2020","Tongji Hospital，Tongji Medical College Affiliated，Huazhong University of Science ＆ Technology, Wuhan, Hubei, China",,"https://ClinicalTrials.gov/show/NCT04260308"
204,"NCT04202016","The Rate of Space Closure With Piezocision-based Corticotomy in Different Facial Types: A Split-mouth Design","RCT","Recruiting","No Results Available","Class II Div 1 Malocclusion","Procedure: Piezocision Surgery","Rate of space closure|Root resorption","Jordan University of Science and Technology|University of Edinburgh|University of Sydney","Female","15 Years to 29 Years   (Child, Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Screening","20190232","November 1, 2018","October 2020","December 2020","December 17, 2019",,"June 26, 2020","Postgraduate orthodontic clinics, Jordan University of Science and Technology, Irbid, Jordan",,"https://ClinicalTrials.gov/show/NCT04202016"
205,"NCT02922556","Piloting a Novel, Mobile Cognitive Training Tool for Patients With Major Depressive Disorder (MDD)","MDD","Completed","No Results Available","Major Depressive Disorder","Other: Computerized Plasticity-Based Adaptive Cognitive Training|Other: Commercially available computerized training","Change scores for depressive symptoms using Beck Depression Scale (BDI)|Change scores for anxiety symptoms using Generalized Anxiety Disorder (GAD-7)|Change scores for functional health and well being using the 12-Item Short Form Health Survey (SF-12)|Change scores for depressive symptoms using Patient Health Questionnaire (PHQ-9)","Posit Science Corporation","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","28","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","PSC-1008-2015","September 2015","June 21, 2019","June 21, 2019","October 4, 2016",,"June 25, 2019","Posit Science Corporation, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT02922556"
206,"NCT02600884","Efficacy Trial of a Brief Parent-Based Adolescent Sexual Health Intervention",,"Completed","No Results Available","Increase HPV Vaccination Uptake|Delay Sexual Debut","Behavioral: Families Talking Together Plus (FTT+HPV)|Behavioral: Brief motivational interviewing (BMI)","Change in parent child communication as assessed by the Families Talking Together Plus HPV (FTT + HPV) survey administered to parents|Change in parent child communication as assessed by the FTT + HPV survey administered to parents|Change in intentions for sex as assessed by the FTT + HPV survey administered to youths|Change in parental monitoring as assessed by the FTT + HPV survey administered to parents|Change in parental involvement as Assessed by the FTT + HPV survey administered to parents|Change in parental involvement as assessed by the FTT + HPV survey administered to parents|Change in intentions for communication as assessed by the FTT + HPV survey administered to parents|Change in intentions for HPV vaccination of child as assessed by the FTT + HPV survey administered to parents|Change in sexual activity as assessed by the FTT + HPV survey administered to youths|Change in knowledge of HPV risk factors as assessed by the FTT + HPV survey administered to youths|Change in parental communication as assessed by the FTT + HPV survey administered to youths|Change in HPV vaccine received as assessed by the FTT + HPV survey administered to youths","The University of Texas Health Science Center, Houston","All","11 Years and older   (Child, Adult, Older Adult)","Not Applicable","1183","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","HSC-SN-15-0091","September 2015","November 2018","April 2019","November 9, 2015",,"July 12, 2019","The University of Texas Health Science Center at Houston, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT02600884"
207,"NCT04130477","Tunnel Attachments With Clear Aligners vs Clear Aligners",,"Not yet recruiting","No Results Available","Malocclusion","Device: Tunnel attachments and light Nickel Titanium wire|Device: Clear Aligner therapy","1) Horizontal movement in millimeters|2) Vertical movement in mm|3) angular movement in degrees","Harvard School of Dental Medicine","All","12 Years to 65 Years   (Child, Adult, Older Adult)","Not Applicable","34","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","HarvardSDM","November 1, 2019","April 30, 2021","May 30, 2021","October 17, 2019",,"October 17, 2019",,,"https://ClinicalTrials.gov/show/NCT04130477"
208,"NCT02467660","Meditation or Health & Wellness Education Via Internet for Adults 50-80 Years Old",,"Completed","No Results Available","Stress, Physiological|Stress, Psychological","Behavioral: Mindfulness Meditation|Behavioral: Health & Wellness Education","Golden Stroop Cognitive Task Total Score|Heart Rate Variability|Composite multi-domain physiologic measure|Rey Auditory Verbal Learning Task Total Score|Verbal Fluency Total Score|Letter Number Sequencing Total Score|Systolic and Diastolic Blood Pressure|Respiration Rate|Salivary Cortisol Levels","Oregon Health and Science University","All","50 Years to 80 Years   (Adult, Older Adult)","Not Applicable","64","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research","11847","June 2015","August 2018","January 2019","June 10, 2015",,"March 13, 2019","Hatfield Research Center, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT02467660"
209,"NCT03277508","Assistive Soft Robotic Glove Intervention Using Brain-Computer Interface for Elderly Stroke Patients",,"Completed","No Results Available","Stroke","Device: BCI Robot Assisted Hand Therapy|Device: CPM Robot Assisted Hand Therapy","Action Research Arm Test|Fugl-Meyer Assessment|Grip Strength Test","National University Hospital, Singapore|National University, Singapore|Agency for Science, Technology and Research","All","55 Years to 90 Years   (Adult, Older Adult)","Not Applicable","11","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Device Feasibility","2017/00312","March 2, 2018","April 22, 2019","April 22, 2019","September 11, 2017",,"April 30, 2019","National University Hospital, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT03277508"
210,"NCT01563276","Postural Instability in Progressive Supranuclear Palsy",,"Completed","No Results Available","Progressive Supranuclear Palsy|Parkinson's Disease",,"Relative contributions of vestibular and visual information to postural control in PSP|Postural Response Latencies|Gait patterns and postural transitions|Perception of vertical and horizontal references","Oregon Health and Science University","All","40 Years to 85 Years   (Adult, Older Adult)",,"36","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","IRB00007924","December 2011","May 10, 2013","May 10, 2013","March 26, 2012",,"September 13, 2019","Oregon Health and Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT01563276"
211,"NCT02928666","Integration of Guidelines for Comorbidities",,"Unknown status","No Results Available","Type 2 Diabetes Mellitus|Lung Diseases, Obstructive|Osteoporosis|Hypertension|Osteoarthritis","Other: DSS for mitigating interactions between recommendations","Number of conflicting recommendations detected out of total number of conflicts","Rambam Health Care Campus|University of Haifa","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Investigator)|Primary Purpose: Basic Science","RambamMC-16-IH-0400-16-RMB","October 2018","July 2019","September 2019","October 10, 2016",,"April 28, 2017",,,"https://ClinicalTrials.gov/show/NCT02928666"
212,"NCT04081090","Clinical Translational Science Institute (CTSI) Brain HQ Modules vs. Active Controls for Elderly Survivors of ICU",,"Recruiting","No Results Available","Neurocognitive Disorders","Behavioral: Brain HQ Cognitive Modules","Tailored Online Cognitive Rehabilitation|Adherence to Online Intervention Modules|Improvement in Neurocognitive Function part 1|Improvement in Neurocognitive Function part 2|Measure Differences in Cognitive Performance","Medical College of Wisconsin","All","65 Years and older   (Older Adult)","Not Applicable","70","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","32542","January 15, 2019","December 31, 2021","December 31, 2021","September 9, 2019",,"November 7, 2019","Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT04081090"
213,"NCT02758093","Speed of Processing Training in Adults With HIV","SOP","Active, not recruiting","No Results Available","HIV|Cognition - Other|Impaired Driving","Behavioral: Speed of Processing Training|Other: Internet Navigational","Mean Speed of Processing Measures at baseline|Mean Speed of Processing Measures at 10 - 12 weeks after baseline|Mean Speed of Processing Measures at 1 year after baseline|Mean Speed of Processing Measures at 2 years after baseline|Driving Simulation (a measure of everyday functioning)|Number of vehicular crashes identified in State Crash Records for the 5 years prior to enrollment|Driving Habits Questionnaire (a measure of everyday functioning)|Timed Instrument Activities of Daily Living (a measure of everyday functioning)|Medication Adherence (a measure of everyday functioning)|Number of vehicular crashes identified in State Crash Records at 2.5 years after enrollment|Number of vehicular crashes identified in State Crash Records at 5 years after enrollment","University of Alabama at Birmingham","All","40 Years and older   (Adult, Older Adult)","Not Applicable","217","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","F160122002","September 2016","September 2020","April 2021","May 2, 2016",,"December 16, 2019","University of Alabama at Birmingham, Birmingham, Alabama, United States",,"https://ClinicalTrials.gov/show/NCT02758093"
214,"NCT00599209","Health Information Technology in the Nursing Home",,"Completed","No Results Available","Patient Safety|Prescribing Practices|Laboratory Monitoring Practices","Other: clinical decision support","extent to which a computer-based clinical decision-support system (accompanying computerized provider order-entry) can improve the quality of medication ordering and monitoring|costs associated with this system and the system's impact on the productivity of providers","University of Massachusetts, Worcester|Baycrest Centre for Geriatric Care|Agency for Healthcare Research and Quality (AHRQ)","All","Child, Adult, Older Adult","Not Applicable","23","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","11390|5R01HS015430","September 2004","September 2008","September 2008","January 23, 2008",,"August 4, 2011","Meyers Primary Care Institute, Worcester, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT00599209"
215,"NCT01198210","The Effect of Peritonsillar Infiltration of Ketamine and Dexamethasone for Postoperative Pain Relief in Children Following Adenotonsillectomy",,"Unknown status","No Results Available","Tonsillectomy","Drug: saline|Drug: Ketamine|Drug: Dexamethasone|Drug: ketamine-dexamethasone","pain will be assessed by [observational pain scores (OPS)]|time to first demand of analgesia|postoperative analgesic consumption|nausea, vomiting will be assessed by questioning their parents.|bleeding will be assessed by questioning their parents|family satisfaction will be assessed by questioning their parents.","Qazvin University Of Medical Sciences","All","3 Years to 12 Years   (Child)","Phase 1|Phase 2","160","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","ACTRN12610000658011","July 2010","November 2013","December 2013","September 10, 2010",,"May 7, 2013","Qazvin university of medical science, Qazvin, Iran, Islamic Republic of",,"https://ClinicalTrials.gov/show/NCT01198210"
216,"NCT03237520","Comparing Virtual Reality Therapy With Modified-CIMT Versus Modified-CIMT Alone in Hemiparetic Children",,"Unknown status","No Results Available","Hemiparesis","Other: Virtual Reality Therapy|Other: mCIMT","8 weeks of VRT with mCIMT versus mCIMT alone|To compare the improvement in the sub domains(dissociated movements, grasp, protective extension and weight bearing) of QUEST score between the 2 groups|Comparing the improvement in speed of movements between 2 groups|Comparing the improvement in muscle strength between 2 groups|Functional Magnetic Resonance Imaging(fMRI) in the 2 groups|fMRI changes copared with clinical improvement in 2 groups before and after intervention|DTI(Diffusion Tensor Imaging) changes compared with clinical improvement in 2 groups before and after intervention|Diffusion Tensor Imaging changes in 2 groups|Sustained improvement|Quality of life improvement|Compliance","All India Institute of Medical Sciences, New Delhi","All","5 Years to 18 Years   (Child, Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","VRT with CIMT vs CIMT alone","September 2017","August 2018","August 2018","August 2, 2017",,"August 10, 2017",,,"https://ClinicalTrials.gov/show/NCT03237520"
217,"NCT03873441","Innovative Game-Aided Rehabilitation Platform for Rehabilitation of Balance in Children With Cerebral Palsy",,"Not yet recruiting","No Results Available","Cerebral Palsy","Other: Computer Games-Aided Balance Training Protocol|Other: Conventional Balance Training Protocol","Peabody Developmental Motor Scale-2 (PDMS-2)|Gross Motor Function Measure|COP Displacement Measures","University of Manitoba|SDM College of Medical Sciences & Hospital","All","3 Years to 8 Years   (Child)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","HS22614 (H2019:081)","July 2019","July 2020","July 2020","March 13, 2019",,"March 15, 2019","School of Medical Rehabilitation , University of Mantioba, Winnipeg, Manitoba, Canada|University of Manitoba, Winnipeg, Manitoba, Canada",,"https://ClinicalTrials.gov/show/NCT03873441"
218,"NCT02562469","ACTIVATE: A Computerized Training Program for Children With ADHD",,"Completed","No Results Available","ADHD","Other: ACTIVATE","ADHD symptoms on the Disruptive Behavior Rating Scale","New York University","All","7 Years to 11 Years   (Child)","Not Applicable","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","ACTIVATE","September 2015","August 2017","August 2017","September 29, 2015",,"October 2, 2018","New York University, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT02562469"
219,"NCT03929367","PK Sampling After IV Oxytocin and Effects on Sensory Function in Healthy Volunteers",,"Active, not recruiting","No Results Available","Chronic Pain","Drug: Oxytocin","Oxytocin Concentration|Light Touch Frequency Threshold|Sustained Heat","Wake Forest University Health Sciences","All","18 Years to 60 Years   (Adult)","Phase 4","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","IRB00056413","May 10, 2019","July 2020","July 2020","April 26, 2019",,"June 30, 2020","Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03929367"
220,"NCT02443558","Brainwave Control of a Wearable Robotic Arm for Rehabilitation and Neurophysiological Study in Cervical Spine Injury","CSI:Brainwave","Completed","No Results Available","Spinal Cord Injuries","Other: Brain-Computer Interface control of robotic arms.|Device: MERCURY v2.0 robotic arms","BCI control (yes/no). (ability of participants to modulate brainwave activity in order to achieve control of the BCI)|Initial Functional Improvement (Greek translation of the Spinal Cord Independence Measure, version III (g-SCIM-III)|Long-term Functional Improvement (Greek translation of the Spinal Cord Independence Measure, version III (g-SCIM-III)|BCI performance (classification accuracy (percentage of voluntary non-erroneous commands to overall number of detected commands) and by bit rate (number of commands per minute)","Aristotle University Of Thessaloniki|Cervical Spine Research Society","All","14 Years and older   (Child, Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","90886","December 15, 2016","December 31, 2018","December 31, 2018","May 14, 2015",,"February 17, 2020","Lab of Medical Physics, Faculty of Medicine, Aristolte University of Thessaloniki, Thessaloníki, Thessaloniki, Greece",,"https://ClinicalTrials.gov/show/NCT02443558"
221,"NCT03645811","Integrative Medicine on Exam Anxiety",,"Completed","Has Results","Anxiety|Educational Problems","Behavioral: Music Therapy|Behavioral: EFT","The Situational-Continuous Anxiety Inventory","Istanbul Saglik Bilimleri University","All","18 Years to 24 Years   (Adult)","Not Applicable","96","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","10840098-604.01.01-E.11892","January 1, 2017","May 31, 2017","May 14, 2018","August 24, 2018","March 11, 2020","March 11, 2020","Medipol Universtiy, Istanbul, Turkey","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/11/NCT03645811/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03645811"
222,"NCT01979991","Model-Based Image Reconstruction for X-Ray CT in Lung Imaging",,"Completed","No Results Available","Lung Diseases","Procedure: CT Imaging and Reconstruction","Developement of a computer program to improve CT image quality","University of Michigan|National Institutes of Health (NIH)|General Electric","All","18 Years and older   (Adult, Older Adult)","Phase 1","184","Other|NIH|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Investigator)|Primary Purpose: Basic Science","HUM00038447","August 2010","March 2015","December 2015","November 8, 2013",,"February 5, 2016","University of Michigan Hospital, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT01979991"
223,"NCT03766139","Regenerative Potential of Supercell Glue and Platelet Rich Fibrin Matrix",,"Recruiting","No Results Available","Intrabony Periodontal Defect","Biological: SUPERCELL GLUE|Biological: PRFM ALONE","Early wound healing index (Supercell in early wound healing index)|Change in probing pocket depth and clinical attachment gain (Supercell as a regenerative novel material)|Change in the bone level (Supercell as a biological material)|Change in the clinical parameters of gingival index and plaque index (Supercell as a regenerative material using clinical indices)","KLE Society's Institute of Dental Sciences","All","25 Years to 60 Years   (Adult)","Early Phase 1","17","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","PARVATHY61","December 2018","June 2019","November 2019","December 6, 2018",,"December 7, 2018","Kle Society'S Institute of Dental Sciences, Bangalore, Karnataka, India",,"https://ClinicalTrials.gov/show/NCT03766139"
224,"NCT03731962","Using Preprocedural Urine NMR(Nuclear Magnetic Resonance) -Based Metabolomics Analysis",,"Completed","No Results Available","Contrast-induced Nephropathy|Coronary Angiography","Procedure: Coronary Angiography","developing CIN|Urine Metabolomics","Shahid Beheshti University of Medical Sciences","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","SBMU23567/J","August 1, 2018","September 1, 2018","November 1, 2018","November 6, 2018",,"November 7, 2018","Nooshin Dalili, Tehran, Iran, Islamic Republic of",,"https://ClinicalTrials.gov/show/NCT03731962"
225,"NCT02378727","CompuFlo® Assessment Study for the Epidural Space Verification","COMPASS","Unknown status","No Results Available","Verification of Needle Tip Placement in the Lumbar Epidural Space","Device: Active: Comparator Loss Of Resistance Syringe|Device: Experimental: CompuFlo® Epidural System","Primary Effectiveness Objective (successful performance of lumbar epidural procedure)","Milestone Scientific, Inc","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","400","Industry","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","EPI-INT14-01","January 2015","July 2016","July 2016","March 4, 2015",,"July 6, 2016","University of California Irvine, Irvine, California, United States|Vitamed Research, Rancho Mirage, California, United States|San Diego Pain Institute, San Diego, California, United States|Northwestern Memorial Hospital, Chicago, Illinois, United States|University of Texas Houston, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT02378727"
226,"NCT02404857","BCI Post-stroke Neurorehabilitation","BCI-stroke","Completed","No Results Available","Poststroke/CVA Hemiparesis|Paralytic Stroke|Hand Flaccid Paralysis","Device: EEG based Brain Computer Interface","Performance of the BCI-system (evaluation of performance through patient questionaires & the performance of the BCI classifier during intended and imagined hand movements)|EEG sensory-motor rhythm signals (Detailed analysis of the EEG signals in relation to the severity of the paresis and movement condition)","University Hospital, Montpellier|Université Montpellier|National University of Ireland, Maynooth|Centre Hospitalier Universitaire de Nīmes","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","9431","January 2015","October 2015","October 2015","April 1, 2015",,"November 24, 2015","CHRU Lapeyronie, Montpellier, Herault, France",,"https://ClinicalTrials.gov/show/NCT02404857"
227,"NCT03466892","Repetitive Thinking in FibroMyalgia and Attentional Bias","PRFM-BA","Recruiting","No Results Available","Chronic Pain","Other: Questionnaires and computer paradigm","To measure attentional bias using a visual probe task paradigm.","Centre Hospitalier Universitaire, Amiens","All","18 Years and older   (Adult, Older Adult)",,"40","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","PI2018_843_0003","April 26, 2018","April 25, 2019","April 25, 2019","March 15, 2018",,"August 8, 2018","CHU Amiens Picardie, Amiens, Picardie, France",,"https://ClinicalTrials.gov/show/NCT03466892"
228,"NCT02507895","Effect of Brain-Computer Interfaced-Assisted Motor Imagery for Gait Retraining in Stroke Patients",,"Completed","No Results Available","Stroke","Device: MI-BCI","changes of "" gait parameters measured by "" from baseline to post-training and 4-6 weeks after training|Changes of ""cortical excitability measured by TMS"" from baseline to post-training and 4-6 weeks after training|changes of "" cortical excitability measured by fMRI/DTI"" from baseline to post-training and 4-6 weeks after training|Mobility changes from baseline to post-training and 4-6 weeks after training, as measured by ""timed up-and-go test""|changes of walking speed measured by ""10 metre walk test"", from baseline to post-training and 4-6 weeks after training","National University Hospital, Singapore|National University Health System, Singapore|Agency for Science, Technology and Research","All","21 Years to 70 Years   (Adult, Older Adult)","Not Applicable","26","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","BCI-LL2012/00658","October 2013","November 2017","January 2018","July 24, 2015",,"May 17, 2018","National University Hospital, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT02507895"
229,"NCT02439827","The ""Fortaleça Sua Saúde"" Program for Active and Healthy Lifestyle Among Brazilian Students",,"Completed","No Results Available","Adolescent Behavior","Behavioral: ""Fortaleça sua Saúde"" program","Change from baseline in weekly time in moderate-to-vigorous physical activity at 4 months|Change from baseline in the daily time using TV/computer/video games at 4 months|Change from baseline in the healthy eating score at 4 months|Change from baseline in the body mass index at 4 months|Change from baseline in the waist circumference at 4 months|Change from baseline in the quality of life score at 4 months|Change from baseline in the self-rated health score at 4 months|Change from baseline in the stress score at 4 months|Change from baseline in the sleepiness score at 4 months|Change from baseline in the academic performance score at 4 months|Change from baseline in the depression scale at 4 months among obese patients|Change from baseline in the eating disorders scale at 4 months among obese patients|Change from baseline in the objectively-measured physical activity time at 4 months among obese patients|Change from baseline in the body image score at 4 months","Universidade Federal de Santa Catarina|Universidade Federal do Ceara|Secretaria Municipal de Educação de Fortaleza, Ceará, Brazil","All","12 Years to 15 Years   (Child)","Not Applicable","1085","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","UniversidadeFSC","July 2014","December 2014","June 2015","May 12, 2015",,"February 2, 2017",,,"https://ClinicalTrials.gov/show/NCT02439827"
230,"NCT02618135","Brain-Computer Interface-based Programme for the Treatment of ASD/ADHD","ASDBCI","Unknown status","No Results Available","Attention Deficit Hyperactivity Disorder|Autism Spectrum Disorders","Other: Intervention Group|Other: Control Group","ADHD Rating Scale (clinicians)|ADHD Rating Scale (parent)|ADHD Rating Scale (clinician and parent)|ADHD Rating Scale|Social Responsiveness Scale|Clinical Global Assessment Scale (C-GAS)|Clinical Global Impression Severity Scale (CGI-S)|Clinical Global Impression Improvement Scale (CGI-I)|Conners' Continuous Performance Test (CPT-II)","Duke-NUS Graduate Medical School|Institute of Mental Health, Singapore|Agency for Science, Technology and Research","All","8 Years to 12 Years   (Child)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","2015/00841","May 2016","August 2017","July 2018","December 1, 2015",,"August 2, 2017","Institute of Mental Health, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT02618135"
231,"NCT03773016","Touchscreen Technology and Art for People With Dementia in Care Homes",,"Enrolling by invitation","No Results Available","Mild Dementia|Moderate Dementia","Behavioral: Art apps","Change on Wellbeing","University of Nottingham","All","Child, Adult, Older Adult","Not Applicable","12","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other","18080","February 20, 2019","April 12, 2019","April 12, 2019","December 12, 2018",,"March 22, 2019","University of Nottingham, Nottingham, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03773016"
232,"NCT02992821","Pocket Sized Carotid Stenosis Screening by Junior Doctors",,"Completed","No Results Available","Ischemic Attack, Transient|Transient Ischemic Attack|Stroke|Cerebrovascular Accident|Cerebrovascular Apoplexy","Procedure: Bed-side pocket size ultrasound imaging|Procedure: High frame rate tracking doppler","Proportion of patients without need for further diagnostic imaging|Reliability of bed-side ultrasound examinations of the carotid arteries performed by junior doctors with pocket-sized scanners|Proportion of interpretable examinations with bed-side ultrasound examinations of the carotid arteries performed by junior doctors with pocket-sized scanners|Time use of junior doctors performing carotid ultrasound with pocket-sized scanners.|Accuracy of high frame rate tracking doppler compared to conventional doppler measurements and computed tomography for grading carotid stenosis.","Levanger Hospital|Norwegian University of Science and Technology|St. Olavs Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","74","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","LS_Carot_16","December 2016","July 2018","July 2018","December 14, 2016",,"April 1, 2019","Department of Medicine, Hospital of Levanger, Levanger, Norway|St. Olav University Hospital, Trondheim, Norway",,"https://ClinicalTrials.gov/show/NCT02992821"
233,"NCT02494908","Evidence of Neuroplasticity After Performing a Cognitive Task in Idiopathic Parkinson's Disease Patients",,"Unknown status","No Results Available","Parkinson Disease","Behavioral: Playing a computer game simulating a car race","seeing evidence of microstructural brain tissue changes in Diffusion Tensor Imaging (DTI) MRI","Dr. Sharon Hassin|Bar-Ilan University, Israel|Tel Aviv University|Sheba Medical Center","All","30 Years to 80 Years   (Adult, Older Adult)","Not Applicable","80","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2372-15-SMC","July 2015","January 2018","July 2018","July 10, 2015",,"July 10, 2015","Movement Disorders Institute, Sheba Medical center, Ramat Gan, Israel",,"https://ClinicalTrials.gov/show/NCT02494908"
234,"NCT02578147","JUEGA: A Fun Study for Hispanic/Latino Adolescent Girls",,"Terminated","No Results Available","Adolescent Behavior","Behavioral: Mighty Girls|Behavioral: Game Girls","Change in sexual intentions from baseline (pre-intervention)|Change in risky sexual behavior from baseline (pre-intervention)|Change in sexual intentions from baseline (pre-intervention) as affected by the change in peer resistance self-efficacy|Change in sexual intentions from baseline (pre-intervention) as affected by implementation quality|Change in risky sexual behavior from baseline (pre-intervention) as affected by the change in peer resistance self-efficacy|Change in risky sexual behavior from baseline (pre-intervention) as affected by implementation quality|Costs of implementation of the intervention","University of Miami|National Institute of Nursing Research (NINR)","Female","11 Years to 14 Years   (Child)","Not Applicable","552","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","20140697|R01NR014851","September 2015","December 2018","December 2018","October 16, 2015",,"October 2, 2019","School of Nursing and Health Studies, Coral Gables, Florida, United States",,"https://ClinicalTrials.gov/show/NCT02578147"
235,"NCT01833104","Plasticity of the Compassionate Brain",,"Completed","No Results Available","Healthy Subjects","Behavioral: Presence - Perspective - Affect|Behavioral: Presence - Affect - Perspective.|Behavioral: Affect","Changes in several structural MRI measures (MRI-based cortical thickness, mprage; T1-mapping, mp2rage; automatic amygdala volumetry; tensor-based morphometry, Diffusion Tensor Imaging; Flair)|Changes in functional magnetic resonance imaging (fMRI) measure: Regulation and Generation of Emotions (RAGE)|Changes in functional magnetic resonance imaging (fMRI) measure: Resting State measurement|Changes in functional magnetic resonance imaging (fMRI) measure: Emotional Anticipation (EmoAnt)|Changes in functional magnetic resonance imaging (fMRI) measure: Modulation of pain perception|Changes in functional magnetic resonance imaging (fMRI) measure: Cued flanker task (CueFla), an attention and orienting task|Changes in functional magnetic resonance imaging (fMRI) measure: a Theory of Mind and Social Cognition task (the EmpaToM)|Changes in stress physiology: ""diurnal cortisol profile""|Changes in autonomic nervous system functions: Physiological Resting Baseline (electrocardiogram (ECG), electrodermal activity (EDA), and breathing)|Changes in a Virtual Reality Setting: The Panopticon --> attention and change detection|Changes in a Virtual Reality Setting: The Crowded Room --> changes in social distance to avatars|Changes in a Virtual Reality Setting: The Affect Gallery --> changes in affective preferences|Changes in a Virtual Reality Setting: Room 101 --> acute stress reactions|Computer-based experiment: Changes in the Inhibition and Alerting task (Stop-Signal-Reaction Time task).|Computer-based experiment: Changes in Working Memory Performance|Computer-based experiment: Changes in the Task Emotional Switching Paradigm|Computer-based experiment: Changes in the Emotional Granularity task|Changes in autonomic nervous system functions and computer experiment: Changes in the Socio-affective Video Task (SoVT)|Computer-based experiment: Changes in the ""Visual Spatial Perspective Taking Task"" by Samson|Computer-based experiment: Changes in the ""Emotional Attentional Blink"" paradigm|Computer-based experiment: Changes in the ""Trust Game""|Computer-based experiment: Changes in the ""Punishing Game""|Computer-based experiment: Changes in the ""Dictator Game""|Computer-based experiment: Changes in the ""Self-complexity Task""|Computer-based experiment: ""Self-reference Task""|Computer-based experiment: Changes in the ""Mind-wandering task""|Computer-based experiment: Changes in ""Donation Task""; willingness to make donations in the economic computer experiment.|Computer-based experiment: ""Social Discounting"" Task|Changes in interoception: Heart Beat Perception Task|Changes in autonomic nervous system functions: Local Power Biofeedback and Heart Rate Biofeedback|Stress Physiology: ""Trier Social Stress Test"" (TSST)|Changes in autonomic nervous system functions: ""Physiological Signature of Meditation states""|Changes telomere length (+ number of neutrophils, lymphocytes, and monocytes)|Training induced short-term changes in oxytocin blood level (pre/post Meditation)|Changes in amount of plasma levels (blood samples) of interleukin-6, brain-derived neurotrophic factor, C-reactive protein.|Changes in ""subjective experience sampling by smartphones or by means of an internet platform""|Questionnaire: Changes in ""Adult temperament questionnaire (ATQ)""|Questionnaire: Change in ""ADHS-Selbstbeurteilungsfragebogen (ADHS-SB)"".|Questionnaire: Change in ""FFA Freiburger Fragebogen zur Achtsamkeit"".|Questionnaire: Change in questionnaire ""Five Facets Mindfulness Questionnaire (FFMQ)"".|Questionnaire: Change in ""Multidimensional Assessment of Interoceptive Awareness (MAIA)"".|Questionnaire: Change in ""Self-Compassion Scale"" by Kristin Neff (SCS).|Questionnaire: Change in ""The Short Affect intensity scale (only serenity subscale) (SAIS)"".|Questionnaire: Change in ""Compassion scale - How I typically act towards others (COSN)"".|Questionnaire Participants and Observer: Change in ""Interpersonal Reactivity Index (IRI)"".|Questionnaire: Change in ""Types of Positive Affect (TTPAS)"".|Questionnaire: Change in ""Fears of Compassion Scales (FOCS)"".|Questionnaire: Change in ""Borderline Personality Questionnaire (BPQ)"".|Questionnaire: Change in ""Narcissistic Personality Inventory (NPI)"".|Questionnaire: Change in ""Cognitive Emotion Regulation Questionnaire (CERQ)"".|Questionnaire Participants and Observers: Change in ""Brief COPE"" inventory.|Questionnaire: Change in ""Berkeley Expressivity Questionnaire (BEQ)"".|Questionnaire: Change in ""Range and Differentiation of Emotion Scale (RDEES)"".|Questionnaire: Change in ""An Instrument to Measure Social Value Orientation (SVO) "" by van Lange et al.|Questionnaire: Change in ""Emotion Regulation of Others and Self (EROS)"".|Questionnaire: Change in ""Friendship, Compassionate and Self-Image Goals Scale"".|Questionnaire: Change in ""Self Importance of Moral Identity Scale"".|Questionnaire: Change in ""Self Dyadic Perspective-Taking Scale and Other Dyadic Perspective Taking Scale (SDPT /ODPT )"".|Questionnaire: Change in ""Self Construal Scale"".|Questionnaire Participants and Observers: Change in ""Prosocialness Scale"" by Capara.|Questionnaire: Change in ""Twenty Statement Test (TST)"".|Questionnaire: Change in ""The Machiavellianism Scale"".|Questionnaire: Change in ""NEO Fünf Faktoren Inventar (NEO FFI)"".|Questionnaire: Change in ""Pain Catastrophizing Questionnaire (PCS)"".|Questionnaire: Change in ""Unsicherheitstoleranz-Skala (Uncertainty Intolerance, UI-18)"".|Questionnaire: Change in ""Trier Inventory for Chronic Stress (TICS)"".|Questionnaire: Change in ""Perceived Stress Scale (PSS-10)"".|Questionnaire: Change in ""Parental Bonding Inventory (PBI)"".|Questionnaire: Change in ""Freiburger Beschwerdeliste (FBL)"".|Questionnaire: Change in ""Pittsburgh Sleep Inventory (PSQI)"".|Questionnaire: Change in ""Multi Motive Grid (MMG)"".|Questionnaire: Change in ""Mental Health Continuum short form (MHC-SF)"".|Questionnaire Participants and Observers: Change in ""Satisfaction with Life Scale (SWLS)"".|Questionnaire: Change in ""Becks Depression Inventory (BDI-2)"".|Questionnaire: Change in ""Ego Resiliency Scale (ER-89)"".|Questionnaire: Change in ""Experiences in Close Relationships - revised (ECR-RD)"".|Questionnaire: Change in ""UCLA Lonliness Scale"".|Questionnaire: Change in ""Positive Affect Negative Affect Schedule (PANAS)"".|Questionnaire: Change in ""modified Differential Emotions Scale (mDES)"".|Questionnaire: Change in ""Toronto Alexithymia Scale (TAS-20)""|Questionnaire: Change in ""Profile of Mood States - 2nd Edition (POMS-2)"".|Questionnaire: Change in ""STAI -X1 State, State Trait Anxiety Inventory"".|Questionnaire: Change in ""Subjective Sensory Sensitivity questionnaire"" following Fox et al. (2012)"".|Questionnaire: Change in ""Private Body Consciousness subscale of the Body Consciousness Questionnaire (PBCS)"".|Questionnaire - Observer only: Change in ""Perceived Responsiveness Scale (12 items)"" filled out by observers.|Questionnaire - Observer only: Change in ""Capitalization"" by Gable et al., 2004 filled out by observers|Questionnaire - Observer only: Change in ""Dyadic Adjustment Scale (DAS)"".|Questionnaire - Observer: Change in ""Ten Item Personality Scale (TIPI-10)""|Questionnaire - Observer only: Change in ""Inclusion of Other in the Self Scale (IOS)""|Stress physiology: Changes in ""Long-term cortisol levels from hair samples""|Assessment of gene variants / polymorphisms|Questionnaire: Change in ""Affiliation Tendency and Rejection Sensitivity Scales""|Questionnaire: Change in ""Spontaneous Activity Questionnaire (SAQ)""|Questionnaire: Change in ""Spontaneous and Deliberate Mind Wandering Scales (MDD, MDS)""|Questionnaire: Change in ""Subscales from the NEO Persönlichkeitsinventar nach Costa and McCrae - revised version (NEO-PI-R)""|Questionnaire: Change in ""Soziale Erwünschtheits-Skala-17 (SES-17)""|Questionnaire: Change in ""State-Trait Anxiety Inventory (STAI-X2; STAI-Trait)"".","Max Planck Institute for Human Cognitive and Brain Sciences|European Research Council","All","20 Years to 55 Years   (Adult)","Not Applicable","332","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","ReSource","January 2013","February 2016","February 2016","April 16, 2013",,"December 14, 2016","Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Sachsen, Germany|Max Planck Institute, Humboldt University, Campus Nord, Haus 5, Berlin, Germany",,"https://ClinicalTrials.gov/show/NCT01833104"
236,"NCT00732901","Clinical Neurobiology of Serotonin and Addiction",,"Completed","Has Results","Cocaine Dependence","Drug: Escitalopram|Drug: Placebo","Immediate Memory Task|Attentional Bias as Measured by the Cocaine Stroop Task.|Cocaine Positive Urines","Virginia Commonwealth University|National Institute on Drug Abuse (NIDA)|The University of Texas Health Science Center, Houston","All","18 Years to 55 Years   (Adult)","Phase 2|Phase 3","160","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","HM15289 - 2|P20DA024157|DA 024157","June 2008","February 2013","February 2013","August 12, 2008","March 30, 2017","March 8, 2019","University of Texas Health Science Center-Houston; Substance Abuse Research Clinic, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT00732901"
237,"NCT03827187","Awareness Detection and Communication in Disorders of Consciousness",,"Not yet recruiting","No Results Available","Disorder of Consciousness|Paralysis|Motor Neuron Disease|Stroke|Physical Disability","Other: Motor imagery based EEG-BCI","Change in performance accuracy of BCI use pre- and post- training|Change in ability to use imagined movements to consistently communicate yes-no responses to closed questions over multiple sessions by participant with Prolonged Disorder of Consciousness|Diagnostic utility of BCI data provided through study completion to clinicians|Changes in Wessex Head Injury Matrix and Coma Recovery Scale Scores due to potential therapeutic benefit of engaging in motor imagery|Change in performance accuracy as a factor of whether feedback was presented as music or broadband noise,|Changes in performance accuracy as a results of time of day of research experimentation","University of Ulster|National Rehabilitation Hospital, Ireland|St Conal’s Campus Rehabilitation Unit, Letterkenny, Ireland|Belfast Health and Social Care Trust|Western Health and Social Care Trust|South Eastern Health and Social Care Trust|Southern Health and Social Care Trust|Northern Health and Social Care Trust|Barnsley Hospital NHS Foundation Trust|NHS Lothian|Walton Centre NHS Foundation Trust|Hull University Teaching Hospitals NHS Trust|Northern Lincolnshire and Goole Hospitals NHS Foundation Trust|Imperial College Healthcare NHS Trust|Woodland Neuro rehab Center, York (Christchurch Group)|Glenside care, Salisbury|Frenchay Brain Injury Rehabilitation Centre, Bristol|Royal Hospital for Neuro-disability","All","10 Years to 80 Years   (Child, Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","136640","April 15, 2019","April 15, 2024","April 15, 2024","February 1, 2019",,"March 21, 2019",,,"https://ClinicalTrials.gov/show/NCT03827187"
238,"NCT03197454","Brain Enhancement Training Towards Elders Resilience to Aging","BETTER Aging","Active, not recruiting","No Results Available","Age-related Cognitive Decline","Other: Computerized Plasticity-Based Adaptive Cognitive Training|Other: Commercially available computerized training","Change in performance on global cognitive composite score|Change in performance on processing speed composite score|Change in performance on working memory|Changes in performance on episodic memory|Change in performance on executive function|Change in brain function|Change in brain structure|Change in task-related brain activation|Change in functional performance|Change in Depressive Symptoms","Posit Science Corporation|University of Iowa|The University of Texas at Dallas|National Institute on Aging (NIA)","All","65 Years and older   (Older Adult)","Not Applicable","120","Industry|Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","PSC-0605-17","June 1, 2018","March 1, 2021","April 30, 2021","June 23, 2017",,"April 3, 2020","University of Iowa, Iowa City, Iowa, United States|University of Texas at Dallas, Dallas, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03197454"
239,"NCT01716000","Optical Imaging and User Perception Study of Vaginal Gel",,"Completed","No Results Available","Characterize Gel Distribution in the Vagina|Study Women's Sensory Perceptions and Preferences of Gel","Other: vaginal gel imaging|Behavioral: computer aided self interview","number and frequency of adverse events|extent of vaginal gel coating|uniformity of vaginal gel coating|subject perception and preference of vaginal gel","Duke University|National Institute of Allergy and Infectious Diseases (NIAID)|ImQuest Pharmaceuticals, Inc.|The Miriam Hospital","Female","21 Years to 45 Years   (Adult)","Not Applicable","56","Other|NIH|Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","Pro00038440|U19AI077289","January 2013","November 2013","November 2013","October 29, 2012",,"July 24, 2014","Duke University Medical Center, Durham, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT01716000"
240,"NCT03781271","ElectroMagnetic-guided Interstitial Catheter Navigation for Gynecological brachyTherapy","E-MINT","Recruiting","No Results Available","Cervical Cancer","Device: Electromagnetic Navigation","Treatment Plan Target Volume and Organs at Risk Dosimetry","Sunnybrook Health Sciences Centre","Female","Child, Adult, Older Adult","Not Applicable","10","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","143-2018","October 1, 2019","October 2020","February 2021","December 19, 2018",,"March 17, 2020","Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03781271"
241,"NCT00577096","Effects of Exercise in Combination With Epoetin Alfa",,"Completed","Has Results","Multiple Myeloma","Drug: Epoetin Alfa|Behavioral: Exercise|Biological: Autologous Peripheral Blood Stem Cell Transplantation|Biological: Red Blood Cell Transfusion|Drug: Thalidomide|Drug: Heparin, Low-Molecular-Weight|Biological: Platelet Transfusion|Drug: Melphalan|Drug: Total Therapy II","Number of Red Blood Cell Transfusions Needed to Maintain Hemoglobin Levels (Short Term)|Number of Red Blood Cell Transfusions Needed to Maintain Hemoglobin Levels (Long Term)|Number of Platelet Transfusions Needed to Maintain Adequate Number of Platelets.(Short Term)|Number of Platelet Transfusions Needed to Maintain Adequate Number of Platelets. (Long Term)|Number of Stem Cell Collection Attempts (Short Term)|Number of Stem Cell Collection Attempts (Long Term)|Total Number of Days of Stem Cell Collection (Short Term)|Total Number of Days of Stem Cell Collection (Long Term)|Hemoglobin Levels Before Chemotherapy and During Transplantation Period (Short Term)|Hemoglobin Levels Before Chemotherapy and During Transplantation Period (Long Term)","University of Arkansas|National Institutes of Health (NIH)|Ortho Biotech Clinical Affairs, L.L.C.","All","Child, Adult, Older Adult","Not Applicable","120","Other|NIH|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","IRB # 29287|R01NR008937|Ortho Biotech Clinical Affairs","October 2001","June 2004","June 2004","December 19, 2007","April 21, 2011","April 6, 2015","University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States",,"https://ClinicalTrials.gov/show/NCT00577096"
242,"NCT02922569","Home-Based, Online, Mindfulness and Cognitive Training for Soldiers and Veterans With TBI","CogMind","Active, not recruiting","No Results Available","Mild Traumatic Brain Injury","Other: Computerized Plasticity-Based Adaptive Cognitive Training|Other: Commercially available computerized training|Other: Mindfulness Training|Other: Traumatic Brain Injury Information Session","Changes in performance on global cognitive composite score|Changes in performance on processing speed composite score|Changes in performance on memory composite score|Changes in performance on executive function composite score|Change in functional performance|Change in TBI functional status|Changes in brain function|Changes in brain structure|Changes in task-related brain activation","Posit Science Corporation|VA Connecticut Healthcare System","All","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Industry|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","PSC-0616-16","March 31, 2017","August 30, 2020","September 14, 2020","October 4, 2016",,"April 3, 2020","Veterans Affairs Connecticut Health Care System, West Haven, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT02922569"
243,"NCT03117478","Brain and Mindfulness","MEDITATION","Recruiting","No Results Available","Healthy","Other: Magneto-encephalography (MEG)|Other: Electro-encephalography (EEG)|Other: Functional Magnetic Resonance Imaging (fMRI)|Other: Anatomical Magnetic Resonance Imaging (aMRI)|Other: Meditation","Anatomical MRI scan|Functional MRI scan|EEG|Behavioral measure : Accuracy of the performed task actions|Psychophysics: Pain threshold|Psychophysiology : Respiration|Subjective experience of the participant|Studies biomarkers of inflammation|Behavioral measure : Speed of the performed task actions|Psychophysiology : Heart|Psychophysiology : Heart rate variability|Psychophysiology : Muscles|Psychophysiology : Eyes|Psychophysiology : Pupillar response|Electrogastrogram","Hospices Civils de Lyon","All","25 Years to 70 Years   (Adult, Older Adult)","Not Applicable","285","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","69HCL16_0678","March 19, 2016","February 19, 2021","March 19, 2021","April 18, 2017",,"September 8, 2017","Le Vinatier, Bron, France",,"https://ClinicalTrials.gov/show/NCT03117478"
244,"NCT02246426","Treatment of Social Cognition in Schizophrenia Trial","TRuSST","Completed","No Results Available","Schizophrenia","Other: Computerized plasticity-based adaptive cognitive training|Other: Commercially available computerized training","Change in Spatial Cognition (Multiple scores are aggregated to arrive at a single composite score)|Change in Performance on the UCSD Performance-based Skills Assessment (Co-Primary Composite Measure)|Symptoms utilizing the Positive and Negative Syndrome Scale|Psychosocial Functioning utilizing the Global Functioning Scale|Social Functioning utilizing the Social Functioning Scale|Independent Functioning utilizing the Specific Levels of Function|Functional Capacity utilizing Virtual Reality Functional Capacity Assessment|Quality of Life utilizing the Quality of Life Scale|Motivational systems utilizing Behavioral Inhibition/Behavioral Activation Scale|Pleasure utilizing the Temporal Experience of Pleasure Scale|Social Perception utilizing The Awareness of Social Inference Test|Emotion Perception utilizing the Morphed Faces Task|Theory of Mind utilizing the Faux Pas Test|Source Memory utilizing Source Memory Test|Hostility Bias utilizing Ambiguous Intentions Hostility Questionnaire","Posit Science Corporation|National Institute of Mental Health (NIMH)|University of Minnesota|VA Greater Los Angeles Healthcare System|University of California, Los Angeles|Rush University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","149","Industry|NIH|Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","PSC-1004-14|R44MH091793","March 2015","August 30, 2018","August 30, 2018","September 22, 2014",,"September 26, 2019","Greater Los Angeles VA, Los Angeles, California, United States|UCLA, Los Angeles, California, United States|Rush University, Chicago, Illinois, United States|University of Minnesota, Minneapolis, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT02246426"
245,"NCT03696667","Affect Regulation Based on Brain-computer Interface Towards Treatment for Depression",,"Completed","No Results Available","Emotion Regulation","Device: BCI","Emotion regulation questionnaire (ERQ)|Positive and Negative Affect Scale (PANAS)|Brief Assessment of Cognition - Short form|Geriatric Depression Scale (GDS)|Positive Mental Health (PMH) instrument|Body Awareness Questionnaire (BAQ)|Subjective Happiness Scale|Connor-Davidson Resilience Scale 25 (CD-RISC-25)|The Frenchay Activities Index (FAI)|Medical Outcomes Study: 20-item short form survey instrument|Outcome rating scale|Usability questionnaire","Institute of Mental Health, Singapore|Agency for Science, Technology and Research|Duke-NUS Graduate Medical School","All","60 Years to 85 Years   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","2017/00297","March 8, 2018","September 26, 2018","September 26, 2018","October 5, 2018",,"October 5, 2018","Duke-NUS Medical School, Singapore, Singapore|Institute of Mental Health, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT03696667"
246,"NCT01387581","Does the Aid of MelaFind Affect Clinical Management Decisions",,"Completed","Has Results","Melanoma",,"Sensitivity|Specificity","MELA Sciences, Inc.","All","Child, Adult, Older Adult",,"227","Industry","Observational","Observational Model: Case Control|Time Perspective: Prospective","20101","October 2011","March 2012","March 2012","July 4, 2011","November 14, 2014","November 14, 2014","MELA Sciences, Irvington, New York, United States",,"https://ClinicalTrials.gov/show/NCT01387581"
247,"NCT02200432","Patient Experience Recommender System for Persuasive Communication Tailoring","PERSPECT","Completed","No Results Available","Smoking Cessation","Other: PERSPeCT Recommender System","message influence","University of Massachusetts, Worcester","All","18 Years and older   (Adult, Older Adult)","Not Applicable","972","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","14762","May 2014","March 2015","June 2015","July 25, 2014",,"July 9, 2015","The University of Massachusetts Medical School, Worcester, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02200432"
248,"NCT00033553","Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer",,"Completed","No Results Available","Lung Cancer","Drug: carboplatin|Drug: gemcitabine hydrochloride|Drug: paclitaxel|Radiation: radiation therapy","Response|Overall Survival|Toxicity","Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)","All","18 Years and older   (Adult, Older Adult)","Phase 2","69","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CALGB-30105|U10CA031946|CDR0000069300","March 2002","September 2006","June 2010","January 27, 2003",,"July 19, 2016","Northeast Alabama Regional Medical Center, Anniston, Alabama, United States|Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States|Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States|Naval Medical Center - San Diego, San Diego, California, United States|Veterans Affairs Medical Center - San Diego, San Diego, California, United States|UCSF Comprehensive Cancer Center, San Francisco, California, United States|Veterans Affairs Medical Center - San Francisco, San Francisco, California, United States|CCOP - Christiana Care Health Services, Newark, Delaware, United States|Lombardi Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States|Walter Reed Army Medical Center, Washington, District of Columbia, United States|Veterans Affairs Medical Center - Washington, DC, Washington, District of Columbia, United States|Broward General Medical Center, Fort Lauderdale, Florida, United States|Memorial Regional Cancer Center at Memorial Regional Hospital, Hollywood, Florida, United States|CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States|Florida Hospital Cancer Institute, Orlando, Florida, United States|Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States|University of Chicago Cancer Research Center, Chicago, Illinois, United States|Louis A. Weiss Memorial Hospital, Chicago, Illinois, United States|CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States|West Suburban Center for Cancer Care, River Forest, Illinois, United States|Fort Wayne Medical Oncology and Hematology, Incorporated, Fort Wayne, Indiana, United States|CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States|Holden Comprehensive Cancer Center at University of Iowa, Iowa City, Iowa, United States|Baptist Hospital East - Louisville, Louisville, Kentucky, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States|UMASS Memorial Cancer Center - University Campus, Worcester, Massachusetts, United States|Lakeland Cancer Care Center at Lakeland Hospital - St. Joseph, Saint Joseph, Michigan, United States|Veterans Affairs Medical Center - Minneapolis, Minneapolis, Minnesota, United States|University of Minnesota Cancer Center, Minneapolis, Minnesota, United States|Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia, Missouri, United States|Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia, Missouri, United States|CCOP - Kansas City, Kansas City, Missouri, United States|Siteman Cancer Center at Barnes-Jewish Hospital, Saint Louis, Missouri, United States|Missouri Baptist Cancer Center, Saint Louis, Missouri, United States|UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska, United States|CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Veterans Affairs Medical Center - Las Vegas, Las Vegas, Nevada, United States|New Hampshire Oncology-Hematology, PA - Hooksett, Hooksett, New Hampshire, United States|Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Cancer Institute of New Jersey at the Cooper University Hospital, Camden, New Jersey, United States|Veterans Affairs Medical Center - Buffalo, Buffalo, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., East Syracuse, New York, United States|Elmhurst Hospital Center, Elmhurst, New York, United States|Queens Cancer Center of Queens Hospital, Jamaica, New York, United States|CCOP - North Shore University Hospital, Manhasset, New York, United States|North Shore University Hospital, Manhasset, New York, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, United States|New York Weill Cornell Cancer Center at Cornell University, New York, New York, United States|Mount Sinai Medical Center, New York, New York, United States|SUNY Upstate Medical University Hospital, Syracuse, New York, United States|Veterans Affairs Medical Center - Syracuse, Syracuse, New York, United States|Veterans Affairs Medical Center - Asheville, Asheville, North Carolina, United States|Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States|NorthEast Oncology Associates - Concord, Concord, North Carolina, United States|Veterans Affairs Medical Center - Durham, Durham, North Carolina, United States|Duke Comprehensive Cancer Center, Durham, North Carolina, United States|Cape Fear Valley Health System, Fayetteville, North Carolina, United States|CCOP - Southeast Cancer Control Consortium, Goldsboro, North Carolina, United States|Lenoir Memorial Cancer Center, Kinston, North Carolina, United States|Comprehensive Cancer Center at Moore Regional Hospital, Pinehurst, North Carolina, United States|Zimmer Cancer Center at New Hanover Regional Medical Center, Wilmington, North Carolina, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus, Ohio, United States|Oklahoma University Medical Center, Oklahoma City, Oklahoma, United States|Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States|Lifespan: The Miriam Hospital, Providence, Rhode Island, United States|Veterans Affairs Medical Center - Dallas, Dallas, Texas, United States|Vermont Cancer Center at University of Vermont, Burlington, Vermont, United States|Martha Jefferson Hospital, Charlottesville, Virginia, United States|Virginia Oncology Associates - Norfolk, Norfolk, Virginia, United States|MBCCOP - Massey Cancer Center, Richmond, Virginia, United States|Oncology and Hematology Associates of Southwest Virginia, Incorporated - Roanoke, Roanoke, Virginia, United States|St. Mary's Medical Center, Huntington, West Virginia, United States",,"https://ClinicalTrials.gov/show/NCT00033553"
249,"NCT04026061","Pilot Study Person-centred Tablet Intervention",,"Completed","No Results Available","Dementia|Mobile Applications|Computers|Neurological Rehabilitation|Activities of Daily Living","Behavioral: FMA group|Behavioral: Control group","Self-management abilities people with dementia|Participation in daily and social activities people with dementia|Feeling of competence informal carers|Perceived self-efficacy people with dementia|Perceived autonomy people with dementia|Quality of life people with dementia|Positive care experiences informal carers|Quality of life informal carers","Saxion University of Applied Sciences|University of Twente|Radboud University|VU University Medical Center","All","Child, Adult, Older Adult","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Supportive Care","FindMyApps","October 31, 2017","December 12, 2017","March 22, 2018","July 19, 2019",,"July 19, 2019","Saxion University of applied Sciences, Enschede, Overijssel, Netherlands",,"https://ClinicalTrials.gov/show/NCT04026061"
250,"NCT00630396","Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke","MINOS","Completed","Has Results","Stroke, Acute","Drug: Minocycline","Maximally Tolerated Dose of IV Minocycline|Half-life of IV Minocycline|90 Day Modified Rankin Scale Score","David Hess, MD|National Institute of Neurological Disorders and Stroke (NINDS)|University of Kentucky|Oregon Health and Science University|Augusta University","All","19 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","60","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","R01NS055728-01A1|07-02-202","May 2008","January 2010","January 2010","March 7, 2008","January 13, 2012","January 13, 2012","University of Kentucky, Lexington, Kentucky, United States|Oregon Health & Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT00630396"
251,"NCT03221452","Adaptation of a Cognitive Training Intervention for Diabetes Self-Management",,"Unknown status","No Results Available","Cognitive Function Abnormal|Diabetes Mellitus, Type 2","Behavioral: Memory, Attention, and Problem Solving Skills for Diabetes","Change in Diabetes Self-Care Activities|General Self-Efficacy Scale|Multifactorial Memory Questionnaire|Change in executive function|Center for Epidemiologic Studies Depression Scale","University of Texas at Austin","All","40 Years to 70 Years   (Adult, Older Adult)","Not Applicable","29","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","2016-08-0001","September 2, 2016","June 10, 2017","October 2017","July 18, 2017",,"July 18, 2017",,,"https://ClinicalTrials.gov/show/NCT03221452"
252,"NCT01830933","Breast Cancer Risk Reduction: A Patient Doctor Intervention","BreastCARE","Completed","Has Results","Breast Cancer","Other: BreastCARE","Knowledge of Breast Cancer Risk Factors|Percentage of Participants With Correct Perception of Risk|Percentage of Participants Who Had a Discussion of Breast Cancer Risk|Percentage of Participants Who Reported Discussion of Mammography Screening","University of California, San Francisco|Susan G. Komen Breast Cancer Foundation|California Breast Cancer Research Program","All","40 Years to 74 Years   (Adult, Older Adult)","Not Applicable","1235","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","150B-0158","June 2011","August 2012","December 2012","April 12, 2013","May 16, 2013","August 19, 2014","San Francisco General Hospital (SFGH), San Francisco, California, United States|University of California, San Francisco Mt. Zion campus, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT01830933"
253,"NCT00565864","Neurocognitive and Metabolic Effects of Mild Hypothyroidism",,"Completed","Has Results","Hypothyroidism","Drug: L-thyroxine (L-T4)","Executive Function|Resting Energy Expenditure","Oregon Health and Science University","All","20 Years to 75 Years   (Adult, Older Adult)","Phase 4","173","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","IRB00002265","August 2008","August 2013","August 2013","November 30, 2007","August 22, 2018","August 22, 2018","Oregon Health and Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT00565864"
254,"NCT04444258","Teaching Fetal Development With Virtual Reality",,"Not yet recruiting","No Results Available","Educational Problems","Other: Implementing virtual reality glasses without computer support|Other: Application of computer aided virtual reality glasses|Other: Teaching fetal development theoretically","To provide midwifery students to learn fetal development week by week","Karabuk University|Saglik Bilimleri Universitesi","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","105","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Basic Science","2020/263","September 15, 2020","January 15, 2021","February 15, 2021","June 23, 2020",,"June 23, 2020","Karabuk University, Karabuk, Turkey",,"https://ClinicalTrials.gov/show/NCT04444258"
255,"NCT01845506","The Application of a Wireless Sensor Technology for Vital Statistics in CHILDREN AND ADULTS",,"Not yet recruiting","No Results Available","Fever|COPD|Obesity|Congenital Heart Disease|Respiratory Distress","Device: Cardiorespiratory monitor|Device: Wireless pressure sensor","The primary outcome is the level of agreement between cardiorespiratory monitor and sensor information for heart rate.|Level of agreement between cardiorespiratory monitor and sensor information for blood pressure|Level of agreement between cardiorespiratory monitor and sensor information for temperature|Level of agreement between cardiorespiratory monitor and sensor information for oxygen saturation","Lawson Health Research Institute|Lauren Faught|Michael Greff|Michael Rieder|Safieddin Safavi-Naeini","All","Child, Adult, Older Adult","Not Applicable","500","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","2166","January 2019","September 2020","December 2020","May 3, 2013",,"August 14, 2018","Children's Hospital London Health Sciences Center, London, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT01845506"
256,"NCT00446615","Multifaceted Intervention to Improve Prescribing in Patients With Chronic Kidney Disease",,"Unknown status","No Results Available","Chronic Kidney Disease","Behavioral: computer decision support tool|Behavioral: audit and feedback|Behavioral: group learning session","The primary outcome will be a change in the number of appropriately written prescriptions for the targeted medications 3 and 6 months after the educational intervention and introduction of the clinical decision support tool.|Prescribers' perception of their knowledge of and comfort with adjusting doses of medications as measured in a Likert scale and their assessement of the ease of use of the decision support tool|, cost savings, time for prescribers to use the decision support tool, number of times the decision support tool was used.","Hamilton Health Sciences Corporation|National Research System-College of Family Physicians of Canada|McMaster University","All","65 Years and older   (Older Adult)","Not Applicable",,"Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","CR-168","March 2007",,"March 2007","March 13, 2007",,"March 13, 2007","Stonechurch Family Health Centre, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT00446615"
257,"NCT03556670","Active Workplace Study",,"Active, not recruiting","No Results Available","Sedentary Lifestyle|Occupational Exposure|Health Behavior|Safety Issues","Behavioral: Total Worker Health|Other: Control","Sedentary behavior|Height|Body weight|Percent body fat|Blood pressure|Resting heart rate|Hemoglobin A1c|Endothelial functioning|Depression symptoms|Job Stress|Work Family Conflict|General Life Stress|Job satisfaction|Global Health|Support at work|Dietary behaviors|Physical Activity survey|Sleep Quality|Sleep Distrubance|Sleep Impairment|Safety climate|Musculoskeletal pain|Lost work time|Physical activity accelerometer|Occupational Sitting|Job Turnover Intentions|Lost Work Time","Oregon Health and Science University|Portland State University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","264","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","Active Workplace Study","July 10, 2018","July 2020","July 2020","June 14, 2018",,"December 18, 2019","Oregon Health & Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT03556670"
258,"NCT03302741","Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings",,"Unknown status","No Results Available","Spasticity","Drug: Botulinum neurotoxin (BTX)|Other: Physical Therapy|Device: Standard BTX injection (ultrasound guided)|Device: 3-dimensional innervation zone (3DIZ) guided injection","Spasticity as assessed by reflex torque of elbow flexors|Spasticity as assessed by the Modified Ashworth Scale (MAS)","The University of Texas Health Science Center, Houston|University of Houston","All","21 Years to 75 Years   (Adult, Older Adult)","Phase 4","16","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","HSC-MS-17-0174","November 21, 2017","September 1, 2019","September 1, 2019","October 5, 2017",,"May 2, 2018","The University of Texas Health Science Center at Houston, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03302741"
259,"NCT02358915","A Two-step Training Paradigm for Voluntary Control of the Peri-auricular Muscles",,"Completed","No Results Available","Non-disabled Volunteers|Lacking Voluntary Control of Ear Muscles","Device: FastStart neuromuscular electrical stimulator","The surface EMG signal amplitude of the auricular muscles at the maximum voluntary contraction|The computer game performance score","University of Southern California","All","18 Years to 64 Years   (Adult)","Early Phase 1","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","HS-14-00672","February 2015","August 2016","August 31, 2016","February 9, 2015",,"April 5, 2017","University of Southern California-Health Sciences Campus, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT02358915"
260,"NCT03679468","Improving Cognition in People With Progressive Multiple Sclerosis Using Aerobic Exercise and Cognitive Rehabilitation",,"Recruiting","No Results Available","Multiple Sclerosis, Primary Progressive|Cognitive Impairment","Other: Cognitive Rehabilitation|Other: Sham Exercise|Other: Sham Cognitive Rehabilitation|Other: Aerobic Exercise","Change from baseline cognitive Information processing speed at 12 weeks and 6 months|Change from baseline cognitive verbal memory at 12 weeks and 6 months|Change from baseline cognitive visual memory at 12 weeks and 6 months|Change from baseline anxiety & depression, at 12 weeks and 6 months|Change from baseline depression, at 12 weeks and 6 months|Change from baseline fatigue, at 12 weeks and 6 months|Change from baseline perceived deficits, at 12 weeks and 6 months|Change from baseline subjective impact of walking, at 12 weeks and 6 months|Change from baseline impact of Multiple Sclerosis, at 12 weeks and 6 months|Change from baseline quality of life, at 12 weeks and 6 months|Change from baseline global function, at 12 weeks and 6 months","Sunnybrook Health Sciences Centre|University of Florence|Fondazione Italiana Sclerosi Multipla|University College, London|Kessler Foundation|University of Alabama at Birmingham|University of Southern Denmark|Hasselt University|University of Plymouth|University of Genoa|St. Michael's Hospital, Toronto|Ospedale San Raffaele","All","25 Years to 60 Years   (Adult)","Not Applicable","360","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","232-2018","March 18, 2019","November 2022","November 2023","September 20, 2018",,"March 20, 2019","Sunnybrook Health Science Center, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03679468"
261,"NCT01803061","Use of Computer-based Patient-reported Data to Assess Long Term and Late Effects of Head and Neck Cancer at the Point-of-care",,"Completed","No Results Available","Head and Neck Cancer Patients|Late Effects","Behavioral: WebCan","Prevalence of late effects|Quality of life","Danish Cancer Society|The Ministry of Science, Technology and Innovation, Denmark|Sygekassernes Helsefond","All","Child, Adult, Older Adult","Not Applicable","300","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","WebCan","September 2010","July 2014","July 2014","March 4, 2013",,"March 6, 2015","Danish Cancer Society Research Center, Unit of Suvivorship, Copenhagen, Denmark|Herlev Hospital, Herlev, Denmark",,"https://ClinicalTrials.gov/show/NCT01803061"
262,"NCT02427659","VR High Tech Pain Control Burn Wound Care","VRH2O","Completed","No Results Available","Pain|Burn","Behavioral: Virtual Reality Distraction|Behavioral: Audio (sound of nature)|Behavioral: Control standard nurse wound care","""Pain"" as measured by McGill Short Form Pain Questionnaire|""Pain"" as measured by Nurse Graphic Rating Scale|""Pain and anxiety"" as measured by Graphic Rating Scale","National Institute of General Medical Sciences (NIGMS)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","8","NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Other","41673","November 2011","November 2016","August 2017","April 28, 2015",,"March 13, 2019","University of Washington; Harborview Medical Center, Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT02427659"
263,"NCT04052347","Decision Aid to Assist Low-Risk Nulliparous Women Considering Induction of Labor At 39 Weeks","DAWN","Not yet recruiting","No Results Available","Pregnancy Related|Elective Induction","Behavioral: Shared decision-making with a Decision-aid|Behavioral: routine shared decision-making","Assess if the utilization of a decision-aid|Composite neonatal morbidity|Maternal morbidities","The University of Texas Health Science Center, Houston","Female","18 Years to 45 Years   (Adult)","Not Applicable","314","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","HSC-MS-19-0490","September 1, 2019","September 1, 2022","September 1, 2023","August 9, 2019",,"August 9, 2019","The University of Texas Health Science Center at Houston, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT04052347"
264,"NCT01982994","Intervention to Motivate Standing &Walking in Gastrointestinal Cancer Surgical Patients",,"Completed","No Results Available","Gastrointestinal Neoplasms","Behavioral: Education/Daily Planning","Percentage of patients with diagnosed gastrointestinal cancer who showed daily compliance using activity monitors and tablet computers to measure physical activity.|Percentage of patients with a diagnosis of gastrointestinal cancer that benefit from an intervention of physical activity daily planning and education.","Milton S. Hershey Medical Center|Penn State University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","32","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Supportive Care","41440","October 2013","July 2015","December 2018","November 13, 2013",,"February 22, 2019","Penn State Hershey Medical Center, Hershey, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT01982994"
265,"NCT01901211","Physical and Social Benefits of Multi-Player Interactive Computer Play Games in Youth With Cerebral Palsy",,"Completed","Has Results","Cerebral Palsy","Other: Exergaming Intervention","Change in the 7.5 Meter Shuttle Run Test for Gross Motor Function Classification Scale (GMFCS) Level III (SRT-III)|Change in the Social Wellbeing Domain of the KINDL-R Quality of Life Questionnaire|Handheld Dynamometry Measures of Knee Flexors and Knee Extensors|The 30-second Wingate Cycle Test|Anthropometric Measurements|Total Score of the KINDL-R Questionnaire|The Self-Worth Domain of the KINDL-R Questionnaire|Gaming Data|StepWatch Activity Monitors|Anthropometric Measurements (Weight)","Holland Bloorview Kids Rehabilitation Hospital|Queen's University|Natural Sciences and Engineering Research Council, Canada","All","9 Years to 19 Years   (Child, Adult)","Not Applicable","11","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","13-423","September 2013","April 5, 2014","April 5, 2014","July 17, 2013","March 17, 2017","January 2, 2019","Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT01901211"
266,"NCT00161382","Development and Evaluation of an HIV, STD, and Pregnancy Prevention Program for Middle School Students",,"Completed","Has Results","HIV Infections|Sexually Transmitted Diseases|Pregnancy","Behavioral: HIV, STD, and pregnancy prevention curriculum|Behavioral: Standard sexual education curriculum","Initiation of Sexual Intercourse|Knowledge|Self-efficacy|Attitudes|Perceived Norms|Barriers|Communication With Parents|Proportion of Students That Are Sexually Active","The University of Texas Health Science Center, Houston|National Institute of Mental Health (NIMH)","All","11 Years to 16 Years   (Child)","Not Applicable","3007","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","R01MH066640|R01MH066640-01","September 2002","March 2007","July 2008","September 12, 2005","June 24, 2014","July 8, 2014","University of Texas Houston Health Science Center - School of Public Health, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT00161382"
267,"NCT01218568","Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial",,"Completed","No Results Available","Hepatic Encephalopathy","Drug: Rifaximin plus lactulose|Drug: Lactulose","Reversal of hepatic encephalopathy|Death|duration of hospital stay","Institute of Liver and Biliary Sciences, India","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","ILBS HE-01","October 2010","September 2012","October 2012","October 11, 2010",,"April 4, 2013","Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India",,"https://ClinicalTrials.gov/show/NCT01218568"
268,"NCT01344044","Brain-Computer Interface (BCI) Based Intervention for Attention Deficit Hyperactivity Disorder (ADHD)",,"Completed","No Results Available","Attention Deficit Hyperactivity Disorder","Device: BCI","Attention Deficit Hyperactivity Disorder Rating Scale (ADHD Rating Scale) 4th Edition","National Healthcare Group, Singapore|Duke-NUS Graduate Medical School|Agency for Science, Technology and Research|Singapore Clinical Research Institute","All","6 Years to 12 Years   (Child)","Phase 2|Phase 3","192","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","DSRB Domain A/09/395","January 2011","May 13, 2016","May 13, 2016","April 28, 2011",,"March 30, 2017","Child Guidance Clinic, Institute of Mental Health, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT01344044"
269,"NCT03933189","Physical Therapy to Treat Chronic Pain in Survivors of Torture and Trauma",,"Recruiting","No Results Available","Chronic Pain|Disability Physical","Other: Physical Therapy","Change in Patient Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) Computer Adaptive Test (CAT)|Change in Patient Reported Outcomes Measurement Information System (PROMIS) Pain Interference (PI) Computer Adaptive Test (CAT)|Change in Patient Reported Outcomes Measurement Information System (PROMIS) 29|Change in Brief Pain Inventory|Change in Central Sensitization Inventory|Change in Pain pressure threshold sensory testing|Change in Two-point discrimination sensory testing","University of Vermont","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","00000128","June 18, 2019","May 15, 2020","May 15, 2020","May 1, 2019",,"July 12, 2019","Dee Physical Therapy, South Burlington, Vermont, United States",,"https://ClinicalTrials.gov/show/NCT03933189"
270,"NCT02331121","Multimedia First Aid Program for Families","FirstAid_2","Completed","No Results Available","Injury","Behavioral: Family First Aid Online Training|Behavioral: Text-only Online Training","Knowledge (knowledge score was calculated by summing the number of items answered correctly and dividing by the total number of items to arrive at the percent of items correctly endorsed.)|Self-efficacy (assessed with a 5-point scale)","Oregon Center for Applied Science, Inc.|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","182","Industry|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)","SBIR82RR-II|R43HD049156","June 2012","February 2013","February 2013","January 6, 2015",,"October 14, 2016","Oregon Center for Applied Science, Eugene, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT02331121"
271,"NCT03123666","Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With Cirrhosis",,"Active, not recruiting","No Results Available","Cirrhosis","Drug: GMCSF|Other: Placebo","Survival in both groups|Development of extra pulmonary organ failure during the course of study.","Institute of Liver and Biliary Sciences, India","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","160","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","ILBS-Cirrhosis-09","April 19, 2017","October 19, 2020","October 19, 2020","April 21, 2017",,"February 20, 2020","Institute of Liver and Biliary Sciences, New Delhi, Delhi, India",,"https://ClinicalTrials.gov/show/NCT03123666"
272,"NCT03255915","PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study)","PrEP-Pod-IVR","Recruiting","No Results Available","HIV Prevention","Drug: Tenofovir Disoproxil Fumarate (TDF)-Emtricitabine (FTC)|Other: Placebo","Safety of Vaginal IVRs releasing TDF-FTC by reports of Adverse Events|Characterization of pharmacokinetics of TDF-FTC released by an IVR - plasma|Characterization of pharmacokinetics of TDF-FTC released by an IVR - vagina|Characterization of pharmacokinetics of TDF-FTC released by an IVR - rectum|Acceptability of IVR assessed via computer assisted self interviews|Acceptability of IVR assessed via in depth interviews|Adherence|Acceptability of IVR assessed via in depth interviews - male partners","Oak Crest Institute of Science|The Miriam Hospital|Johns Hopkins University|University of California, Los Angeles|University of California, San Diego|Vanderbilt University|The University of Texas Medical Branch, Galveston|National Institutes of Health (NIH)|National Institute of Allergy and Infectious Diseases (NIAID)","Female","18 Years to 45 Years   (Adult)","Early Phase 1","10","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","17-0131|1U19AI113048-01","September 20, 2018","May 2020","June 2020","August 21, 2017",,"April 1, 2020","University of Texas Medical Branch, Galveston, Texas, United States","""Informed Consent Form: Screening Consent"", https://ClinicalTrials.gov/ProvidedDocs/15/NCT03255915/ICF_003.pdf|""Informed Consent Form: Enrollment Consent"", https://ClinicalTrials.gov/ProvidedDocs/15/NCT03255915/ICF_004.pdf|""Informed Consent Form: Male Partner Consent"", https://ClinicalTrials.gov/ProvidedDocs/15/NCT03255915/ICF_005.pdf","https://ClinicalTrials.gov/show/NCT03255915"
273,"NCT02667171","COPD Online Rehabilitation (CORe)","CORe","Completed","No Results Available","Pulmonary Disease, Chronic Obstructive","Behavioral: Supervised COPD Rehabilitation (control group)|Behavioral: Online COPD rehabilitation (experimental)","Change in 6-Minute Walk Test Distance (6MWT)|Change in 30 second sit-to-stand test (30-STST)|Change in Activity level (ActivPAL)|Change in Clinical COPD Questionaire (CCQ)|Change in COPD Assessment Test (CAT)|Change in Hospital Anxiety and Depression Scale (HADS)|Change in Euro Qol (EQ5D)|Total attendance in rehabilitation|number of hospital admissions|Number of hospital days|Outpatient visits in hospital and at general practioner|Mortality","University Hospital Bispebjerg and Frederiksberg|TrygFonden, Denmark|Danish Lung Association|Region Capital Denmark|University of Copenhagen","All","18 Years and older   (Adult, Older Adult)","Not Applicable","134","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","E-12910 01-01-01","March 1, 2016","December 31, 2018","December 31, 2019","January 28, 2016",,"March 26, 2020","Bispebjerg and Frederiksberg Hospital, Copenhagen, Copenhagen Northwest, Denmark|Amager Hospital, Copenhagen, Denmark|Frederikssund hospital, Frederikssund, Denmark|Gentofte Hospital, Hellerup, Denmark|Herlev Hospital, Herlev, Denmark|Hillerød hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark",,"https://ClinicalTrials.gov/show/NCT02667171"
274,"NCT03567863","Study Comparing Pancreatic EUS-FNB With the 20-gauge Procore® and the 22-gauge Acquire® Needles","HISTOPAN","Completed","No Results Available","Pancreas Cancer|Pancreatic Adenocarcinoma","Device: 20-GAUGE PROCORE® first, then 22-GAUGE ACQUIRE®|Device: 22-GAUGE ACQUIRE® first, then 20-GAUGE PROCORE®","cumulative length of tissue core biopsies per needle pass|Presence of core biopsy specimen|Sensitivity|Specificity|Positive Predictive Value|Negative Predictive Value|Computer Aided Morphometric Evaluation of the Tumor + Stroma Surface|Success rate of isolation of tumor cells|Morbidity|Feasibility|inter evaluation of the anatomopathological criteria used (presence of a biopsy core, length of target tissue core per needle pass)|determination of transcriptomic signatures of pancreatic adenocarcinoma subtypes|intra-observer evaluation of the anatomopathological criteria used","Société Française d'Endoscopie Digestive","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Diagnostic","2018-A00276-49","June 24, 2018","September 29, 2019","September 29, 2019","June 26, 2018",,"October 1, 2019","David Karsenti, Charenton-le-Pont, Ile De France, France",,"https://ClinicalTrials.gov/show/NCT03567863"
275,"NCT01965951","Remediation of Spatial Neglect Trial","RESPONSE","Completed","No Results Available","Stroke|Acquired Brain Injury|Hemispatial Neglect","Other: Computerized Plasticity-based Adaptive Cognitive Training|Other: Commercially available computerized training","Performance on Posner Cueing Task|Change in Spatial Cognition (Multiple scores are aggregated to arrive at a single composite score)|Change in Cognitive Performance (Multiple scores are aggregated to arrive at a single composite score)|Change in Functional Ability (Multiple scores are aggregated to arrive at a single composite score)|Change in Quality of Life (Multiple scores are aggregated to arrive at a single composite score)|Change in Quality of Sleep: Pittsburgh Sleep Quality Index (Multiple scores are aggregated to arrive at a single composite score)","Posit Science Corporation|Washington University School of Medicine|VA Boston Healthcare System|Spaulding Rehabilitation Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","96","Industry|Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","PSC-1004-13","July 2013","March 2017","March 2017","October 18, 2013",,"July 7, 2020","Washington University School of Medicine, Saint Louis, Missouri, United States","""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/51/NCT01965951/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT01965951"
276,"NCT01735721","Comparative Study of Algipore and Decalcified Freeze-dried Bone Allograft in Open Maxillary Sinus Augmentation",,"Completed","No Results Available","Disorder of Maxillary Sinus|Maxillary Sinus Floor Augmentation","Procedure: Open Sinus Lift","increase in bone height|Bone Density","Mashhad University of Medical Sciences","All","Child, Adult, Older Adult","Phase 2","10","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","86319","March 2009","June 2010","June 2010","November 28, 2012",,"April 8, 2015","Amir Moeintaghavi, Mashhad, Khorasan Razavi, Iran, Islamic Republic of",,"https://ClinicalTrials.gov/show/NCT01735721"
277,"NCT04186104","Artificial Intelligence in Children's Clinic",,"Recruiting","No Results Available","Artificial Intelligence|Outpatient","Other: Routine diagnostic process|Other: Artificial intelligence assisted diagnosis process","Evaluate the efficiency of the two processes|Evaluate patients' rate of satisfaction for medical processes|Evaluate rate of single visit and rate of return visit|Economic measurements|Work efficiency of doctors|Evaluate the accuracy of examination items prescribed by the AI system and inexperienced physicians","Shanghai Jiao Tong University School of Medicine","All","2 Months to 18 Years   (Child, Adult)","Not Applicable","2000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","SCMCIRB-K2019020-2","March 21, 2020","June 30, 2020","December 31, 2020","December 4, 2019",,"May 21, 2020","Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China|Shanghai Children's Medical Center, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT04186104"
278,"NCT01950091","Internet App to Self-Manage Occasional Low Back Pain","BackPain2","Completed","No Results Available","Low Back Pain","Behavioral: FitBack on-line intervention|Other: Alternative Website Control","Change in responses to the Modified Oswestry Low Back Pain Disability Questionnaire|Change in responses to psycho-social measures (attitudes, knowledge, self efficacy, intentions); self treatment measures","Oregon Center for Applied Science, Inc.|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","606","Industry|NIH","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","Back Pain II Study|R44AR054652","January 2013","July 2013","July 2013","September 25, 2013",,"October 23, 2013",,,"https://ClinicalTrials.gov/show/NCT01950091"
279,"NCT03078998","Leap Motion Based Exercises in Upper Extremity Rehabilitation of The Children","LMBE","Completed","No Results Available","Rehabilitation|Physical Therapy","Device: Leap Motion Based Exercises","Jebsen Taylor Hand Function Test|Nine Hole Peg Test|Childhood Health Assessment Questionnaire|Duruoz Hand Index","Istanbul University|The Scientific and Technological Research Council of Turkey","All","5 Years to 17 Years   (Child)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","108400987275","April 1, 2016","December 14, 2016","July 15, 2017","March 14, 2017",,"April 20, 2018",,,"https://ClinicalTrials.gov/show/NCT03078998"
280,"NCT01859286","Improving Signout Accuracy and Information Delivery in the Emergency Department","SAID-ED","Completed","No Results Available","Medical Errors Related to Emergency Department Sign Out","Other: standardized sign out process","Sign out related errors|perception of sign out","The University of Texas Health Science Center, Houston","All","Child, Adult, Older Adult",,"321","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","HSC-MS-11-0655","February 2012","May 2012",,"May 21, 2013",,"May 21, 2013","Memorial Hermann Hospital - Texas Medical Center, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT01859286"
281,"NCT03131518","From Cars to Bikes - the Feasibility and Effect of Bicycling for Transportation Among Parents of Toddlers",,"Completed","No Results Available","Bicycling Distance|Bicycling Time|Physical Activity Level|Cardiorespratory Fitness|Body Composition","Behavioral: Access to an e-bicycle with trailer|Behavioral: Access to a longtail bicycle|Behavioral: Access to a traditional bike with trailer","Amount of bicycling|Physical activity level|Cardiorespiratory fitness|Body composition|Blood pressure","University of Agder|Stiftelsen Helse og Rehabilitering|Nasjonalforeningen for folkehelsen","All","18 Years to 67 Years   (Adult, Older Adult)","Not Applicable","36","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","1320 98842","June 2, 2017","June 25, 2018","June 25, 2018","April 27, 2017",,"June 29, 2018","University of Agder, Kristiansand, Norway",,"https://ClinicalTrials.gov/show/NCT03131518"
282,"NCT02829307","A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects",,"Completed","Has Results","Drug-Related Side Effects and Adverse Reactions","Drug: 89Zr-GSK3128349 1 mg","Mean Standardized Uptake Values (SUVs) Derived From Positron Emission Tomography-Computer Tomography (PET-CT) Data|Mean Volume of ROI for Each Organ at All Time Points|Area Under Concentration-time Curve From Time Zero (Pre-dose) to Last Time of Quantifiable Concentration (AUC [0-t]) and Area Under the Concentration-time Curve From Time Zero Extrapolated to Infinite Time (AUC [0-inf]) of 89Zr-GSK3128349 and GSK3128349|Percent Area Under the Curve Obtained by Extrapolation (AUCex) and Percent Area Under the First Moment Curve Obtained by Extrapolation (AUMCex) of 89Zr-GSK3128349 and GSK3128349|Maximum Observed Plasma Concentration (Cmax) of 89Zr-GSK3128349|Cmax of GSK3128349|Apparent Terminal Phase Half-life (t1/2) and Mean Residence Time (MRT) of 89Zr-GSK3128349 and GSK3128349|Elimination Rate Constant (Lambda-z) of 89Zr-GSK3128349|Volume of Distribution at a Steady State (Vss) and Volume of Distribution in the Terminal Phase (Vz) of 89Zr-GSK3128349 and GSK3128349|Area Under the First Moment Curve From Pre-dose Extrapolated to Infinite Time (AUMC [0-inf]) and Area Under the First Moment Curve From Pre-dose Extrapolated to Last Time of Quantifiable Concentration (AUMC [0-t]) of 89Zr-GSK3128349|AUMC (0-inf) and AUMC (0-t) of GSK3128349|Clearance of 89Zr-GSK3128349 and GSK3128349|Mean Organ and Effective Dose|Number of Participants With Adverse Events (AE) and Serious Adverse Events (SAE)|Number of Participants With Clinical Chemistry Data of Potential Clinical Concern|Number of Participants With Hematology Data of Potential Clinical Concern|Number of Participants With Electrocardiogram (ECG) Values of Potential Clinical Concern|Number of Participants With Vital Signs of Potential Clinical Concern|Number of Participants With Positive Anti-GSK3128349 Antibody Assay|Serum Titers of Anti-GSK3128349 Antibodies","GlaxoSmithKline|PRA Health Sciences for clinical study conduct.","Male","50 Years to 65 Years   (Adult, Older Adult)","Phase 1","8","Industry|Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","117169","August 23, 2016","January 27, 2017","January 27, 2017","July 12, 2016","September 7, 2018","September 7, 2018","GSK Investigational Site, Zuidlaren, Netherlands","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/07/NCT02829307/Prot_000.pdf|""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/07/NCT02829307/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT02829307"
283,"NCT02807480","Approach-Avoidance Conflict-a Multi-level Predictor for Therapy Response",,"Recruiting","No Results Available","Generalized Anxiety Disorder","Behavioral: Exposure-based therapy|Behavioral: Behavioral Activation therapy|Behavioral: Computer-based behavioral assessment|Behavioral: Surveys and Interviews|Device: Magnetic resonance imaging (MRI)|Device: Electroencephalography (EEG)","For Aim1: Baseline generalized anxiety disorder symptoms as measured by the Generalized Anxiety Disorder - 7 item scale (GAD-7).|For Aims 2 and 3: Change in generalized anxiety disorder symptoms as measured by the Generalized Anxiety Disorder - 7 item scale (GAD-7).|Change in anxiety symptoms as measured by the Patient Reported Outcomes Measurement Information System (PROMIS) Anxiety Scale.|Change in depressive symptoms as measured by the Patient Reported Outcomes Measurement Information System (PROMIS) Depression Scale.|Change in level of disability as measured by the Sheehan Disability Scale|Change in depressive symptoms as measured by the Beck Depression Inventory - II.|Change in worry symptoms as measured by the Penn State Worry Questionnaire.","Laureate Institute for Brain Research, Inc.|National Institute of Mental Health (NIMH)","All","18 Years to 55 Years   (Adult)","Not Applicable","100","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2015-006-02|1K23MH108707-01A1","June 2016","April 2021","April 2021","June 21, 2016",,"March 18, 2020","Laureate Institute for Brain Research, Tulsa, Oklahoma, United States",,"https://ClinicalTrials.gov/show/NCT02807480"
284,"NCT04377100","Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses",,"Not yet recruiting","No Results Available","Anxiety|Healthy Volunteers","Behavioral: Computer task questionnaires","Patterns of neural connectivity as predictors","National Institute of Mental Health (NIMH)|National Institutes of Health Clinical Center (CC)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","750","NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","999920112|20-M-N112","July 14, 2020","February 28, 2021","February 28, 2021","May 6, 2020",,"July 9, 2020","National Institute of Mental Health (NIMH), Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT04377100"
285,"NCT03978871","Effect of Emotion Mindsets on Emotion Processing",,"Enrolling by invitation","No Results Available","Emotions","Behavioral: Growth Mindset|Behavioral: Control","Mean Change from Pre to Post Mindset Manipulation on Emotion Mindset Scale (measures beliefs about whether emotions are fixed or malleable)|Mean Change from Pre to Post Mindset Manipulation on Emotional Self-efficacy Scale (measure beliefs about ability to control emotions)|Mean Change from Pre to Post Mindset Manipulation on Emotional Self-efficacy Vignettes (measure beliefs about ability to control emotions in specific situations)|Mean Difference in Performance on Go/nogo Task|Mean Difference in Emotion Regulation Strategies|Mean Difference in Amygdala Activation|Mean Difference in Frontal Parietal Network-Amygdala Connectivity|Mean Change on Self-Reported State Negative Affect|Mean Change from Baseline in Emotion Mindset Scores at 2 Months|Mean Change from Baseline in Emotion Mindset Scores at 4 Months|Mean Change from Baseline in Emotional Self-efficacy Scale Scores at 2 Months (measure beliefs about ability to control emotions)|Mean Change from Baseline in Emotional Self-efficacy Scale Scores at 4 Months (measure beliefs about ability to control emotions)|Mean Change from Baseline in Emotional Self-efficacy Vignettes Scores at 2 months|Mean Change from Baseline in Emotional Self-efficacy Vignettes Scores at 4 months|Mean Change from Baseline in Self-Reported Emotion Regulation Strategies Scores at 2 months|Mean Change from Baseline in Self-Reported Emotion Regulation Strategies Scores at 4 months|Mean Difference on Self-Reported State Negative Affect","University of Illinois at Urbana-Champaign|Auburn University","Female","13 Years to 18 Years   (Child, Adult)","Not Applicable","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","18021","August 27, 2018","December 15, 2021","April 15, 2022","June 7, 2019",,"June 19, 2020","University of Illinois, Champaign, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT03978871"
286,"NCT00522899","The Mental Activity and eXercise Trial for Seniors","MAX","Completed","No Results Available","Cognitive Impairment","Behavioral: Group 1|Behavioral: Group 2|Behavioral: Group 3|Behavioral: Group 4","Change in cognitive function summary score|Visual processing speed summary score (mental activity group), executive function summary score (exercise group), other measures (e.g., leisure activity, physical performance, physical function, depressive symptoms, sleep quality)","University of California, San Francisco|Alzheimer's Association|National Institute on Aging (NIA)|Posit Science Corporation|YMCA of San Francisco","All","65 Years and older   (Older Adult)","Not Applicable","126","Other|NIH|Industry","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","BarnesDeborahE-1|K01AG024069|IIRG-06-27306","August 2007","December 2009","June 2011","August 30, 2007",,"April 9, 2012","San Francisco Veterans Affairs Medical Center, San Francisco, California, United States|University of California, San Francisco, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT00522899"
287,"NCT00909220","Using Affective Differences to Predict Response to Behavioral Treatment for Major Depressive Disorder",,"Completed","Has Results","Depression","Behavioral: Behavioral Activation","Analyses of Covariance to Test for Group Differences (MDD vs. Healthy) on Clinician-rated Depression Severity After 16 Weeks of Behavioral Activation Psychotherapy, Controlling for Baseline Depression Severity.|Analyses of Covariance to Test for Group Differences (MDD vs. Healthy) on Patient-rated Depression Severity After 16 Weeks of Behavioral Activation Psychotherapy, Controlling for Baseline Depression Severity.|Pre-treatment Frontal EEG Asymmetry Score as a Predictor of Negative Affect at Post-treatment|A Two Level Hierarchical Model Testing the Association Between Negativity Bias Change During BA Treatment With Patient-reported Depression Severity (Week 16 IDS-SR).","Northwestern University|National Institute of Mental Health (NIMH)|University of Chicago|Dartmouth College","All","18 Years to 72 Years   (Adult, Older Adult)",,"77","Other|NIH","Observational","Observational Model: Case-Control|Time Perspective: Prospective","R21MH082133","May 2009","April 2012","April 2012","May 27, 2009","January 16, 2018","April 17, 2018",,,"https://ClinicalTrials.gov/show/NCT00909220"
288,"NCT02427100","Evaluation of a Shelter-Based Diet and Physical Activity Intervention for Homeless Adults",,"Completed","Has Results","Dietary Modification|Physical Activity","Behavioral: Diet/Physical Activity","Automated Self-Administered 24-Hour Dietary Recall: Fruit/Vegetable, Cups|Accelerometer-Measured Physical Activity: Moderate to Vigorous Intensity Physical Activity","University of Texas Southwestern Medical Center|The University of Texas Health Science Center, Houston|American Cancer Society, Inc.|Simmons Cancer Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","32","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","STU 062014-031","April 2015","September 2015","September 2015","April 27, 2015","May 6, 2019","May 6, 2019",,,"https://ClinicalTrials.gov/show/NCT02427100"
289,"NCT02839395","The Effects of Acute vs. Chronic of Screen Illumination on: Sleep Efficacy and Architecture, Physiology, Emotion and Behavior: Possible Effect on Human Health",,"Completed","No Results Available","Sleep|Emotion","Other: No intervention- base line|Other: Acute|Other: Chronic","body temperature|Melatonin secretion|sleepiness|BSI Questionnaire|Subjective sleepiness|attention|total Sleep time|Sleep efficiency|sleep latency to sleep stage1|sleep latency to sleep stage2|wake %TIB|REM %TIB|staege1%TIB|stage2%TIB|stage4%TIB","Assuta Medical Center","All","20 Years to 45 Years   (Adult)","Not Applicable","19","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","0005-16-ASMC","August 2016","October 2016","December 2016","July 21, 2016",,"January 9, 2018",,,"https://ClinicalTrials.gov/show/NCT02839395"
290,"NCT03591497","Role of Virtual Reality in Improving Balance in Patients With Myelopathy",,"Completed","No Results Available","Myelopathy|Virtual Reality","Other: Virtual Reality","Change in Berg Balance Scale (BBS)|Change in Tinetti performance oriented mobility assessment (POMA)|Change in Functional reach test (forward and lateral)|Difference in Berg Balance Scale (BBS) between groups|Difference in Tinetti performance oriented mobility assessment (POMA) between groups|Difference in Functional reach test (forward and lateral) between groups|Difference in Hospital anxiety and depression scale (HADS) between groups|Difference in Spinal cord independence measurement scale (SCIM) between groups|Difference in Walking Index for Spinal Cord Injury II (WISCI II) between groups","National Institute of Mental Health and Neuro Sciences, India","All","18 Years to 60 Years   (Adult)","Not Applicable","33","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IEC (BS & NS DIV)/2017-18","February 1, 2018","May 30, 2018","May 30, 2018","July 19, 2018",,"July 19, 2018","National Institute of Mental Heath and Neurosciences, Bangalore, Karnataka, India",,"https://ClinicalTrials.gov/show/NCT03591497"
291,"NCT02674438","Comparison of Outcomes and Access to Care for Heart Failure Trial","COACH","Recruiting","No Results Available","Heart Failure","Other: Risk stratification and transitional care intervention","Clinical outcome|Process outcome|Death|CV readmission|Death or CV readmission|Days alive and out of hospital","Institute for Clinical Evaluative Sciences","All","18 Years and older   (Adult, Older Adult)","Phase 3","4000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","2","September 2016","October 2020","October 2020","February 4, 2016",,"December 3, 2019","Toronto Genera Hospital, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02674438"
292,"NCT01641432","Computerized Attention Training for Individuals With Acquired Brain Injury",,"Completed","No Results Available","Acquired Brain Injury|Stroke|Hemispatial Neglect","Behavioral: Tonic and Phasic Attention Training|Behavioral: Active Comparator","Attention and Memory","Posit Science Corporation","All","21 Years to 80 Years   (Adult, Older Adult)","Phase 1","27","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)","BPI-1002-2011","July 2011","July 2013",,"July 16, 2012",,"July 22, 2014","Brain Plasticity Institute, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT01641432"
293,"NCT02329340","Safety Skills Training: Parents of School-Aged Children","SAS_2","Completed","No Results Available","Injuries","Behavioral: Am Academy of Pediatrics print materials|Behavioral: Family safety 1-2-3","Behavioral measure: identification of correct/incorrect car booster safety seat, seat belt, and bicycle helmet placement|Knowledge of injury prevention strategies|Attitudes and beliefs about injury prevention strategies|Self-efficacy for engaging in injury prevention strategies","Oregon Center for Applied Science, Inc.|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2","175","Industry|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","SBIR76R-2|R44HD048005","September 2009","August 2010","August 2010","December 31, 2014",,"December 31, 2014","Oregon Center for Applied Science, Eugene, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT02329340"
294,"NCT02647645","Cognitive Training With and Without tDCS to Improve Cognition in HIV",,"Terminated","Has Results","HIV|Mild Neurocognitive Disorder","Device: Transcranial direct current stimulation|Procedure: Cognitive training|Device: Sham transcranial direct current stimulation","Working Memory: Participants' Rate of Improvement|Center for Epidemiological Studies Depression Scale (CES-D)|Patient's Own Assessment of Function (PAOF)","Nova Southeastern University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","21","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","1203142F","September 2015","May 2017","May 2017","January 6, 2016","October 15, 2018","October 10, 2019","NSU Psychiatry Research Office, Fort Lauderdale, Florida, United States","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/45/NCT02647645/Prot_000.pdf|""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/45/NCT02647645/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT02647645"
295,"NCT00928993","An Evaluation of Actigraphy as an Indicator of Sleep and Wake in Children",,"Completed","No Results Available","Sleep Monitoring",,,"Oregon Health and Science University|Philips Respironics","All","6 Months to 18 Years   (Child, Adult)",,"48","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","IRB00005369","June 2009","May 2011","June 2013","June 26, 2009",,"December 27, 2019","Multnomah Pavilion, OHSU, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT00928993"
296,"NCT00242658","Computerized Health Education to Promote Physical Activity",,"Completed","Has Results","Hypertension","Behavioral: Tailored Physical Activity Intervention","7-Day Physical Activity Recall (7-Day PAR)|Change in Behavioral Processes of Change Between Baseline and 6 Months","Milton S. Hershey Medical Center|National Heart, Lung, and Blood Institute (NHLBI)|Thomas Jefferson University","All","21 Years to 65 Years   (Adult, Older Adult)","Phase 1","394","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)","269|7R01HL067005-03|02F.214 CHIP","May 2005","December 2007","March 2008","October 20, 2005","June 6, 2011","November 12, 2012","Jefferson Family Medicine Associates, Philadelphia, Pennsylvania, United States|Jefferson Medical College, Department of Health Policy, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT00242658"
297,"NCT02929979","Cognitive Remediation for Alcohol Use Disorder and Posttraumatic Stress Disorder",,"Completed","No Results Available","Alcohol Use Disorder|PTSD|Cognitive Dysfunction","Behavioral: Cognitive Training|Behavioral: Cognitive training placebo control","The WAIS-IV (Wechsler, 2008) Processing Speed Index|Trail Making Test (TMT) - Part A|Computerized Approach Avoidance Tasks for Alcohol and Threat|The Revised Hopkins Verbal Learning Test|The Brief Visual Memory Test Revised|The Wechsler Adult Intelligence Scale-IV Working Memory Index|The Conners' Continuous Performance Task II|The Color-Word Interference Test (DKEFS)|The Iowa Gambling Task|The Delay Discounting Task|Trail Making Test (TMT) - Part B|The Wisconsin Card Sorting Test - computer version 4 Research Edition|The Tower Test (DKEFS)|Alcohol Use|Functional Status - Inventory of Psychosocial Functioning|PTSD Symptom Severity","VA Office of Research and Development","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","93","U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","D1492-W|1IK2RX001492-01A1","January 1, 2015","July 21, 2019","July 21, 2019","October 11, 2016",,"July 24, 2019","VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto, California, United States",,"https://ClinicalTrials.gov/show/NCT02929979"
298,"NCT04276506","Effect of Information Given and Music on the Care of Patient Who Will Undergo Coronary Angiography",,"Recruiting","No Results Available","Anxiety State|Invasive Procedure","Other: music group|Other: information group","State anxiety level|heart rate|respiratory rate|blood pressure","Eastern Mediterranean University","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","184","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","EasternMUU","September 10, 2019","February 2020","March 2020","February 19, 2020",,"February 19, 2020","EMU Health Science Faculty, Famagusta, Cyprus",,"https://ClinicalTrials.gov/show/NCT04276506"
299,"NCT04417140","A Prospective, Double-Blinded, Randomized Controlled Trial of dHACM for Incisional Hernia Prophylaxis","NO-HERNIA","Recruiting","No Results Available","Incisional Hernia","Biological: dHACM (AmnioWrap)","Incidence of IH as determined by physical exam or abdominal ultrasound demonstrating a midline fascial defect and hernia sac> 4mm diameter|Intraoperative and postoperative complications","Louisiana State University Health Sciences Center in New Orleans|LSUHSC-NO","All","18 Years and older   (Adult, Older Adult)","Phase 4","533","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","LSUHSC-NO IRB # 19-174","May 20, 2020","May 20, 2022","May 20, 2022","June 4, 2020",,"June 4, 2020","University Medical Center, New Orleans, Louisiana, United States",,"https://ClinicalTrials.gov/show/NCT04417140"
300,"NCT04239378","Comparison of Autogenous Dentin Matrix Versus Bovine-Derived Xenograft for Socket Preservation",,"Recruiting","No Results Available","Alveolar Bone Resorption","Procedure: socket preservation","Height of Alveolar Crest and Bucco-Lingual Ridge Width|Alveolar Ridge Width Gain(ARWG) and Vertical Bone Height Gain(VBHG)|New Bone Formation % and Residual Bone Graft|Plaque Index|Bleeding Index|Patient Reported Outcome Measures for Pain and Esthetics","Krishnadevaraya College of Dental Sciences & Hospital","All","18 Years to 55 Years   (Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","02_D012_101639","December 10, 2019","November 2021","November 2021","January 27, 2020",,"February 5, 2020","Krishnadevaray College of Dental Science and Hospital, Bangalore, Karnataka, India",,"https://ClinicalTrials.gov/show/NCT04239378"
301,"NCT02041845","Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer","THORA","Active, not recruiting","No Results Available","Small Cell Lung Carcinoma","Radiation: 45 Gy in 30 fractions|Radiation: 60 Gy in 40 fractions","survival|progression free survival (PFS)|Local control|overall survival|toxicity|health related quality of life (HRQoL)","Norwegian University of Science and Technology|St. Olavs Hospital|Oslo University Hospital|University Hospital of North Norway|Sorlandet Hospital HF","All","18 Years and older   (Adult, Older Adult)","Not Applicable","177","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2013/2163","January 2014","June 2020","June 2023","January 22, 2014",,"July 8, 2020","Rigshospitalet København, København, Denmark|Odense University Hospital, Odense, Denmark|Haukeland Universitetssykehus, Bergen, Norway|Vestre Viken HF, Drammen Sykehus, Drammen, Norway|Førde Sentralsykehus, Førde, Norway|Sykehuset Innlandet Gjøvik, Gjøvik, Norway|Haugesund sykehus, Haugesund, Norway|Sykehuset Levanger, Levanger, Norway|Sykehuset Namsos, Namsos, Norway|Akershus Universitetssykehus, Oslo, Norway|Oslo Universitetssykehus, Radiumhospitalet, Oslo, Norway|Sykehuset Østfold (Kalnes/Sarpsborg), Sarpsborg, Norway|Universitetssjukehuset i Stavanger, Stavanger, Norway|University Hospital of North Norway, Pulmonology Department, Tromsø, Norway|Cancer Clinic at St. Olavs Hospital, Trondheim, Norway|Ålesund sykehus, Ålesund, Norway|Gävle Sjukhus, Gävle, Sweden|Sahlgrenska Sjukehuset, Göteborg, Sweden|Skånes universitetssjukhus, Lund, Sweden|Karolinska University Hospital, Stockholm, Sweden|Norrlands Universitetssjukehus, Umeå, Sweden|Universitetssjukehuset i Ôrebro, Örebro, Sweden",,"https://ClinicalTrials.gov/show/NCT02041845"
302,"NCT01891721","Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia",,"Completed","Has Results","Schizophrenia","Behavioral: Brain Fitness Program (BFP)|Behavioral: Cognitive Package (Cogpack)|Behavioral: Commercial Computer Games (Sporcle)","Neurocognition|Electroencephalography (EEG)|Functional Capacity","VA Office of Research and Development","All","25 Years to 65 Years   (Adult, Older Adult)","Not Applicable","105","U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","MHBB-015-12F","November 21, 2013","June 30, 2018","June 30, 2018","July 3, 2013","August 14, 2019","August 14, 2019","Local Board and Care Facilities, Los Angeles, California, United States|VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles, California, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/21/NCT01891721/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT01891721"
303,"NCT02026128","Optical Coherence Tomography (OCT) in Uveitis",,"Recruiting","No Results Available","Uveitis",,"Number of anterior chamber cells|Number of keratic precipitates (KP)|Number of vitreous cells|Degree of anterior chamber flare","Oregon Health and Science University","All","18 Years and older   (Adult, Older Adult)",,"75","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","OHSU IRB#00008052","March 2012","December 2022","December 2022","January 1, 2014",,"April 13, 2020","Oregon Health & Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT02026128"
304,"NCT03844178","Pupil Centroid Shift Compensation in Photorefractive Keratectomy Candidates",,"Recruiting","No Results Available","Pupil Centroid Shift","Procedure: The option for compensation of Pupil centroid shift was ON|Procedure: The option for compensation of Pupil centroid shift was OFF|Drug: installation of Tetracaine 1%|Procedure: Photorefractive keratectomy (PRK)","Postoperative refractive error|Root Mean Square (RMS) of higher order aberration","Shahid Beheshti University of Medical Sciences","All","18 Years to 40 Years   (Adult)","Phase 2","104","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","97362","February 10, 2019","June 1, 2019","July 1, 2019","February 18, 2019",,"February 18, 2019","Ophthalmic Research Center, Tehran, Iran, Islamic Republic of",,"https://ClinicalTrials.gov/show/NCT03844178"
305,"NCT02094989","ECG and VCG in Dependence of Body Posture","EVER","Completed","No Results Available","Coronary Heart Disease|Arrhythmia","Other: posture dependence of VCG-ECG-transformation","posture dependence of the individual VCG-ECG-Transformation matrix|artifacts in the ECG morphology|posture dependence of electrical heart axis","Bern University of Applied Sciences","Male","18 Years to 60 Years   (Adult)",,"46","Other","Observational","Time Perspective: Prospective","BFH-001","January 2013","March 2013","March 2013","March 24, 2014",,"March 24, 2014","CTU, Bern, Switzerland",,"https://ClinicalTrials.gov/show/NCT02094989"
306,"NCT02811172","Behavior of Biomarkers During Pregnancy and Lactation Through a Biological Multi-paradigm Model: BECOME Study Protocol","BECOME","Completed","No Results Available","Pregnancy|Gestational Diabetes|Hypertension|Obesity","Other: BEhavior of biomarkers during pregnanCy and lactatiOn","Triglyceride levels|prolactin levels|glucose levels|cholesterol levels|Nutritional evaluation|Collection of samples: mother's milk|Mother's milk: short-chain fatty acid|Mother's milk: Total fatty acid profile|Bioactive peptides","Universidad de Granada","Female","Child, Adult, Older Adult",,"224","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","SPID201600X080546IV0","January 2017","August 2018","January 2019","June 23, 2016",,"February 25, 2019","Universidad de Granada, Granada, Spain",,"https://ClinicalTrials.gov/show/NCT02811172"
307,"NCT02681653","Study the Impact of Statins in Septic Shock",,"Completed","No Results Available","Septic Shock","Drug: Atorvastatin|Drug: Placebo","Mortality|Cytokines in septic shock|Vasopressor free days.|Ventilation free days.|Renal replacement free days.|Transfusion free days.|Total parenteral nutrition free days.","Sanjay Gandhi Postgraduate Institute of Medical Sciences","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","PGI/IMP/IEC/56/19.08.2011","January 2012","October 2014","January 2015","February 12, 2016",,"February 12, 2016","Department of Immunology, SGPGIMS, Lucknow, UP, India|Department of Critical Care Medicine, Lucknow, Uttar Pradesh, India",,"https://ClinicalTrials.gov/show/NCT02681653"
308,"NCT02755636","Pro-Change Population Health Solution","PCPHS","Unknown status","No Results Available","Risk Behavior","Behavioral: PCPHC|Other: Usual care","Change in number of cancer risk behaviors|Change in consumer engagement|Adherence with cancer screenings|Change in satisfaction with medical care|Change in well-being|Change in health-related quality of life","Pro-Change Behavior Systems|Community Health Center, Inc.","All","21 Years to 75 Years   (Adult, Older Adult)","Phase 2","780","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","HHSN261201500015C","May 2016","July 2017","July 2017","April 29, 2016",,"June 2, 2016","Connecticut Health Center, Inc., Middletown, Connecticut, United States|Pro-Change Behavior Systems, Inc., South Kingstown, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT02755636"
309,"NCT03841552","Efficacy of Augmented Feedback on Lumbar Postural and Movement Control During Physiotherapy and Home Exercise",,"Completed","No Results Available","Low Back Pain","Device: Augmented Feedback|Other: Control Group","Change from Baseline ratio of the range of motion (ROM) of the stabilized lumbar spine (ROMLS) over the moving body segment, the hip (ROMHip)|Changes from Baseline of the mean absolute deviation of lumbar agular displacement","Zurich University of Applied Sciences|Danube University Krems|MedBase Brunngasse Winterthur","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","KEK-ZH-Nr. 2011-0522","October 1, 2012","April 30, 2013","April 30, 2013","February 15, 2019",,"February 15, 2019","Zurich University of Applied Sciences, Winterthur, Zurich, Switzerland",,"https://ClinicalTrials.gov/show/NCT03841552"
310,"NCT03279354","Smartphone Parent-child Partner Exercises Application Study",,"Completed","No Results Available","Physical Activity","Behavioral: Family Move app intervention|Behavioral: ""HK FitNuts"" app intervention","Change from Baseline Child Psychosocial Health at 1 month and 6 month post intervention|Change from Baseline Child Total Physical Activity Score (MET-minutes/week) at 1 month and 6 month post intervention|Change from Baseline Parental Mental and Physical Health at 1 month and 6 month post intervention|Change from Baseline Child SDQ Total Difficulties Scores at 1 month and 6 month post intervention|Change from Baseline Parent Total Physical Activity Score (MET-minutes/week) at 1 month and 6 month post intervention|Change from Baseline Parental DASS scores on each subscale (Depression, Anxiety and Stress) at 1 month and 6 month post intervention","The University of Hong Kong","All","7 Years to 16 Years   (Child)","Not Applicable","186","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","UW17-179","June 1, 2017","December 31, 2018","June 30, 2019","September 12, 2017",,"March 26, 2020","The University of Hong Kong, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT03279354"
311,"NCT02408874","Inhaled Nanosilver Study",,"Withdrawn","No Results Available","Inflammatory Disease",,"To evaluate the impact of nanosilver exposure on ex vivo inflammatory response of bronchoscopy-derived cells (i.e. alveolar macrophage and epithelial cells) to challenge with a TLR agonist","National Institute of Environmental Health Sciences (NIEHS)|National Institutes of Health Clinical Center (CC)","All","18 Years to 60 Years   (Adult)",,"0","NIH","Observational","Observational Model: Cohort|Time Perspective: Prospective","150104|15-E-0104","April 3, 2015","November 20, 2017","November 20, 2017","April 6, 2015",,"December 17, 2019",,,"https://ClinicalTrials.gov/show/NCT02408874"
312,"NCT02080351","A Simple Cognitive Task to Reduce the Build-Up of Flashbacks After a Road Traffic Accident","SCARTA","Completed","No Results Available","Post-traumatic Stress Disorders","Behavioral: Simple cognitive task","Number of flashbacks recorded by participants in a Flashback Record in the week after the accident|Post-traumatic Stress Diagnostic Scale (PDS)|Impact of Event Scale - Revised (IES-R)|Hospital Anxiety and Depression Scale (HADS)","University of Oxford|Oxford University Hospitals NHS Trust|National Institute for Health Research, United Kingdom|Medical Research Council Cognition and Brain Sciences Unit","All","18 Years and older   (Adult, Older Adult)","Not Applicable","71","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","12/SC/0485","March 2014","January 2015","March 2015","March 6, 2014",,"June 1, 2015","Emergency Department, John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02080351"
313,"NCT02933684","D-Cycloserine and Virtual Reality Exposure Therapy",,"Withdrawn","No Results Available","Social Anxiety Disorder","Drug: Seromycin|Behavioral: Virtual Reality Exposure Therapy|Drug: Placebo","Change in scores on the Liebowitz Social Anxiety Scale-self report version (LSAS-SR)|Change in behavioral avoidance|Change in scores on the Clinical Global Improvement Scale, Patient Report|Change in scores on the Social Phobia Scale|Change in scores on the Social Interaction Anxiety Scale|Change in scores on the Patient Health Questionnaire|Change in scores on the Sheehan Disability Scale|Change in scores on the Quality of Life Inventory","Georgia State University|Emory University","All","18 Years and older   (Adult, Older Adult)","Phase 2","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","ULTR000454","January 1, 2015","December 31, 2016","December 31, 2016","October 14, 2016",,"April 13, 2018","Georgia State University, Atlanta, Georgia, United States",,"https://ClinicalTrials.gov/show/NCT02933684"
314,"NCT03465137","Using the Neuroscience of Fear Extinction for Anxiety Reduction","UNFEAR","Recruiting","No Results Available","Social Anxiety","Behavioral: Coordinated Anxiety Learning and Management (CALM)","Liebowitz Social Anxiety Scale (LSAS)|Patient Health Questionnaire (PHQ-9)|Brief Fear of Negative Evaluation (BFNE)|World Health Organization Quality of Life scale (WHO-QOL)","Stanford University","All","18 Years to 50 Years   (Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRB-44722","January 14, 2018","March 30, 2023","December 31, 2023","March 14, 2018",,"September 18, 2019","Stanford University Department of Psychiatry & Behavioral Sciences, Palo Alto, California, United States",,"https://ClinicalTrials.gov/show/NCT03465137"
315,"NCT04181983","Personalized Exercise Programs for Older Adults - a Digital User-friendly Application",,"Recruiting","No Results Available","Healthy Older Adults|Exercise","Other: Personalized exercise program|Other: WHO exercise guidelines","Balance|Leg Strength|Upper extremities flexibility|Upper extremities strength","Hadassah Medical Organization|Zinman College of Physical Education and Sports Sciences","All","65 Years to 99 Years   (Older Adult)","Not Applicable","360","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","JMJYN-HMO-CTIL","October 27, 2019","October 2021","December 2021","December 2, 2019",,"December 2, 2019","Hadassah medical Organization, Jerusalem, Israel",,"https://ClinicalTrials.gov/show/NCT04181983"
316,"NCT03725345","Genetic and Neural Factors in Alcohol-Related Cognition",,"Not yet recruiting","No Results Available","Alcohol Abuse","Behavioral: MRI Scanner","Changes in alcohol-influenced behavior","Virginia Commonwealth University|National Institute on Alcohol Abuse and Alcoholism (NIAAA)","All","21 Years to 45 Years   (Adult)","Not Applicable","808","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","HM20013938|K01AA026647","March 20, 2021","September 19, 2023","September 19, 2023","October 31, 2018",,"November 12, 2019","Virginia Commonwealth University, Richmond, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT03725345"
317,"NCT04066985","Targeting Adolescent Depressive Symptoms Via Brief, Web-Based Interventions",,"Recruiting","No Results Available","Depression|Depressive Disorder|Behavioral Symptoms|Mood Disorders|Mental Disorders","Behavioral: Growth Mindset Online Single-Session Program|Behavioral: Self-Kindness Online Single-Session Program|Behavioral: Supportive Therapy Online Single-Session Program (Control)","Change in Mood and Feelings Questionnaire; Youth-Report|Change in Screen for Child Anxiety and Related Disorders; Youth-Report|Change in Implicit Theories of Personality Questionnaire; Youth-Report|Change in Self-Hate Scale; Youth-Report|Change in Self-Judgment Subscale of Self-Compassion Scale; Youth-Report|Change in Fear of Self-Compassion Scale; Youth-Report|Change in Beck Hopelessness Scale-Short Version; Youth-Report|Change in Primary Perceived Control Scale for Children; Youth-Report|Change in Secondary Perceived Control Scale for Children; Youth-Report","Child Mind Institute|Stony Brook University","All","11 Years to 17 Years   (Child)","Not Applicable","501","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","Pro00034009","October 1, 2019","October 31, 2020","October 31, 2020","August 26, 2019",,"October 4, 2019","Child Mind Institute, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04066985"
318,"NCT01312649","Feeling of Being in Control of One's Own Action",,"Completed","No Results Available","Schizophrenia|Bipolar Disorders","Behavioral: Experimental psychology methods (computer tests)",,"University Hospital, Strasbourg, France","All","18 Years to 55 Years   (Adult)","Not Applicable","198","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science","4880","April 2011","June 15, 2017","June 15, 2017","March 11, 2011",,"March 22, 2018","Pôle de Psychiatrie - Hôpital civil, Strasbourg, France",,"https://ClinicalTrials.gov/show/NCT01312649"
319,"NCT01084746","Tailored Interactive Intervention to Increase CRCS","PCCaSO","Completed","No Results Available","Colorectal Cancer Screening","Behavioral: PC-based tailored intervention|Behavioral: Printed educational materials","Increase patient completion of colorectal cancer screening (CRCS) among patients ages 50 to 64 years old.|Secondary goals are to increase understanding of factors that predict completion of CRCS and to assess the cost-effectiveness of the intervention.","The University of Texas Health Science Center, Houston|National Cancer Institute (NCI)","All","50 Years to 64 Years   (Adult)","Not Applicable","1224","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Prevention","HSC-SPH-01-084|R01CA097263-05","January 2005","June 2008","June 2008","March 10, 2010",,"May 11, 2018","University of Texas Health Science Center at Houston School of Public Health, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT01084746"
320,"NCT02368899","Computerized Alcohol Misuse Intervention System for Health Care","CAMI","Completed","No Results Available","Alcoholism","Other: Computerized Alcohol Misuse Intervention|Other: Attention Control (AC)","Change in drinking behavior as measured by self-reported alcohol use after completing the computerized alcohol misuse intervention (CAMI)|Changes in participant motivation to stop or cut down alcohol use as measured by self-reported interest in reduction of alcohol use after completing the computerized alcohol misuse intervention (CAMI)","Research Circle Associates, LLC|University of Maryland, Baltimore County|National Institute on Alcohol Abuse and Alcoholism (NIAAA)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","61","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Screening","RCA-AA020451-R42|2R42AA020451-02","November 2016","April 17, 2017","April 17, 2017","February 23, 2015",,"May 10, 2017","Family Health Centers of Baltimore, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT02368899"
321,"NCT04430543","Neural and Behavioral Effects of Cognitive Bias Modification (CBM)",,"Recruiting","No Results Available","Alcohol Drinking","Behavioral: Cognitive Bias Modification|Behavioral: Sham Training","BOLD signal change in ROIs (amygdala, NAcc, mPFC, dlPFC) during alcohol cue-reactivity|BOLD signal change in ROIs (amygdala, NAcc, mPFC, dlPFC) during INHIBIT cue-reactivity|BOLD signal change in ROIs (amygdala, NAcc, mPFC, dlPFC) during INDULGE cue-reactivity|Drinking Behavior|Alcohol Craving","Boston University Charles River Campus|National Institute on Alcohol Abuse and Alcoholism (NIAAA)","All","18 Years to 34 Years   (Adult)","Not Applicable","40","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","4633E|1F31AA025522-01A1","August 21, 2019","March 31, 2021","September 29, 2021","June 12, 2020",,"June 12, 2020","Rajen Kilachand Center for Integrated Life Sciences and Engineering at Boston University, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04430543"
322,"NCT03387267","Videofluoroscopic Swallowing Study (VFSS)","PORSCHE","Terminated","No Results Available","Stroke|Parkinson Disease|Multiple Sclerosis|Oropharyngeal Dysphagia|Alzheimer Disease|Dementia","Device: Dysphagia Detection System","The primary efficacy of the Dysphagia Detection System (DDS) will be measured as the sensitivity & specificity obtained from comparing the DDS swallow safety outcome simultaneously to the VFSS swallow safety outcome for thin barium (THIN-Ba) stimuli|The sensitivity & specificity DDS for swallow safety using MILD-Ba will be measured as the sensitivity & specificity obtained from comparing the DDS predicted swallow safety outcome with the VFSS swallow safety outcome for MILD-Ba|The sensitivity & specificity DDS for swallow efficiency using THIN-Ba will be measured as the sensitivity & specificity obtained from comparing the DDS predicted swallow efficiency outcome with the VFSS swallow efficiency outcome for THIN-Ba|The sensitivity & specificity DDS for swallow efficiency using MILD-Ba will be measured as the sensitivity & specificity obtained from comparing the DDS predicted swallow efficiency outcome with the VFSS swallow efficiency outcome for MILD-Ba|The sensitivity & specificity DDS for swallow safety using MOD-Ba will be measured as the sensitivity & specificity obtained from comparing the DDS predicted swallow safety outcome with the VFSS swallow safety outcome for MOD-Ba|The sensitivity & specificity DDS for swallow efficiency using MOD-Ba will be measured as the sensitivity & specificity obtained from comparing the DDS predicted swallow efficiency outcome with the VFSS swallow efficiency outcome for MOD-Ba","Nestlé|Cytel Inc.|Regulatory and Clinical Research Institute Inc|Nestec Ltd.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","442","Industry|Other","Interventional","Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Screening","16.21.CLI","October 24, 2017","July 23, 2018","July 23, 2018","January 2, 2018",,"January 31, 2019","Rancho Research Institute, Rancho Los Amigos National Rehabilitation Center, Downey, California, United States|University of Colorado Denver, Aurora, Colorado, United States|Medstar Rehabilitation Hospital, Washington, District of Columbia, United States|Shirley Ryan AbilityLab, Chicago, Illinois, United States|Marionjoy Rehabilitation Hospital, Wheaton, Illinois, United States|Kentucky Clinic, Lexington, Kentucky, United States|Boston Medical Center, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|New York Presbyterian/Weill Cornell Medical Center, New York, New York, United States|New York Presbyterian Hospital/Columbia University Medical Center, New York, New York, United States|The Burke Medical Research Institute, White Plains, New York, United States|The Cleveland Clinic Foundation, Cleveland, Ohio, United States|Helsinki University Central Hospital, Helsinki, Finland",,"https://ClinicalTrials.gov/show/NCT03387267"
323,"NCT04095728","Investigating the Efficacy of Brain Octane® Oil on Cognition, Coordination, Reaction Time and Measurements of Physical Performance in Recreationally Active Adults",,"Recruiting","No Results Available","Healthy","Dietary Supplement: Brain Octane Oil|Other: Placebo","Comparison of the change from baseline to day 30 between Brain Octane® Oil vs. placebo on reaction time as assessed by Dynavision D2 tests after first and second doses of Brain Octane® Oil|Comparison of the change from baseline to day 30 between Brain Octane® Oil vs. placebo on coordination as assessed by a Dynavision D2 test after first and second doses of Brain Octane® Oil|Comparison of the change from baseline to day 30 between Brain Octane® Oil vs. placebo on the ability to perform cognitive tasks as assessed by a Dynavision D2 test and mod. Serial Sevens Test after first and second doses of Brain Octane® Oil|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in VO2Max (maximal oxygen consumption using cycle ergometer testing) as measured by Cardiocoach|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in gas exchange threshold (GET, a measure of aerobic efficiency) as measured by Cardiocoach|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in recovery from physical stress using Physical Fatigue Questionnaire|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in recovery from physical stress using Delayed Onset Muscle Soreness (DOMS) Questionnaire|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in acetoacetate plasma ketone measured before the first and second Dynavision tests|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in beta-hydroxybutyrate plasma ketone measured before the first and second Dynavision tests|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in glucose measured before first and second Dynavision D2 tests|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in insulin measured before first and second Dynavision D2 tests|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in creatine kinase measured before and after cycle ergometer testing|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in fat body weight|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in percent body fat|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in lean dry mass|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in percent lean dry mass|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in total body water|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in percent body weight body water|Comparison of the change from baseline to day 30 between Brain Octane® Oil versus placebo in basal metabolic rate","Bulletproof 360, Inc.|KGK Science Inc.","All","25 Years to 55 Years   (Adult)","Phase 2","30","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","19BCHB","September 30, 2019","February 2020","February 2020","September 19, 2019",,"January 21, 2020","KGK Science Inc., London, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04095728"
324,"NCT02943824","Machine-learning Optimization for Prostate Brachytherapy Planning","MOPP","Completed","No Results Available","Prostatic Neoplasms","Other: Machine Learning Planning|Other: Radiation Therapist Planning","post-operative prostate V100%|Pre-operative planning time|Pre-operative dosimetry|Frequency & magnitude of plan modifications","Sunnybrook Health Sciences Centre","Male","Child, Adult, Older Adult","Not Applicable","42","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other","1.1.1","August 24, 2017","August 24, 2018","September 4, 2018","October 25, 2016",,"September 6, 2018","Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02943824"
325,"NCT03968081","Exploration of Theory of Mind in a Situation of Social Rejection in Borderline Personality Disorder","LIMITOM","Recruiting","No Results Available","Borderline Personality Disorder|Social Rejection|Social Skills|Cognitive Function 1, Social","Behavioral: Cyberball","Theory of mind performance|Evolution of theory of mind performance after cyberball - accuracy|Evolution of theory of mind performance after cyberball - reaction time|Mentalization performance|Social rejection sensibility - intentional rejection|Social rejection sensibility - difference between intentional and non intentional rejection","Versailles Hospital","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research","P18/12_LIMITOM","June 26, 2019","June 21, 2022","December 21, 2022","May 30, 2019",,"July 23, 2019","Centre Hospitalier de Versailles, Le Chesnay, France",,"https://ClinicalTrials.gov/show/NCT03968081"
326,"NCT03300245","Nasal Septum Deviation May Affect Facial Morphologic Parameters.","Nasalseptum","Unknown status","No Results Available","Nasal Septal Deviation","Radiation: Maxillofacial CT","The nasal deviation angle|The lateral and intermediate nasal bone thickness|Nasal bone length|Internasal angle","Assiut University","All","18 Years to 60 Years   (Adult)",,"50","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","17100286","August 1, 2018","January 1, 2019","March 1, 2019","October 3, 2017",,"July 3, 2018","Assiut university, Assiut, Egypt",,"https://ClinicalTrials.gov/show/NCT03300245"
327,"NCT04223154","The Effect of Dorsolateral Prefrontal Cortex Theta Burst Stimulation on Alcohol Cue Reactivity and Cognitive Control: a Double-blind, Sham Controlled Study of Heavy Alcohol Drinkers With a History of Alcohol Related Injury.",,"Recruiting","No Results Available","Alcohol Drinking|Alcohol Use Disorder|Trauma Injury|Alcohol Dependence|Alcohol Abuse","Device: Real iTBS to the dlPFC|Device: Sham iTBS to the dlPFC","Neuroimaging outcomes: change in drug cue reactivity as specified by changes in BOLD signal|Behavioral outcomes: change in cognitive performance (measured by stroop task) in the presence of an alcohol cue|Acute changes in craving","Wake Forest University Health Sciences","All","21 Years to 65 Years   (Adult, Older Adult)","Not Applicable","48","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","IRB00063018","July 2020","September 2021","September 2021","January 10, 2020",,"July 8, 2020","Wake Forest Baptist Health Sciences, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT04223154"
328,"NCT04415775","Changes in Metabolic Activity, and Gait Function by Dual-task Cognitive Game-based Treadmill Intervention in Parkinson's Disease.","CMAGDT","Not yet recruiting","No Results Available","Parkinson Disease","Other: Game based treadmill Program|Other: Conventional Gait Rehabilitation","NDWP scores|Step Length Coefficient of Variability","University of Manitoba|Weston Brain Institute","All","55 Years to 70 Years   (Adult, Older Adult)","Not Applicable","67","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","B2020:043","September 1, 2020","August 1, 2023","November 1, 2023","June 4, 2020",,"June 4, 2020","College of Rehabilitation Sciences, University of Manitoba, Winnipeg, Manitoba, Canada",,"https://ClinicalTrials.gov/show/NCT04415775"
329,"NCT03342924","Associations of Cognition, Fitness, and Body Composition Among Ethnic Minority Youth",,"Completed","No Results Available","Obesity|Physical Activity|Cognitive Function 1, Social","Other: Flanker Test and physical fitness test","Cognition|Socioeconomic Status|Aerobic Endurance|Arm Strength|Lower Body Power|Weight|Waist Circumference|Sagittal Abdominal Height|Percent Body Fat|Body Mass Index|Height","University of Miami|University of Tennessee Health Science Center","All","8 Years to 12 Years   (Child)","Not Applicable","212","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","20120584","June 2014","June 2014","June 2014","November 17, 2017",,"November 17, 2017","Le Bonheur, Memphis, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT03342924"
330,"NCT02461693","Evaluating the Role of Expectations in Response to Caffeine Consumption: An RCT",,"Completed","Has Results","Caffeine|Affect|Cognitive Ability, General|Mood","Drug: Caffeine|Drug: Placebo","Mood State Score on POMS-2 Test|Vigilance Score on Computer-based Test Using Random, Visual Stimulus: Proportion Correct (Out of 60)|Vigilance Score on Computer-based Test Using Random, Visual Stimulus: Number Correct, Number of False Alarm Hits|Vigilance Score on Computer-based Test Using Random, Visual Stimulus: Mean Time to a Correct Hit","University of Alabama at Birmingham","All","18 Years and older   (Adult, Older Adult)","Not Applicable","205","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","F150410009","June 2015","October 2015","October 2015","June 3, 2015","July 12, 2017","July 12, 2017",,,"https://ClinicalTrials.gov/show/NCT02461693"
331,"NCT01118988","Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents",,"Completed","Has Results","Irritable Bowel Syndrome (IBS)|Functional Abdominal Pain|Fibromyalgia|Complex Regional Pain Syndrome (CRPS)|Myofacial Pain|Chronic Daily Headaches|Migraine Headaches|Chronic Pain","Behavioral: Mentorship","Adherence to Physician Recommended CAM Therapies|Body Map and Pain Assessment|Pittsburgh Sleep Quality Index (PSQI)|Child Symptom Inventory (CSI)|Child Anxiety Sensitivity Inventory (CASI) - Child Report|Health Belief Scale (HBS) Short Version - Child Report|Emotion Regulation Questionnaire (ERQ) - Child Answer|Emotion Expression Scale for Children (EESC)|Functional Disability Inventory (FDI)|Revised Child Anxiety and Depression Scale (RCADS) Child Report|Beck Depression Inventory 2 (BDI-2) #18|Child Health Questionnaire - Child Report (CHQ)|Positive and Negative Affect Scale (PANAS)","University of California, Los Angeles","All","12 Years to 18 Years   (Child, Adult)","Not Applicable","27","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","1R21HD057421-01A2","December 2009","June 2011","June 2011","May 7, 2010","March 9, 2016","September 30, 2016","UCLA Pediatric Pain Management Clinic, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT01118988"
332,"NCT00977847","Integrating Patient Generated Family Health History From Varied Electronic Health Record (EHR) Entry Portals",,"Completed","No Results Available","Family Characteristics|Health Status|Family Research","Other: Electronic Health Portals for collecting Family History data","Project will seek to demonstrate that family history data can be accurately reported by 5000 diverse patients using three portals, and that these data can be used to tailor an individual's health care based on their familial risk.|Develop three portals for collection of patient generated family history data integrated with an EHR: computer tablets in waiting rooms; a secure internet portal for use at home; and an interactive voice response system to get data by phone.|Evaluate facilitators and barriers to adoption and implementation of these portals by assessing differences in patient preferences, privacy, convenience, and understanding. Validate data collected by each portal by a genetic counselor.|To conduct a 4-armed pilot RCT to measure the reach and effectiveness of integrating family history data with a patient's EHR.|For patients in the RCT who report a family history that is associated with an increased risk of coronary artery disease, we will examine how often their physician initiates screening and/ or primary prevention based on the family history information.","Brigham and Women's Hospital","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","5000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","2009P0011908|1RC1HG005331-01","November 2010","March 2012","March 2012","September 16, 2009",,"March 20, 2012","Brigham and Women's Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT00977847"
333,"NCT03268694","Investigation of Oscillations Underlying Human Cognitive and Affective Processing Using Intracranial EEG",,"Terminated","No Results Available","Working Memory|Emotions","Behavioral: Working Memory Task|Behavioral: Reward Learning Task|Behavioral: Facial Emotion Recognition Task","Intracranial EEG Spectra Power|Task Performance: Reaction Times|Intracranial EEG Functional Connectivity Analysis","University of North Carolina, Chapel Hill|National Institute of Neurological Disorders and Stroke (NINDS)","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","4","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","17-1301|R21NS094988-01A1","August 7, 2017","July 29, 2018","July 29, 2018","August 31, 2017",,"January 13, 2020","University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03268694"
334,"NCT02885233","Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis",,"Completed","No Results Available","Multiple Sclerosis","Behavioral: Free From Falls Online|Behavioral: Waitlist Control","Difference in mean change in total falls between intervention and control arms|Difference in patient reported outcomes including physical function, fatigue, self efficacy, psychosocial illness impact, social participation and satisfaction, and perception of global health between intervention and control arms.|Quantitative assessment of the web-based program|Qualitative assessment of the web-based program","Oregon Health and Science University|University of Alabama at Birmingham","All","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","00015595","February 15, 2017","January 25, 2018","January 25, 2018","August 31, 2016",,"April 9, 2018","Oregon Health Sciences University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT02885233"
335,"NCT03927846","Implementation of Nurse-guided Web-based Cognitive Behavioral Therapy for Pain Management",,"Active, not recruiting","No Results Available","Chronic Musculoskeletal Pain","Behavioral: Nurse-guided Web-based Cognitive Behavioral Therapy","PROMIS (patient reported-outcomes measurement information system) pain intensity|PROMIS pain interference|Completed phone calls|Completed learning modules per treatment arm","Wake Forest University Health Sciences","All","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care","IRB00056912","July 17, 2019","December 2020","February 2021","April 25, 2019",,"April 28, 2020","Wake Forest Baptist Health, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03927846"
336,"NCT02962622","Cognition Metabolism and Exercise Among Women Living With HIV in Puerto Rico","CMEx","Unknown status","No Results Available","HIV","Other: High intensity interval training (HIIT)","Cardio-respiratory fitness as measured by maximal oxygen consumption (VO2max)|Metabolic syndrome classification based on the National Cholesterol Education Program (NCEP) criteria|Neurocognitive function as measured by memory testing","University of Puerto Rico","Female","21 Years and older   (Adult, Older Adult)","Not Applicable","45","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)","UPuertoRico","November 2014","June 2017","December 2017","November 11, 2016",,"November 11, 2016","Medical Sciences Campus, San Juan, Puerto Rico",,"https://ClinicalTrials.gov/show/NCT02962622"
337,"NCT03063385","Puerto Rico Cuidalos Parent-adolescent Program",,"Completed","Has Results","HIV/AIDS and Infections|Sexually Transmitted Diseases|Pregnancy Prevention","Behavioral: Parental Communication intervention|Behavioral: Health promotion control condition","Change From Baseline to 3 Months in Parent - Adolescent Sexual Risk Communication (Parental Perspective)|Change From Baseline to 6 Months in Parent - Adolescent Sexual Risk Communication (Parental Perspective)|Change From Baseline to 12 Months in Parent - Adolescent Sexual Risk Communication (Parental Perspective)","University of Pennsylvania|National Institute of Nursing Research (NINR)|University of Puerto Rico|Yale University","All","13 Years to 17 Years   (Child)","Not Applicable","660","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","820216|7R01NR013505","September 2012","August 2016","June 2017","February 24, 2017","October 16, 2019","October 16, 2019",,"""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/85/NCT03063385/Prot_000.pdf","https://ClinicalTrials.gov/show/NCT03063385"
338,"NCT00183638","A Tailored Interactive Website for Promoting Condom Use Among Young Adults","Youthnet","Completed","No Results Available","HIV Infections|Sexually Transmitted Diseases","Behavioral: Internet-based tailored prevention messages|Behavioral: Non-tailored messages","Condom use with non main partners|Self-efficacy for condom use and condom negotiation|Attitudes and norms towards condom use","University of Colorado, Denver|National Institute of Mental Health (NIMH)","All","18 Years to 25 Years   (Adult)","Phase 2","1870","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","02-0764a|R01MH063690|DAHBR 9A-ASI","June 2003","December 2008","December 2008","September 16, 2005",,"November 27, 2013","University of Colorado Health Sciences Center, Aurora, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT00183638"
339,"NCT03200028","CCTAP: Cognitive Control Training for Treatment of AUD-PTSD",,"Completed","No Results Available","Alcohol Use Disorder|Post Traumatic Stress Disorder","Other: Computerized Plasticity-Based Adaptive Cognitive Training","Acceptability|Usability","Posit Science Corporation|VA Palo Alto Health Care System","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","9","Industry|U.S. Fed","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","PSC-0613-17","April 1, 2018","February 28, 2019","February 28, 2019","June 27, 2017",,"October 15, 2019","Veterans Affairs Palo Alto Health Care System, Palo Alto, California, United States",,"https://ClinicalTrials.gov/show/NCT03200028"
340,"NCT02934165","Safety Skills Training For Parents of Preschool Children","Preschool_2","Completed","No Results Available","Behavior","Behavioral: Family Safety 123|Behavioral: AAP TIPP sheets","Behavioral measure: Change from baseline in identification of correct/incorrect child car safety seat and booster seat situations and bicycle helmet placement situations.|Change in knowledge of injury prevention strategies|Change in attitudes and beliefs about injury prevention strategies|Change in self-efficacy for engaging in injury prevention strategies|Change in car safety knowledge of injury prevention|Change in car safety attitudes & beliefs of injury prevention|Change in car safety self-efficacy in performing injury prevention skills|Change in wheeled sports knowledge of injury prevention|Change in wheeled sports attitudes & beliefs of injury prevention|Change in wheeled sports self-efficacy in performing injury prevention skills","Oregon Center for Applied Science, Inc.|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","151","Industry|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","SBIR72RR-2|R44HD047068","September 2009","September 2010","September 2010","October 14, 2016",,"October 14, 2016","Oregon Center for Applied Science, Eugene, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT02934165"
341,"NCT04025255","The Memory and Cognitive Performance Study",,"Completed","No Results Available","Cognitive Function|Memory|Brain Health","Dietary Supplement: Braini|Dietary Supplement: Placebo","Montreal Cognitive Assessment (MoCA)|Cambridge Brain Sciences (CBS) Health Assessment","Vita Naturel, LLC|University of North Carolina, Asheville","All","18 Years to 30 Years   (Adult)","Not Applicable","50","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Other","1428244-1","July 1, 2019","September 19, 2019","September 19, 2019","July 18, 2019",,"November 13, 2019","University of North Carolina at Asheville, Asheville, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT04025255"
342,"NCT01059032","Enhancement and Restoring of Low Dose Abdominal CT Images",,"Completed","No Results Available","Radiation Protection","Other: Using a 3 dimentional post processing filter","Rating of image quality","Lars Borgen|Sykehuset Buskerud HF|University of Oslo","All","60 Years to 90 Years   (Adult, Older Adult)","Phase 1","12","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Diagnostic","15017044793","December 2009","December 2010","December 2011","January 29, 2010",,"June 2, 2015","Buskerud Hospital, Drammen, Norway",,"https://ClinicalTrials.gov/show/NCT01059032"
343,"NCT04193969","Changes in Radicular Pain and Pain Modulation",,"Recruiting","No Results Available","Back Pain|Back Pain With Radiation","Diagnostic Test: Pressure pain assessment using computer controlled cuff algometry|Diagnostic Test: Temporal summation (TS)|Diagnostic Test: Conditioned pain modulation (CPM)|Diagnostic Test: Low back pain rating scale (LBPRS-pain)|Diagnostic Test: Oswestry Disability Index","Cuff sensitivity, measured with computer-controlled cuff algometry|Temporal summation of pain (increase in pain during repeated pain stimuli at same intensity) measured with computer-controlled cuff algometry|Conditioned pain modulation (change in pain sensitivity during a competing pain stimulus) measured with computer-controlled cuff algometry|Leg pain (measured on the low back pain rating scale)|Back pain and leg pain (measured on the low back pain rating scale)|Disability (Measured on the Oswestry Disability index)","Spine Centre of Southern Denmark","All","18 Years to 60 Years   (Adult)","Not Applicable","80","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","S-20190091","November 1, 2019","January 2021","June 2021","December 11, 2019",,"March 13, 2020","Spine Centre of Southern Denmark, Middelfart, Denmark",,"https://ClinicalTrials.gov/show/NCT04193969"
344,"NCT02647801","Self-control and Mindfulness Within Ambulatorily Assessed Network Systems Across Health Related Domains","SMASH","Completed","No Results Available","Self Regulation","Behavioral: Mindfulness intervention","Three items from the State Self-control Capacity Scale (SSCCS)|Three items from the Mindfulness Attention Awareness Scale (MAAS)|Eight affect items based on the affective circumplex (Russel, 2003)|Attention (state)|Four items from the Situational Motivation Scale (SIMS)|Five emotion regulation strategies (Koval, Brose, Pe et al., 2015)|Three items from the Dutch eating behavior questionnaire (DEBQ)|Three items from the Work related Flow Inventory (WOLF)|Three items from the State Adult Attachment Measure (SAAM)|Three items from the Recovery Experience Questionnaire|Self-Control Scale (SCS-KD)|WHO-Five Well-Being Index|Emotion Regulation Questionnaire (ERQ)|Adult Attachment Scale (AAS)|Dutch eating behavior questionnaire (DEBQ)|Mindful Attention and Awareness Scale (MAAS)|Big Five Inventory (BFI-44)|Breath counting task (Levinson et al., 2014)|Brief Symptom Inventory (BSI-18)|Kentucky Inventory of Mindfulness Skills (KIMS)","Johannes Gutenberg University Mainz","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","137","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2015-JGU-psychEK-011","September 2015","December 2016","December 2016","January 6, 2016",,"March 7, 2017","Department of Psychology, Johannes Gutenberg University Mainz, Mainz, Rhineland-Palatinate, Germany",,"https://ClinicalTrials.gov/show/NCT02647801"
345,"NCT01889056","Non-erythroid Effects of Erythropoietin on Cognitive Function and Exercise Capacity in Humans",,"Unknown status","No Results Available","Healthy","Drug: Erythropoietin (Epoetin beta)|Drug: Placebo","Cognitive Function|Exercise Capacity","University of Zurich","All","18 Years to 35 Years   (Adult)","Phase 1|Phase 2","32","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","EPOPERF CH12","February 2013","September 2013","December 2013","June 28, 2013",,"June 28, 2013","University Hospital Zurich, Medical intensive care unit, Zurich, ZH, Switzerland",,"https://ClinicalTrials.gov/show/NCT01889056"
346,"NCT01772485","Online Neuroplasticity Training for Remediation of ADHD in Adolescent Children (ONTRAC)",,"Completed","No Results Available","Attention Deficit Hyperactivity Disorder","Behavioral: Cognitive Training|Behavioral: Active Control","ADHD rating scale IV change from baseline|CGIC change from baseline","Posit Science Corporation|John E. Fogarty International Center (FIC)","All","11 Years to 17 Years   (Child)","Not Applicable","31","Industry|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","ADHD-India|5R24TW007988-05","January 2013","May 2015","May 2015","January 21, 2013",,"September 12, 2019","All India Institute of Medical Sciences, New Delhi, Delhi, India",,"https://ClinicalTrials.gov/show/NCT01772485"
347,"NCT00264394","Cardiovascular Risk Factor Management in HIV Infection",,"Completed","No Results Available","Coronary Heart Disease|Dyslipidemia|Diabetes Mellitus, Non-Insulin-Dependent|HIV Infection","Behavioral: Updated CHD risk profiles|Behavioral: Guidelines","Reduction in total cholesterol in the entire SHCS population|The reduction in total cholesterol, systolic and diastolic blood pressure, and Framingham 10-year CHD risk score in individuals with a greater than or equal to 10% 10 year risk of CHD (according to the Framingham risk profile)","University Hospital, Basel, Switzerland|Swiss National Science Foundation|Bristol-Myers Squibb","All","18 Years and older   (Adult, Older Adult)","Phase 4","4097","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","SNF 3345-062041 SHCS 480|480","July 2006","October 2008","February 2010","December 12, 2005",,"May 28, 2015","Departement Innere Medizin Kantonsspital St. Gallen, St. Gallen, Canton St. Gall, Switzerland|Ospedale Civico Lugano, Lugano, Canton Ticino, Switzerland|Abteilung für Infektionskrankheiten & Spitalhygiene, Universitätsspital Zürich, Zurich, Canton Zurich, Switzerland|University Hospital Basel, Basel, Kanton Basel Stadt, Switzerland|Division Maladies Infectieuses, Hopital Universitaire Vaudois (CHUV), Lausanne, Vaud, Switzerland|Klinik und Poliklinik für Infektiologie, Inselspital, Berne, Switzerland|Division des Maladies Infectieuses, Hopital Universitaire Geneve, Geneva, Switzerland",,"https://ClinicalTrials.gov/show/NCT00264394"
348,"NCT01116544","Treatment of Chronic Stroke With AMES + EMG Biofeedback","AMES","Completed","Has Results","Stroke|Plegia|Paresis|Cerebrovascular Accident","Device: AMES Therapy (assisted movement and enhanced sensation)","Box and Blocks Test|Fugl-Meyer (UL) Assessment|Stroke Impact Scale (Physical Problems, Mobility, Hand, ADL)|Stroke Impact Scale (Stroke Recovery)|Strength Test Flexion|Strength Test Extension","AMES Technology|Oregon Health and Science University|Emory University|Northwestern University","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","46","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","CT NS060192","September 21, 2007","February 28, 2011","February 28, 2011","May 5, 2010","November 18, 2019","November 18, 2019","Emory University School of Medicine, Atlanta, Georgia, United States|Northwestern University, Chicago, Illinois, United States|Oregon Health and Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT01116544"
349,"NCT01973270","Community-Based Cognitive Training in Early Schizophrenia","COTES","Completed","No Results Available","Schizophrenia|Psychosis","Behavioral: Neuroadaptive cognitive training","Neurocognition|Functioning|Auditory Processing Speed|Reward Sensitivity|Functional Capacity|Social Functioning|Internalized Stigma","University of California, San Francisco","All","18 Years to 35 Years   (Adult)","Not Applicable","174","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","R01MH102063-01","December 2013","August 21, 2019","August 21, 2019","October 31, 2013",,"September 17, 2019","Prevention and Recovery in Early Psychosis (PREP) Program, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT01973270"
350,"NCT02443727","The Role of Oxytocin in the Perception of Faces",,"Completed","No Results Available","Healthy","Drug: Syntocinon (synthetic oxytocin)|Other: Placebo","Functional Magnetic Resonance Imaging (fMRI) Data|Eye movements data|Implicit Attitudes toward infants|Theory of mind","Rodrigo Cardenas|U.S. National Science Foundation|Penn State University",,"18 Years to 25 Years   (Adult)","Early Phase 1","71","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","STUDY00001225","April 2015","December 2015","September 2016","May 14, 2015",,"May 31, 2017",,,"https://ClinicalTrials.gov/show/NCT02443727"
351,"NCT01427660","iDecide.Decido: Diabetes Medication Decision Support Study","iDecide","Completed","No Results Available","Diabetes, Type 2","Behavioral: Community Health Worker Diabetes Education: Print media|Behavioral: CHW Diabetes Education: tailored web site","Changes in decisional conflict|Medication adherence and intensification","University of Michigan|Agency for Healthcare Research and Quality (AHRQ)","All","21 Years and older   (Adult, Older Adult)","Not Applicable","190","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","1R18HS019256-01","September 2011","September 2013","October 2013","September 1, 2011",,"September 9, 2014","Community Health and Social Service (CHASS), Detroit, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT01427660"
352,"NCT04435210","Efficacy of Nifedipine Versus Hydralazine in Management of Severe Hypertension in Pregnancy",,"Completed","No Results Available","Hypertension","Drug: Hydralazine|Drug: Nifedipine","Number of drug doses|Number of patients with side effects|Number of fetuses with fetal heart rate irregularity|Number of live birth and stillbirth|Mean birth weight|APGAR score|Number of babies admitted into NICU|Number of patients requiring additional anti-hypertensive drug","Adebayo Joshua Adeniyi|Alex Ekwueme Federal University Teaching Hospital","Female","18 Years to 49 Years   (Adult)","Not Applicable","69","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","FETHA/REC/VOL1/2017/590","August 13, 2018","February 9, 2019","February 20, 2019","June 17, 2020",,"June 17, 2020","Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Ebonyi, Nigeria",,"https://ClinicalTrials.gov/show/NCT04435210"
353,"NCT01661894","Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly","3ECog","Completed","No Results Available","Alzheimer's Disease|Mild Cognitive Impairment|Age-Related Cognitive Decline|Dementia","Device: BrainPalTM","Total Score on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)|Number of Adverse Events reported by participants on the Safety Measurement Form|Usability Measurement","Duke-NUS Graduate Medical School|Agency for Science, Technology and Research|National University, Singapore|Singapore Clinical Research Institute|Singapore General Hospital","All","60 Years to 70 Years   (Adult, Older Adult)","Phase 1","82","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","11-363","April 2012","April 2014","April 2014","August 10, 2012",,"July 25, 2014","Duke-NUS Graduate Medical School, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT01661894"
354,"NCT01946607","Antidepressants, Emotions and Personality",,"Completed","No Results Available","Antidepressive Agents, Second-Generation","Drug: Citalopram|Drug: Placebo","Eye gaze fixations over the region of the eyes and whole face region of facial expressions during a gender discrimination task of emotional facial expressions|Scanpath length over the eye region and whole face region of facial expressions during a gender discrimination task of emotional facial expressions|Scanning time over the eyes region and whole face of facial expressions during a gender discrimination task of emotional facial expressions|Gaze maintenance over the eyes region and whole face of facial expressions during a gender discrimination task of emotional facial expressions|Accuracy and reaction time of emotional facial expressions recognition during a facial expressions recognition task|Recall and recognition scores and reaction times during a memory task for emotionally valenced self-descriptors|Eye-blink reflex magnitudes in response to pleasant, unpleasant and neutral pictures during an emotion potentiated startle task|High Frequency Heart Rate Variability (HF-HRV) during an emotion regulation task of unpleasant pictures|Affect ratings during an emotion regulation task of unpleasant pictures","University of Oxford|Medical Research Council Cognition and Brain Sciences Unit","All","18 Years to 50 Years   (Adult)","Not Applicable","42","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","09/H0605/60","July 2009","November 2010","November 2010","September 19, 2013",,"September 19, 2013","University of Oxford, Department of Psychiatry, Warneford Hospital, Oxford, Oxfordshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT01946607"
355,"NCT03698773","Pain Relief Satisfaction With New Educational Materials",,"Recruiting","No Results Available","Patient Satisfaction","Other: Access to routine information|Other: Access to website","Patient satisfaction with pain control in labor|Epidural analgesia utilization rate","University of New Mexico","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research","18-642","October 1, 2018","June 2020","June 2020","October 9, 2018",,"March 25, 2020","University of New Mexico Hospital, Albuquerque, New Mexico, United States",,"https://ClinicalTrials.gov/show/NCT03698773"
356,"NCT01911195","Reconstructing Consciousness and Cognition","RCC","Completed","No Results Available","Postoperative Cognitive Dysfunction","Drug: ISOFLURANE- Experimental Arm|Other: Control Group: Cognitive Testing","Neurocognitive scores|Brain network connectivity","University of Michigan|University of Pennsylvania|Washington University School of Medicine|James S McDonnell Foundation","All","20 Years to 40 Years   (Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","McDonnell RCC","July 2013","February 9, 2015","February 9, 2015","July 30, 2013",,"November 30, 2017","University of Michigan, Ann Arbor, Michigan, United States|Washington University in St. Louis, Saint Louis, Missouri, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT01911195"
357,"NCT04099056","Brain Stimulation and Decision-making",,"Suspended","No Results Available","Depression","Device: Transcranial Magnetic Stimulation (TMS)","Staggered Effort-Based Decision-Making Task","Emory University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","IRB00110965","November 11, 2019","April 2021","April 2021","September 23, 2019",,"May 18, 2020","Emory University, Atlanta, Georgia, United States",,"https://ClinicalTrials.gov/show/NCT04099056"
358,"NCT03944317","Azithromycin (AZ) and Sulphadoxine-pyrimethamine (SP) for Malaria Prevention in Pregnant Women (IPT-AZ/IPT-SP)",,"Not yet recruiting","No Results Available","Malaria in Pregnancy|Pregnancy","Drug: Sulfadoxine pyrimethamine|Drug: Azithromycin","malaria parasitaemia during pregnancy|malaria parasitaemia at the point of delivery","Federal Medical Centre, Owo","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","168","Industry","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","FMCOWO","June 1, 2019","November 30, 2019","January 31, 2020","May 9, 2019",,"May 10, 2019","FMCOWO, Owo, Ondo, Nigeria",,"https://ClinicalTrials.gov/show/NCT03944317"
359,"NCT04150120","eHealth as an Aid for Facilitating and Supporting Self-management in Families With Long-term Childhood Illness","eChildHealth","Enrolling by invitation","No Results Available","Preterm Birth|Pediatric Cancer|Hirschsprung Disease|Congenital Malformation|Congenital Heart Disease|Nutrition Disorder, Child","Device: e-health device with application","The PedsQL Healthcare Satisfaction Generic Module|Cost-utility ratios|The child's general and specific health status|The PedsQL 2.0 Family Impact Module|The Parental Stress (Parental - Persistent Role Problems)|Adverse events that occurs during the study period|The Clavien-Dindo Classification|Length of hospital stay|Number of routine and acute visits|Health economic variables: Family time|Health economic variables: Family economy|Health economic variables: Hopsital resources|Health economic variables: Health care resources|Health economic variables: Health care expenditures|Health economic variables: Productivity|Health economic variables: Utility|EQ-5D-3L","Lund University|Skane University Hospital|Rigshospitalet, Denmark","All","up to 47 Months   (Child)","Not Applicable","420","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","2018-01399","October 15, 2019","October 15, 2024","December 31, 2024","November 4, 2019",,"November 4, 2019","Rigshospitalet, Copenhagen, Denmark|Hillerød Hospital, Hillerød, Denmark|Neonatal Department, Skåne University Hospital, Lund, Skåne, Sweden|Paediatric Cardiology Department, Skåne University Hospital, Lund, Skåne, Sweden|Paediatric Oncology Department, Skåne University Hospital, Lund, Skåne, Sweden|Paediatric Surgery Department, Skåne University Hospital, Lund, Skåne, Sweden",,"https://ClinicalTrials.gov/show/NCT04150120"
360,"NCT01134978","Neural Mechanisms of the Contextual Interference Effect: A fNIRs and EEG Study","GRID12007","Completed","No Results Available","Healthy Individuals|Learning","Behavioral: Practice Order","metabolic measures of neural activity in the dorsolateral prefrontal cortex|Behavioral measures","Drexel University|Pennsylvania Department of Health","All","18 Years to 55 Years   (Adult)","Phase 1","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","16758","November 2007","December 2010","June 2011","June 2, 2010",,"November 7, 2011","Cognitive Motor Movement Neuroscience Lab (CoMMoNS) - rm 3612 NCB, Drexel University, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT01134978"
361,"NCT02384005","The Feasibility of Self or Partner-assisted Digital Anal Exam Screening",,"Completed","No Results Available","Anus Neoplasms","Other: Self-anal exam arm","Kappa agreement will be calculated between lay person and nurse practitioner on the anal exam results.|Odds ratios will be calculated for the association between partnership status and concordance between participant and clinician.|Odds ratios will be calculated for the association between age and concordance between participant and clinician.|Odds ratios will be calculated for the association between waist circumference and concordance between participant and clinician.|Odds ratios will be calculated for the association between race and concordance between participant and clinician.|Odds ratios will be calculated for the association between ethnicity and concordance between participant and clinician.|Number of persons who state that a self-DAE is an acceptable procedure.|Number of persons with adverse events after conducting a self-DAE.|Number of persons who state they have the ability to conduct a self-DAE.|Number of persons who state they intend to seek subsequent care in the event of an abnormal result to a self-DAE.","The University of Texas Health Science Center, Houston|National Cancer Institute (NCI)|Baylor College of Medicine","Male","27 Years to 80 Years   (Adult, Older Adult)","Not Applicable","201","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening","HSC-SPH-13-0671|1R21CA181901-01A1","February 2015","April 2016","April 2016","March 10, 2015",,"May 12, 2016","University of Texas School of Public Health, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT02384005"
362,"NCT04040465","Asprin Dosing Estimator in Healthy Adults",,"Not yet recruiting","No Results Available","Aspirin Sensitivity","Drug: Aspirin","Height|Weight|Urine TBX2 Collection (Thromboxane levels)|Salicylate Levels|Aspirin Reaction Units (ARU)|Complete Blood Count (CBC)|High-sensitivity C-reactive protein (hs-CRP)|Blood Pressure (mmHg)|Heart Rate (BPM)|Respiratory Rate (breaths per minute)","University of Utah|University of Colorado, Denver","All","18 Years to 55 Years   (Adult)","Early Phase 1","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","IRB_00117303","February 1, 2020","May 1, 2020","May 1, 2020","July 31, 2019",,"January 29, 2020",,,"https://ClinicalTrials.gov/show/NCT04040465"
363,"NCT02498054","Diabetic Mellitus Patients Glucose Range Awareness After Experiencing a New Blood Glucose Meter Feature",,"Completed","No Results Available","Diabetes Mellitus","Behavioral: Education with new meter feature.","Success rate to categorize blood glucose values into accepted ranges.|Actual time taken to categorize blood glucose values into accepted ranges on the questionnaire provided.","LifeScan","All","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","80","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","3135718","July 2015","August 2015","August 2015","July 15, 2015",,"September 14, 2016","NHS Lothian, Edinburgh, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02498054"
364,"NCT02478034","Effects of Mineralocorticoid Receptor Stimulation on Cognition","MR-STIM","Completed","No Results Available","Individuality","Other: Fludrocortisone","social cognition|memory|decision making","Charite University, Berlin, Germany","All","18 Years to 30 Years   (Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","WI-CO-2","May 2015","March 2016","March 2016","June 23, 2015",,"March 7, 2016","Charite University, Berlin, Germany",,"https://ClinicalTrials.gov/show/NCT02478034"
365,"NCT03835611","Evaluating Effect of Cognitive Game Based Treadmill Exercise Program in Parkinson Disease",,"Terminated","No Results Available","Parkinson Disease","Other: Game based treadmill Platform|Other: Control Group","Retention to GTP|Sample size calculation","University of Manitoba","All","55 Years to 70 Years   (Adult, Older Adult)","Phase 1","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","H2018:338","March 1, 2019","July 1, 2019","August 1, 2019","February 8, 2019",,"March 25, 2020","College of Rehabilitation Sciences, University of Manitoba, Winnipeg, Manitoba, Canada",,"https://ClinicalTrials.gov/show/NCT03835611"
366,"NCT03335306","Epidemiological Study on Body Constitution Classified by Traditional Chinese Medicine Theory",,"Completed","No Results Available","Body Constitution",,"Prevalence of constitution types classified by the BCQ or CCMQ|Short Form-12 (SF-12) Health-related quality of life of people with different constitution types|Chinese quality of life (ChQOL) (HK version) Health-related quality of life of people with different constitution types","Chinese University of Hong Kong|The University of Hong Kong|Hospital Authority, Hong Kong","All","18 Years to 85 Years   (Adult, Older Adult)",,"6400","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","HKCTR-1355","July 2011","July 2012","July 2012","November 7, 2017",,"January 9, 2018","The Chinese University of Hong Kong, Hong Kong, Hksar, China",,"https://ClinicalTrials.gov/show/NCT03335306"
367,"NCT04389879","CAD/CAM Fixed Retainers vs. Conventional Multistranded Fixed Retainers in Orthodontic Patients. Comparison of Stability, Retainer Failure Rate, Adverse Effects, Cost-effectiveness, and Patient Satisfaction. A Randomized Controlled Clinical Trial","Retention","Recruiting","No Results Available","Relapse","Other: Bonding of either CAD/CAM or conventional multistranded stainless steel fixed retainer","Stability|Failure rate and survival time|Adverse effects|Cost-effectiveness|Patient satisfaction","University of Aarhus|University of Oslo","All","12 Years to 25 Years   (Child, Adult)","Not Applicable","126","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","01286","September 1, 2018","November 2025","December 2025","May 15, 2020",,"May 19, 2020","Aarhus University, Aarhus, Denmark",,"https://ClinicalTrials.gov/show/NCT04389879"
368,"NCT03748849","Pain Sensory Profile Changes Following Treatment of Chronic Low Back Pain","LBP","Completed","No Results Available","Low Back Pain","Procedure: Physiotherapy","Change in cuff-pressure mechanical sensitivity, measured with a computer-controlled pressure cuff|Sensitivity to mechanical point pressure measured with a handheld pressure algometer|Temporal summation of pain (increase in pain from repeated nociceptive stimuli at the same intensity) measured with a computer-controlled pressure cuff|Conditioned pain modulation (change in pain sensitivity following the onset of a competing, nociceptive stimulus) measured with a computer-controlled pressure cuff|Pain (measured on a numeric rating scale)|Disability measured on the Roland-Morris Disability Questionnaire","Aalborg University","All","18 Years to 40 Years   (Adult)",,"40","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","N-20150048","January 20, 2016","January 7, 2019","January 7, 2019","November 21, 2018",,"May 13, 2020","Department of Health Science and Technology, Aalborg, Nordjylland, Denmark",,"https://ClinicalTrials.gov/show/NCT03748849"
369,"NCT01513018","Effects of High and Low Tidal Volumes on Arterial Oxygenation and Pulmonary Shunt During One-Lung Ventilation",,"Completed","No Results Available","Postoperative Lung Injury","Other: high tidal volumes|Other: low tidal volume","low (5ml/kg) tidal volume on arterial oxygenation|high (10 ml/kg) tidal volumes on arterial oxygenation|low (5 ml/kg)tidal volumes on Intrapulmonary shunt|high (10 ml/kg) tidal volumes on Intrapulmonary shunt","The Cleveland Clinic","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","DEOEC RKEB/IKEB 2976-2009","June 2009","September 2009","September 2009","January 20, 2012",,"January 20, 2012","University of Debrecen, Medical and Health Science CenterDepartment of Anesthesiology and Intensive Care, Debrecen, Hungary",,"https://ClinicalTrials.gov/show/NCT01513018"
370,"NCT03828214","Post Stroke Walking Kinematics Using the Honda Walking Assist Robotic Exoskeleton",,"Completed","No Results Available","Stroke","Device: Robotic exoskeleton for walking assist","Gait Kinematics|Lower limb electromyography (EMG)|Force platforms|Stair climbing Ascend/Descend test","College of St. Scholastica, Inc.|Honda R and D Americas, Inc.","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","12","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","001","December 11, 2018","August 31, 2019","August 31, 2019","February 4, 2019",,"January 23, 2020","College of St. Scholastica-Health Science Center, Duluth, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03828214"
371,"NCT04000672","Patient Specific Instrumentation (PSI) Referencing Osteotomy Technological Transfer - a Randomized Control Trial (RCT)","ProtectedHTO","Recruiting","No Results Available","Osteotomy|Randomized Controlled Trial","Procedure: 3D printed patient specific metal jigs (PSI jig)|Procedure: HTO with navigation","Knee Society knee score|Knee Society function score|Oxford Knee Score|Range of motion|Pain Visual Analog Scale (VAS) score|Measurement of knee displacement","Chinese University of Hong Kong","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","2019.050","July 1, 2019","June 2022","December 2022","June 27, 2019",,"May 27, 2020","Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong",,"https://ClinicalTrials.gov/show/NCT04000672"
372,"NCT01944514","Implantable Cardioverter Defibrillators - Improving Risk Stratification","ICD-IRS","Completed","No Results Available","Sudden Cardiac Death|Implantable Defibrillator User|Myocardial Infarction|Arrhythmias, Cardiac",,"Regional Restitution Instability Index|Peri-infarct zone","University Hospitals, Leicester|University of Leicester|Da Vinci Health Technology Innovation Network|LivaNova","All","18 Years and older   (Adult, Older Adult)",,"92","Other|Industry","Observational","Observational Model: Case Control|Time Perspective: Prospective","UHL-10824: ICD-IRS","January 2010","November 2012",,"September 17, 2013",,"September 20, 2013",,,"https://ClinicalTrials.gov/show/NCT01944514"
373,"NCT01796158","Pilot Test of Computerized MET to Reduce Adolescent Alcohol Use",,"Withdrawn","No Results Available","Alcohol Abuse","Behavioral: cASBI+cMET|Behavioral: cASBI","cMET completion|cMET satisfaction","Boston Children’s Hospital","All","12 Years to 18 Years   (Child, Adult)","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","JKR34_PA-13-078","September 2013","March 2016","March 2016","February 21, 2013",,"October 7, 2016","Boston Children's Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT01796158"
374,"NCT04152343","An Intraoperative Guidance Platform for Radio Frequency Ablation",,"Recruiting","No Results Available","Hepatocellular Carcinoma","Device: RFA Physics Library -- a Planning and Guidance Platform (PGP)","Rate of Technical Success|Rate of Local Occurrence","Dartmouth-Hitchcock Medical Center|National Cancer Institute (NCI)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","52","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","SF19108|2R44CA189515","December 7, 2019","September 2020","January 2021","November 5, 2019",,"January 27, 2020","Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States",,"https://ClinicalTrials.gov/show/NCT04152343"
375,"NCT04166422","Virtual Reality and Video Games in Cardiac Rehabilitation Programs","VirtualCORE","Active, not recruiting","No Results Available","Adherence, Patient|Physical Disability|Cardiovascular Diseases|Treatment Adherence|Satisfaction","Other: Cardiac rehabilitation program|Other: Experimental intervention","METS in ergometry and ejection fraction|6 minute walking test|Functional Independence Measure (MIF)|Short Form Quality of Life (SF36)","Universidad Rey Juan Carlos","All","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","VIRTUAL CORE URJC","November 12, 2019","November 11, 2020","November 11, 2021","November 18, 2019",,"November 18, 2019","Roberto Cano de la Cuerda, Alcorcón, Madrid, Spain",,"https://ClinicalTrials.gov/show/NCT04166422"
376,"NCT02088333","Effectiveness of an mHealth Colorectal Cancer Screening Intervention","mCRC","Completed","No Results Available","Colorectal Neoplasms","Behavioral: mCRC intervention|Behavioral: Healthy Lifestyles video","Completion of CRC Screening|CRC Screening Attitudes and Beliefs|Intention to receive CRC screening|Self-efficacy|Ability to make a screening decision|CRC screening discussions|Satisfaction with screening decision|CRC screening test order|Cost of the mCRC intervention|Usability of the mCRC system","Wake Forest University Health Sciences|National Cancer Institute (NCI)|University of North Carolina, Charlotte","All","50 Years to 74 Years   (Adult, Older Adult)","Not Applicable","450","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Health Services Research","CCCWFU 59A13|1R01CA178941","June 2014","May 2016","October 2016","March 14, 2014",,"August 13, 2018","Hillsdale Family Medicine, Advance, North Carolina, United States|Foothills Family Medicine, Mount Airy, North Carolina, United States|Wilkes Internal Medicine, Wilkesboro, North Carolina, United States|Downtown Health Plaza, Winston-Salem, North Carolina, United States|Peace Haven Family Medicine, Winston-Salem, North Carolina, United States|Reynolda Family Medicine, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT02088333"
377,"NCT00336297","Testing Methods of Screening for Woman Abuse in Health Care Settings.",,"Completed","No Results Available","Domestic Violence","Procedure: Woman Abuse Screening Tool|Procedure: Partner Violence Screen|Procedure: Computerized screening|Procedure: Face to face screening|Procedure: Written screening on forms","disclosure rates for past year exposure to intimate partner violence|participant satisfaction with completing the instruments|missing data","Hamilton Health Sciences Corporation|Ontario Women’s Health Council|McMaster University","Female","18 Years to 64 Years   (Adult)","Not Applicable","2000","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","MacMillan_VAW_Testing_Trial","May 2004",,"February 2005","June 13, 2006",,"November 29, 2006","Cambridge Memorial Hospital - Emergency Department, Cambridge, Ontario, Canada|Carlisle Medical Centre, Carlisle, Ontario, Canada|City of Hamilton Public Health and Community Services Department, Hamilton, Ontario, Canada|Hamilton Health Sciences Colposcopy Clinic, Hamilton, Ontario, Canada|Victoria Family Medical Centre, London, Ontario, Canada|London Health Sciences - Victoria Hospital Clinic 5A, London, Ontario, Canada|Norfolk General Hospital - Emergency Department, Simcoe, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT00336297"
378,"NCT03197181","Frontopolar Cortex and Motivation in Healthy Older Adults",,"Recruiting","No Results Available","Motivation in Healthy Older Adults","Device: transcranial direct current stimulation","participants' decisions to exert cognitive or physical effort for monetary rewards","University of Zurich","All","65 Years to 80 Years   (Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","FPC-17-AGING-01","January 16, 2018","June 2020","June 2020","June 23, 2017",,"April 16, 2020","University of Zurich, Zürich, Switzerland",,"https://ClinicalTrials.gov/show/NCT03197181"
379,"NCT02156128","Subjective Memory Complaints, Objective Memory Performance and Cognitive Training",,"Completed","No Results Available","Fatigue Syndrome, Chronic|Chronic Pain|Anxiety Disorders|Depressive Disorder|Sleep Disorders","Behavioral: Cogmed working memory training|Behavioral: Control group","Working memory capacity|Subjective memory complaints (SMC)|Transfer to inhibition","Norwegian University of Science and Technology","All","18 Years to 59 Years   (Adult)","Not Applicable","54","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","100878","October 2013","March 2015","April 2015","June 5, 2014",,"January 25, 2017","NKSS Nasjonal kompetansetjeneste for sammensatte symptomlidelser, Trondheim, Norway",,"https://ClinicalTrials.gov/show/NCT02156128"
380,"NCT00494689","Transcranial and Rapid Magnetic Stimulation for Gait Apraxia Due to Normal Pressure Hydrocephalus and Cerebral Ischemia",,"Unknown status","No Results Available","Walking|Cognitive Function",,,"Devathasan Neurology Practice Pte Ltd","All","Child, Adult, Older Adult",,"30","Other","Observational","Observational Model: Case Control|Time Perspective: Longitudinal|Time Perspective: Prospective","02","January 2002",,"June 2007","July 2, 2007",,"July 2, 2007","Devathasan Neurology Practice #11-16 MEMC, Singapore, Singapore|Devathasan Neurology Practice, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT00494689"
381,"NCT02360488","Telerehabilitation in the Home Versus Therapy In-Clinic for Patients With Stroke",,"Completed","Has Results","Stroke","Device: Telerehabilitation Therapy|Behavioral: In-Clinic Therapy","Change in Arm Motor Fugl-Meyer Score From Baseline to 30 Days Post-therapy","University of California, Irvine","All","18 Years and older   (Adult, Older Adult)","Phase 1","124","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","1U01NS091951-01A1","September 2015","April 2018","April 2018","February 10, 2015","February 28, 2020","February 28, 2020","University of California, Irvine, Irvine, California, United States|UCSD Stroke Center, San Diego, California, United States|Brooks Rehabilitation Clinical Research Center, Jacksonville, Florida, United States|Emory Rehabilitation Hospital, Atlanta, Georgia, United States|Rehabilitation Institute of Chicago, Chicago, Illinois, United States|Spaulding Rehabilitation Hospital, Charlestown, Massachusetts, United States|Kessler Institute for Rehabilitation, Saddle Brook, New Jersey, United States|Mount Sinai, New York, New York, United States|Burke Rehabilitation Hospital, White Plains, New York, United States|MetroHealth Rehabilitation Institute of Ohio, Cleveland, Ohio, United States|MUSC Center for Rehabilitation Research in Neurological Conditions, Charleston, South Carolina, United States|Harborview Medical Center, Seattle, Washington, United States","""Study Protocol, Statistical Analysis Plan, and Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/88/NCT02360488/Prot_SAP_ICF_000.pdf","https://ClinicalTrials.gov/show/NCT02360488"
382,"NCT03203954","Testing the Neuroscience of Guided Learning in Depression",,"Recruiting","No Results Available","Major Depressive Disorder","Behavioral: Standard Learning|Behavioral: Guided Learning: Instructed statistics|Behavioral: Guided Learning: Changing statistics","Task performance|Neuroimaging measures|Symptoms","Virginia Polytechnic Institute and State University|National Institute of Mental Health (NIMH)","All","18 Years to 55 Years   (Adult)","Not Applicable","216","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Other","MDDLEARNING|R01MH106756","May 1, 2016","January 2021","January 2021","June 29, 2017",,"November 7, 2019","Virginia Tech Carilion Research Institute, Roanoke, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT03203954"
383,"NCT02502513","Prevention of Intrusive Memories and Posttraumatic Stress Symptoms After Emergency Cesarean Section",,"Completed","No Results Available","Posttraumatic Stress Disorder|Acute Stress Disorder","Behavioral: Brief computerized intervention","Number of intrusive memories recorded by participants in an intrusive memory diary in the week after the emergency cesarean section|Posttraumatic Stress Diagnostic Scale (PDS)|Acute Stress Disorder Scale (ASDS)|Hospital Anxiety and Depression Scale (HADS)","Centre Hospitalier Universitaire Vaudois|University of Lausanne Hospitals|Medical Research Council Cognition and Brain Sciences Unit","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","56","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","480/2012","June 2013","September 2015","October 2015","July 20, 2015",,"January 28, 2016","Centre Hôpital Universitaire Vaudois, Lausanne, Vaud, Switzerland",,"https://ClinicalTrials.gov/show/NCT02502513"
384,"NCT02075827","Metabolic Response to Playing Video Games: Two Arm Trial",,"Unknown status","No Results Available","Appetite and General Nutritional Disorders|Sedentary Lifestyle","Behavioral: Competitive video game|Behavioral: Little Big Planet","Food intake|Blood pressure|Heart rate|Salivary leptin|Salivary ghrelin|Salivary cortisol|Visual analogue scale|Grip strength|Memory recall","University College, London","Male","18 Years to 30 Years   (Adult)","Not Applicable","72","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","UCL0326011","February 2014","October 2014",,"March 3, 2014",,"March 3, 2014","UCL Institute of Child Health, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02075827"
385,"NCT04152421","Acceptability and Clinical, Cognitive and Brain Efficacy of the Pilot of a Computerized Psychotherapy Program Based on Behavioural and Cognitive Techniques in the Depressed Patient","STOP DEPRESS","Recruiting","No Results Available","Depression","Other: Software use","Beck Depression Inventory","Centre Hospitalier Universitaire de Nice","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","17-AOI-05","November 15, 2019","July 2020","July 2020","November 5, 2019",,"February 20, 2020","Hôpital Pasteur - Service de Psychiatrie, Nice, France",,"https://ClinicalTrials.gov/show/NCT04152421"
386,"NCT04180592","Real Time MRI Fused to Cone Beam CT Guided Biopsies of the Prostate.",,"Recruiting","No Results Available","Prostate Cancer","Procedure: CT Fusion + Transrectal U/S Guided Prostate Biopsy","Accuracy of CT fusion biopsy [number of biopsies that show clinically significant prostate cancer]|Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]).|Tolerability of CT fusion biopsy","Queen's University","Male","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","6018147","November 6, 2019","July 2020","August 2020","November 27, 2019",,"December 4, 2019","Kingston Health Sciences Centre, Kingston, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04180592"
387,"NCT00352924","Agriculture Health Study",,"Active, not recruiting","No Results Available","Prostate Cancer|Pesticide Exposure|Lymphoma|Multiple Myeloma",,"Cancer incidence in pesticide applicators|Non-cancer disease incidence in pesticide applicators|Disease in spouses and children of farmers|measurement of pesticide and other agricultural exposures|Agricultural exposures and biomarkers of exposure, biologicaleffect, and biomarkers of pre-clinical disease and genetic susceptibilityfactors|Disease risk and dietary exposures","National Cancer Institute (NCI)|Environmental Protection Agency (EPA)|National Institutes of Health Clinical Center (CC)","All","18 Years to 89 Years   (Adult, Older Adult)",,"89655","NIH|U.S. Fed","Observational","Observational Model: Cohort|Time Perspective: Prospective","999993013|OH93-NC-N013","April 30, 1993",,,"July 17, 2006",,"February 27, 2020","University of Iowa, Iowa City, Iowa, United States|Research Triangle Institute, Research Triangle Park, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT00352924"
388,"NCT03599661","Developing and Validating Fertilit-e",,"Recruiting","No Results Available","Malignant Neoplasm","Other: Interview|Other: Questionnaire Administration","Evaluation of Fertilit-e alpha- Usability|Evaluation of Fertilit-e alpha- Comprehensibility","Wake Forest University Health Sciences","All","18 Years to 39 Years   (Adult)","Not Applicable","24","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","IRB00047585|CCCWFU 01717","August 15, 2018","April 2021","April 2021","July 26, 2018",,"July 1, 2020","Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03599661"
389,"NCT00676182","Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury",,"Completed","Has Results","Traumatic Brain Injury|Post-traumatic Stress Disorder","Other: Telerehabilitation","Functional Independence MeasureTM (FIM)/Functional Assessment Measure (FAM) (Total Score)|Craig Handicap Assessment and Reporting Technique (CHART)|Patient Competency Rating Scale (PCRS) (Total Score)|PTSD Checklist Military Form (PCL-M) (Total Score)|Modified PTSD Symptom Scale: Self-Report - Frequency (Total Score)|Modified PTSD Symptom Scale: Self-Report - Severity|Alcohol Use Disorders Identification Test (AUDIT) (Total Score)|Beck Depression Inventory Score (Total Score)","VA Office of Research and Development","All","18 Years to 55 Years   (Adult)",,"81","U.S. Fed","Observational","Observational Model: Case-Only|Time Perspective: Prospective","SDR 08-267|a14714","July 2008","April 2015","August 2015","May 12, 2008","March 25, 2016","March 25, 2016","North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville, Florida, United States|James A. Haley Veterans' Hospital, Tampa, FL, Tampa, Florida, United States",,"https://ClinicalTrials.gov/show/NCT00676182"
390,"NCT01379105","Electromyographic Responses by Static Stretching and Neural Mobilization",,"Completed","No Results Available","Electromechanical Dissociation","Other: neural mobilization|Other: Static Stretching","electromyography response|Flexibility effort","Euro-American Network of Human Kinetics","Male","17 Years to 30 Years   (Child, Adult)","Not Applicable","45","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","0111","August 2010","September 2010","October 2010","June 23, 2011",,"June 23, 2011","College Santo Agostinho, Teresina, Piauí, Brazil",,"https://ClinicalTrials.gov/show/NCT01379105"
391,"NCT02440451","Rt-fMRI NF Intervention Study in ASD","NF-ASD","Completed","Has Results","Autism Spectrum Disorder","Device: Neurofeedback using BCI","FEEST - Facial Expression of Emotion: Stimuli and Tests|ATEC - Autism Treatment Evaluation Checklist|VABS - Vineland Adaptive Behaviour Scale","University of Coimbra","All","16 Years to 30 Years   (Child, Adult)","Not Applicable","15","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IBILI-VB-2015-02","February 2016","September 2017","September 2018","May 12, 2015","November 13, 2018","February 20, 2019",,"""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/51/NCT02440451/SAP_000.pdf|""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/51/NCT02440451/Prot_001.pdf","https://ClinicalTrials.gov/show/NCT02440451"
392,"NCT02478021","Effects of Hydrocortisone on Social Cognition and Memory","CORT-COG","Completed","No Results Available","Individuality","Other: Hydrocortisone","social cognition|memory|cognitive flexibilty","Charite University, Berlin, Germany","All","18 Years to 30 Years   (Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","WI-CO-1","September 2014","May 2015","May 2015","June 23, 2015",,"June 23, 2015","Charite University, Berlin, Germany",,"https://ClinicalTrials.gov/show/NCT02478021"
393,"NCT00100503","Brain Reorganization Following Constraint-Induced Therapy in Children With Cerebral Palsy",,"Completed","No Results Available","Cerebral Palsy",,,"National Institute of Neurological Disorders and Stroke (NINDS)|National Institutes of Health Clinical Center (CC)","All","7 Years to 17 Years   (Child)",,"50","NIH","Observational",,"050066|05-N-0066","December 27, 2004",,"August 30, 2006","January 3, 2005",,"July 2, 2017","National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT00100503"
394,"NCT03509168","The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy.","MM","Unknown status","No Results Available","Uterine Fibroid","Drug: Misoprostol Pfizer Brand|Other: Non-insertion of Misoprostol Pfizer Brand","intraoperative blood loss during open myomectomy in milliliters|duration of surgery|duration of hospital stay|need for blood transfusion|Serious adverse outcomes|drop in postoperative hemoglobin concentration","Makerere University","Female","15 Years to 49 Years   (Child, Adult)","Phase 2|Phase 3","46","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","myomectomy trial","January 10, 2018","May 30, 2018","June 3, 2018","April 26, 2018",,"April 30, 2018","Makerere University, Kampala, Central, Uganda",,"https://ClinicalTrials.gov/show/NCT03509168"
395,"NCT00767767","The Effect of Intravenous Anesthetics on Fear Learning and Memory",,"Completed","Has Results","Phobias","Drug: Placebos|Drug: Propofol 0.45mcg/mL|Drug: Propofol 0.90mcg/mL|Drug: Thiopental 1.5mcg/mL|Drug: Thiopental 3mcg/mL","GSR Trial 1","Weill Medical College of Cornell University|National Institutes of Health (NIH)|National Institute of General Medical Sciences (NIGMS)","All","18 Years to 50 Years   (Adult)","Not Applicable","67","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","0710009434|K08GM083213","October 2008","May 2011","May 2011","October 7, 2008","April 10, 2017","May 15, 2019","Weill Cornell Medical College/New York Presbyterian Hospital, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT00767767"
396,"NCT01849822","Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia",,"Completed","No Results Available","Tetraplegia","Device: Neural Prosthetic System","Patient control over the end effector (virtual or physical)|Absence of infection or irritation|Score on the Action Research Arm Test","Richard A. Andersen, PhD|University of Southern California|Rancho Los Amigos National Rehabilitation Center|California Institute of Technology","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","1","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","16384","February 2013","January 2019","January 2019","May 9, 2013",,"January 22, 2019","Rancho Los Amigos National Rehabilitation Center, Downey, California, United States|University of Southern California, Los Angeles, California, United States|California Institute of Technology, Pasadena, California, United States",,"https://ClinicalTrials.gov/show/NCT01849822"
397,"NCT04433351","Sensory-Motor Integration for Speech Rehabilitation in Patients With Post-stroke Aphasia","SEMO","Not yet recruiting","No Results Available","Aphasia Non Fluent|Stroke","Device: Enriched rehabilitation|Device: Simple rehabilitation","Evaluation of acoustic changes in the speech signal before and after each rehabilitation protocol|Evaluation of changes in inner speech abilities before and after each rehabilitation protocol - Inner speech testing 1|Evaluation of changes in inner speech abilities before and after each rehabilitation protocol - Inner speech testing 2|Clinical language assessment 1a|Evaluation of changes in language abilities before and after rehabilitation - Clinical language assessment 1b|Clinical language assessment 2a|Evaluation of changes in language abilities before and after rehabilitation - Clinical language assessment 2b|Evaluation of changes in language abilities before and after each rehabilitation protocol - Clinical language assessment 3|Clinical language assessment 4|Evaluation of changes in language abilities before and after each rehabilitation protocol - Clinical language assessment 5|Evaluation of changes in language abilities before and after each rehabilitation protocol - Clinical language assessment 6|Evaluation of changes in cognitive level before and after each rehabilitation protocol - Neuropsychological assessment 1|Evaluation of changes in specific executive functions before and after each rehabilitation protocol - Neuropsychological assessment 2|Evaluation of changes in specific executive functions before and after each rehabilitation protocol - Neuropsychological assessment 3|Evaluation of changes in specific executive functions before and after each rehabilitation protocol - Neuropsychological assessment 4|Evaluation of changes in non-verbal episodic memory before and after each rehabilitation protocol - Neuropsychological assessment 5|Evaluation of changes in mental rotation abilities before and after each rehabilitation protocol - Neuropsychological assessment 6|Evaluation of mood changes before and after each rehabilitation protocol - Neuropsychological assessment 7|Evaluation of mood changes before and after each rehabilitation protocol - Neuropsychological assessment 8|Neuropsychological assessment 9|Evaluation of brain network activation (with measurement of BOLD, Blood Oxygen Level Dependent) before and after rehabilitation - Evaluation-brain 1|Evaluation of brain functional connectivity before and after rehabilitation - Evaluation-brain 2|Evaluation of brain anatomical connectivity before and after rehabilitation - Evaluation-brain 3","University Hospital, Grenoble|Laboratoire de Psychologie et NeuroCognition|GIPSA-LAB","All","55 Years to 75 Years   (Adult, Older Adult)","Not Applicable","36","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2020-A00720-39","September 1, 2020","September 1, 2021","September 1, 2022","June 16, 2020",,"June 16, 2020",,,"https://ClinicalTrials.gov/show/NCT04433351"
398,"NCT04110548","Emotion and Craving Regulation Among Individuals With Internet Gaming Disorders",,"Recruiting","No Results Available","Internet Gaming Disorder|Emotion Regulation","Procedure: Emotion Regulation Task|Procedure: Craving Regulation Task","Behavioral outcome","Beijing Normal University","All","18 Years to 30 Years   (Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","ER&CR_IGD","September 26, 2019","March 30, 2020","May 30, 2020","October 1, 2019",,"October 10, 2019","Beijing Normal University, Beijing, Beijing, China",,"https://ClinicalTrials.gov/show/NCT04110548"
399,"NCT02693756","Home-based Motor Imagery for Gait Stability in Older Adults. A Cross-over Feasibility Study. (MIGS-F)","MIGS-F","Recruiting","No Results Available","Gait, Unsteady","Other: Motor imagery","Composite Endpoint ""feasibility""|Adherence to the motor imagery exercises|Change in the Lyapunov Exponent in the three acceleration axes ""anterio-posterior"", ""medio-lateral"" and ""vertical""","University of Applied Sciences of Western Switzerland","All","40 Years and older   (Adult, Older Adult)","Not Applicable","32","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","PHYVS2016-1","February 2016","June 2021","September 2021","February 29, 2016",,"August 6, 2019","Hochschule für Gesundheit HES-SO Valais-Wallis, Leukerbad, Valais, Switzerland",,"https://ClinicalTrials.gov/show/NCT02693756"
400,"NCT04083859","Digital Outreach Intervention for Lung Cancer Screening","mPATH-Lung","Not yet recruiting","No Results Available","Lung Cancer","Other: mPATH-Lung|Other: Lung health video","Completion of a lung cancer screening CT scan|Knowledge of LCS among patients who indicate a strong preference for or against screening|Knowledge of LCS among all patients|Intention to receive LCS|Lung cancer screening decision|Proportion of patients with LCS clinic visits scheduled|Proportion of patients with LCS clinic visits completed|Proportion of patients with LCS scans ordered|Lung cancer screening test results|Number of LCS false positives|Invasive procedures following LCS scan|Proportion of patients with complications following LCS|Overscreening|Reach of digital outreach strategy|Reach of mPATH-Lung program|Acceptability of mPATH-Lung program|Appropriateness of mPATH-Lung program","Wake Forest University Health Sciences|University of North Carolina, Chapel Hill","All","55 Years to 77 Years   (Adult, Older Adult)","Not Applicable","1320","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","IRB00060382","September 2020","May 2023","May 2024","September 10, 2019",,"June 26, 2020","University of North Carolina- Chapel Hill, Chapel Hill, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT04083859"
401,"NCT04223648","Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma",,"Not yet recruiting","No Results Available","Malignant Melanoma","Drug: tremelimumab/durvalumab, ipilimumab/nivolumab and nivolumab monotherapy","PD1+ cell pharmacodynamic response in blood to tremelimumab/durvalumab treatment|Safety including adverse events (AEs) and lab values|Overall response (OR)","Yale University","All","18 Years and older   (Adult, Older Adult)","Early Phase 1","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2000025925","February 2020","February 2022","February 2025","January 10, 2020",,"January 10, 2020",,,"https://ClinicalTrials.gov/show/NCT04223648"
402,"NCT01454141","Cognitive Control Training for Depression",,"Completed","No Results Available","Depression","Other: Cognitive Control Training|Other: Peripheral Vision Task","Change in Beck Depression Inventory|Change in Positive and Negative Affective Scale (PANAS)|Emotional Response and Recovery Task|Changes in Visual Analog Scales","Boston University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","56","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","BU-2182E","July 2010","June 2011","June 2011","October 18, 2011",,"October 18, 2011","Boston University, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT01454141"
403,"NCT00786747","Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities",,"Completed","No Results Available","Colorectal Neoplasms","Behavioral: Personally tailored computer program|Behavioral: Non-tailored control computer program","Up to date colorectal cancer screening status|Up to date colonoscopy screening status|Up to date fecal occult blood testing status|Colorectal cancer screening self-efficacy|Perceived barriers to colorectal cancer screening|Readiness to undergo colorectal cancer screening","University of California, Davis|University of Rochester|City University of New York, School of Public Health","All","50 Years to 75 Years   (Adult, Older Adult)","Not Applicable","1164","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Screening","NCI -1R01CA131386-01A1|ARRA CA13138602S1","February 2010","October 2011","November 2012","November 6, 2008",,"December 3, 2015","University of California, Davis Health System, Sacramento, California, United States|University of Colorado, Aurora, Colorado, United States|Sophie Davis School of Biomedical Education, City University of New York,, New York City, New York, United States|University of Rochester School of Medicine and Dentistry, Rochester, New York, United States|University of Texas Health Sciences Center, San Antonio, Texas, United States",,"https://ClinicalTrials.gov/show/NCT00786747"
404,"NCT01650532","Stretching and Yoga Exercise Study","SAYExercise","Completed","No Results Available","Aging","Behavioral: Yoga Condition|Behavioral: Stretching Condition","Changes in cognition as assessed by a neuropsychological battery of computer based and paper pencil tests from baseline to 8 weeks|Change in functional fitness from baseline to 8 weeks|Change in psychosocial outcomes from baseline to 8 weeks|Change in salivary cortisol from baseline to 8 weeks|Change in heart rate variability from baseline to 8-weeks","University of Illinois at Urbana-Champaign","All","55 Years to 80 Years   (Adult, Older Adult)","Not Applicable","118","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","UIUC_IRB_12362","May 2012","March 2013","March 2013","July 26, 2012",,"February 23, 2017","University of Illinois at Urbana Champaign, Urbana, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT01650532"
405,"NCT02104128","Effects of Bupropion in Depression",,"Completed","No Results Available","Depression","Drug: Bupropion","Change in haemodynamic (i.e. BOLD signal) response|Change in questionnaire measures of subject mood and anhedonia|Change in accuracy and reaction time","University of Oxford|Janssen Research & Development, LLC","All","18 Years to 50 Years   (Adult)","Not Applicable","80","Other|Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","Bup_dep_1|13/SC/0569|OxH 1005","January 2014","May 2016","May 2016","April 4, 2014",,"May 12, 2016","University of Oxford, Oxford, Oxfordshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02104128"
406,"NCT02853032","Image-guided, Robotically Delivered TMS Treatment for Combat-Related PTSD",,"Completed","No Results Available","Stress Disorders, Post-Traumatic","Device: Active repetitive transcranial magnetic stimulation|Device: robotic arm|Device: Sham repetitive transcranial magnetic stimulation","Change in PTSD severity (PCL-5)|Change in depression severity (MADRS)|Change in PTSD severity (CAPS-5)|Clinically significant response (MADRS)|Clinically significant response (CAPS-5)|Clinically significant response (PCL-5)|Remission from PTSD (CAPS-5)|Remission from PTSD (PCL-5)|Remission from depression (MADRS)|Functional connectivity changes (measured by resting-state functional Magnetic Resonance Imaging) of the targeted brain network(s) following rTMS treatment|Incidence of treatment-emergent adverse events and serious adverse events","The University of Texas Health Science Center at San Antonio|Laurel Ridge Treatment Center|The Consortium to Alleviate PTSD","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","129","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","HSC20160191H","July 5, 2017","March 25, 2019","June 21, 2019","August 2, 2016",,"September 24, 2019","Laurel Ridge Treatment Center, San Antonio, Texas, United States",,"https://ClinicalTrials.gov/show/NCT02853032"
407,"NCT02023827","Computerized Stage-Matched Intervention for Juvenile Offenders",,"Unknown status","No Results Available","Delinquency|Substance Abuse","Behavioral: RAYS Intervention","Criminal recidivism based on self-report|Criminal recidivism based on official records|Substance use abstinence based on self-report|Total count of criminal behavior based on self-report|Stage of change for staying out of trouble with the law|Emotional distress|Substance use frequency|Substance-related problems|Stage of change for quitting alcohol and drugs|Abstinence confirmed by urine drug testing","Pro-Change Behavior Systems|Iowa Juvenile Court Services","All","13 Years and older   (Child, Adult, Older Adult)","Phase 2","1000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","5R44DA024900","August 2013","October 2016","October 2016","December 30, 2013",,"September 28, 2016","Iowa Juvenile Court Services, District 6, Cedar Rapids, Iowa, United States|Iowa Juvenile Court Services, District 7, Davenport, Iowa, United States|Iowa Juvenile Court Services, District 5, Des Moines, Iowa, United States|Iowa Juvenile Court Services, District 3, Sioux City, Iowa, United States|Iowa Juvenile Court Services, District 1, Waterloo, Iowa, United States",,"https://ClinicalTrials.gov/show/NCT02023827"
408,"NCT02470273","Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)",,"Active, not recruiting","No Results Available","Melanoma",,"A comparison between gold standard histopathology screening results and mAID screening results|A comparison between gold standard histopathology screening results and analysis of the standard dermatoscope image.","Rockefeller University|Oregon Health and Science University|University of California, Irvine|Skin and Cancer Associates","All","18 Years to 80 Years   (Adult, Older Adult)",,"1000","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","DGA-0860|Q141095","August 2015","July 2021","July 2021","June 12, 2015",,"April 22, 2020","Beckman Laser Institute at University of California Irvine, Irvine, California, United States|Chao Family Comprehensive Cancer Center, Orange, California, United States|The University of California (Davis), Sacramento, California, United States|Skin and Cancer Associates, Plantation, Florida, United States|Oregon Health Sciences University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT02470273"
409,"NCT02167750","Effect of Phytochemicals on Aspects of Cognitive Performance",,"Unknown status","No Results Available","Cognitive Performance","Other: Cherry Flavored Beverage","The primary outcome will be the changes in the ratings from computer administered tasks within the domains of mood, short-term recognition memory, and attention from pre- to post-study product consumption and between treatment conditions","PepsiCo Global R&D","All","17 Years to 50 Years   (Child, Adult)","Not Applicable","24","Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","PEP-1404","April 2014","October 2014","October 2014","June 19, 2014",,"June 19, 2014","Univerysity of Georgia, Athens, Georgia, United States",,"https://ClinicalTrials.gov/show/NCT02167750"
410,"NCT02141932","Pocket-size Cardiovascular Ultrasound in Stroke",,"Completed","No Results Available","Ischemic Attack, Transient|Transient Ischemic Attack|Stroke|Cerebrovascular Accident|Cerebrovascular Apoplexy|Apoplexy","Procedure: Bed-side pocket size ultrasound imaging|Device: GE Ultrasound Vscan","Proportion of patients without need for further diagnostic imaging|Reliability of bed-side ultrasound examinations of the carotid arteries and the heart by pocket-sized scanners|Feasibility of bed-side ultrasound examinations of the carotid arteries and the heart by pocket-sized scanners","Levanger Hospital|Norwegian University of Science and Technology","All","18 Years and older   (Adult, Older Adult)","Not Applicable","80","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","LH_Card2014-1","September 2014","December 2015","December 2015","May 20, 2014",,"January 12, 2016","Levanger Hospital, Levanger, Norway",,"https://ClinicalTrials.gov/show/NCT02141932"
411,"NCT00469924","Effect of an Automated Paging System on Response to Critical Laboratory Values",,"Completed","No Results Available","Critical Laboratory Values|Drug Laboratory Interactions|Drug Drug Interactions","Procedure: Real Time Clinical Alerting","(1) time to response, defined as the time to a physician order and (2) quality of response, defined as whether the response was concordant with existing evidence based protocols of care.|Secondary outcome measures will be: length of stay, mortality, time to resolution and frequency of recurrence.","Sunnybrook Health Sciences Centre|University Health Network, Toronto","All","Child, Adult, Older Adult","Not Applicable","271","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)","Etchells1","February 2006","June 2008","September 2008","May 7, 2007",,"May 17, 2016","Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT00469924"
412,"NCT03584490","Reducing Assessment Barriers for Patients With Low Literacy",,"Suspended","No Results Available","Health Literacy","Other: Computerized Talking Touchscreen","The degree of differential item functioning (DIF) in NIH Patient-Reported Outcomes Measurement Information System (PROMIS Profile 57 v 2.0)|The degree of differential item functioning (DIF) in the Berlin Questionnaire (sleep)|NIH Toolbox - Meaning and Purpose|Posttraumatic Stress Disorder Checklist (PTSD Checklist/PCL-5)|Ruminative Responses Scale (RRS; 10-item version)|Patient Health Questionnaire (PHQ-9)|Exit interview: Participant comfort during assessment","Northwestern University|National Institutes of Health (NIH)|National Institute on Minority Health and Health Disparities (NIMHD)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1200","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","STU00202907|1R01MD010440-01A1","September 14, 2018","March 1, 2021","March 1, 2021","July 12, 2018",,"June 11, 2020","Northwestern University, Chicago, Illinois, United States","""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/90/NCT03584490/ICF_003.pdf|""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/90/NCT03584490/Prot_005.pdf|""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/90/NCT03584490/SAP_008.pdf","https://ClinicalTrials.gov/show/NCT03584490"
413,"NCT02741986","Integrating Data, Algorithms and Clinical Reasoning for Surgical Risk Assessment","IDEALIST","Recruiting","No Results Available","Postoperative Complications","Other: Risk estimation","Area under the receiver operating curve (AUC) of risk estimates|Sensitivity and specificity of risk estimates|Positive and negative predictive values","University of Florida|National Institute of General Medical Sciences (NIGMS)","All","18 Years to 100 Years   (Adult, Older Adult)",,"200","Other|NIH","Observational","Observational Model: Other|Time Perspective: Prospective","IRB201600262-N|R01GM110240","October 2016","May 2021","May 2022","April 18, 2016",,"November 22, 2019","UF Health, Gainesville, Florida, United States",,"https://ClinicalTrials.gov/show/NCT02741986"
414,"NCT01315730","The Effects of Tactile Speech Feedback on Stuttering Frequency",,"Withdrawn","No Results Available","Stuttering","Device: Tactile Stimulation","Speech Fluency","University of Mississippi, Oxford|West Virginia University|Auburn University|University of Louisiana at Lafayette","All","18 Years and older   (Adult, Older Adult)","Phase 1","0","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","UMO-0001","March 2011",,,"March 15, 2011",,"May 12, 2014","The University of Mississippi, University, Mississippi, United States",,"https://ClinicalTrials.gov/show/NCT01315730"
415,"NCT02802293","Treatment of Depression With Connectivity Guided Robotically Delivered rTMS",,"Suspended","No Results Available","Major Depressive Disorder","Device: repetitive transcranial magnetic stimulation|Device: robotic arm","Change in depression severity (MADRS)|Clinically significant response (MADRS)|Remission from depression (MADRS)|Functional connectivity changes of the targeted brain network(s) following rTMS treatment|Incidence of treatment-emergent adverse events and serious adverse events","The University of Texas Health Science Center at San Antonio|IKARE Mood, Trauma, Recovery Clinic","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","CE-MDD-LRTC|HSC20160129H","August 17, 2017","July 2022","July 2023","June 16, 2016",,"May 12, 2020","Ikare, Mood, Trauma, Recovery Clinic, San Antonio, Texas, United States",,"https://ClinicalTrials.gov/show/NCT02802293"
416,"NCT03733366","Thermal Comfort of Different Desktop Materials","Materials","Completed","No Results Available","Office Desk Ergonomics","Other: Desk surface","Change of the skin temperature measured on forearm|Attention test|Adjusted Mood and feelings questionnaire","University of Primorska|Innorenew CoE","All","18 Years to 35 Years   (Adult)","Not Applicable","16","Other","Interventional","Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other","Thermal comfort","November 5, 2018","February 28, 2019","April 30, 2019","November 7, 2018",,"October 4, 2019","Faculty of Health Sciences, Izola, Slovenia",,"https://ClinicalTrials.gov/show/NCT03733366"
417,"NCT04122326","Monitoring and Evaluation of Posture in Office Workstations With Artificial Intelligence",,"Active, not recruiting","No Results Available","Musculoskeletal Pain|Musculoskeletal Injury|Musculoskeletal Strain","Behavioral: Workstation Modification","Change in Pain on the Visual Analog Pain Scale from baseline|Posture on the Rapid Upper Limb Assessment","University of Southern California|U.S. National Science Foundation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other|U.S. Fed","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","UP-19-00140","May 1, 2019","October 25, 2019","May 1, 2020","October 10, 2019",,"November 4, 2019","University of Southern California, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT04122326"
418,"NCT03796936","3MDR to Treat PTSD With mTBI (3MDR)","3MDR","Recruiting","No Results Available","Posttraumatic Stress Disorder|Traumatic Brain Injury","Behavioral: Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation (3MDR) Therapy","Change in PTSD Checklist for DSM5 (PCL-5) score|Change in Neurobehavioral Symptom Inventory (NSI) score|Change in Patient Health Questionnaire depression module (PHQ-9) score|Change in Insomnia Severity Index (ISI) score","Walter Reed National Military Medical Center|Uniformed Services University of the Health Sciences","All","18 Years and older   (Adult, Older Adult)","Phase 2","20","U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","WRNMMC-2018-0201","January 11, 2019","December 2020","December 2020","January 8, 2019",,"January 25, 2019","Walter Reed National Military Medical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT03796936"
419,"NCT03835299","Addressing Fear and Risk of Vasovagal Reactions Among High School Donors",,"Active, not recruiting","No Results Available","Blood Donors","Behavioral: Fear Intervention","Repeat Blood Donation Attempts|Blood Donation Confidence|Vasovagal Reactions to Blood Donation","Ohio University|New York Blood Center","All","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","4035","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","NYBC 1243761","February 15, 2019","September 15, 2020","September 15, 2020","February 8, 2019",,"March 3, 2020","Ohio University, Athens, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT03835299"
420,"NCT03384992","Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors","FoRtitude","Completed","No Results Available","Breast Cancer|Fear of Cancer","Other: Diaphragmatic breathing and relaxation|Other: Cognitive restructuring|Other: Scheduled worry practice|Other: Telephone coaching|Other: Usual care","Fear of Cancer Recurrence Inventory (FCRI) total score (minus Coping and Reassurance subscales)|Impact of Events Scale - Revised|Concerns about Recurrence Scale (CARS) - 4 item severity score|PROMIS Anxiety Computer adaptive test|PROMIS Depression Computer adaptive test|PROMIS Sleep Disturbance Computer adaptive test|PROMIS Fatigue Computer adaptive test|PROMIS Global Health|PROMIS Applied Cognition Computer adaptive test|Breast Cancer Self-Efficacy scale (BCSE)","Wake Forest University Health Sciences|National Cancer Institute (NCI)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","215","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Supportive Care","IRB00036679|1R21CA173193-01A1","March 2014","December 5, 2015","December 5, 2015","December 28, 2017",,"April 30, 2018",,,"https://ClinicalTrials.gov/show/NCT03384992"
421,"NCT03481075","Patient Specific Biomechanical Modeling of Abdominal Aortic Aneurysm to Improve Aortic Endovascular Repair","AAA2D3DIII","Active, not recruiting","No Results Available","Aortic Aneurysm","Other: Biomechanical computer program","Clinical validation of the biomechanical prototype software|Fluoroscopy time|Contrast agent used","Centre hospitalier de l'Université de Montréal (CHUM)|Siemens Corporation, Corporate Technology|Natural Sciences and Engineering Research Council, Canada|MEDTEQ","All","Child, Adult, Older Adult","Not Applicable","20","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","17.310","November 18, 2018","July 1, 2021","September 1, 2021","March 29, 2018",,"April 6, 2020","Centre Hospitalier de l'université de Montréal, Montréal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT03481075"
422,"NCT01834261","Brain Dynamics of Oxytocin",,"Completed","Has Results","Brain Dynamics in Healthy Adults","Drug: Syntocinon Nasal Spray, 40IU|Drug: Syntocinon Placebo Formulation, 40IU","Number of Benevolent Rounds|Number of Malevolent Rounds|Functional Connectivity Between OFC and AMY","Stony Brook University|Martinos Center for Biomedical Imaging","All","18 Years to 45 Years   (Adult)","Phase 1","51","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","293408|N000141210393","April 2013","May 2015","May 2015","April 17, 2013","March 17, 2017","March 17, 2017","Martinos Imaging Center at the McGovern Institute for Brain Research at MIT, Cambridge, Massachusetts, United States|Martinos Center for Biomedical Research, Building 149, 13th Street, Charlestown, Massachusetts, United States|Bioengineering Building , Stony Brook University, Stony Brook, New York, United States",,"https://ClinicalTrials.gov/show/NCT01834261"
423,"NCT04268914","VR to Reduce Pre-Operative Anxiety",,"Recruiting","No Results Available","Virtual Reality|Augmented Reality|IV Stick|Mask Induction|Ambulatory Surgery|Pain|Anxiety","Device: Oculus Go VR|Device: Mira Prism VR","VAS anticipatory anxiety measure|STAI-C (if elementary or junior high aged), STAI-Y (if in high school or college)|Child State Anxiety Index (CASI) or Anxiety Sensitivity Index (ASI) if 18 and older|The Faces Pain Scale (FPS-R)|Child Satisfaction Questionnaire|CAMPIS-R|Yale Preoperative Anxiety Scale (m-YPAS; Kain et al., 1995; Kain et al., 1997)|Parent Anxiety Scale|STAI|Parent Pain Scale|7-item self-report measure of healthcare provider's perceptions about the child's cooperation, pain, distress, and anxiety|6-item self-report measure of healthcare provider's perceptions about the child's cooperation, distress, and anxiety|Malaise Scale (MS)|Blood pressure and heart rate (BP/ HR)|Child Presence Questionnaire|Behavior Assessment System for Children (BASC-2)|Parent Satisfaction Questionnaire|Pediatric Anesthesia Emergence Delirium (Sikich, 2004; PAED)|Watcha Scale (Watcha et al., 1992)|Analgesic Requirements","Children's Hospital Los Angeles|AppliedVR Inc.","All","10 Years to 21 Years   (Child, Adult)","Not Applicable","450","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","CHLA-15-00461","December 4, 2015","October 21, 2020","October 21, 2020","February 13, 2020",,"February 13, 2020","Children's Hospital Los Angeles, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT04268914"
424,"NCT02752152","Counseling and Reminders for Regular HIV and STIs Screening","Napneung-1","Recruiting","No Results Available","HIV, Hepatitis B, Hepatitis C and Syphilis Infections","Behavioral: Computer-assisted counseling|Behavioral: On-demand counseling|Behavioral: Standard counseling|Behavioral: Appointment + reminder|Behavioral: Reminder|Behavioral: No appointment and no reminder","Percentage of participants from at-risk populations coming for a HIV re-test","Institut de Recherche pour le Developpement|Chiang Mai University|Expertise France","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1600","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","Napneung-1","December 2015","January 31, 2021","February 2021","April 26, 2016",,"October 3, 2019","Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand|MAP Foundation testing facility, Chiang Mai, Thailand|Special clinic of Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand",,"https://ClinicalTrials.gov/show/NCT02752152"
425,"NCT03366233","The Role of Brain Activation and Cerebral Blood Flow in Mental Fatigue.",,"Completed","No Results Available","Mental Fatigue|Healthy","Other: Mental fatigue|Other: Control","Blood Oxygen Level Dependent - Signal during a 10-min cognitive task (i.e. Flanker task)","Vrije Universiteit Brussel","All","18 Years to 35 Years   (Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","MF-MRI","February 1, 2018","November 9, 2018","November 9, 2018","December 8, 2017",,"October 8, 2019","Human Physiology and Sports Physiotherapy Research Group, Brussels, (non-US), Belgium",,"https://ClinicalTrials.gov/show/NCT03366233"
426,"NCT01964261","Providing Closed Loop Cortical Control of Extracorporeal Devices to Patients With Quadriplegia",,"Recruiting","No Results Available","Quadriplegia","Device: Neural Prosthetic System 2 (NPS2)","Patient control over the end effector (virtual or physical)|Absence of infection or irritation","Richard A. Andersen, PhD|University of Southern California|Rancho Los Amigos National Rehabilitation Center|California Institute of Technology","All","22 Years to 65 Years   (Adult, Older Adult)","Not Applicable","2","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","HS-13-00492","November 2013","September 2020","January 2021","October 17, 2013",,"July 25, 2019","Rancho Los Amigos National Rehabilitation Center, Downey, California, United States|University of Southern California, Los Angeles, California, United States|California Institute of Technology, Pasadena, California, United States",,"https://ClinicalTrials.gov/show/NCT01964261"
427,"NCT02105779","Optimizing Cognitive Remediation Outcomes in Schizophrenia","CAST","Completed","No Results Available","Schizophrenia|Psychosis","Other: Targeted Cognitive Training|Other: Social Cognitive Training","Change from Baseline Social Cognition at 6 months","University of California, San Francisco","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","172","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","R01MH082818","December 2009","May 2016","July 26, 2016","April 7, 2014",,"April 5, 2019","San Francisco Veterans Medical Center, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT02105779"
428,"NCT04266470","Monitoring Blood Flow and Metabolic Activity in Malignant Tissue of Head and Neck Region",,"Recruiting","No Results Available","Squamous Cell Carcinoma of Head and Neck","Device: Lara Scan|Diagnostic Test: PET/CT Scan - Pre-treatment and Post-treatment","Percentage of Tests That Input Function (IF) Could Be Calculated|Change in Areas Under the Curve (AUC) Measurements|Change in Time to Peak Arterial Blood Flow","Wake Forest University Health Sciences|National Cancer Institute (NCI)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","10","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility","IRB00056907|P30CA012197|WFBCCC 01919","March 9, 2020","December 2020","December 2020","February 12, 2020",,"June 5, 2020","Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT04266470"
429,"NCT02189876","Females of African American Legacy Empowering Self (FemAALES)","FemAALES","Completed","No Results Available","HIV","Behavioral: Standard of Care|Behavioral: FemAALES","Change in number of sex partners from baseline|Change in frequency of unprotected sex from baseline.|Change in bacterial STDs from baseline|Change in Safer Sex Negotiation Skills and Behaviors","Charles Drew University of Medicine and Science|National Institute on Minority Health and Health Disparities (NIMHD)|University of California, Los Angeles|St. John's Well Child & Family Center","Female","18 Years to 54 Years   (Adult)","Not Applicable","256","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","MD-13-010|P20MD000182","July 2013","April 2018","April 2018","July 15, 2014",,"August 3, 2018","St. John's Well Child and Family Center, Los Angeles, California, United States|Charles Drew University of Medicine and Science, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT02189876"
430,"NCT03159156","Respiration and Applied Tension Strategies to Reduce Vasovagal Reactions to Blood Donation",,"Unknown status","No Results Available","Syncope, Vasovagal","Behavioral: Applied Tension|Behavioral: Respiration Control|Behavioral: Applied Tension/Respiration Control","Change in End Tidal CO2|Change in Respiration Rate|Blood Donation Reactions Inventory|Research Assistant Observations|Change in Spielberger State Anxiety Scale Score|Medical Fears Survey|Change in Systolic Blood Pressure|Change in Diastolic Blood Pressure|Change in Heart Rate|Blood Donor Return","McGill University|Canadian Institutes of Health Research (CIHR)","All","18 Years to 39 Years   (Adult)","Not Applicable","408","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","MOP-133459","September 15, 2015","May 31, 2018","May 31, 2018","May 18, 2017",,"May 18, 2017","McGill University, Montréal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT03159156"
431,"NCT02453204","STAND UP - Sedentary Behaviour in Older Adults: Investigating a New Therapeutic Paradigm","STAND-UP","Completed","No Results Available","Older Adults","Behavioral: Sitting|Behavioral: Standing|Behavioral: Walking","Insulin area under the curve|Glucose area under the curve|Triglyceride area under the curve|1H NMR Metabolomics spectroscopy|Blood pressure|Felt Arousal Scale (0-5)|Feeling Scale (-5 to +5)|Semantic Verbal Fluency Test (number of items)|Hopkins Verbal Learning Test (number of words recalled)|Trail Making Tests A (time to complete)|Trail Making Tests B (time to complete)|Rapid Visual Information Processing Test (number of sequences detected and errors)|Karolinska Sleepiness Scale (1-9)","University of Leicester|University of Glasgow|National Institute for Health Research, United Kingdom|National Health Service, United Kingdom","All","65 Years to 79 Years   (Older Adult)","Not Applicable","76","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","0482|MR/K025090/1|CRN18120|UOLE0482","April 2015","March 2017","March 2017","May 25, 2015",,"January 30, 2020","BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Avenue, Glasgow, United Kingdom|Leicester Diabetes Centre, Diabetes Research Unit, University of Leicester, Leicester General Hospital, Leicester, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02453204"
432,"NCT03633149","Choices4Health: Intervention to Prevent Substance-exposed Pregnancy","C4H","Recruiting","No Results Available","Prenatal Alcohol Exposure|Prenatal Tobacco Exposure|Prenatal Marijuana Exposure","Behavioral: Computer tablet-delivered C4H|Behavioral: Person-delivered C4H|Behavioral: Brief Advice","Change in risk of alcohol-exposed pregnancy (AEP) as measured by self-reported daily standard drinks, vaginal sex, and use of contraception on the Timeline Followback calendar.|Change in risk of tobacco-exposed pregnancy (TEP) as measured by self-reported daily number of cigarettes, vaginal sex, and use of contraception on the Timeline Followback calendar.|Change in risk of marijuana-exposed pregnancy (MEP) as measured by self-reported marijuana use, vaginal sex, and use of contraception on the Timeline Followback calendar.|Change in risk drinking as measured by self-reported number of standard drinks on the Timeline Followback calendar.|Change in cigarette smoking as measured by self-reported number of cigarettes smoked each day on the Timeline Followback calendar.|Change in marijuana use as measured by self-reported use for each day on the Timeline Followback calendar.","University of Texas at Austin|Baylor College of Medicine|The University of Texas Health Science Center, Houston|University of Houston","Female","18 Years to 44 Years   (Adult)","Not Applicable","240","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","R01AA022924","June 28, 2018","April 2020","June 2020","August 16, 2018",,"February 6, 2020","University of Texas at Austin, Austin, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03633149"
433,"NCT04001959","Potential for Dentine Discoloration of Silver Diamino Fluoride Associated With Potassium Iodide",,"Recruiting","No Results Available","Dental Caries in Children","Procedure: Silver Diamine Fluoride with Potassium Iodide","Dentin color change|Clinical success based on the International System for Assessment and Detection of Caries (ICDAS)|Parental Satisfaction Scale","Federal University of the Valleys of Jequitinhonha and Mucuri","All","1 Year to 10 Years   (Child)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","04243718.0.0000.5108","May 2, 2019","July 2019","September 2019","June 28, 2019",,"July 5, 2019","Priscila Seixas Mourão, Diamantina, MG, Brazil",,"https://ClinicalTrials.gov/show/NCT04001959"
434,"NCT04277104","Does Acoustic Stimulation During Sleep Boost Slow Wave Sleep and Memory Performance?",,"Recruiting","No Results Available","Healthy|Mild Cognitive Impairment|Alzheimer Disease","Other: Closed loop acoustic stimulation|Other: Sham acoustic stimulation","Change from baseline episodic memory performance after three nights of intervention|Change from baseline performance in computer-based verbal new learning task (episodic memory) after three nights of intervention|Improvements in sleep physiology|Improvement in episodic memory performance at follow-ups|Improvement in new learning of episodic memory at follow-ups|Decreases in plasma amyloid-beta","University of Bern","All","60 Years to 85 Years   (Adult, Older Adult)","Not Applicable","72","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","2018-01979","October 20, 2019","July 2021","July 2021","February 20, 2020",,"February 20, 2020","University Hospital of Old Age Psychiatry and Psychotherapy, Bern, Switzerland",,"https://ClinicalTrials.gov/show/NCT04277104"
435,"NCT01146639","DynaCT in Preoperative Imaging Before Insertion of Stentgraft","DynaCT","Completed","No Results Available","Abdominal Aortic Aneurysm","Radiation: DynaCT|Drug: Iodixanol","Verify clinical usefulness of DynaCT images in preoperative imaging.","Norwegian University of Science and Technology","All","60 Years and older   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","rek 4.2008.802","August 2008","May 2010","June 2010","June 17, 2010",,"January 18, 2017","St Olavs Hospital, Operating Room of the Future., Trondheim, Norway",,"https://ClinicalTrials.gov/show/NCT01146639"
436,"NCT02154568","Study of Airflow in the Lungs Using Helium MRI",,"Unknown status","No Results Available","COPD|Healthy|Constrictive Bronchitis","Drug: hyperpolarized helium MRI of the chest","Hyperpolarized helium MRI flow velocity map|Spirometry (FEV1)|Spirometry (FVC)","University of Virginia","All","18 Years and older   (Adult, Older Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","16885|W81XWH-09-2-0027","November 2013","June 2018","July 2018","June 3, 2014",,"October 19, 2017","University of Virginia Health System, Charlottesville, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT02154568"
437,"NCT03517891","The Baby Act Trial",,"Recruiting","No Results Available","Obesity in Childhood","Behavioral: WIC+","Adequate weight gain during first year|Objective assessment of infant activity.|Objective sleep measures|General Infant Feeding Practices Questionnaire|Diet quality|Rate of infant growth.|Reported measures of physical activity|Reported measures of sleep|Weight|Length|Head Circumference","University of Puerto Rico|Marshfield Clinic Research Foundation|Florida International University","All","Child, Adult, Older Adult","Not Applicable","480","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","A4540117","May 11, 2018","June 2021","June 2022","May 8, 2018",,"February 27, 2020","University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico",,"https://ClinicalTrials.gov/show/NCT03517891"
438,"NCT03419052","MINDSpeed Food and Brain Training RCT","MINDSpeed","Recruiting","No Results Available","Low Education","Behavioral: Speed of processing","Executive Cognitive Function Composite Score","Indiana University|National Institutes of Health (NIH)","All","60 Years and older   (Adult, Older Adult)","Not Applicable","180","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","1703766063","February 11, 2019","May 31, 2021","May 31, 2021","February 1, 2018",,"February 15, 2019","Regenstrief Institute, Indianapolis, Indiana, United States",,"https://ClinicalTrials.gov/show/NCT03419052"
439,"NCT02800538","The Effects of Intragastric Administration of Nutrients on Executive Control in Healthy Subjects.",,"Completed","No Results Available","Healthy Volunteers","Dietary Supplement: intragastric infusion of nutrient","trial making task|digital span task|memory task","Universitaire Ziekenhuizen Leuven|KU Leuven","All","17 Years and older   (Child, Adult, Older Adult)","Not Applicable","26","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","S56123","May 25, 2015","June 27, 2017","June 27, 2017","June 15, 2016",,"September 11, 2017","University Hospitals Leuven, campus Gasthuisberg, Leuven, Belgium",,"https://ClinicalTrials.gov/show/NCT02800538"
440,"NCT02358941","Neurofeedback and Computerized Cognitive Training in Different Settings for Children and Adolescents With ADHD",,"Completed","No Results Available","Attention Deficit Hyperactivity Disorder","Behavioral: Neurofeedback training|Behavioral: Computerized cognitive training","ADHD behavioral symptoms|Neuropsychological performance, EEG parameters","University of Zurich|Swiss National Science Foundation","All","8 Years to 16 Years   (Child)","Not Applicable","102","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment","SNF: 320030_149411/1","December 2013","March 2017","September 2017","February 9, 2015",,"October 26, 2017","University Clinic of Child and Adolescent Psychiatry, University of Zürich, Zurich, Switzerland",,"https://ClinicalTrials.gov/show/NCT02358941"
441,"NCT02801266","Improving Contraceptive Counseling in the United States","ICC","Completed","No Results Available","New Behavioral Protocol|Treatment as Usual","Behavioral: Evidence informed birth control counseling","Patient satisfaction with counselors as assessed by 5 point Likert rating scales using questionnaire designed for this study at immediate posttest.|Patient satisfaction with counseling session as assessed by 5 point Likert rating scales using a questionnaire designed for this study at immediate posttest.|Patient satisfaction with clinic experience overall as assessed by 5 point Likert rating scales using a questionnaire designed for this study at immediate posttest.|Patient satisfaction with clinic experience overall as assessed by 5 point Likert rating scales using a questionnaire designed for this study at 6 months.|Patient satisfaction with clinic experience overall as assessed by 5 point Likert rating scales using a questionnaire designed for this study at 12 months.|Type of contraceptive method currently using (including none and dual use) as assessed by a questionnaire designed for this study (e.g., what method of birth control are you currently using).","New York University|Planned Parenthood Federation of America","Female","18 Years to 30 Years   (Adult)","Not Applicable","1418","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","FPRPA006057|12-9103","October 2012","October 2014","October 2015","June 15, 2016",,"June 15, 2016","New York University, Silver School of Social Work, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT02801266"
442,"NCT03400423","The Acute Effects of Caffeine on Exercise and Cognition","AEC","Unknown status","No Results Available","Adult Population","Drug: Caffeine|Behavioral: Moderate Intensity Exercise","3-back on the N-back task|0,1, and 2 back on the N-back task","Western University, Canada","All","18 Years to 64 Years   (Adult)","Phase 4","64","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","Acute Exercise and Caffeine","February 1, 2018","June 1, 2018","August 1, 2018","January 17, 2018",,"January 17, 2018",,,"https://ClinicalTrials.gov/show/NCT03400423"
443,"NCT04043884","sEmg Biofeedback Training in Individuals With Subacromial Pain Syndrome",,"Not yet recruiting","No Results Available","Shoulder Pain","Other: sEmg biofeedback training|Other: Strength training","Shouder pain|Shoulder function|Root Mean Square (RMS)|The kinematics of the scapula|Peak of muscular torque|Peak torque time|Range of motion","Universidade Federal do Rio Grande do Norte","All","30 Years to 60 Years   (Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","AKAO2019","August 30, 2019","December 30, 2019","March 30, 2020","August 2, 2019",,"August 7, 2019","Jamilson Simões Brasileiro, Natal, Rio Grande Do Norte, Brazil|Araken kleber Azevedo de Oliveira, Parnamirim, Rio Grande Do Norte, Brazil",,"https://ClinicalTrials.gov/show/NCT04043884"
444,"NCT02277665","Clinical Trial Tobacco Marijuana","RCTTM","Completed","Has Results","Cannabis Use Disorder|Tobacco Use Disorder","Behavioral: CUD Treatment|Behavioral: Tobacco Treatment","Tobacco Quit Attempts|Tobacco Abstinence|Cannabis Abstinence|Weeks of Continuous Cannabis Abstinence|Treatment Attendance|Initiation of Nicotine Replacement Therapy (NRT)","Dartmouth-Hitchcock Medical Center|National Institute on Drug Abuse (NIDA)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","67","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","STUDY00028307 D14233|5R01DA032243","December 18, 2014","January 18, 2017","January 18, 2017","October 29, 2014","January 8, 2019","January 8, 2019","Geisel School of Medicine at Dartmouth; State Building Site, Concord, New Hampshire, United States|Geisel School of Medicine at Dartmouth; Rivermill Complex Site, Lebanon, New Hampshire, United States|University of Washington School of Social Work, Seattle, Washington, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/65/NCT02277665/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02277665"
445,"NCT02884349","The Relationship Between Component Position and RoM",,"Recruiting","No Results Available","Arthropathy of Hip","Procedure: RoM assessment","Actual hip range of movement in degrees measured using clinical movement analysis|Theoretical hip range of movement in degrees calculated from CT scans|On-table hip range of movement in degrees as measured by the operative navigation computer|Combined anteversion in degrees of the acetabular cup and femoral stem system measured from CT scans|Leg length discrepancy|Oxford Hip Score|EQ-5D|Harris Hip Score|Patient satisfaction measured on a five point Likert scale|Number of dislocations in cohort|Number of revisions in cohort|Number of infections in cohort|Operative time in minutes|Blood loss volume|Blood transfusion (Yes/No)","Golden Jubilee National Hospital","All","40 Years to 70 Years   (Adult, Older Adult)","Not Applicable","90","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","Ortho 15-08","October 2016","December 2020","December 2020","August 31, 2016",,"August 1, 2019","Golden Jubilee National Hospital, Clydebank, West Dunbartonshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02884349"
446,"NCT02228187","Brain-Computer Interface System for Training Memory and Attention in Elderly",,"Completed","No Results Available","Alzheimer's Disease|Mild Cognitive Impairment|Age-Related Cognitive Decline|Dementia","Device: Brain-Computer Interface","Total Score of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)|Sum of Scaled Score of the Rivermead Behavioral Memory Test-II|Number of Adverse Events/Serious Adverse Events Reported|Usability Measure of the Brain-Computer Interface training system","Duke-NUS Graduate Medical School|Agency for Science, Technology and Research|National University, Singapore|Singapore Clinical Research Institute|Singapore General Hospital|Tan Tock Seng Hospital","All","60 Years to 80 Years   (Adult, Older Adult)","Phase 2","240","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","B-14-099","July 2015","June 2017","June 2017","August 28, 2014",,"August 2, 2017","Duke-NUS Medical School, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT02228187"
447,"NCT01588301","Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention","APACHE-2","Completed","No Results Available","Cervical Cancer|Human Papillomavirus Infection","Behavioral: Attending for cervical cytology|Behavioral: Kit for Self-collected vaginal sample","Comparison of women's attitude according to the arm: participation or not to a whole screening action|Analysis in sub-groups|Identification of the psychological determinants and mechanisms (checks and motivational factors)","University Hospital, Tours","Female","30 Years to 65 Years   (Adult, Older Adult)","Early Phase 1","5998","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Screening","INCA08-KH / APACHE-2","February 2012","December 2012","December 2012","April 30, 2012",,"September 12, 2014",,,"https://ClinicalTrials.gov/show/NCT01588301"
448,"NCT03706534","Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms",,"Active, not recruiting","No Results Available","Breast Cancer|Breast Lesions|Breast Mass","Device: Ultrasound Image review with CADe|Device: Ultrasound Image review with CADx|Device: Ultrasound Image manual review|Procedure: Biopsy","Concordance rate|Reporting time|Consensus|Accuracy|Sensitivity|Specificity|Area Under Curve","Samsung Medison|University of Rochester","All","19 Years and older   (Adult, Older Adult)","Not Applicable","300","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Device Feasibility","300.08-2018-Samsungmedison-S","September 20, 2018","November 30, 2019","January 31, 2020","October 16, 2018",,"October 29, 2019","University of Rochester, Rochester, New York, United States",,"https://ClinicalTrials.gov/show/NCT03706534"
449,"NCT01665105","Study on the Effect of Electroacupuncture at Both Zusanli and at Both Yanglingquan Acupoints on Cardiovascular Activity",,"Completed","No Results Available","Reaction of Autonomic Nervous System|Reaction of Acupuncture|Reaction of Blood Circulation","Device: acupuncture","From pulse wave, pulse rate variability and skin blood flow to measure cardiovascular activities with electroacupuncture at Zusanli and at Yanglingquan.|From skin blood flow and skin temperature to measure cardiovascular activities with electroacupuncture at Zusanli and at Yanglingquan.","China Medical University Hospital","All","20 Years to 40 Years   (Adult)","Not Applicable","24","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Factorial Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","DMR101-IRB2-101","July 2012","November 2012","May 2013","August 15, 2012",,"July 12, 2013","China Medical University Hospital, Taichung City, Taiwan",,"https://ClinicalTrials.gov/show/NCT01665105"
450,"NCT02793076","Physical and Emotional Benefits of Group Dance Intervention for Breast Cancer Survivors",,"Completed","No Results Available","Cancer","Other: Bollywood Dance","Change in Body Image Scale (BIS)|Change in Plumbline|Change in Qualitative Open Ended Surveys","University of the Sciences in Philadelphia|Cancer Support Community of Greater Philadelphia","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","12","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","840697-4","February 2016","May 2016","May 2016","June 8, 2016",,"June 8, 2016","Cancer Support Community, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT02793076"
451,"NCT03999450","Preventing Premature Death in Patients With Serious Opioid-related Infection",,"Active, not recruiting","No Results Available","Opioid Use","Behavioral: brief motivational intervention (BMI)|Behavioral: cognitive behavioral therapy","Percentage of participants who completed the week 4 follow up assessments|Percentage of participants who report intervention acceptability|Change in mean readiness|Change in mean self-regulation","University of Rochester|National Center for Advancing Translational Science (NCATS)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","11","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","RSRB00003696","October 8, 2019","May 31, 2020","May 31, 2020","June 26, 2019",,"March 31, 2020","University of Rochester Medical Center, Rochester, New York, United States",,"https://ClinicalTrials.gov/show/NCT03999450"
452,"NCT01014026","Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention","APACHE-1","Completed","No Results Available","Uterine Cervical Neoplasms|Uterine Cervical Dysplasia","Other: Screening test","Concordance between the three HPV tests","University Hospital, Tours","Female","20 Years to 65 Years   (Adult, Older Adult)","Phase 3","734","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic","INCA08-KH/APACHE-1","September 2009","March 2011","March 2011","November 16, 2009",,"May 13, 2011","IRSA 37, La Riche, France|IRSA 72, Le Mans, France|Service d'Orthogénie, CHRU Tours, Tours, France|Service de Gynécologie, CHRU Tours, Tours, France|Association Paul Metadier, Tours, France",,"https://ClinicalTrials.gov/show/NCT01014026"
453,"NCT03043326","Demonstration Project on the Feasibility to Implement PrEP in MSM and TG Women",,"Recruiting","No Results Available","HIV Prevention","Drug: Tenofovir Disoproxil Fumarate and Emtricitabine","Acceptability, use and adherence of a pre-exposure prophylaxis (PrEP) program using the co-formulation tenofovir disoproxil fumarate 300 mg/emtricitabine 200 mg (TDF/FTC) administered daily by mouth,|Evaluating the deviation of the indication of use of PrEP through self-reporting of its sale or sharing with third parties.|Describing the changes over time in risky sexual behavior among study participants.","Asociación Civil Impacta Salud y Educación, Peru|Gilead Sciences","Male","18 Years and older   (Adult, Older Adult)",,"1000","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","PrEP Peru","January 23, 2017","January 31, 2020","January 31, 2022","February 6, 2017",,"July 8, 2019","Asociacion Civil Selva amazonica, Iquitos, Maynas, Peru|Asociacion Via Libre, Lima, Peru|Asociacion Civil Impacta Salud y Educacion- Barranco CRS, Lima, Peru|Epicentro, Lima, Peru|Asociación Civil Impacta Salud y Educación-San Miguel CRS, Lima, Peru",,"https://ClinicalTrials.gov/show/NCT03043326"
454,"NCT04208490","Implementation and Effectiveness Trial of HN-STAR","HN-STAR","Not yet recruiting","No Results Available","Head and Neck Cancer","Other: HN-STAR Intervention","Change in HNC-Specific QOL|Change in QoL|Change symptom burden|Change in symptom burden|Change in pain|Change in patient activation|Change in perceived quality of cancer care|Adherence and surveillance of guideline concordant care","Wake Forest University Health Sciences|National Cancer Institute (NCI)|Memorial Sloan Kettering Cancer Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","470","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","IRB00060694","August 2020","December 2022","December 2022","December 23, 2019",,"May 20, 2020",,,"https://ClinicalTrials.gov/show/NCT04208490"
455,"NCT00349050","Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception",,"Withdrawn","No Results Available","Pain|Trigeminal Neuralgia|Neuropathic Pain","Device: laboratory pain assessment|Procedure: transcranial magnetic stimulation","Clinical neuropathic pain ratings, activity levels, analgesic medication usage, mood ratings, laboratory pain measures (thermal and mechanical pain thresholds, suprathreshold pain ratings, and wind-up pain ratings).","Medical University of South Carolina|National Institute of Neurological Disorders and Stroke (NINDS)","All","21 Years to 60 Years   (Adult)","Phase 2|Phase 3","0","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","K23NS050485-01A2","July 2006","October 2010","October 2010","July 6, 2006",,"April 30, 2012","Brain Stimulation Laboratory, Department of Psychiatry and Behavioral Sciences Medical University of South Carolina 5-North, IOP, 67 President Street, Charleston, South Carolina, United States",,"https://ClinicalTrials.gov/show/NCT00349050"
456,"NCT03868280","Fracture Table vs. Lateral Positioning for Intramedullary Fixation of Femur Fractures","FLiP","Not yet recruiting","No Results Available","Femur Fracture","Procedure: Antegrade femoral nailing Supine Position|Procedure: Antegrade Femoral Nailing Lateral Position","Postoperative femur malrotation|Postoperative femur alignment|Functional gait abnormalities|Walking/Gait ability|Persistent post-surgical Pain (PPSP): 5-point Likert scale|ROM|SF- 12 score (12 Item short Form survey)","Hamilton Health Sciences Corporation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","HiREB 5815","June 2019","June 2021","June 2022","March 11, 2019",,"March 12, 2019","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03868280"
457,"NCT01929564","Broccoli and Vascular Health Study","BASH","Completed","No Results Available","Cardiovascular Diseases","Other: Beneforte broccoli|Other: Parthenon Broccoli","The primary outcome measure is to assess the change in CVD risk after a 12 week broccoli intervention by assessing the change in concentration of LDL-cholesterol on which the power calculation was based.|To assess the effects of the broccoli intervention clinical biomarkers of CVD. The effect of the intervention on arterial stiffness will also be measured on a sub section of the total cohort (measurements carried out on the Reading cohort).","Quadram Institute Bioscience|Biotechnology and Biological Sciences Research Council|Technology Strategy Board, United Kingdom|Monsanto Company, LLC|University of Reading","All","50 Years and older   (Adult, Older Adult)","Not Applicable","95","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","IFR01/2012","July 2012","May 2014","May 2014","August 28, 2013",,"July 29, 2014","University of Reading, Reading, Berkshire, United Kingdom|Institute of Food Research, Norwich, Norfolk, United Kingdom",,"https://ClinicalTrials.gov/show/NCT01929564"
458,"NCT02241382","Cologne Cardioversion Study",,"Completed","No Results Available","Atrial Arrhythmia|Heart Failure","Device: Internal Electrocardioversion|Device: External Electrocardioversion","Combined Safety Endpoint|Efficacy Endpoint: restoration of sinus rhythm|Induction of ventricular fibrillation|Lead parameter indicators of impairment|Troponin|Recurrence at follow-up","Universitätsklinikum Köln|Medtronic","All","18 Years to 99 Years   (Adult, Older Adult)","Not Applicable","230","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","UKK-CCS-2014","September 2014","January 24, 2018","January 24, 2018","September 16, 2014",,"January 26, 2018","Royal Adelaide Hospital, Adelaide, Australia|University Hospital Lübeck, Lübeck, Schleswig-Holstein, Germany|University Hospital Aachen, Aachen, Germany|Heart & Diabetes Center NRW, Bad Oeynhausen, Germany|University Hospital Bonn, Bonn, Germany|Klinikum Coburg GmbH, Coburg, Germany|University Hospital Cologne, Cologne, Germany|Vinzenz Hospital, Cologne, Germany|Krankenhaus Neu-Bethlehem, Göttingen, Germany|University Heart Center Hamburg, Hamburg, Germany|St.Georg Hospital, Hamburg, Germany|Klinikum Leverkusen GmbH, Leverkusen, Germany|Klinikum Oldenburg, Oldenburg, Germany",,"https://ClinicalTrials.gov/show/NCT02241382"
459,"NCT01418703","Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus","MDB003","Completed","Has Results","Type 1 Diabetes Mellitus","Device: Closed Loop Control (CLC)|Device: Open Loop","Hypoglycemic Events|Percent Time Spent in Near Normoglycemia|Mean Glucose","University of Virginia|Abbott Diabetes Care|Insulet Corporation|DexCom, Inc.|University of California, Santa Barbara","All","21 Years to 65 Years   (Adult, Older Adult)","Not Applicable","38","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","14356","October 2009","December 2010","December 2010","August 17, 2011","November 13, 2014","November 13, 2014","University of Virginia Health System, Charlottesville, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT01418703"
460,"NCT03344328","Prevalence, Intensity and Consequences of Bortezomib-induced Neuropathic Disorders.","PREVIB","Recruiting","No Results Available","Chemotherapy Induced Peripheral Neuropathy|Multiple Myeloma","Drug: Bortezomib","Prevalence of peripheral neuropathy|Chronic pain|Screening of neuropathic pain|Anxiety and Depression Score|Hearing disorders|Health -related quality of life related to chemotherapy treatment.","University Hospital, Clermont-Ferrand","All","18 Years and older   (Adult, Older Adult)",,"360","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","CHU-359","January 15, 2019","December 31, 2019","January 31, 2020","November 17, 2017",,"July 1, 2019","CHU Clermont-Ferrand, Clermont-Ferrand, France",,"https://ClinicalTrials.gov/show/NCT03344328"
461,"NCT03527550","Cognitive Control Training for Urgency in a Naturalistic Clinical Setting",,"Enrolling by invitation","No Results Available","Impulsive Behavior|Mental Disorders","Other: Cognitive Control Training","Change in Average Score on Negative Urgency Scale (4 items from the Short UPPS-P Impulsive Behavior Scale)|Change in Average Score on the Positive Urgency Scale (4 Items from the Short UPPS-P Impulsive Behavior Scale).|Change in estimated Stop-Signal Reaction Time (SSRT) on Stop-Signal Task (ms)|Feasibility of assessing change in event-related potentials (ERPs) during a Stop-Signal Task in a partial hospital population|Completion Rates|Average Perceived Helpfulness of Training","Mclean Hospital|National Institute of Mental Health (NIMH)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","90","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2017P001550|1F32MH115530","September 11, 2018","February 2021","February 2021","May 17, 2018",,"December 6, 2019","McLean Hospital, Belmont, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT03527550"
462,"NCT03512782","Post-discharge Monitoring of Patients With Heart Failure","CARDIOENF","Not yet recruiting","No Results Available","Heart Failure","Other: CARDIOENF","hospital readmission|signs and symptoms of decompensation of heart failure","Instituto de Cardiologia do Rio Grande do Sul|Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil|Irmandade Santa Casa de Misericórdia de Porto Alegre","All","18 Years and older   (Adult, Older Adult)","Not Applicable","142","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","5085_15","September 1, 2018","March 30, 2019","April 30, 2019","May 1, 2018",,"September 5, 2018","Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Rio Grande Do Sul, Brazil",,"https://ClinicalTrials.gov/show/NCT03512782"
463,"NCT03459651","Effect of Turner Syndrome on Number Sense",,"Not yet recruiting","No Results Available","Turner Syndrome","Behavioral: ANS training","Single and multiple-operand addition and subtraction accuracy|Single and multiple-operand addition and subtraction response time","Stanford University","Female","6 Years to 40 Years   (Child, Adult)","Not Applicable","250","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","092883","August 2020","March 31, 2023","March 31, 2023","March 9, 2018",,"September 18, 2019","Center for Interdisciplinary Brain Sciences Research, Stanford, California, United States",,"https://ClinicalTrials.gov/show/NCT03459651"
464,"NCT01267292","Psychopharmacology for Cocaine Dependence - Buspirone",,"Completed","Has Results","Cocaine Dependence","Drug: Buspirone|Drug: Placebo for Buspirone|Drug: Methylphenidate|Drug: Placebo for Methylphenidate","Attentional Bias as Assessed by Score on the Stroop Task|Risky Decision Making as Assessed by Score on the Risky Decision Making Task|Subjective Effects as Assessed by the Addiction Research Center Inventory (ARCI)|Subjective Effects as Assessed by Score on the Vigor Subscale of the Profile of Mood States (POMS)|Subjective Effects as Assessed by Score on the ""Feel High"" Subscale of the Drug Effects Questionnaire (DEQ)|Subjective Effects as Assessed by the ""Elated"" Subscale of the Visual Analogue Scale (VAS)|Heart Rate|Systolic Blood Pressure|Diastolic Blood Pressure|Rapid Response Inhibition as Assessed by the Immediate Memory Task (IMT)|Reversal Learning as Assessed by Number of Perseverative Errors on the Reversal Learning Task","The University of Texas Health Science Center, Houston","All","18 Years to 60 Years   (Adult)","Phase 2","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","NIDA-P50-09262-Project2.1","March 2011","December 2015","December 2015","December 28, 2010","May 4, 2017","May 4, 2017","The University of Texas Health Science Center at Houston, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT01267292"
465,"NCT02706106","Assessment of a Knee Brace in Patients With Osteoarthritis",,"Unknown status","No Results Available","Osteoarthritis","Device: Knee brace","Change on pain sensation|Change on leg function|Change on agility","Irmandade da Santa Casa de Misericordia de Sao Paulo","All","40 Years to 60 Years   (Adult)","Phase 4","108","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","SCMAA01","November 2015","March 2016","March 2016","March 11, 2016",,"March 11, 2016","Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil",,"https://ClinicalTrials.gov/show/NCT02706106"
466,"NCT03830190","Cost-effectiveness of Nursing Interventions for Patients With PD","NICE-PD","Recruiting","No Results Available","Parkinson Disease","Other: Parkinson's disease nurse specialist care","Disease-specific health-related quality of life: Parkinson's disease Questionnaire (PDQ-39)|Motor symptoms|Longitudinal Parkinson's disease symptoms|Mobility|Non-motor symptoms (anxiety and depression)|Non-motor symptoms|Health-related quality of life: EuroQoL5D (EQ5D)|Experienced quality of and experience with provided healthcare: Consumer Quality Index (CQI)|Self-management|Medication adherence|Health-related quality of life of the caregiver: EuroQoL5D (EQ5D)|Caregiver burden|Caregiver quality of life: CarerQol-7D|Skills of proactive coping of the caregiver|Medical consumption of the patient|Productivity loss of the patient|Medical consumption of the caregiver related to providing care to the patient|Productivity loss of the caregiver related to providing care to the patient|Nighttime sleep problems and daytime sleepiness","Radboud University|ZonMw: The Netherlands Organisation for Health Research and Development|Zambon SpA","All","18 Years and older   (Adult, Older Adult)","Not Applicable","240","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","NICE-PD","January 7, 2019","December 31, 2020","March 31, 2021","February 5, 2019",,"March 15, 2019","Radboud University Medical Center, Department of Neurology, Nijmegen, Gelderland, Netherlands","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/90/NCT03830190/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03830190"
467,"NCT02136082","Asha Improving Health and Nutrition of Indian Women With AIDS and Their Children","Asha2","Completed","No Results Available","HIV Infection","Behavioral: Asha Support + Training|Behavioral: Asha Support + Food|Behavioral: Asha Support + Training + Food|Behavioral: Asha Support Only","Change in weight|Change in CD4+ T cell count|Change in muscle mass|Change in ART adherence|Change in depressive symptomatology|Change in internalized stigma|Change in nutritional adequacy|Change in lipid normalization|Change in anthropometric parameters and psychomotor development of the index children","University of California, Los Angeles|All India Institute of Medical Sciences, New Delhi|University of California, San Francisco|University of California, Irvine","Female","18 Years to 50 Years   (Adult)","Not Applicable","600","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","NIHMS098729","August 2013","June 2018","June 2018","May 12, 2014",,"October 9, 2018","All India Institute of Medical Sciences (AIIMS), New Delhi, India",,"https://ClinicalTrials.gov/show/NCT02136082"
468,"NCT02979457","Degree of Worry as a Predictor for Utilization of Acute Health Care",,"Completed","No Results Available","Health Care Delivery|Telephone Hotlines|Patient Participation","Behavioral: Awareness of degree of worry","call-handlers awareness of callers' DOW affects triage outcome|Does telephone consultation have a relieving effect on callers to a medical hotline?","University of Southern Denmark|Emergency Medical Services, Capital Region, Denmark","All","Child, Adult, Older Adult","Not Applicable","11340","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Health Services Research","usoutherndenmark - hejdi","January 24, 2017","May 15, 2017","May 1, 2018","December 1, 2016",,"May 14, 2018","Hejdi Gamst-Jensen, Ballerup, Denmark",,"https://ClinicalTrials.gov/show/NCT02979457"
469,"NCT02744846","Short- and Long-Term Effects of Antibiotics on Childhood Growth","ABX","Completed","Has Results","Obesity","Drug: Antibiotics exposure","Body Mass Index Z-score Difference at 48-72 Months, Exposed vs. No Antibiotics Less Than 24 Months|Body Mass Index Z-score Difference at 10 Years, Exposed vs. No Antibiotics Less Than 24 Months","Harvard Pilgrim Health Care|Patient-Centered Outcomes Research Institute|National Patient-Centered Clinical Research Network|ADVANCE CDRN|Chicago Area Patient-Centered Outcomes Research Network (CAPriCORN)|Greater Plains Collaborative Clinical Data Research Network|Mid-South Clinical Data Research Network|New York City Clinical Data Research Network|OneFlorida Clinical Research Consortium|PEDSnet: A Pediatric Learning Health System CDRN|PORTAL CDRN|Research Action for Health Network (REACHnet)|Scalable Collaborative Infrastructure for a Learning Healthcare System (SCILHS)|Genetic Alliance|StatLog","All","up to 11 Years   (Child)",,"681739","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","OBS-1505-30699","February 2016","December 2018","December 2018","April 20, 2016","December 20, 2019","December 20, 2019",,"""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/46/NCT02744846/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02744846"
470,"NCT02855606","Acceptability of HIV Oral PrEP Among MSM and TGW",,"Unknown status","No Results Available","Patient Acceptance of Health Care",,"Acceptability and factors affecting the decision to take oral PrEP|Adherence to PrEP by self-report|Adherence to PrEP by pill count","Chiang Mai University","Male","18 Years and older   (Adult, Older Adult)",,"200","Other","Observational","Observational Model: Other|Time Perspective: Prospective","PrEP@PIMAN","December 2015","December 2017","June 2018","August 4, 2016",,"February 2, 2017","Piman Center, Chiang Mai, Thailand",,"https://ClinicalTrials.gov/show/NCT02855606"
471,"NCT02768896","Monitoring Brain Waves in Response to Visual and/or Auditory Stimulation in Parkinson's Disease Patients",,"Unknown status","No Results Available","Parkinson's Disease","Behavioral: Baseline|Behavioral: visual stimuli|Behavioral: Auditory stimuli|Behavioral: Visual and auditory stimuli","Voltage fluctuation resulting from brain activity after visual stimuli|Voltage fluctuation resulting from brain activity after auditory stimuli|Voltage fluctuation resulting from brain activity after visual and auditory stimuli","Rambam Health Care Campus|Technion, Israel Institute of Technology","All","18 Years to 99 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","0182-16RMB","June 2016","January 2018","February 2018","May 11, 2016",,"June 7, 2016",,,"https://ClinicalTrials.gov/show/NCT02768896"
472,"NCT02685839","Development of an Intelligent POWER Rehabilitation Cluster Machine and Its Clinical Testing and Assessment",,"Unknown status","No Results Available","Frailty Syndrome|Intelligent POWER Rehabilitation Cluster Machine","Device: Intelligent POWER Rehabilitation Cluster Machine|Other: general physical therapy","Tilburg Frailty Indicator (TFI)|balance test (sec)|flexibility test_1st (cm)|flexibility test_2nd (cm)|general mobility test (sec)|hand-eye coordination test (sec)|muscle endurance test (times/2 min)|muscle strength test (kgw)|visual test|hearing test (sec)|Activity of daily living (ADL)|Instrumental Activities of Daily Living (IADL)|Functional Independence Measure (FIM)|36-Item Short Form Health Survey (SF-36)","Taipei Veterans General Hospital, Taiwan","All","60 Years to 85 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment","2015-06-003B","May 2015","June 2016","July 2018","February 19, 2016",,"May 24, 2016","Power Rehabilitation Room, Taipei Veterans General Hospital Integrative Rehabilitation Center, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT02685839"
473,"NCT02614651","AUgmented REality for the Visually Impaired - Part 1","AUREVI 1","Completed","No Results Available","Retinitis Pigmentosa|Glaucoma","Procedure: Find visual comfort threshold related to light intensity|Procedure: Find the size of the visual field|Procedure: Effectiveness of brightness control|Procedure: Performance of color correction|Device: Vuzix Wrap 1200DX virtural reality glasses","The maximum brightness value for visual comfort (THRESHOLD_MAX)|The minimum value of the perceptible light contrast in low light perceptible (THRESHOLD_MIN)|The speed of light change adaptation within a pre-specified range (getting dimmer)|The speed of light change adaptation within a pre-specified range (getting brighter)|Optimal range (in degrees) of the visual field provided by the device ""RV glasses + camera""|Response time in seconds|Number of correct responses","Centre Hospitalier Universitaire de Nīmes","All","18 Years and older   (Adult, Older Adult)","Not Applicable","15","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","LOCAL/2015/IMGD-01|2016-A00099-42","May 2016","April 20, 2017","May 29, 2017","November 25, 2015",,"July 19, 2017","CHRU de Nîmes - Hôpital Universitaire Carémea, Nîmes Cedex 09, France",,"https://ClinicalTrials.gov/show/NCT02614651"
474,"NCT01820221","Sutures vs. Staples Skin Closure After C-section in Obese Patients",,"Terminated","No Results Available","Obesity|Pregnancy","Procedure: Suture vs. staples closure method after c-section in obese women.","Wound complication rates|Post-operative pain","University of Arkansas","Female","18 Years to 50 Years   (Adult)","Not Applicable","148","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","138350","March 2013","February 2017","February 2017","March 28, 2013",,"February 3, 2017","University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States",,"https://ClinicalTrials.gov/show/NCT01820221"
475,"NCT00940368","A Study to Assess the Anti-Emetic Efficacy of Ginger in Children and Adolescents Receiving Chemotherapy",,"Unknown status","No Results Available","Nausea|Vomiting","Dietary Supplement: Provision of capsules containing ginger powder or placebo","Reduction in the Incidence and Severity of Chemotherapy Induced Nausea and Vomiting","All India Institute of Medical Sciences, New Delhi","All","8 Years to 21 Years   (Child, Adult)","Phase 3","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Health Services Research","T-10/27.02.2009","June 2009","December 2009","January 2010","July 16, 2009",,"July 28, 2009","Dr. B.R. Ambedkar Institute Rotary Cancer Hospital, New Delhi, Delhi, India",,"https://ClinicalTrials.gov/show/NCT00940368"
476,"NCT02027597","Improving Oral Health With Serious Games","AOTSM","Completed","No Results Available","Caries|Tooth Decay|Cavities|Gingivitis","Other: Attack of the S. Mutans|Other: Follow-up|Other: SnowWorld","Self-Efficacy|Self-care behavior","University of Washington|National Institute of Dental and Craniofacial Research (NIDCR)|National Institute on Minority Health and Health Disparities (NIMHD)","All","8 Years to 12 Years   (Child)","Not Applicable","161","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","35095-EB|5R44DE019043-02","October 2008","December 2010","August 2011","January 6, 2014",,"January 6, 2014","Firsthand Technology Inc., Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT02027597"
477,"NCT02947126","Multilevel Models of Therapeutic Response in the Lungs",,"Active, not recruiting","No Results Available","Cystic Fibrosis","Drug: Hypertonic Saline|Drug: Isotonic Saline|Drug: Indium-DTPA|Drug: Technetium Sulfur Colloid","Mucociliary Clearance|DTPA absorption rate","University of Pittsburgh|National Heart, Lung, and Blood Institute (NHLBI)","All","12 Years and older   (Child, Adult, Older Adult)","Not Applicable","62","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","PRO15070376|1U01HL131046-01","January 2017","August 2020","August 2020","October 27, 2016",,"December 13, 2019","University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT02947126"
478,"NCT04030897","Promoting Treatment Access Following Pediatric Primary Care Depression Screening",,"Recruiting","No Results Available","Depression","Behavioral: Parent-Directed Online Single-Session Program|Behavioral: Youth-Directed Online Single-Session Program|Behavioral: Information/Psychoeducation/Referral","Mental Health Treatment-Seeking Behavior Checklist|Change in Children's Depression Inventory 2 - Youth Report Total Score|Change in Pediatric Symptom Checklist - Youth-Report Total score|Change in Pediatric Symptom Checklist- Parent Report Total score|Change in Pediatric Symptom Checklist- Youth Internalizing Score (parent report)|Change in Beck Hopelessness Scale - 4 (Youth Report)|Change in Beck Hopelessness Scale - 4 (Parent Report)|Change in Brief Symptom Inventory - 18|Change in Barriers to Accessing Care Evaluation (BACE)|Change in Attitudes Toward Therapy Scale - Parent|Mental Health Treatment Access at 3-month follow-up|Change in Perceived Stress Scale|Change in Pediatric Symptom Checklist - Youth-Report Internalizing Score|Change in Children's Depression Inventory 2 - Parent Report total score","Stony Brook University|The Klingenstein Third Generation Foundation","All","11 Years to 16 Years   (Child)","Not Applicable","246","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","IRB2019-00241","January 15, 2020","April 30, 2021","August 30, 2021","July 24, 2019",,"March 6, 2020","Stony Brook University, Stony Brook, New York, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/97/NCT04030897/Prot_SAP_002.pdf","https://ClinicalTrials.gov/show/NCT04030897"
479,"NCT03920592","Virtual Reality and Prevention of Bullying",,"Completed","No Results Available","Bullying of Child","Behavioral: Virtual Reality of Bullying","Self-assessment manikin (SAM)|Heart rate (HR) and heart rate variability (HRV)|Electrodermal activity (EDA)|The Inventory of Callous-Unemotional Traits (ICU) in Children|Empathy toward victim|Ad-hoc items regarding bullying|Ad-hoc item on ""presence""","Narcis Cardoner, MD, PhD|Eurecat|Recercaixa|Escola Parc del Guinardó|Fundació FC Barcelona|Corporacion Parc Tauli","All","9 Years to 12 Years   (Child)","Not Applicable","34","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","CSMPT_NC_2019_1","April 10, 2019","April 12, 2019","April 12, 2019","April 19, 2019",,"April 29, 2019","Corporació Sanitària Parc Taulí, Sabadell, Spain",,"https://ClinicalTrials.gov/show/NCT03920592"
480,"NCT04389255","Developing a Balance Assessment System",,"Completed","No Results Available","Healthy People|Assessment","Other: Star Excursion Balance Test|Device: Balance Master device","Newly Developed Balance Assessment System|Star Excursion Balance Test|Balance Master device","Marmara University","All","18 Years to 25 Years   (Adult)",,"65","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","09.2019.274","March 1, 2019","May 1, 2019","June 27, 2019","May 15, 2020",,"May 15, 2020","Marmara University, Faculty of Health Sciences, Istanbul, Turkey",,"https://ClinicalTrials.gov/show/NCT04389255"
481,"NCT02667080","Sperm Quality in Consecutive Sperm Samples After 4-7 Days and 2 Hours of Sexual Abstinence",,"Completed","No Results Available","Semen Quality","Other: 2-7 days of Sexual abstinence|Other: 2 hours of sexual abstinence","Routine semen quality assessment|Outcome of ART treatments","Aalborg University|Aalborg University Hospital","Male","18 Years to 50 Years   (Adult)","Not Applicable","43","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","N-20140023","April 2014","November 1, 2016","November 1, 2016","January 28, 2016",,"January 24, 2017","Aalborg University Hospital, Dronninglund Fertility Clinic, Dronninglund, Denmark",,"https://ClinicalTrials.gov/show/NCT02667080"
482,"NCT02181114","Your Path to Transplant: A Randomized Control Trial of A Tailored Computer Education Intervention for Living Donor Kidney Transplant",,"Completed","No Results Available","End Stage Renal Disease","Behavioral: Expert System Coaching","Patient LDKT Attitude & Decision-Making Measure: Readiness|Patient LDKT Attitude & Decision Making Measure: Decisional Balance|Patient LDKT Attitude & Decision Making Measure: Self-efficacy|Patient LDKT Attitude & Decision Making Measure: Small Steps towards LDKT and DDKT|Patient LDKT Attitude & Decision Making Measure: Transplant Knowledge|Final Outcome: Pursuit of Transplant","University of California, Los Angeles|University of Rhode Island","All","18 Years and older   (Adult, Older Adult)","Not Applicable","815","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","DK088711-1","May 2014","December 2017","December 2017","July 3, 2014",,"May 1, 2018","UCLA Division of Nephrology, Los Angeles, California, United States|University of Rhode Island, Kingston, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT02181114"
483,"NCT03728114","Effects of RIC on Cognitive Function and Blood Oxygen Levels in Unacclimatized Adult at High Altitude",,"Not yet recruiting","No Results Available","Adult","Device: RIC|Device: sham RIC","Attentional network test|basic fibroblast growth factor|platelet derived growth factor|vascular endothelial growth factor|the rate of Adverse event|distal radial pulses|the number of erythema in the skin|the number of patients not tolerating RIC procedure,and refuse to continue the RIC procedure|the number of patients with any other adverse events related to RIC intervention as determined by the principle investigator.|heart rate|blood pressure|blood oxygen saturation (SaO2)|cerebral oxygen saturation(TOI)|The peak systolic blood flow velocity (PSV) of bilateral middle cerebral artery (MCA)|end-diastolic blood flow velocity (EDV) of bilateral middle cerebral artery (MCA)|the mean flow velocity (MFV) of the subjects' bilateral middle cerebral artery (MCA)|pulse index (PI) of the subjects' bilateral middle cerebral artery (MCA)|The degree of palpation of tenderness--visual analogue scale|the number of patients with any other adverse events related to RIC intervention as determined by the principle investigator","Affiliated Hospital to Academy of Military Medical Sciences|Xuanwu Hospital, Beijing","Male","18 Years to 30 Years   (Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","ERIC-HA","November 2018","November 2018","December 2018","November 1, 2018",,"November 7, 2018",,,"https://ClinicalTrials.gov/show/NCT03728114"
484,"NCT01701791","Telemedicine for Depression in Primary Care",,"Unknown status","No Results Available","Depression","Other: Computerized Decision Support System","Proportion of patients reaching remission|Number of GP appointments actually attended during follow-up","IRCCS Centro San Giovanni di Dio Fatebenefratelli","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","RF-2010-2316063","November 2012","January 2016","May 2016","October 5, 2012",,"February 24, 2016","Health Telematic Network srl, Brescia, Italy|IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy|Dipartimento di Scienze Mediche Sperimentali e Cliniche, Università di Udine, Udine, Italy|Marco B. Rocchi, Urbino, Italy",,"https://ClinicalTrials.gov/show/NCT01701791"
485,"NCT01154296","HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.","Aware","Completed","Has Results","HIV/AIDS|Sexually Transmitted Infections","Behavioral: RESPECT-2 Counseling","STI Incidence|Sexual Risk Behavior -- # of Sex Acts|Sexual Risk Behavior -- # of Unprotected Sex Acts|Sexual Risk Behavior -- # of Partners|Sexual Risk Behavior -- # of Unprotected Partners|Sexual Risk Behavior -- # of Sex Acts With Substance Use","Columbia University|National Institute on Drug Abuse (NIDA)|University of Pittsburgh|University of California, San Francisco|Oregon Health and Science University|Medical University of South Carolina|Research Foundation for Mental Hygiene, Inc.|Duke University|The Emmes Company, LLC|San Francisco Department of Public Health|University of California|Weill Medical College of Cornell University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","5012","Other|NIH|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Screening","AAAK3153|1RC2DA028973-01","April 2010","July 2011","February 2012","June 30, 2010","September 29, 2014","September 29, 2014","Los Angeles Gay & Lesbian Center, Los Angeles, California, United States|San Francisco Department of Public Health, San Francisco, California, United States|Whitman-Walker Clinic, Washington, District of Columbia, United States|Duval County Health Department, Jacksonville, Florida, United States|Miami-Dade County Health Department, Miami, Florida, United States|Multnomah County Health Department, Portland, Oregon, United States|Allegheny County Health Department, Pittsburgh, Pennsylvania, United States|Richland County Health Department, Colombia, South Carolina, United States|Public Health Seattle & King County, Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT01154296"
486,"NCT03094962","Development of a Musculoskeletal Model of the PIP Joint",,"Completed","No Results Available","Patient Specific Computational Modeling","Other: Motion capture|Diagnostic Test: MR scan|Diagnostic Test: CT scan","Capturing hand kinematics using Vicon optical motion capture|Capturing images of the soft tissue in the hand using MR imaging|Capturing images of the bony structures in the hand using CT scanning","University of Southampton","All","18 Years and older   (Adult, Older Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","PUNI1713","January 21, 2015","September 5, 2017","September 5, 2017","March 29, 2017",,"November 15, 2018","University Hospital Southampton, Southampton, Hampshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03094962"
487,"NCT01851122","The Effect of the Amino Acid L-Theanine on Alertness and Vigilance",,"Completed","No Results Available","Theanine, (L)-Isomer","Dietary Supplement: L-theanine capsule","Alertness|Well-Being","The University of Texas Health Science Center, Houston","All","18 Years and older   (Adult, Older Adult)","Not Applicable","26","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","HSC-GEN-11-0299","November 2011","October 2012","October 2012","May 10, 2013",,"May 10, 2013","Physicians at Sugar Creek, Sugar Land, Texas, United States",,"https://ClinicalTrials.gov/show/NCT01851122"
488,"NCT03148678","Scrutinizing and Promoting Mindfulness Via New Technologies",,"Recruiting","No Results Available","Mindfulness|Stress|Mood|Working Memory","Behavioral: Mindfulness|Other: Contingent RT-fMRI-NF|Other: Sham RT-fMRI-NF|Behavioral: Mind Wandering","Blood oxygenation level dependent (BOLD) Signal assessed by MRI|State mindfulness assessed by State Mindfulness Scale|Subjective stress reactivity assessed by Visual Analog Scale|Subjective mood assessed by Multidimensional Mood State Questionnaire|Emotional reactivity assessed by emotion recognition task|Working Memory assessed by N-back task test|Cognitive flexibility assessed by computer version of Wisconsin card sorting Task test","University Hospital, Basel, Switzerland|University of Basel|Korea University","Male","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","GRNP_2013S1A2A2035364_1_2","March 31, 2017","September 30, 2020","September 30, 2020","May 11, 2017",,"March 31, 2020","Korea University, Seoul, Korea, Republic of|University of Basel, Basel, Switzerland",,"https://ClinicalTrials.gov/show/NCT03148678"
489,"NCT01348841","Wound Interdisciplinary Teams (WIT): A Community- Based Pragmatic Randomized Controlled Trial","WIT","Completed","No Results Available","Wound of Skin","Other: Systematic referral to MDWCT and comprehensive primary care","Time to Healing|proportion of wound healed|Wound recurrence|time to discontinuation of wound service|Health Related Quality of Life (HRQOL)|client satisfaction|cost and resource use","University of Toronto|Ontario Ministry of Health and Long Term Care","All","18 Years and older   (Adult, Older Adult)","Not Applicable","451","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","25973","May 2011","June 2013","October 2013","May 5, 2011",,"October 25, 2013","THETA Collaborative, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT01348841"
490,"NCT03294460","Nicotinic Receptor Genetic Variation and Alcohol Reward",,"Recruiting","No Results Available","Alcohol Drinking","Drug: Alcohol (Oral)|Drug: Alcohol (IV)|Drug: Alcohol (Ethanol)","To examine the effect of CHRNA5 (rs16969968) genetic variation on neural correlates of incentive salience for alcohol, as measured by BOLD response during the Alcohol-Food Incentive Delay (AFID) task using fMRI.|To examine the effect of CHRNA5 (rs16969968) genetic variation on IV alcohol self-administration, as measured by BrAC exposure (peak BrAC, number of infusions, time to binge-level) in non-smoking, non-dependent drinkers.|To examine the effect of CHRNA5 (rs16969968) genetic variation on resting-state functional connectivity (rsFC) among brain regions associated with the salience network, including dorsal anterior cingulate cortex, ventral striatum and extended am...|To examine the effect of CHRNA5 (rs16969968) genetic variation on the rate of IV alcohol self-administration, as measured by the preferred rate during the second IV-ASA session in non-smoking, non-dependent drinkers.|To examine the relationship between fMRI measures (BOLD response during AFID and rsFC measures) and IV alcohol self-administration, and any differences in the degree of association among these measures by CHRNA5 genotype.","National Institute on Alcohol Abuse and Alcoholism (NIAAA)|National Institutes of Health Clinical Center (CC)","All","21 Years to 60 Years   (Adult)","Phase 1","128","NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","170171|17-AA-0171","June 10, 2019","December 31, 2023","December 31, 2023","September 27, 2017",,"June 5, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT03294460"
491,"NCT01981135","Interaction Effects of Temperature and Ozone","TROPICOZ","Completed","No Results Available","Exposure to Environmental Pollution, Non-occupational","Other: Clean Air|Other: Ozone","Forced expired volume in the first second (FEV1)|Index of clotting/coagulation factor|Index of inflammatory markers|Forced Vital Capacity|Changes in heart rate variability","Environmental Protection Agency (EPA)","All","18 Years to 55 Years   (Adult)","Not Applicable","16","U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","#11-0772","September 2011","March 2014","January 2015","November 11, 2013",,"February 10, 2015","U.S. EPA Human Studies Facility, Chapel Hill, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT01981135"
492,"NCT04253587","Labyrinth Intervention in High-Fidelity Long-Term Memory","LABYR","Recruiting","No Results Available","Long-Term Memory Decline|Mild Cognitive Impairment","Device: LabyrinthVR|Device: Placebo Games|Device: Coherence","MDT change in mnemonic discrimination|WALK change in recall|Changes in volumetric-based brain morphometry associated with training-induced changes in mnemonic discrimination|Changes in task-based cortical functional connectivity associated with training-induced changes in mnemonic discrimination|Four Mountains Test change in spatial memory|Test of Visual Attention change in top-down control","University of California, San Francisco","All","62 Years to 85 Years   (Adult, Older Adult)","Not Applicable","300","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","19-27586","October 1, 2019","December 2021","June 2022","February 5, 2020",,"February 5, 2020","UCSF Mission Bay, San Francisco, California, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/87/NCT04253587/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT04253587"
493,"NCT02707055","A Novel Compound for Alcoholism Treatment: A Translational Strategy",,"Recruiting","No Results Available","Alcoholism","Drug: PF-05190457|Behavioral: MI-VF|Other: Placebo|Other: Counseling","The primary aim will be to determine whether PF-05190457, compared to placebo, reduces alcohol cue-elicited craving.|To determine whether PF-05190457, compared to placebo, reduces brain blood oxygen level dependent (BOLD) response during exposure to alcohol cues|To determine whether PF-05190457, compared to placebo, reduces food choices in a virtual buffet conducted in a virtual reality context","National Institute on Alcohol Abuse and Alcoholism (NIAAA)|National Institutes of Health Clinical Center (CC)","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 2","55","NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","160080|16-AA-0080","June 15, 2016","December 31, 2020","December 31, 2020","March 14, 2016",,"May 11, 2020","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT02707055"
494,"NCT03214783","A Case-control Study to Assess the Association Between Facial Characteristics and Coronary Artery Diseases",,"Completed","No Results Available","Coronary Artery Disease","Other: Facial characteristics","The association between facial factors and increased risk of coronary artery diseases","China National Center for Cardiovascular Diseases","All","Child, Adult, Older Adult",,"2300","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","2017-907","July 10, 2017","October 31, 2018","October 31, 2018","July 12, 2017",,"November 6, 2018","Fuwai Hospital Chinese Academay of Medical Science and National Center for Cardiovascular Diseases, Beijing, Beijing, China",,"https://ClinicalTrials.gov/show/NCT03214783"
495,"NCT03181763","""Evaluation of MDMA on Startle Response",,"Recruiting","No Results Available","Startle Response","Drug: Placebo|Drug: MDMA|Behavioral: Acoustic startle","EMG of right orbicularis oculi muscle|Systolic blood pressure pre-drug|Systolic blood pressure 45 min post-drug|Systolic blood pressure 1 h 15 min post-drug|Systolic blood pressure 1 h 45 min post-drug|Systolic blood pressure 3 h post-drug|Systolic blood pressure 4 h post-drug|Systolic blood pressure 5 h post-drug|Systolic blood pressure 6 h post-drug|Diastolic blood pressure pre-drug|Diastolic blood pressure 45 min post-drug|Diastolic blood pressure 1 h 15 min post-drug|Diastolic blood pressure 1 h 45 min post-drug|Diastolic blood pressure 3 h post-drug|Diastolic blood pressure 4 hours post-drug|Diastolic blood pressure 5 hours post-drug|Diastolic blood pressure 6 hours post-drug|Pulse pre-drug|Pulse 45 min post-drug|Pulse 1 h 15 min post-drug|Pulse 1 h 45 min post-drug|Pulse 3 h post-drug|Pulse 4 h post-drug|Pulse 5 h post-drug|Pulse 6 h post-drug|Body temperature pre-drug|Body temperature 45 minutes post-drug|Body temperature 1 h 15 minutes post-drug|Body temperature 1 h 45 minutes post-drug|Body temperature 3 hours post-drug|Body temperature 4 hours post-drug|Body temperature 5 hours post-drug|Body temperature 6 hours post-drug|Plasma oxytocin (OT) levels predrug|Plasma oxytocin (OT) levels 5 min post-drug|Plasma oxytocin (OT) levels 20 min post-drug|Plasma oxytocin (OT) levels 95 min post-drug|Plasma oxytocin (OT) levels 110 min post-drug|Plasma oxytocin (OT) levels 185 min post-drug|Plasma oxytocin (OT) levels 200 min post-drug|Plasma oxytocin (OT) levels 240 min post-drug|Plasma oxytocin (OT) levels 300 min post-drug","Multidisciplinary Association for Psychedelic Studies","All","21 Years to 55 Years   (Adult)","Phase 1","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","MPVA-4","September 21, 2017","July 10, 2020","July 10, 2020","June 9, 2017",,"February 19, 2020","Emory University, Atlanta, Georgia, United States",,"https://ClinicalTrials.gov/show/NCT03181763"
496,"NCT02669225","Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People",,"Completed","No Results Available","Normal Physiology","Other: [18F]florbetaben","(1) To assess if there are differences in [18F] florbetaben binding(reflecting A load) in subjects after SD compared to RW when measured in the morning.|(2) To assess if there are differences in brain A accumulation during RW and SD and to assess if there are differences in brain Aclearance (comparisons of RW versus SD) between young and older participants.|This is an exploratory aim to assess if there are differences in brain function and neurochemistry between RW and SD using MRI and1H-MRS and determine if the variability on the effects of SD is related to differences in brain glymphatic funct...","National Institute on Alcohol Abuse and Alcoholism (NIAAA)|National Institutes of Health Clinical Center (CC)","All","18 Years and older   (Adult, Older Adult)","Early Phase 1","22","NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","160059|16-AA-0059","May 2, 2016","January 24, 2017","July 11, 2018","February 1, 2016",,"June 30, 2020","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT02669225"
497,"NCT01183819","Cognitive Control and Physical Exercise",,"Terminated","No Results Available","Cognitive Function|Day-to-Day Function","Behavioral: Space Fortress|Behavioral: Aerobic Exercise|Behavioral: Stretching|Behavioral: Control Games","Changes in measures of executive control function and episodic memory at 6 months|Changes in brain structure, resting cerebral blood flow and network efficiency at 6 months|Change in aerobic capacity at 6 months|Changes in measures of executive control function and episodic memory at 1 year","Columbia University|National Institute on Aging (NIA)","All","60 Years to 75 Years   (Adult, Older Adult)","Not Applicable","12","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science","AAAE5848|R01AG034178","February 2010","June 2015","June 2015","August 18, 2010",,"August 5, 2015","Columbia University Medical Center, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT01183819"
498,"NCT01391650","Stability of the Knee Joint After Single and Double Bundle Anterior Cruciate Ligament Reconstruction",,"Completed","No Results Available","Rupture of Anterior Cruciate Ligament","Procedure: 'biomechanic of the knee'","measurement of rotational and anterior-posterior movement tibia to femur before the replacement of ACL|measurement of rotational and anterior-posterior movement tibia to femur after the replacement of ACL","Hospital Znojmo|Masaryk University","All","18 Years to 53 Years   (Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","DBVSB","March 2010","May 2011","May 2011","July 12, 2011",,"May 23, 2012","Hospital Znojmo, Znojmo, Czech Republic",,"https://ClinicalTrials.gov/show/NCT01391650"
499,"NCT03099616","Automated Closed Loop Propofol Anaesthesia Versus Desflurane Inhalation Anaesthesia In Bariatric Surgery",,"Completed","No Results Available","Anesthesia; Bariatric Surgery","Drug: Propofol|Drug: Desflurane","Early Recovery|Early recovery|Intermediate recovery|Changes in intra-operative heart rate (beats per minute)|Change in Intra-operative blood pressure - systolic , diastolic, and mean (mmHg)|Postoperative Sedation|Postoperative Nausea and Vomiting|Postoperative Analgeisa|Patient Satisfaction|Anesthesia Depth Consistency","Dr Nitin Sethi|Sir Ganga Ram Hospital","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 4","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","EC/01/17/1105","April 4, 2017","December 2, 2019","December 2, 2019","April 4, 2017",,"December 23, 2019","Sir Ganga Ram Hospital, New Delhi, Delhi, India",,"https://ClinicalTrials.gov/show/NCT03099616"
500,"NCT03188211","E-learning to Improve Oral Anticoagulant Use in Hospitalized Older People With AF","SIM-AF","Completed","No Results Available","Simulation Training|Anticoagulant Drugs|Elderly|Atrial Fibrillation|Drug Prescriptions|Internal Medicine|Geriatrics","Other: E-learning educational program|Other: Control","Elderly with AF prescribed with OAC|Number of access to Dr Sim|Total duration of connection to Dr Sim|Elderly patients with AF prescribed with any antiplatelet agent|Elderly patients with AF newly prescribed with OAC agents|Patients experiencing any cerebro or cardiovascular events|Re-hospitalization rate|Minor bleeding events|Major bleeding event","Mario Negri Institute for Pharmacological Research","All","65 Years and older   (Older Adult)","Not Applicable","247","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other","BMS ISR # CV185-483","September 1, 2017","January 22, 2018","September 30, 2018","June 15, 2017",,"November 13, 2018","Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi, Bologna, Bo, Italy|Istituto Fondazione Poliambulanza, Brescia, BS, Italy|Policlinico Universitario Mater Domini, Catanzaro, CZ, Italy|AO Universitaria Policlinico di Modena, Modena, Italia, Italy|Azienda Ospedaliera S. Gerardo di Monza, Monza, MB, Italy|Ospedale degli Infermi, Rivoli, TO, Italy|Azienda Ospedaliera Universitaria - Ospedale Riuniti, Trieste, TS, Italy|A.O. Ospedale di Circolo e Fondazione Macchi, Varese, VA, Italy|Azienda Consorziale Ospedaliera Policlinico, Bari, Italy|Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy|Azienda Ospedaliera Universitaria ""Policlinico Vittorio Emanuele"", Catania, Italy|Azienda Ospedaliera Universitaria San Martino - IST, Genoa, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy|Azienda Ospedaliera di Padova, Padova, Italy|Azienda Ospedaliera Universitaria Policlinico P. Giaccone, Palermo, Italy|Azienda SocioSanitaria Territoriale, Ospedale Civile ""C.Mira"" di Casorate Primo, Pavia, Italy|Policlinico San Matteo, Pavia, Italy|Ospedale San Giovanni Calibita Fatebenefratelli, Roma, Italy|Policlinco Universitario Agostino Gemelli, Rome, Italy|Ospedale SS Annunziata, Sassari, Italy",,"https://ClinicalTrials.gov/show/NCT03188211"
501,"NCT04286737","The Effect of Therapeutic Touch on Colic Symptoms in Infantile Colic Infants: A Randomized Controlled Study",,"Recruiting","No Results Available","Infantile Colic|Therapeutic Touch","Other: Therapeutic Touch","Infantile Colic Scale|Crying Time|Sleeping Time","Karamanoğlu Mehmetbey University","All","up to 12 Weeks   (Child)","Not Applicable","64","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","2019/2123","March 2, 2020","June 30, 2020","September 30, 2020","February 27, 2020",,"April 20, 2020","Karamanoğlu Mehmetbey University, Karaman, Turkey",,"https://ClinicalTrials.gov/show/NCT04286737"
502,"NCT02460536","Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth",,"Completed","No Results Available","Anxiety Disorders","Behavioral: Attention Bias Modification treatment (ABMT)|Behavioral: Exposure only +ABMT|Behavioral: Attention training only +ABMT|Behavioral: Placebo group","Change from baseline in anxiety symptoms - the Pediatric Anxiety Rating (PARS)|Change from baseline in anxiety related emotional disorders symptoms - Child/Parent Version (SCARED-C/P)","Tel Aviv University","All","10 Years to 18 Years   (Child, Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","2009341","May 2015","May 2018","May 2018","June 2, 2015",,"September 18, 2018","Tel-Aviv University, Tel-Aviv, Israel",,"https://ClinicalTrials.gov/show/NCT02460536"
503,"NCT01087346","Parents Thoughts About Kids and Eating",,"Completed","No Results Available","Overweight","Behavioral: Reading Information","The number of calories selected for participant's index child in a virtual buffet food selection task","National Human Genome Research Institute (NHGRI)|National Institutes of Health Clinical Center (CC)","All","18 Years to 100 Years   (Adult, Older Adult)","Not Applicable","1148","NIH","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","100076|10-HG-0076","November 19, 2010","July 12, 2019","July 12, 2019","March 16, 2010",,"June 16, 2020","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT01087346"
504,"NCT03077945","A Cognitive Behavioral Stress Intervention for Women Who Smoke",,"Completed","No Results Available","Smoking, Cigarette|Smoking Cessation|Stress|Stress, Emotional|Stress Reaction","Behavioral: heart rate variability biofeedback and cognitive reappraisal|Behavioral: control tasks","Change in cigarette craving|Change in heart rate variability|Performance on a stress task|Changes in smoking behavior at follow-up","Rutgers, The State University of New Jersey|Nepalese Psychological Association|New Jersey Psychological Association","Female","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","70","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","16-782M","December 1, 2016","May 30, 2017","May 30, 2017","March 13, 2017",,"March 14, 2018","Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey, United States",,"https://ClinicalTrials.gov/show/NCT03077945"
505,"NCT03693040","Digital Health Feedback System (DHFS) for Longitudinal Monitoring of ARVs Used in HIV Pre-exposure Prophylaxis (PrEP)",,"Recruiting","No Results Available","HIV Prevention","Device: Digital Health Feedback System","Medication Taking Adherence|The system positive detection accuracy (PDA) will be derived|Determine the percentage of participants starting or continuing HIV PrEP who find the DHFS acceptable and easy to use.","University of California, San Diego|National Institute of Mental Health (NIMH)|Gilead Sciences|Proteus Digital Health, Inc.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other|NIH|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","161618|R01MH110057","December 1, 2016","December 31, 2020","December 31, 2022","October 2, 2018",,"June 5, 2020","UCSD AntiViral Research Center, San Diego, California, United States|San Ysidro Health, San Diego, California, United States",,"https://ClinicalTrials.gov/show/NCT03693040"
506,"NCT03966859","7-day Atorvastatin and Emotional Processing",,"Recruiting","No Results Available","Healthy","Drug: Atorvastatin 20mg|Other: Lactose placebo","Accuracy and reaction times during facial expression recognition task|Accuracy and reaction times during faces dot-probe task|Accuracy and reaction times during emotional categorisation task|Accuracy during emotional recall task|Accuracy and reaction times during emotional recognition memory task|Accuracy and reaction times during reward processing|Changes in C-Reactive Protein levels","University of Oxford|Wellcome Trust","All","18 Years to 50 Years   (Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science","R61966/RE001","June 19, 2019","February 1, 2021","February 1, 2021","May 29, 2019",,"June 25, 2019","Riccardo De Giorgi, Oxford, United Kingdom","""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/59/NCT03966859/ICF_000.pdf|""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/59/NCT03966859/Prot_SAP_001.pdf","https://ClinicalTrials.gov/show/NCT03966859"
507,"NCT01625598","Computer Detection of Diabetic Retinopathy Compared to Clinical Examination","CDDR","Completed","No Results Available","Diabetic Retinopathy","Procedure: Photography of the retina|Procedure: Retinal photography","Sensitivity of detecting moderate non proliferative diabetic retinopathy or more severe DR and/or significant macular edema on a person-specific basis.|Specificity (true negatives divided by true negatives plus false positives) at detecting more than moderate non proliferative diabetic retinopathy and/or significant macular edema on a person-specific basis.|Sensitivity on an eye-specific basis [Clinical examination only]|Specificity on an eye-specific basis [Clinical examination only]","IDx LLC|University of Pennsylvania|University of Iowa|The University of Texas Health Science Center, Houston|Iowa Eye Center, Cedar Rapids IA|VitreoRetinal Surgery, PA|Retina Consultants Houston|Barnet Dulaney Perkins Eye Center","All","18 Years and older   (Adult, Older Adult)",,"600","Industry|Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","001","April 2012","April 2014","April 2014","June 21, 2012",,"April 22, 2014","Barnet Dulaney Perkins Eye Center, Mesa, Arizona, United States|Barnet Dulaney Perkins Eye Center, Phoenix, Arizona, United States|Iowa Eye Center, Cedar Rapids, Iowa, United States|University of Iowa Department of Ophthalmology and Visual Sciences, Iowa City, Iowa, United States|Retina Consultants of Houston, Houston, Texas, United States|Robert Cizik Eye Clinic - University of Texas Houston, Houston, Texas, United States|Retina Consultants of Houston, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT01625598"
508,"NCT02768922","Aphasia Telerehabilitation","AT","Completed","No Results Available","Stroke|Aphasia","Other: Aphasia telerehabilitation|Other: Standard face-to-face aphasia rehabilitation","Naming ability assessed by NGA|Language function other than naming (repetition) assessed by NGA|Language function other than naming (comprehension ) assessed by NGA|Sentence Production by VAST|Functional communication assessed by CETI|Naming immediately after intervention assessed by NGA|Repetition immediately after intervention assessed by NGA|Comprehension immediately after intervention assessed by NGA|Experiences of patients with the telerehabilitation by questionnaire|Experiences of patients with the telerehabilitation by semi-structured interviews.|Experiences of SLPs with the telerehabilitation by semi-structured interviews|Quality of life assessed by SAQOL-39.","Sunnaas Rehabilitation Hospital|South-Eastern Norway Regional Health Authority","All","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","62","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","21524505","May 3, 2016","September 27, 2018","December 31, 2018","May 11, 2016",,"April 1, 2019","Sunnaas Rehabilitation Hospital, Nesoddtangen, Norway",,"https://ClinicalTrials.gov/show/NCT02768922"
509,"NCT02942823","Kids Obesity Prevention Program Part 2","KOP-2","Unknown status","No Results Available","Obesity|Child","Other: The serious game ""KOP""","Knowledge of the parents about nutrition and psychosocial aspects by a self-developed questionnaire specific for the serious game|Knowledge of the children about nutrition and psychosocial aspects by a self-developed questionnaire specific for the serious game|Interaction of pupils and their parents for the intervention group by a self-developed questionnaire tailored for this study|Acceptance of the serious game by the parents using a self-developed questionnaire specific for the serious game|Nutrition Score (Ernährungsmusterindex) by Kleiser et al., 2007 used in the KIGGS cohort (Studie zur Gesundheit von Kindern und Jugendlichen in Deutschland)|Food frequency of specific foods which are addressed in the serious game|Physical activity using a validated questionnaire filled in by the children and also the parents|Intentions of children to stick to a healthy lifestyle by using a tailored questionnaire specific for the contents of the serious game","University Hospital Tuebingen|Science Campus Tuebingen|Department of School Psychology, University of Tuebingen","All","9 Years to 12 Years   (Child)","Not Applicable","34","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","KOP_2","October 2016","April 2017",,"October 24, 2016",,"October 24, 2016",,,"https://ClinicalTrials.gov/show/NCT02942823"
510,"NCT03685968","King Vision® and GlideScope® in Difficult Airways",,"Completed","Has Results","Airway Management","Device: Video laryngoscopes","Overall Successful Tracheal Intubation for All 3 Video Laryngoscopes - GSAVL, KVChVL and KVNChVL|First-attempt Successful Intubation for All 3 Video Laryngoscopes - GSAVL, KVChVL and KVNChVL","The University of Texas Health Science Center, Houston|King Systems Corporation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","225","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","HSC-MS-13-0024","March 6, 2013","November 17, 2015","December 17, 2015","September 26, 2018","January 4, 2019","January 8, 2019",,,"https://ClinicalTrials.gov/show/NCT03685968"
511,"NCT03979027","Acute Effects of Breakfast Compared With No Breakfast on Cognitive Function and Subjective State in 11-13 Year Old Children",,"Completed","No Results Available","Healthy","Dietary Supplement: Breakfast: ready-to-eat-cereal and milk","Change from baseline Paired Associates Learning (PAL) performance|Simple Reaction Time task performance|5-Choice Reaction Time task performance|Rapid Visual Information Processing task (RVIP) performance|Subjective unipolar visual analogue scale ratings of hunger|Subjective unipolar visual analogue scale ratings of cheerfulness|Subjective unipolar visual analogue scale ratings of energy|Subjective unipolar visual analogue scale ratings of motivation to try hard|Subjective unipolar visual analogue scale ratings of ease of distraction|Subjective unipolar visual analogue scale ratings of ease of focusing|Subjective unipolar visual analogue scale ratings of feeling of awake|Subjective unipolar visual analogue scale ratings of bad temperedness|Subjective unipolar visual analogue scale ratings of cognitive test battery difficulty|Subjective unipolar visual analogue scale ratings of concentration during the cognitive test battery|Subjective unipolar visual analogue scale ratings of performance on the cognitive test battery|Subjective unipolar visual analogue scale ratings of frustration during the cognitive test battery","University of Leeds|Kellogg Company","All","11 Years to 13 Years   (Child)","Not Applicable","234","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","RTECCOG1113","January 4, 2011","April 28, 2011","April 28, 2011","June 7, 2019",,"June 7, 2019","Human Appetite Research Unit, University of Leeds, Leeds, West Yorkshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03979027"
512,"NCT03062150","Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression","MISO","Completed","No Results Available","Major Depression","Drug: Placebo|Drug: Fludrocortisone|Drug: D-Cycloserine","Emotional dot probe|Facial recognition task|Multifaceted Empathy Test (MET)|Virtual Water Maze","Charite University, Berlin, Germany|NeuroCure Clinical Research Center, Charite, Berlin","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","232","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","OT 209/7-1|2014-005239-15","September 27, 2016","February 11, 2019","February 11, 2019","February 23, 2017",,"June 23, 2020","Charité Universitätsmedizin Berlin, Berlin, Germany",,"https://ClinicalTrials.gov/show/NCT03062150"
513,"NCT02934633","Parent Training in Child Safety Practices","BabySafety_2","Completed","No Results Available","Injury","Behavioral: Keeping Baby Safe 2-DVD package|Behavioral: The Injury Prevention Program (TIPP) sheets","Change in parent motivation to implement injury prevention strategies|Change in parent knowledge of injury prevention practices","Oregon Center for Applied Science, Inc.|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","All","13 Years to 65 Years   (Child, Adult, Older Adult)","Phase 2","414","Industry|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)","SBIR 63-2|R44HD044281","August 2006","August 2008","August 2008","October 17, 2016",,"October 17, 2016","Oregon Center for Applied Science, Eugene, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT02934633"
514,"NCT03915028","Thermal Cures in the Treatment of Multiple Sclerosis","SPA-SEP","Recruiting","No Results Available","Multiple Sclerosis","Other: Spa therapy","Benefit of spa treatment on quality of life assessed by the scale SEP-59|Benefit of a spa treatment based on average number of steps per day for one week assessed by actimeter|Benefit of a thermal cure based on treatment consumption of hospital and ambulatory care|Benefit of a thermal cure based on depression and anxiety assessed by the scale Hospital Anxiety and depression scale|Benefit of a thermal cure based on tiredness assesed by the fatigue impact scale|Benefit of a thermal cure regarding pain assessed by the scale DN 4","Association Francaise pour la Recherche Thermale","All","18 Years and older   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2018-A02411-54","May 23, 2019","May 2021","August 2021","April 16, 2019",,"July 10, 2019","Département de Médecine Physique et de Réadaptation, Hopital LAPEYRONIE, Montpellier, France",,"https://ClinicalTrials.gov/show/NCT03915028"
515,"NCT03086551","Modulating Interaction of Motor Learning Networks in Rehabilitation of Stroke",,"Completed","Has Results","Stroke|Stroke, Chronic|Stroke, Middle Cerebral Artery With Infarction","Device: Active continuous theta burst stimulation (cTBS)|Device: Placebo (Sham) continuous theta burst stimulation|Behavioral: Motor Practice","Change From Baseline in Sequential Response Time to Post-Intervention|Change From Baseline in Time to Complete the Jebsen-Taylor Hand Function Test|Change in Sequential Response Time Immediately Follow an Individual Bout of Non-invasive Brain Stimulation (e.g. Within Session)|Motor Evoked Potential Amplitude (in Microvolts) at Pre-baseline and Post-Intervention|Change From Baseline in Cortical Excitability Post-Intervention","University of Michigan","All","50 Years to 75 Years   (Adult, Older Adult)","Not Applicable","12","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","1R03NS096484-01","April 1, 2016","March 30, 2019","March 30, 2019","March 22, 2017","April 27, 2020","April 27, 2020","Human Sensorimotor Laboratory, School of Kinesiology, University of Michigan, Ann Arbor, Michigan, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/51/NCT03086551/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03086551"
516,"NCT02149186","Interactive Motor Imagery in Virtual Reality",,"Completed","No Results Available","Spinal Cord Injury|Stroke","Device: iCTuS-L","Sensorimotor Assessment","University of Zurich","All","16 Years to 80 Years   (Child, Adult, Older Adult)","Not Applicable","79","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","EK-24 2009/PB_2016-00545","October 2009","December 2019","December 2019","May 29, 2014",,"January 7, 2020","Curt, Armin, MD, Zurich, Switzerland",,"https://ClinicalTrials.gov/show/NCT02149186"
517,"NCT01955889","Mobile Health Technology to Promote Physical Activity in Persons With Parkinson Disease",,"Completed","No Results Available","Parkinson Disease","Behavioral: Mobile Health Technology|Behavioral: Stretching & Strengthening Exercises|Behavioral: Walking with Pedometer","Change from Baseline in Physical Activity Level|Change from Baseline in BriefBEST Balance Test|Change from Baseline in Six Minute Walk Test|Change from Baseline in Falls Self-Efficacy Scale International|Change from Baseline in Unified Parkinson's Disease Rating Scale|Change from Baseline in Parkinson's Disease Questionnaire-39|Change from Baseline in Self-Efficacy Exercise Scale|Change from Baseline in Functional Gait Assessment|Change from Baseline in Fatigue Severity Scale|Change from Baseline in Geriatric Depression Scale|Change from Baseline Apathy Scale|Change from Baseline in Godin Leisure-Time Exercise Questionnaire","Boston University Charles River Campus","All","18 Years to 100 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","BU-SAR-635","October 2013","July 2015","July 2015","October 8, 2013",,"July 19, 2017","Center for Neurorehabilitation, College of Health & Rehabilitation Sciences, Sargent College, Boston University, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT01955889"
518,"NCT03093376","Neurally Targeted Interventions to Reduce Early Childhood Anxiety",,"Recruiting","No Results Available","Anxiety Disorders","Behavioral: Effortful Control Camp|Behavioral: Waitlist","Change from Baseline Error Related Negativity (ERN) at Post-Intervention|Change from Baseline Fear Potentiated Startle (FPS) at Post-Intervention|Change in Anxiety Symptoms","University of Michigan|Michigan State University|One Mind Institute","All","48 Months to 83 Months   (Child)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","HUM00117593","March 30, 2017","December 2020","December 2020","March 28, 2017",,"April 13, 2020","University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT03093376"
519,"NCT03027141","Self-Face Recognition After Face Transplantation",,"Enrolling by invitation","No Results Available","Disfigurement of Face","Behavioral: Face recognition task","Average percentage of the self in the morphs that participants judge to be ""like self"" for the self- face before disfigurement,|Average percentage of the self in the morphs that participants judge to be ""like self"" for the self- face before before surgery|Average percentage of the self in the morphs that participants judge to be ""like self"" for the self- face after surgery.","NYU Langone Health","All","Child, Adult, Older Adult","Not Applicable","5","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","16-01144","February 1, 2017","August 1, 2020","August 2020","January 20, 2017",,"November 8, 2019","New York University School of Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03027141"
520,"NCT03068091","Assessment of Lung Movement With Computed Tomography (CT)",,"Completed","Has Results","Interstitial Lung Disease","Device: Chest CT|Diagnostic Test: Pulmonary Function Testing","Lung Motion as Assessed by CT|Lung Motion: Lobar Strain Which is a Ratio","University of Missouri-Columbia|Henry M. Jackson Foundation for the Advancement of Military Medicine","All","18 Years and older   (Adult, Older Adult)","Not Applicable","25","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2006114","July 1, 2017","September 30, 2018","October 31, 2018","March 1, 2017","April 8, 2020","May 1, 2020","University of Missouri-Columbia, Columbia, Missouri, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/91/NCT03068091/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03068091"
521,"NCT03592368","Hostile Interpretation Bias Training to Treat Irritability",,"Suspended","No Results Available","Irritable Mood|Mood Disorders","Device: IBT","Change in Interpretation Bias|Neural response in threat learning system.|Learning Rate|Irritability","University of Colorado, Denver","All","13 Years to 17 Years   (Child)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","17-0464","October 15, 2018","February 2021","August 2021","July 19, 2018",,"April 6, 2020","University of Colorado, School of Medicine, Aurora, Colorado, United States","""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/68/NCT03592368/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT03592368"
522,"NCT02012881","LCoMotion. Learning, Cognition and Motion. Effect of a Four Month School-based Cluster-randomized Intervention","LCoMotion","Completed","No Results Available","Cognitive Function","Behavioral: Physical activity intervention|Behavioral: Usual practice","Executive function accuracy|Academic achievement|Physical activity|Aerobic fitness|Anthropometric measures|Questionnaire","University of Southern Denmark|The Danish Ministry of Education","All","12 Years to 16 Years   (Child)","Not Applicable","870","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","S-20130104","October 2013","June 2014","June 2014","December 16, 2013",,"June 26, 2014","Institute of Sports Science and Clinical Biomechanics, Odense, Denmark",,"https://ClinicalTrials.gov/show/NCT02012881"
523,"NCT00674570","Veteran Stress and Learning Study","VSL","Completed","Has Results","Stress Disorders, Posttraumatic","Drug: Hydrocortisone|Drug: D-Cycloserine|Drug: Placebo","Proportion of Maximum Skin Conductance Response (SCR) in Microsiemens (µS)","VA Office of Research and Development","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 4","111","U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","CDA-2-037-07F|H841-31915-01A","January 13, 2009","June 22, 2015","June 22, 2015","May 8, 2008","May 30, 2019","May 30, 2019","San Francisco VA Medical Center, San Francisco, CA, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT00674570"
524,"NCT01990521","Prostate Screening Study Using MRI in BRCA Carriers",,"Recruiting","No Results Available","Prostate Cancer","Procedure: MS3TMRI / TRUS Guided Biopsy|Device: MS3TMRI / TRUS Guided Biopsy","Prostate MRI in BRCA carriers|Prostate cancer in BRCA carriers","Toronto Sunnybrook Regional Cancer Centre|Sunnybrook Health Sciences Centre|Women's College Hospital","Male","50 Years and older   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","500-2013","January 2014","December 2020","January 2021","November 21, 2013",,"September 10, 2019","Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT01990521"
525,"NCT03122587","Non-Invasive Brain Stimulation and Substance Use",,"Completed","Has Results","Substance Use Disorders","Device: Transcranial Alternating Current Stimulation at 10 Hz|Device: Transcranial Alternating Current Stimulation at 40 Hz|Device: Active sham transcranial alternating current stimulation","Change in Distress Tolerance (Mean Latency to Quit the PASAT-C)|Change in Inhibitory Control (Mean D-prime on the Go/No-Go)","University of North Carolina, Chapel Hill","All","18 Years to 55 Years   (Adult)","Not Applicable","38","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","16-2342","May 15, 2017","February 1, 2019","February 1, 2019","April 21, 2017","February 13, 2020","March 6, 2020","Southlight Healthcare, Raleigh, North Carolina, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/87/NCT03122587/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03122587"
526,"NCT04261452","Heart Failure Worsens Muscle Strength in COPD",,"Completed","No Results Available","COPD|CHF|Muscle Weakness","Diagnostic Test: isokinetic dynamometer|Diagnostic Test: Cardiopulmonary Exercise Test|Diagnostic Test: Functional Capacity Tests|Diagnostic Test: Lung Function Test|Diagnostic Test: Doppler Echocardiography|Diagnostic Test: Anthropometry and Body Composition","Muscle weakness|Cardiopulmonary function|Clinical tests|Lung Function|Cardiac Function|Body composition","Mayron Faria de Oliveira|Coordination for the Improvement of Higher Education Personnel|Federal University of São Paulo","All","30 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","1275295","August 1, 2014","December 1, 2017","December 1, 2018","February 7, 2020",,"February 7, 2020",,,"https://ClinicalTrials.gov/show/NCT04261452"
527,"NCT00003417","Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme",,"Completed","No Results Available","Brain and Central Nervous System Tumors","Drug: carmustine|Radiation: radiation therapy",,"Radiation Therapy Oncology Group|National Cancer Institute (NCI)","All","18 Years and older   (Adult, Older Adult)","Phase 1|Phase 2","40","Other|NIH","Interventional","Primary Purpose: Treatment","RTOG-9803|CDR0000066432","September 1998","May 2004",,"January 27, 2003",,"November 17, 2015","University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States|Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States|Huntsville Hospital System, Huntsville, Alabama, United States|MBCCOP - Gulf Coast, Mobile, Alabama, United States|Alabama Oncology, LLC, Montgomery, Alabama, United States|DCH Cancer Treatment Center, Tuscaloosa, Alabama, United States|Foundation for Cancer Research and Education, Phoenix, Arizona, United States|Mount Diablo Medical Center, Concord, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Saint Agnes Cancer Center, Fresno, California, United States|California Cancer Center, Fresno, California, United States|Sutter Health Western Division Cancer Research Group, Greenbrae, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Veterans Affairs Medical Center - Long Beach, Long Beach, California, United States|Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States|USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States|CCOP - Bay Area Tumor Institute, Oakland, California, United States|Huntington Cancer Center, Pasadena, California, United States|Robert and Beverly Lewis Family Cancer Care Center, Pomona, California, United States|Radiation Oncology Center - Sacramento, Sacramento, California, United States|Radiation Medical Group, Incorporated, San Diego, California, United States|UCSF Comprehensive Cancer Center, San Francisco, California, United States|O'Connor Hospital, San Jose, California, United States|CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, United States|David Grant Medical Center, Travis Air Force Base, California, United States|Memorial Hospital Cancer Center, Colorado Springs, Colorado, United States|University of Colorado Cancer Center, Denver, Colorado, United States|CCOP - Colorado Cancer Research Program, Incorporated, Denver, Colorado, United States|Saint Mary's Hospital and Medical Center, Grand Junction, Colorado, United States|CCOP - Christiana Care Health Services, Newark, Delaware, United States|University of Florida Health Science Center, Gainesville, Florida, United States|Florida Radiation Oncology Group, Jacksonville, Florida, United States|Holmes Regional Medical Center, Melbourne, Florida, United States|CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States|Veterans Affairs Medical Center - Miami, Miami, Florida, United States|Sylvester Cancer Center, University of Miami, Miami, Florida, United States|Baptist Hospital of Miami, Miami, Florida, United States|MD Anderson Cancer Center Orlando, Orlando, Florida, United States|Bay Medical Center, Panama City, Florida, United States|Gulf Coast Cancer Treatment Center, Panama City, Florida, United States|Sarasota Radiation and Medical Oncology Center, Sarasota, Florida, United States|Tallahassee Memorial Healthcare, Tallahassee, Florida, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States|Emory University Hospital - Atlanta, Atlanta, Georgia, United States|CCOP - Atlanta Regional, Atlanta, Georgia, United States|Medical Center/John B. Amos Community Cancer Center, Columbus, Georgia, United States|Regional Radiation Oncology Center at Rome, Rome, Georgia, United States|MBCCOP - Hawaii, Honolulu, Hawaii, United States|Northwest Community Hospital, Arlington Heights, Illinois, United States|Northwestern Memorial Hospital, Chicago, Illinois, United States|CCOP - Central Illinois, Decatur, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Lutheran General Cancer Care Center, Park Ridge, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|St. John's Medical Center, Anderson, Indiana, United States|Bloomington Hospital, Bloomington, Indiana, United States|Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana, United States|Clarian Health Partners Inc., Indianapolis, Indiana, United States|Community Regional Cancer Care, Indianapolis, Indiana, United States|Ball Memorial Hospital, Muncie, Indiana, United States|CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States|Wendt Regional Cancer Center of Finley Hospital, Dubuque, Iowa, United States|Central Baptist Hospital, Lexington, Kentucky, United States|Cancer Center at Lexington Clinic, Lexington, Kentucky, United States|Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, United States|James Graham Brown Cancer Center, Louisville, Kentucky, United States|Louisville Radiation Oncology, Louisville, Kentucky, United States|Merle M. Mahr Cancer Center, Madisonville, Kentucky, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Tulane University School of Medicine, New Orleans, Louisiana, United States|MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, United States|CCOP - Ochsner, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Anne Arundel Oncology Center, Annapolis, Maryland, United States|Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States|Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland, United States|Harbor Hospital Center, Baltimore, Maryland, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Peninsula Regional Medical Center, Salisbury, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Cape Cod Hospital, Hyannis, Massachusetts, United States|Veterans Affairs Medical Center - Boston (Jamaica Plain), Jamaica Plain, Massachusetts, United States|CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|McLaren Regional Cancer Center, Flint, Michigan, United States|CCOP - Kalamazoo, Kalamazoo, Michigan, United States|Marquette General Hospital, Marquette, Michigan, United States|MidMichigan Medical Center - Midland, Midland, Michigan, United States|CCOP - Beaumont, Royal Oak, Michigan, United States|William Beaumont Hospital, Royal Oak, Michigan, United States|William Beaumont Hospital - Troy, Troy, Michigan, United States|Mayo Clinic Cancer Center, Rochester, Minnesota, United States|CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States|Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States|CCOP - Kansas City, Kansas City, Missouri, United States|Mallinckrodt Institute of Radiology, Saint Louis, Missouri, United States|St. Louis University Health Sciences Center, Saint Louis, Missouri, United States|Cancer Research for the Ozarks, Springfield, Missouri, United States|CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States|CCOP - Montana Cancer Consortium, Billings, Montana, United States|CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States|Methodist Hospital Cancer Center - Omaha, Omaha, Nebraska, United States|Nebraska Health System, Omaha, Nebraska, United States|CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, United States|Norris Cotton Cancer Center, Lebanon, New Hampshire, United States|Elliot Regional Cancer Center, Manchester, New Hampshire, United States|Veterans Affairs Medical Center - East Orange, East Orange, New Jersey, United States|John F. Kennedy Medical Center, Edison, New Jersey, United States|Trinitas Hospital - Jersey Street Campus, Elizabeth, New Jersey, United States|Monmouth Medical Center, Long Branch, New Jersey, United States|South Jersey Regional Cancer Center, Millville, New Jersey, United States|Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital, Mount Holly, New Jersey, United States|Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|Atlantic City Medical Center, Pomona, New Jersey, United States|Valley Hospital, Ridgewood, New Jersey, United States|Community Medical Center, Toms River, New Jersey, United States|St. Francis Medical Center, Trenton, New Jersey, United States|Associated Radiologists, P.A., Warren, New Jersey, United States|Radiation Oncology Associates of Albuquerque, Albuquerque, New Mexico, United States|Cancer Center of Albany Medical Center, Albany, New York, United States|State University of New York Health Science Center at Brooklyn, Brooklyn, New York, United States|New York Methodist Hospital, Brooklyn, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Finger Lakes Radiation Oncology Center, Clifton Springs, New York, United States|CCOP - North Shore University Hospital, Manhasset, New York, United States|Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Champlain Valley Physicians Hospital Medical Center, Plattsburgh, New York, United States|Vassar Brothers Medical Center, Poughkeepsie, New York, United States|James P. Wilmot Cancer Center, Rochester, New York, United States|CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York, United States|Riverhill Radiation Oncology, Yonkers, New York, United States|Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States|Northeast Medical Center, Concord, North Carolina, United States|East Carolina University School of Medicine, Greenville, North Carolina, United States|CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina, United States|Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States|Trinity Cancer Care Center, Minot, North Dakota, United States|Akron General Medical Center, Akron, Ohio, United States|Akron City Hospital, Akron, Ohio, United States|Christ Hospital, Cincinnati, Ohio, United States|Barrett Cancer Center, Cincinnati, Ohio, United States|Ireland Cancer Center, Cleveland, Ohio, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|CCOP - Columbus, Columbus, Ohio, United States|Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States|CCOP - Dayton, Dayton, Ohio, United States|CCOP - Toledo Community Hospital, Toledo, Ohio, United States|St. Anthony Hospital, Oklahoma City, Oklahoma, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|St. John Health System, Tulsa, Oklahoma, United States|CCOP - Oklahoma, Tulsa, Oklahoma, United States|CCOP - Columbia River Oncology Program, Portland, Oregon, United States|Lehigh Valley Hospital, Allentown, Pennsylvania, United States|St. Luke's Hospital Cancer Center, Bethlehem, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Mercy Fitzgerald Hospital, Darby, Pennsylvania, United States|Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States|Pocono Cancer Center, East Stroudsburg, Pennsylvania, United States|Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Veterans Affairs Medical Center - Philadelphia, Philadelphia, Pennsylvania, United States|Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States|Mercy Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States|Reading Hospital and Medical Center, Reading, Pennsylvania, United States|Mercy Hospital Cancer Center - Scranton, Scranton, Pennsylvania, United States|Wilkes Barre General Hospital, Wilkes-Barre, Pennsylvania, United States|York Cancer Center, York, Pennsylvania, United States|Roger Williams Medical Center/BUSM, Providence, Rhode Island, United States|CCOP - Greenville, Greenville, South Carolina, United States|CCOP - Upstate Carolina, Spartanburg, South Carolina, United States|Rapid City Regional Hospital, Rapid City, South Dakota, United States|Jackson-Madison County General Hospital, Jackson, Tennessee, United States|University of Tennessee Cancer Institute, Memphis, Tennessee, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States|Harrington Cancer Center, Amarillo, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|University of Texas - MD Anderson Cancer Center, Houston, Texas, United States|Wilford Hall Medical Center, Lackland Air Force Base, Texas, United States|Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, United States|Bayshore Medical Center, Pasadena, Texas, United States|Dixie Regional Medical Center, Saint George, Utah, United States|University of Utah Health Sciences Center, Salt Lake City, Utah, United States|Latter Day Saints Hospital, Salt Lake City, Utah, United States|Green Mountain Oncology Group, Burlington, Vermont, United States|Vermont Cancer Center, Burlington, Vermont, United States|Cancer Center at the University of Virginia, Charlottesville, Virginia, United States|RMH Regional Cancer Center, Harrisonburg, Virginia, United States|Naval Medical Center, Portsmouth, Portsmouth, Virginia, United States|Bon Secours - St. Mary's Hospital, Richmond, Virginia, United States|Massey Cancer Center, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Deaconess Medical Center, Spokane, Washington, United States|Yakima Valley Memorial Hospital, Yakima, Washington, United States|Schiffler Cancer Center, Wheeling, West Virginia, United States|CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay, Wisconsin, United States|St. Vincent Hospital, Green Bay, Wisconsin, United States|Gundersen Lutheran Medical Foundation, La Crosse, Wisconsin, United States|Southern Wisconsin Radiotherapy Center, Madison, Wisconsin, United States|University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States|Marshfield Clinic, Marshfield, Wisconsin, United States|Community Memorial Hospital, Menomonee Falls, Wisconsin, United States|Columbia Hospital, Milwaukee, Wisconsin, United States|St. Luke's Medical Center, Milwaukee, Wisconsin, United States|Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States|Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee, Wisconsin, United States|All Saints Cancer Center, Racine, Wisconsin, United States|Waukesha Memorial Hospital Regional Cancer Center, Waukesha, Wisconsin, United States|Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada|Cross Cancer Institute, Edmonton, Alberta, Canada|Saint John Regional Hospital, Saint John, New Brunswick, Canada|Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador, Canada|Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada|Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada|Kingston Regional Cancer Centre, Kingston, Ontario, Canada|Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada|Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada|Northeastern Ontario Regional Cancer Centre, Sudbury, Sudbury, Ontario, Canada|Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay, Ontario, Canada|Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada|Princess Margaret Hospital, Toronto, Ontario, Canada|CHUS-Hopital Fleurimont, Fleurimont, Quebec, Canada|Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada|McGill University, Montreal, Quebec, Canada|Centre Hospitalier Universitaire de Quebec, Quebec City, Quebec, Canada|Allan Blair Cancer Centre, Regina, Saskatchewan, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada",,"https://ClinicalTrials.gov/show/NCT00003417"
528,"NCT03265015","Theta Burst Stimulation for Compulsive Behavior Non-invasive Brain Stimulation Study",,"Completed","No Results Available","Compulsive Behavior|Obsessive-Compulsive Disorder","Behavioral: Habit Override Practice|Other: Transcranial Magnetic Stimulation","functional Magnetic Resonance Imaging (fMRI)|Effort to resist compulsive behaviors in response to laboratory triggers|Duration of compulsive behaviors in response to laboratory triggers|Intensity of urges to perform compulsive behaviors in response to laboratory triggers|Goal-directed cognition|Yale-Brown Obsessive Compulsive Scale (Y-BOCS)|WHO Disability Assessment Scale 2.0|Obsessive Compulsive Inventory-Revised (OCI-R)","University of Pittsburgh","All","18 Years to 55 Years   (Adult)","Not Applicable","78","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","R21MH112770","September 15, 2017","March 30, 2020","March 30, 2020","August 29, 2017",,"April 24, 2020","Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03265015"
529,"NCT01767480","Effects of Intensive Robot-assisted Therapy in Patients With Subacute Stroke","RT","Completed","No Results Available","Stroke","Device: RT|Behavioral: Conventional rehabilitation (CR)","Fugl-Meyer Assessment (FMA)|Motor Status Scale (MSS)|Modified Ashworth Scale (MAS)|MyotonPRO|Muscle metabolism (NIRS)|Box and Block Test (BBT)|Revised Nottingham Sensory Assessment (RNSA)|Functional Independence Measure (FIM)|Motor Activity Log (MAL)|ABILHAND Questionnaire|Adelaide Activities Profile (AAP)|EQ-5D-5L|Accelerometers|Functional magnetic resonance imaging (fMRI)|Kinematic analysis|Inflammatory markers|Oxidative stress markers|Erythrocyte deformability|Blood glucose indicators","Chang Gung Memorial Hospital","All","20 Years to 75 Years   (Adult, Older Adult)","Not Applicable","32","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","101-3905A3","January 2013","February 2015","May 2015","January 14, 2013",,"July 21, 2015","Chang Gung Memorial Hospital, Kwei-Shan, Tao-Yuan, Taiwan",,"https://ClinicalTrials.gov/show/NCT01767480"
530,"NCT03538535","Set Your Goal: Engaging Go/No-Go Active Learning",,"Unknown status","No Results Available","Depression|Anxiety","Behavioral: Go/No-Go Active Learning (GOAL)","Integrated Bayesian Information Criterion (BIC) score based on models using modified Q-learning models with two pairs of action values (go and no-go) for each state.","Northwestern University","All","21 Years to 40 Years   (Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","STU00206862","May 1, 2018","March 1, 2019","March 1, 2019","May 29, 2018",,"May 29, 2018","Northwestern University, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT03538535"
531,"NCT01503086","Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy",,"Recruiting","No Results Available","Brain Neoplasm|Recurrent Brain Neoplasm","Procedure: Cognitive Assessment|Other: Computer-Assisted Cognitive Training|Procedure: Psychosocial Assessment and Care|Other: Quality-of-Life Assessment|Other: Questionnaire Administration","Proportion of patients with intervention compliance","Children's Oncology Group|National Cancer Institute (NCI)","All","6 Years to 16 Years   (Child)","Not Applicable","71","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care","ACCL10P1|NCI-2012-00112|COG-ACCL10P1|CDR0000721387|U10CA095861|UG1CA189955","November 18, 2013","March 30, 2027",,"January 2, 2012",,"June 11, 2020","Children's Hospital Colorado, Aurora, Colorado, United States|Alfred I duPont Hospital for Children, Wilmington, Delaware, United States|Children's National Medical Center, Washington, District of Columbia, United States|Nemours Children's Clinic-Jacksonville, Jacksonville, Florida, United States|Nemours Children's Hospital, Orlando, Florida, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States|Blank Children's Hospital, Des Moines, Iowa, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, United States|Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Duke University Medical Center, Durham, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Hospital for Sick Children, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT01503086"
532,"NCT01612091","The Monitoring Messenger: Mobile Patient Monitoring for the Pediatric Intensive Care Unit",,"Withdrawn","No Results Available","Medical Device|User-Computer Interface|Critical Care|Physiologic Monitoring","Device: Monitoring Messenger|Device: Traditional tools","Accuracy of priority assignment in triaging task|Requirements for design of the mobile device","University of British Columbia","All","18 Years and older   (Adult, Older Adult)","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","H12-01270","November 2013","January 2017","January 2017","June 5, 2012",,"October 26, 2017","BC Children's Hospital, Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT01612091"
533,"NCT02355912","Adaptive Recalibration of Prosthetic Leg Neural Control System",,"Recruiting","No Results Available","Amputation","Device: Powered knee and ankle prosthesis","Decreased error rates for pattern recognition system used to predict ambulation modes","Shirley Ryan AbilityLab","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","35","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","STU00101767","January 2015","January 2020","January 2021","February 4, 2015",,"May 20, 2019","Rehabilitation Institute of Chicago, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT02355912"
534,"NCT01507623","Value of Capnography During Nurse Administered Propofol Sedation (NAPS)",,"Completed","No Results Available","Hypoxia","Device: Capnography (Phillips MP20 monitor)","The number of hypoxic events|Actions taken against respiratory insufficiency|The duration of hypoxia|The level of hypoxia","University Hospital, Gentofte, Copenhagen|The Ministry of Science, Technology and Innovation, Denmark","All","Child, Adult, Older Adult","Not Applicable","591","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","NAPS_CAPNOGRAPHY1","September 2010","February 2011","March 2011","January 11, 2012",,"January 11, 2012","Gentofte University Hospital, Hellerup, Denmark",,"https://ClinicalTrials.gov/show/NCT01507623"
535,"NCT02358226","HIV & Drug Abuse Prevention for South African Men",,"Completed","No Results Available","Substance-Related Disorders|Human Immunodeficiency Virus|Alcoholism","Behavioral: Soccer League (SL)|Behavioral: Soccer League/Vocational Training (SL-V)","The primary outcome is the number of outcomes out of 15 outcomes significantly favoring the intervention over the control (Harwood, Weiss & Comulada, 2017)|If a significant number of the 15 outcomes have intervention groups better than control at the end of the study, we will analyze and report on each outcome separately.|Among HIV+, uptake and adherence to ARV medications and medical regimens","University of California, Los Angeles|National Institute on Drug Abuse (NIDA)","Male","18 Years to 29 Years   (Adult)","Phase 3","1211","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","R01DA038675|1R01DA038675-01A1","May 2016","January 2020","January 2020","February 6, 2015",,"February 17, 2020","Stellenbosch University, Stellenbosch, South Africa",,"https://ClinicalTrials.gov/show/NCT02358226"
536,"NCT04169230","Citalopram and Self Emotional Processing",,"Recruiting","No Results Available","Molecular Mechanisms of Pharmacological Action|Depression|Depressive Disorder|Mental Disorder|Antidepressive Agents|Cognition","Drug: Citalopram|Drug: Placebo oral tablet","Social Evaluation Learning Task: Bias Scores|Associative Learning Task: Reaction Times (ms)|Associative Learning Task: Accuracy (% correct)|Self-Esteem Go/No-Go Association Task: d'|Prisoner's Dilemma: Cooperative Behaviours (%)|Prisoner's Dilemma: Reaction Times (ms)|Emotional Categorisation and Recall: Number of words categorised|Emotional Categorisation and Recall: Hits|Emotional Categorisation and Recall: False Alarms","University of Oxford|University of Bath","All","18 Years to 45 Years   (Adult)","Not Applicable","44","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","Acute_Citalopram","October 11, 2019","September 2020","September 2020","November 19, 2019",,"November 19, 2019","University of Oxford, Oxford, United Kingdom","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/30/NCT04169230/Prot_SAP_000.pdf|""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/30/NCT04169230/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT04169230"
537,"NCT02997306","COEBICS: Comparison of Erythema Between Interrupted and Continuous Sutures","COEBICS","Unknown status","No Results Available","Surgical Scar Erythema","Procedure: Superior/Medial Running Sutures|Procedure: Inferior/Lateral Running Sutures","Change in the Intensity of Scar Erythema","University of British Columbia","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","H16-01802","January 2017","October 2017","December 2017","December 20, 2016",,"December 20, 2016","Dermatologic Surgery Centre at the Vancouver General Hospital Skin Care Centre, Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT02997306"
538,"NCT03051178","Wearable Sensor for Responsive DBS for ET",,"Recruiting","No Results Available","Essential Tremor","Device: Responsive deep brain stimulation","Clinical Rating Scale for Tremor (CRST)","University of Florida|Medtronic|De Luca Foundation|National Institute of Neurological Disorders and Stroke (NINDS)","All","21 Years to 90 Years   (Adult, Older Adult)","Not Applicable","25","Other|Industry|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRB201602458 -A|OCR17477","September 18, 2018","December 1, 2020","December 1, 2020","February 13, 2017",,"April 15, 2020","UF Health, Gainesville, Florida, United States|Biomedical Sciences Building, Gainesville, Florida, United States",,"https://ClinicalTrials.gov/show/NCT03051178"
539,"NCT04029740","Exosomal microRNAs as a Biomarker in Panic Disorder and in Response to CBT",,"Recruiting","No Results Available","Panic Disorder","Behavioral: CBT- both internet and face to face|Other: No intervention","Differntial expression of plasma exosomal microRNAs|Change in Panic Disorder Severity Scale (PDSS)|Change in Anxiety Sensitivity Index-3 (ASI-3)|Change in Mobility Inventory|Differntial expression of whole Blood short non-coding RNAs|Change in the Five-Dimensional Curiosity Scale (DCS-5)|Changes in Experiences in Close Relationship Scale-Short (ECR-s)|Changes in Sexual Functioning Questionnaire","Hebrew University of Jerusalem|Hadassah Medical Organization","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","80","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","0577-18-HMO","March 24, 2019","March 24, 2021","March 24, 2021","July 23, 2019",,"December 30, 2019","Hebrew University of Jerusalem, Jerusalem, Israel",,"https://ClinicalTrials.gov/show/NCT04029740"
540,"NCT01723410","Neural and Physiological Responses to Real-World Experiences",,"Completed","No Results Available","Gene Expression","Behavioral: Writing about people|Other: Writing about places, objects","inflammatory gene expression|neural activity","University of California, Los Angeles","All","35 Years to 50 Years   (Adult)","Not Applicable","70","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","GGSC-GRAT","January 2013","January 2015","January 2015","November 7, 2012",,"December 11, 2015","UCLA CTRC & Brain Mapping Center, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT01723410"
541,"NCT02151396","Effect of Working Memory Training on ADHD Brain Function",,"Completed","No Results Available","Attention-Deficit/Hyperactivity Disorder (Combined-subtype)","Behavioral: Working memory training|Device: Functional magnetic resonance imaging (fMRI)","Functional magnetic resonance imaging (fMRI)|Working memory neuropsychological test performance|ADHD clinical dysfunction","Hartford Hospital|National Institutes of Health (NIH)","All","13 Years to 17 Years   (Child)","Phase 3","37","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","R21HD061915","July 2009","February 2013","February 2013","May 30, 2014",,"May 30, 2014","Olin Neurospychiatry Research Center, Hartford, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT02151396"
542,"NCT02517541","A Clinical Investigation Evaluating and Understanding Parameters Affecting the Performance of Ostomy Products",,"Completed","Has Results","Ileostomy - Stoma|Colostomy","Device: SenSura Mio Convex Soft","Leakage Under the Baseplate (cm^2)","Coloplast A/S","All","18 Years and older   (Adult, Older Adult)","Not Applicable","74","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","CP259","September 2015","March 2016","March 2016","August 7, 2015","September 6, 2018","February 5, 2020","University of Chicago Medicine, Chicago, Illinois, United States|Prism research center, Saint Paul, Minnesota, United States|QPS Netherlands, Groningen, Netherlands|Helse Nordbyen, Larvik, Norway|Synexus Midlands, Birmingham, United Kingdom|Pilgrim Hospital, Boston, United Kingdom|Cheltenham General Hospital, Cheltenham, United Kingdom|Kettering General hospital, Kettering, United Kingdom|Lincon Country hospital, Lincoln, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02517541"
543,"NCT03176004","Attention Training to Modify Error-related Negativity and Risk for Anxiety in Adolescence",,"Enrolling by invitation","No Results Available","Anxiety","Other: Attention Bias Modification","Change in Anxiety Symptoms","Florida State University|San Diego State University","All","11 Years to 14 Years   (Child)","Not Applicable","600","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","MH106477","October 2016","January 1, 2020","June 1, 2021","June 5, 2017",,"February 12, 2020","San Diego State University, San Diego, California, United States|Florida State University, Tallahassee, Florida, United States",,"https://ClinicalTrials.gov/show/NCT03176004"
544,"NCT01760473","Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone",,"Completed","Has Results","Heroin Dependence","Drug: Intranasal challenge drug","Drug Self-administration|SOWS","New York State Psychiatric Institute|Indivior Inc.","All","21 Years to 45 Years   (Adult)","Phase 3","27","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","#5879","May 2009","December 2014","December 2014","January 4, 2013","September 8, 2017","September 8, 2017","New York State Psychiatric Institute and Columbia University, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT01760473"
545,"NCT04138446","Effects of Acute Hypobaric Hypoxia Exposure on Neurocognitive Performance of Pre-hospital Emergency Service Providers",,"Completed","No Results Available","Hypobaric Hypoxia|Cognitive Deterioration|Emergency Medicine|Resuscitation|Stress Physiology","Other: Altitude exposure in climate chamber","Digit-Symbol Substitution Task - DSST|Balloon Analog Risk Test - BART|Psychomotor Vigilance Test - PVT|Proportion of correct chest compressions regarding depth, pressure point and pressure release|Reactive oxygen species - ROS|Total antioxidant capacity - TAC","Institute of Mountain Emergency Medicine|Medical University Innsbruck|University of Graz|University of Trento|Azienda Sanitaria dell'Alto Adige|Istituto di Fisiologia Clinica CNR","All","18 Years to 60 Years   (Adult)","Not Applicable","48","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","3489044136","October 25, 2019","November 11, 2019","November 11, 2019","October 24, 2019",,"March 24, 2020","Eurac Research, Institute of Mountain Emergency Medicine, Bolzano, BZ, Italy",,"https://ClinicalTrials.gov/show/NCT04138446"
546,"NCT03030547","Identification of Factors Associated With Physical Activity Levels in Adult Muscle Diseases",,"Unknown status","No Results Available","Muscle Disease","Device: SenseWear activity monitor","Energy expenditure on SenseWear Activity Monitor|Number of steps on SenseWear Activity Monitor|International Physical Activity Scale (IPAQ)|Visual Analog Scale|Fatigue Severity Scale|ACTIVLIM questionaire|Medical Outcomes Short-Form Health Survey|Hand Held Dynamometry|Six Minutes Walk Test|Timed Up and Go Test","Hacettepe University","All","20 Years to 40 Years   (Adult)","Not Applicable","80","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","GO 14/617","March 2016","October 2017","October 2017","January 25, 2017",,"October 17, 2017","Hacettepe University, Faculty of Health Sciences, Ankara, Turkey",,"https://ClinicalTrials.gov/show/NCT03030547"
547,"NCT03771612","Inflammation and Daily Life Study",,"Not yet recruiting","No Results Available","Inflammation","Drug: Naproxen|Drug: Placebos","Self-reported health|Sleep|Depression|Picture viewing task|Monetary reward task","University of California, Los Angeles","All","45 Years to 60 Years   (Adult)","Early Phase 1","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","IDL","March 2020","December 2020","January 2021","December 11, 2018",,"February 6, 2020","UCLA Department of Psychology, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT03771612"
548,"NCT02734602","Imaging SV2A in Mood Disorders",,"Recruiting","No Results Available","Major Depressive Disorder|Post-Traumatic Stress Disorder","Drug: Ketamine|Behavioral: Cognitive Testing|Radiation: PET|Device: MRI","Evidence of synaptic changes in psychiatric disorders confirmed by PET data.|Evidence of synaptic density at time of its greatest anti-depressant response in psychiatric disorders confirmed with PET data.","Yale University|VA Office of Research and Development","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","30","Other|U.S. Fed","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","1511016789","April 2016","January 2021","March 2021","April 12, 2016",,"February 10, 2020","PET Center, New Haven, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT02734602"
549,"NCT03307551","Evaluation of Automated Propofol Delivery in Patients Undergoing Thoracic Surgery",,"Completed","No Results Available","Thoracic Diseases|Surgery","Drug: Propofol","Anaesthesia depth consistency using BIS scores|Performance Characteristic of propofol anaesthesia delivery system|Change in Intra-operative heart Rate (beats per minute)|Change in Intra-operative systolic , diastolic, and mean (mmHg)|Recovery from anesthesia|Intra-operative awareness|Propofol induction dose (mg)|Propofol maintenance dose (mg/kg/hr)","Dr Nitin Sethi|Sir Ganga Ram Hospital","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 4","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","EC/09/17/1254","October 31, 2017","June 25, 2019","June 25, 2019","October 11, 2017",,"July 2, 2019","Sir Ganga Ram Hospital, New Delhi, Delhi, India",,"https://ClinicalTrials.gov/show/NCT03307551"
550,"NCT02065895","Effect of Gain on Closed-Loop Insulin",,"Completed","Has Results","Type 1 Diabetes","Device: HIGH error|Device: NO error|Device: LOW error","Glucose Area Under the Curve (AUC) Breakfast|Peak and Nadir Postprandial Glucose Concentration","Joslin Diabetes Center|Juvenile Diabetes Research Foundation","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","8","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2012P-000401","December 2013","April 2015","April 2015","February 19, 2014","April 6, 2018","May 17, 2018","Joslin Diabetes Center, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02065895"
551,"NCT02941289","Visuospatial Attention, Eye Movements and Instrumental Activities of Daily Living (IADLs) in Alzheimer's Disease","ARVA-MA","Unknown status","No Results Available","Alzheimer's Disease","Procedure: visual search performance of everyday objects in realistic scenes","Total number of fixations during search|Total duration of fixations during search","Centre Hospitalier Universitaire de Nice","All","65 Years to 75 Years   (Older Adult)","Not Applicable","64","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","16-AOI-06","November 2016","May 2017","May 2019","October 21, 2016",,"August 23, 2017","CHU de Nice, Nice, France",,"https://ClinicalTrials.gov/show/NCT02941289"
552,"NCT03374605","Modulating Context Generalization Through Transcranial Direct Current Stimulation",,"Withdrawn","No Results Available","Anxiety and Fear","Device: active tDCS|Device: sham tDCS","Relative frequency of selection of task-specific stimuli","Butler Hospital","All","18 Years to 55 Years   (Adult)","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","1705-002","February 2018","December 2019","December 2019","December 15, 2017",,"August 7, 2018","Butler Hospital, Providence, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT03374605"
553,"NCT03379792","The Influence of Glycemic Control and Obesity on Energy Balance and Metabolic Flexibility in Type 1 Diabetes","ACME","Recruiting","No Results Available","Diabetes","Other: DEXA|Other: MRI|Other: CGM|Other: Whole room calorimeters|Other: Dietary counseling","Oxidation of energy expenditure","Translational Research Institute for Metabolism and Diabetes, Florida","All","19 Years to 39 Years   (Adult)","Not Applicable","33","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","TRIMDFH 1144866","March 8, 2018","December 2020","December 2020","December 20, 2017",,"March 10, 2020","Translational Research Institute for Metabolism and Diabetes, Orlando, Florida, United States","""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/92/NCT03379792/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT03379792"
554,"NCT03060291","Prevention of Substance Use in At-Risk Students: A Family-Centered Web Program",,"Active, not recruiting","No Results Available","Substance Use|Conduct Disorders in Adolescence|Depression|Anxiety","Behavioral: FCU-Online, web/ mobile only|Behavioral: FCU-Online, web/ mobile + coach","Change from Baseline in Youth Behavioral Control across 12 months (parent report)|Change from Baseline in Youth Behavioral Control across 12 months (youth report)|Change from Baseline in Youth Substance Use across 12 months (parent report)|Change from Baseline in Youth Substance Use across 12 months (youth report)|Change from Baseline in Youth Problem Behavior across 12 months (parent report)|Change from Baseline in Youth Problem Behavior across 12 months (youth report)|Change from Baseline in Family Conflict across 12 months (parent report)|Change from Baseline in Family Conflict across 12 months (youth report)|Change from Baseline in Positive Family Relationships across 12 months (parent report)|Change from Baseline in Positive Family Relationships across 12 months (youth report)|Change From Baseline in Positive Behavior Support across 12 months (parent report)|Change from Baseline in Limit Setting across 12 months (parent report)|Change from Baseline in Monitoring across 12 months (parent report)|Change from Baseline in School Involvement across 12 months (parent report)|Change from Baseline in Parenting Self-Efficacy across 12 months (parent report)","University of Oregon|National Institute on Drug Abuse (NIDA)","All","Child, Adult, Older Adult","Not Applicable","347","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","R01DA037628","February 21, 2017","September 30, 2019","September 30, 2019","February 23, 2017",,"October 15, 2018","University of Oregon, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT03060291"
555,"NCT04331704","ANCHORS Alcohol & Sexual Health Study: UH3 Project",,"Not yet recruiting","No Results Available","Alcohol Use, Unspecified|Substance Use|Sex Behavior","Drug: PrEP acronym (pre-exposure prophylaxis)|Behavioral: Initial Web Survey|Behavioral: Interactive Voice Response (IVR) monitoring|Behavioral: Educational material on alcohol and sexual health behavior|Behavioral: Interactive Voice Response (IVR) assessment with personalized information|Behavioral: Personalized information based on web-based survey responses & standardized information","Change in quantity of drinks per week|Change in peak drinking quantity|PrEP levels in blood at end of intervention period|PrEP levels in blood at the end of the follow-up period|PrEP prescription fill with supporting documentation in the intervention period|PrEP prescription fills with supporting documentation during the follow-up period|Reduced alcohol use as a reason for adherence to PrEP|Change in perceived risk of HIV as a reason for adherence to PrEP|Change in sexual risk behavior as a reason for adherence to PrEP|Increased motivation for behavior change as a reason for adherence to PrEP","University of Florida|National Institute on Alcohol Abuse and Alcoholism (NIAAA)","Male","18 Years to 30 Years   (Adult)","Phase 4","88","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","IRB201902818|UH3AA026214|OCR31862","August 2020","August 31, 2022","August 31, 2022","April 2, 2020",,"June 24, 2020","University of Florida, Gainesville, Florida, United States",,"https://ClinicalTrials.gov/show/NCT04331704"
556,"NCT04161209","Citalopram and Stress Reactivity",,"Recruiting","No Results Available","Depression|Depressive Disorder|Mental Disorder|Antidepressive Agents|Cognition|Stress","Drug: Citalopram|Other: Placebo","Heart rate (beats per minute)|Heart rate variability (Root Mean Square Of Successive Differences: RMSSD)|Salivary cortisol|Blood pressure|Subjective measures of stress and arousal","University of Oxford|University of Bath","All","18 Years to 45 Years   (Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","OCST_Citalopram","October 11, 2019","September 2020","September 2020","November 13, 2019",,"November 15, 2019","University of Oxford, Oxford, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04161209"
557,"NCT03211013","Study of the Effects of Oxytocin on Attentional Bias and Startle in PTSD",,"Unknown status","No Results Available","Posttraumatic Stress Disorder","Drug: Oxytocin|Drug: Placebos","Change in attentional bias|Change in startle response -heart rate","Palo Alto Veterans Institute for Research","Male","18 Years to 65 Years   (Adult, Older Adult)","Early Phase 1","40","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","WOS0022ADM","July 10, 2017","February 28, 2019","July 31, 2019","July 7, 2017",,"April 18, 2018","VA Palo Alto Health Care System, Menlo Park, California, United States",,"https://ClinicalTrials.gov/show/NCT03211013"
558,"NCT02602340","Neurocognitive Predictors of Behavioral Therapy Response in Depression",,"Active, not recruiting","No Results Available","Depression","Behavioral: Behavioral Activation therapy","Change in depressive symptoms as measured by the Patient Reported Outcomes Measurement Information System (PROMIS) Depression Scale.|Change in depression-related behaviors as assessed by the Behavioral Activation Depression Scale (BADS) Short Form.|Change in anxiety symptoms as measured by the Patient Reported Outcomes Measurement Information System (PROMIS) Anxiety Scale.|Change in level of disability as measured by the Sheehan Disability Scale|Change in depressive symptoms as measured by the Beck Depression Inventory - II.","Laureate Institute for Brain Research, Inc.","All","18 Years to 55 Years   (Adult)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2015-006-01","October 2015","October 2020","October 2020","November 11, 2015",,"March 18, 2020","Laureate Institute for Brain Research, Tulsa, Oklahoma, United States",,"https://ClinicalTrials.gov/show/NCT02602340"
559,"NCT03298243","Use of Sensory Substitution to Improve Arm Control After Stroke",,"Recruiting","No Results Available","Stroke|Proprioceptive Disorders","Behavioral: Vibrotactile stimulation","Root Mean Square Kinematic Error","Marquette University|Medical College of Wisconsin|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","All","21 Years and older   (Adult, Older Adult)","Not Applicable","28","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","HR-3303|1R15HD093086","October 30, 2017","May 2021","May 2021","October 2, 2017",,"February 19, 2020","Marquette University, Milwaukee, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT03298243"
560,"NCT02481362","Food Choices in Healthy Weight Women",,"Completed","No Results Available","Addictive Behavior|Food Preferences|Food Habits|Healthy|Habituation","Other: CAKE|Other: APRICOTS","Grams of consumption of cake|Grams of consumption of apricots","The University of Tennessee, Knoxville","Female","18 Years to 35 Years   (Adult)","Not Applicable","28","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","UTK IRB-15-02330-XP","June 2015","May 2016","May 2016","June 25, 2015",,"April 5, 2018","Healthy Eating and Activity Laboratory, University of Tennessee, Knoxville, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT02481362"
561,"NCT03895567","Study to Compare Blood Levels of Ceftriaxone Given by Suppository or Injection.","CefREC","Not yet recruiting","No Results Available","Healthy","Drug: A. Ceftriaxone (Roche ®) 500mg (slow intravenous injection)|Drug: B. Ceftriaxone rectal dosage form test formulation 1 (1 x 500mg)|Drug: C. Ceftriaxone rectal dosage form test formulation 2 (1 x 500mg)","Bioavailablity of rectal formulation|Description of Exposure (AUC0-∞)|Description of Peak concentration (Cmax)|Description of Absorption rate (Tmax)|Time above a plasma concentration of 1µg/mL (this concentration is above the MIC90 for major neonatal pathogens and is the lower limit of detection of the assay)|Occurrence of serious adverse events (SAEs) from the date of the first dose to 28 days after the final dose, according to the MedRA classification.|Occurrence of all adverse events from the date of the first dose to 28 days after the final dose, according to the MedRA classification.","University of Oxford|Orofino Pharmaceuticals Group","All","18 Years to 46 Years   (Adult)","Phase 1","37","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","BAC18003","February 2020","September 2021","September 2021","March 29, 2019",,"November 5, 2019",,,"https://ClinicalTrials.gov/show/NCT03895567"
562,"NCT03863366","Effects of Acute Prucalopride Administration in Healthy Volunteers",,"Completed","No Results Available","Molecular Mechanisms of Pharmacological Action|Depression|Depressive Disorder|Mood Disorders|Mental Disorder|Antidepressive Agents|Cognition","Drug: Prucalopride|Other: Placebo","Recognition of positive and negative facial expressions|Recall of emotional words|Recognition of emotional words|Attentional vigilance to emotional faces|Recall of words Auditory Verbal Learning Task (AVLT)|Reward and loss sensitivity|Working memory performance|Contextual learning","University of Oxford","All","18 Years to 40 Years   (Adult)","Not Applicable","41","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","Acute_pruc","February 7, 2017","August 8, 2017","August 8, 2017","March 5, 2019",,"March 5, 2019","University of Oxford, Oxford, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03863366"
563,"NCT04249544","Social Decision Making in Parkinson's Disease",,"Not yet recruiting","No Results Available","Parkinson Disease","Drug: Pramipexole|Drug: Placebo","The change in a harm aversion cognitive moral decision-making task|change in blood flow in the ventral striatum per ASL images","Vanderbilt University Medical Center|United States Department of Defense","All","45 Years to 80 Years   (Adult, Older Adult)","Phase 1","60","Other|U.S. Fed","Interventional","Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Basic Science","Social Decision Making in PD|W81XWH-19-1-0782","July 2020","January 2022","January 2022","January 31, 2020",,"April 24, 2020","Vanderbilt University Medical Center, Nashville, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT04249544"
564,"NCT01094132","Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection","MDC_Algo","Completed","No Results Available","Cervical Cancer|Precancerous Condition","Device: Multispectral Digital Colposcope (MDC)","Detection of cancer or pre-cancerous abnormalities of the cervix by multispectral digital colposcope.","British Columbia Cancer Agency|National Cancer Institute (NCI)|Texas Tech University Health Sciences Center|Brookdale University Hospital Medical Center|William Marsh Rice University|The University of Texas Health Science Center, Houston|M.D. Anderson Cancer Center","Female","18 Years and older   (Adult, Older Adult)","Phase 2","551","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","BCCR-H09-03303|P01CA082710|H09-03303","December 2012","September 1, 2016","November 9, 2016","March 26, 2010",,"July 5, 2019","Brookdale Hospital and Medical Center, Brooklyn, New York, United States|Texas Tech Health Sciences Center, El Paso, Texas, United States|Vancouver General Hospital - Women's Clinic (G&L Diamond Centre), Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT01094132"
565,"NCT02796807","Correlation Between SUV on 68Ga-HBED-CC-PSMA and Gleason Score in Prostate Cancer",,"Completed","No Results Available","Prostate Cancer","Drug: 68Ga-HBED-CC-PSMA (DKFZ-11) PET/CT","SUVmax on 68Ga-PSMA PET/CT in locoregional and metastatic prostate cancer","Sir Mortimer B. Davis - Jewish General Hospital","Male","18 Years to 120 Years   (Adult, Older Adult)","Phase 2","88","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","16-052","May 2016","December 2017","December 2017","June 13, 2016",,"March 6, 2018","Jewish General Hospital, Montreal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT02796807"
566,"NCT02758691","fMRI Study of Effects of Nasal Insulin on Memory",,"Completed","No Results Available","Human Memory|Intranasal Insulin","Drug: Intranasal Insulin|Drug: Intranasal Saline","Change in Memory Recall Performance during functional Magnetic Resonance Imaging task","Virginia Polytechnic Institute and State University","All","18 Years and older   (Adult, Older Adult)","Phase 1","45","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","VT15-462","December 2015","June 2016","May 10, 2017","May 2, 2016",,"October 26, 2018",,,"https://ClinicalTrials.gov/show/NCT02758691"
567,"NCT03056781","Emotional Response in Psychiatric and Control Participants",,"Completed","No Results Available","Schizophrenia|Emotions","Behavioral: social interaction|Behavioral: food consumption","Social Anhedonia Scale|Physical Anhedonia Scale|EEG activity|Verbal behavioral rating|Non-verbal behavioral rating|International Personality Item Pool questionnaires|Following Affective States test|AMNART|MMSE","University of California, Irvine","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","46","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2016-2945","February 15, 2017","August 1, 2018","August 1, 2018","February 17, 2017",,"December 14, 2018","Social Ecology 1, Irvine, California, United States",,"https://ClinicalTrials.gov/show/NCT03056781"
568,"NCT02337647","Evaluation of the Distortion Correction Data Collection (DCDC) App Software",,"Completed","No Results Available","Age-related Macular Degeneration","Other: DCDC App","Functionality of the Distortion Correction Data Collection App (DCDC), as measured by successful usage of the app by subjects.","University of Nebraska","All","55 Years and older   (Adult, Older Adult)","Not Applicable","5","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","625-14","June 2014","March 2016","June 2016","January 13, 2015",,"September 25, 2017","Truhlsen Eye Institute, Omaha, Nebraska, United States",,"https://ClinicalTrials.gov/show/NCT02337647"
569,"NCT02350426","A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques",,"Terminated","No Results Available","Arthritis, Rheumatoid","Other: Gadobutrol|Other: 18F-FDG|Other: 18F-GE-180","Evaluator's assessment of image quality and potential to define abnormality|Standardised Uptake Value (SUV) of 18F-FDG and 18F-GE-180|Tissue-to-reference Ratio (TR) of 18F-FDG and 18F-GE-180|Total Inflammatory Volume (TIV) of 18F-FDG and 18F-GE-180|Exchange Rate (Ktrans)|Interstitial Volume (Ve)|Initial Rate of Enhancement (IRE)|Maximal Signal Intensity Enhancement (ME)|Visual assessment of static 18F-FDG and 18F-GE-180 images using a 4-point visual analysis scale and abnormal joint counts|PET static imaging parameters (SUV, TR and TIV) of 18F-FDG and 18F-GE-180 in selected joints|18F-GE-180 radio-PK modelling indices (total distribution volume; VT) and 18F-GE-180 static imaging metrics (SUV, TR and TIV)|Adverse events (AEs) and serious adverse events (SAEs) assessment","GlaxoSmithKline|Cambridge University Hospitals NHS Foundation Trust","All","30 Years to 85 Years   (Adult, Older Adult)","Phase 1","10","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","201659","August 12, 2015","October 26, 2016","October 26, 2016","January 29, 2015",,"December 4, 2017","GSK Investigational Site, Cambridge, Cambridgeshire, United Kingdom|GSK Investigational Site, Cambridge, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02350426"
570,"NCT01177306","Inuniv and Working Memory",,"Completed","No Results Available","Attention Deficit Hyperactivity Disorder","Drug: extended release guanfacine","Central Nervous System-Vital Signs (CNS-VS)|Wide Range Assessment of Memory and Learning(WRAML)","Lori A. Schweickert, MD|Shire|Schweickert, Lori A., M.D.","All","8 Years to 12 Years   (Child)","Phase 4","18","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","LAS-IST-001","July 2010","December 2013","May 2014","August 9, 2010",,"July 28, 2014","3C Family Services, Cary, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT01177306"
571,"NCT02858752","Memory and Attention in Healthy Children","MASK","Recruiting","No Results Available","Healthy Volunteers","Other: Experience 1 : Auditory and Visual Discrimination|Other: Experience 2 : Passive and Active Auditory Perception|Other: Experience 3 : Visual Attention Training|Other: Experience 4 : Attention and Distractibility|Other: Experience 5 : Sustained Visual Attention","Neuropsychological tests: Proportion of accurate answers|Neuropsychological tests: reaction time of answers (seconds)|Neurophysiological tests: Event-related potentials in response to auditory and visual stimulations|Proportion of accurate answers according to age range of children|reaction time of answers (seconds) according to age range of children|Event-related potentials in response to auditory and visual stimulations according to age range of children","Hospices Civils de Lyon","All","5 Years to 17 Years   (Child)","Not Applicable","400","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","69HCL15_0711","October 6, 2016","October 6, 2020","October 6, 2020","August 8, 2016",,"August 9, 2017","Hopital Femme Mère Enfant, Lyon, France",,"https://ClinicalTrials.gov/show/NCT02858752"
572,"NCT03434093","Modulation of the Parieto-frontal Communication",,"Withdrawn","No Results Available","Normal Physiology","Device: Transcranial Magnetic Stimulation (TMS)|Behavioral: Working Memory Task","Resting state functional connectivity change induced by the paired associative stimulation|Difference in the visual angle error of a working memory task between the DLPFC-PCC and PPC-DLPFC paired associative stimulation","National Institute of Neurological Disorders and Stroke (NINDS)|National Institutes of Health Clinical Center (CC)","All","18 Years to 50 Years   (Adult)","Not Applicable","0","NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","180054|18-N-0054","February 3, 2019","February 25, 2019","February 25, 2019","February 15, 2018",,"February 28, 2019",,,"https://ClinicalTrials.gov/show/NCT03434093"
573,"NCT02265757","Behavioral Interventions to Prevent or Delay Dementia",,"Completed","No Results Available","Mild Cognitive Impairment|Memory Disorders|Mild Dementia|Impaired Cognition|Mild Cognitive Disorder|Amnestic Disorder|Dementia and Amnestic Conditions|Poor Short-term Memory|Memory Impairment","Behavioral: Cognitive Rehabilitation|Behavioral: Computer Brain Fitness Training|Behavioral: Support Group (patient and partner)|Behavioral: Wellness Education|Behavioral: Physical Exercise","Improvement in patient quality of life|improvement in patient memory based everyday functioning|improvement in caregiver mood and sense of burden","Mayo Clinic|Patient-Centered Outcomes Research Institute","All","50 Years and older   (Adult, Older Adult)","Not Applicable","272","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","14-000885","June 2014","March 31, 2018","March 31, 2018","October 16, 2014",,"February 22, 2019","Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/57/NCT02265757/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02265757"
574,"NCT03258580","Sociocultural & Biobehavioral Influences on Pain Expression and Assessment",,"Recruiting","No Results Available","Normal Physiology|Healthy Volunteers|Pain","Device: Medoc thermal stimulator|Device: Electric shock stimulator|Device: Cold water bath|Behavioral: Instructions about pain assessment|Behavioral: Pain assessment performance feedback","Physiological responses (facial muscle movement, skin conductance, respiration, pupil dilation, eye gaze position)|Pain perception (pain ratings)|Questionnaire measures (e.g. Fear of Pain questionnaire, McGill pain questionnaire)","National Center for Complementary and Integrative Health (NCCIH)|National Institutes of Health Clinical Center (CC)","All","18 Years to 60 Years   (Adult)","Not Applicable","320","NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","170155|17-AT-0155","May 9, 2018","January 17, 2021","February 17, 2021","August 23, 2017",,"April 2, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT03258580"
575,"NCT03255031","Ketogenic Diet (KD) in Alcoholism",,"Recruiting","No Results Available","Alcoholism","Dietary Supplement: Ketogenic Diet (KD) / Standard American (SA) Snacks and Shakes","Assessment of ketogenic diet|To assess the effects of a ketogenic diet in alcohol use disorder (AUD) subjects.","National Institute on Alcohol Abuse and Alcoholism (NIAAA)|National Institutes of Health Clinical Center (CC)","All","18 Years and older   (Adult, Older Adult)","Early Phase 1","100","NIH","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","170152|17-AA-0152","October 24, 2017","December 31, 2023","December 31, 2024","August 21, 2017",,"June 18, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT03255031"
576,"NCT03190954","Brain Dopaminergic Signaling in Opioid Use Disorders",,"Recruiting","No Results Available","Normal Physiology|Opioid-Related Disorders","Other: Placebo|Drug: Methylphenidate","Differences in D1R to D2R striatal ratio and in DA release between participants with an OUD and controls and between MAT+, naltrexone, and MAT- groups.|To assess if there is recovery after protracted treatment (comparing treated and non-treated) by repeating fMRI at 6 month follow-up.|To assess the impact of disruptions on striatal D1R to D2R availability on: DA release; Function of brain reward and control networks;Behavior.<br>2) To assess if DA increases as achieved with oral MP influence the brain functional meas...|To assess if DA increases as achieved with oral MP influence the brain functional measures.","National Institute on Alcohol Abuse and Alcoholism (NIAAA)|National Institutes of Health Clinical Center (CC)","All","18 Years to 65 Years   (Adult, Older Adult)","Early Phase 1","300","NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","170114|17-AA-0114","August 17, 2017","December 31, 2024","December 31, 2025","June 19, 2017",,"May 21, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT03190954"
577,"NCT02504905","Propensity to Develop Plasticity in the Parieto-Motor Networks in Dystonia From the Perspective of Abnormal High-Order Motor Processing",,"Recruiting","No Results Available","Writer's Cramp|Healthly Volunteers|Cervical Dystonia","Device: TMS","MEP size at S50 with respect to time (before, and 15-20 min after PAS intervention)","National Institute of Neurological Disorders and Stroke (NINDS)|National Institutes of Health Clinical Center (CC)","All","18 Years to 60 Years   (Adult)","Early Phase 1","80","NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","150167|15-N-0167","August 20, 2015","June 30, 2021","June 30, 2021","July 22, 2015",,"June 29, 2020","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT02504905"
578,"NCT04105712","The Biobehavioral Impact of Diet Quality on Affect and Craving",,"Recruiting","No Results Available","Food Addiction|Withdrawal","Behavioral: Dietary Change (low in highly processed foods)","Change as indicators of physical withdrawal symptoms using heart rate monitoring|Change as indicator of physical withdrawal symptoms using fMRI scan|Change as indicator of affective withdrawal symptom using subjective craving measure|Change as indicator of affective withdrawal symptom using subjective hunger measure|Change as indicator of affective withdrawal symptom using Positive and Negative Affect Scale|Change in food cue reactivity using heart rate monitoring|Change in food cue reactivity using self - report questionnaire","University of Michigan","Female","25 Years to 40 Years   (Adult)","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","HUM00156725","June 18, 2019","May 2021","May 2021","September 26, 2019",,"December 23, 2019","University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT04105712"
579,"NCT03076307","DAT SPECT and Procedural Motor Skills in Parkinson's Disease",,"Completed","No Results Available","Parkinson Disease","Behavioral: Procedural Motor Skills with mirror-drawing of figures","Procedural motor performance (error and time) in PD group|Resting state EEG connectivity in PD and control groups|Difference >20% in error rate and speed improvement in control and PD groups","University Hospital, Geneva","All","18 Years and older   (Adult, Older Adult)","Not Applicable","9","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Primary Purpose: Basic Science","CCER 2016-01469","October 18, 2016","May 20, 2017","July 19, 2017","March 10, 2017",,"July 21, 2017","Division of Neurorehabilitation, Geneva University Hospitals, Geneva, Switzerland",,"https://ClinicalTrials.gov/show/NCT03076307"
580,"NCT02821741","Effects of External Ear Stimulation on Pain Perception and Mood",,"Recruiting","No Results Available","Pain","Device: Transcutaneous Electrical Nerve Stimulator","The difference in pain ratings collected for each subject during the two types of left ear stimulation (cymba conchae and earlobe).|The effect of tVNS on pain threshold, pain unpleasantness, and mood as measured by visual analogue scales (VAS).|Mood and anxiety, as measured by questionnaires taken at the beginning and end of both study sessions.|Autonomic measures will be analyzed to determine whether tVNS has an effect on heart rate variability.","National Center for Complementary and Integrative Health (NCCIH)|National Institutes of Health Clinical Center (CC)","All","18 Years to 50 Years   (Adult)","Early Phase 1","76","NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","160136|16-AT-0136","October 18, 2016","December 30, 2020","December 30, 2020","July 4, 2016",,"May 8, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT02821741"
581,"NCT00281463","Impact of Pushrim Activated Power Assist Wheelchairs on Mobility Among People With Tetraplegia",,"Completed","Has Results","Wheelchair Users","Device: Pushrim Activated Power Assist","Oxygen Consumption","VA Pittsburgh Healthcare System","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","45","U.S. Fed","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","01103, 010842|H133N000019","November 2001","March 2007","January 2008","January 24, 2006","November 18, 2014","November 18, 2014","Human Engineering Research Laboratories, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT00281463"
582,"NCT03819595","BIZI ORAIN: Exercise for All People With Cancer",,"Recruiting","No Results Available","Cancer|Quality of Life|Functional Capacity|Exercise","Other: Supervised exercise|Other: Personalized Program PVS","Change in Functional Capacity (400 meters walk test)|Change in Quality of life (general SF-36)|Change in Quality of life (cancer specific quality of life -European Organization for Research and Treatment of Cancer QLQ-C-30)|symptoms (Cancer-related fatigue - Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue)|physical activity level|concentration of Lipids|concentration of C reactive protein|concentration of glucose|concentration of Insulin|concentration of adiponectin|concentration of TNF|concentration of Interleukins II-1 and II-6|Change in Body composition (fat and muscular weight). (BMI)","Basque Health Service","All","Child, Adult, Older Adult","Not Applicable","1013","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","PI 18/00929","March 1, 2019","December 31, 2022","December 31, 2022","January 28, 2019",,"July 10, 2019","Primary care research unit of Bizkaia, Bilbao, Bizkaia, Spain|Primary care research unit of Bizkaia, Bilbao, Bizkaia, Spain",,"https://ClinicalTrials.gov/show/NCT03819595"
583,"NCT02841449","The Effect of Hydration Status on Glycemic Control and Appetite Regulation",,"Completed","Has Results","Healthy","Behavioral: Hypohydrated|Behavioral: Rehydrated","Glycemic Response|Insulinemic Response|Arginine Vasopressin and Copeptin Response|Ghrelin Response|Energy Intake|Metabolic Rate|Subjective Appetite Ratings|Muscle Volume|Body Water Content","University of Bath|University of Bristol|Loughborough University|European Hydration Institute|Economic and Social Research Council, United Kingdom|Lund University","All","18 Years to 60 Years   (Adult)","Not Applicable","16","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","16/SW/0057","July 2016","January 2017","January 2017","July 22, 2016","June 22, 2020","June 22, 2020","University of Bath, Bath, Somerset, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02841449"
584,"NCT02233829","Dopamine Rhythms in Health and Addiction",,"Suspended","No Results Available","Cocaine Abuse","Drug: Methylphenidate|Drug: C-11 Raclopride","To determine if there is disruption in circadian rhythms in cocaine use disorder (CUD) as compared to healthy controls.|Measuring dopamine signaling|Measuring circadian typology|Measuring sleep patterns","National Institute on Alcohol Abuse and Alcoholism (NIAAA)|National Institutes of Health Clinical Center (CC)","All","21 Years to 55 Years   (Adult)","Early Phase 1","112","NIH","Interventional","Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","140187|14-AA-0187","September 6, 2014","December 31, 2025","December 31, 2025","September 9, 2014",,"March 26, 2020","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT02233829"
585,"NCT01730742","Sleep Deprivation's Regulation of Immune System Function and Behavior","SS","Unknown status","No Results Available","Sleep Deprivation|Sleep","Behavioral: Neuroeconomics task|Behavioral: Portion Size Task|Procedure: Blood sample","Neutrophil phagocytotic function production|Portion Size Task|Neuro-economics task|Circulating hormone levels","Uppsala University","Male","Child, Adult, Older Adult","Not Applicable","18","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","192837465","February 2012","March 2013","March 2013","November 21, 2012",,"November 21, 2012","Uppsala University, Uppsala, Sweden",,"https://ClinicalTrials.gov/show/NCT01730742"
586,"NCT02231892","Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study",,"Completed","Has Results","Healthy Volunteer","Device: TMS","Behavioral Outcome Measure|Imaging Outcome Measures","National Institute on Drug Abuse (NIDA)|National Institutes of Health Clinical Center (CC)","All","18 Years to 55 Years   (Adult)","Not Applicable","104","NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","999914186|14-DA-N186","September 3, 2014","January 3, 2019","September 18, 2019","September 4, 2014","February 24, 2020","February 24, 2020","National Institute on Drug Abuse, Baltimore, Maryland, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/92/NCT02231892/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02231892"
587,"NCT04105868","Adolescent Attention to Emotion Study",,"Recruiting","No Results Available","Depression","Other: Neurofeedback","Change from baseline in affect-biased attention subsequently following neurofeedback (~1 hour)|Change from baseline in sadness after laboratory stressor, which follows neurofeedback|Change from baseline in anxiety after laboratory stressor, which follows neurofeedback","University of Pittsburgh|National Institute of Mental Health (NIMH)","Female","13 Years to 15 Years   (Child)","Not Applicable","70","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","STUDY19010063|K23MH119225","October 16, 2019","March 2024","March 2024","September 26, 2019",,"December 10, 2019","Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT04105868"
588,"NCT02193425","Reliability of the Human Brain Connectome",,"Recruiting","No Results Available","Normal Physiology","Drug: F-18FDG|Device: MRI","The overaching goal of this study is to quantify the reproducibility of multiple measures of brain functional connectivity (FC) during resting conditions and during task performance.|The correlation between glucose metabolism, CBF, lFCD, C, L and S and its contribution to between- subjects FC-variability during RS.|The association between lFCD and the underlying structural connectivity and its contribution to between- subjects FC-variability during RS.|The correlation between physiologic noise and FC measures (lFCD, C, L and S) and its contribution to within- subjects FC-variability during RS and TS conditions.|The dynamics of the FC measures (lFCD, C, L and S) and its contribution to within- subjects FC-variability during RS and TS conditions.","National Institute on Alcohol Abuse and Alcoholism (NIAAA)|National Institutes of Health Clinical Center (CC)","All","18 Years and older   (Adult, Older Adult)","Early Phase 1","180","NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","140144|14-AA-0144","June 8, 2015","March 22, 2021","December 31, 2024","July 17, 2014",,"June 11, 2020","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT02193425"
589,"NCT04453943","Modeling, Optimization, and Control Methods for a Personalized Hybrid Walking Exoskeleton",,"Not yet recruiting","No Results Available","Spinal Cord Injuries|Paraplegia, Spinal|Paraplegia, Incomplete","Device: Exoskeleton Walking - with or without FES|Device: Exoskeleton Sitting to Standing - with or without FES","Controls Algorithm Performance - Limb Angle Errors|Muscle fatigue Index to Measure FES-Induced Muscle Fatigue|Participant Verbal Feedback","North Carolina State University|U.S. National Science Foundation|University of North Carolina, Chapel Hill","All","18 Years to 60 Years   (Adult)","Not Applicable","30","Other|U.S. Fed","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","20553","July 1, 2020","January 1, 2023","January 1, 2023","July 1, 2020",,"July 1, 2020","4212C Engineering Building III 1840 Entrepreneur Dr., Raleigh, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT04453943"
590,"NCT03670212","Investigation of Nicotine Seeking Behavior in Current Smokers","NSS","Completed","No Results Available","Cigarette Smoking","Drug: Yohimbine Hydrochloride|Drug: Hydrocortisone|Drug: Lactose Monohydrate Powder","Cigarette puff vs. money choice task|Letter 2-back task|Cigarette-cued letter N-back task","Wayne State University|National Institute on Drug Abuse (NIDA)","All","21 Years to 35 Years   (Adult)","Phase 1","21","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","1501013735|F31DA040369","January 7, 2016","October 4, 2016","October 4, 2016","September 13, 2018",,"September 13, 2018","Wayne State University, Detroit, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT03670212"
591,"NCT02388672","Evaluation of Effects of Green Coffee Bean Extract (GCE) on Physiological and Psychological Variables",,"Withdrawn","No Results Available","Blood Pressure","Dietary Supplement: decaffeinated coffee|Dietary Supplement: chlorogenic acid|Dietary Supplement: green coffee bean extract supplement|Dietary Supplement: placebo","blood pressure|heart rate|blood glucose|mood (Profile of Mood States (POMS) questionnaire)|cognitive performance (parametric go/no-go task)","University Hospital Tuebingen","All","18 Years to 40 Years   (Adult)","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","GCB1","March 2015","July 2015","July 2015","March 17, 2015",,"January 26, 2016",,,"https://ClinicalTrials.gov/show/NCT02388672"
592,"NCT02543983","Neurobiology of Suicide",,"Recruiting","No Results Available","Healthy Volunteers|Depression","Drug: Ketamine","Study as Whole: Psychiatric, psychological, neuroimaging, sleep and biological differences between participants in Groups 1, 2, 3 and 4|Phase II: Scale for Suicide Ideation|Phase II: Montgomery-Asberg Depression Rating Scale|Phase II: Hamilton Psychiatric Rating Scale for Anxiety|Phase II: Clinical Global Impression Scale|Anhedonia and Hopelessness via the Snaith-Hamilton Pleasure Scale &amp; the Beck Hopelessness Scale|Baseline and Response Biomarkers","National Institute of Mental Health (NIMH)|National Institutes of Health Clinical Center (CC)","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 2","325","NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","150188|15-M-0188","December 2, 2015","July 21, 2021","July 21, 2021","September 9, 2015",,"June 29, 2020","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT02543983"
593,"NCT01186354","Understanding of Genetic Risk Information for Type 2 Diabetes",,"Completed","No Results Available","Diabetes Mellitus, Type 2","Behavioral: Receiving results via genetic counselor","Accurate understanding of genetic risk information|Impact on behavior change","Duke University|National Heart, Lung, and Blood Institute (NHLBI)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","300","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","Pro00021370|1R21HL096573-01A1","July 2010","January 2012","January 2012","August 23, 2010",,"December 17, 2012","Duke University Medical Center, Durham, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT01186354"
594,"NCT01552603","Artificial Pancreas Control System in an Inpatient Setting",,"Completed","Has Results","Type I Diabetes Mellitus","Device: Artificial Pancreas Control Software","Mean Percent of Time in Target Blood Glucose Range|Mean Deviation From Target Blood Glucose","Legacy Health System|Juvenile Diabetes Research Foundation","All","21 Years to 65 Years   (Adult, Older Adult)","Phase 2","14","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2011.11","March 2012","August 2013","September 2013","March 13, 2012","September 17, 2014","June 3, 2016","Legacy Good Samaritan Hospital, Portland, Oregon, United States|Oregon Health and Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT01552603"
595,"NCT04177901","The Use of NIRS in Brachial Plexus Block",,"Active, not recruiting","No Results Available","Arterio-venous Fistula","Device: Near infrared spectroscopy","improvement of tissue oxygenation|primary patency of arteriovenous fistula","Istanbul Medeniyet University","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2019-0260","July 10, 2019","July 10, 2020","July 10, 2020","November 26, 2019",,"November 26, 2019","Medeniyet University, İ̇stanbul, Turkey",,"https://ClinicalTrials.gov/show/NCT04177901"
596,"NCT01747200","Effects of Transcranial Magnetic Stimulation on Object Recognition",,"Completed","No Results Available","Repetitive TMS (rTMS)|Sham rTMS|Bilateral rTMS|Unilateral rTMS","Procedure: Sham rTMS|Procedure: Bilateral rTMS at same frequency and in phase|Procedure: Bilateral rTMS at different frequencies|Procedure: Bilateral rTMSat same frequency and out of phase|Procedure: rTMS over TP8|Procedure: rTMS over TP7","Percentage of correct responses in the midline object recognition task.|Threshold intensity for blocking object recognition","National Institute of Neurological Disorders and Stroke (NINDS)|National Institutes of Health Clinical Center (CC)","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","13","NIH","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Primary Purpose: Basic Science","130035|13-N-0035","November 16, 2012","January 26, 2017","January 26, 2017","December 11, 2012",,"July 2, 2017","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT01747200"
597,"NCT03095053","PGT-A Versus Blastocyst Morphology Selection",,"Completed","Has Results","Pregnancy","Procedure: comprehensive chromosome screening","The Percentage of Patients With a Live Birth|The Percentage of Patients With a Clinical Pregnancy|The Percentage of Pregnancies That Miscarried","Antalya IVF","Female","18 Years to 35 Years   (Adult)","Not Applicable","302","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","euploid versus morphology|Optimizing implantation in FET","March 23, 2017","February 21, 2018","February 21, 2018","March 29, 2017","June 17, 2019","June 17, 2019","Antalya IVF, Antalya, Turkey","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/53/NCT03095053/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03095053"
598,"NCT02473185","Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest",,"Completed","No Results Available","Attention Deficit Hyperactivity Disorder","Drug: Methylphenidate","Change in Weighted summary parameter QbInattention score on the QbTest.|Change in Weighted summary parameter QbActivity score on the QbTest.|Change in Weighted summary parameter QbImpulsivity score on the QbTest.|Change in Self-rated expected performance.|Change in Self-rated mental effort|Change in Self-rated severity of the task|Change in Self-rated experienced performance|Change in Self-rated help from the pill","Region Västmanland","All","18 Years to 60 Years   (Adult)","Phase 4","40","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","2015-03-10/53|2014-005045-53","September 2015","June 2018","June 2018","June 16, 2015",,"August 28, 2018","Landstinget Västmanland, Västerås, Sweden",,"https://ClinicalTrials.gov/show/NCT02473185"
599,"NCT01278654","Lottery Incentives for Moving",,"Completed","No Results Available","Obesity|Sedentary Lifestyle","Behavioral: Incentive to exercise","Walkstation usage|Biometric measures|Questionnaire","Harvard University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","212","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","Walkstation2","March 2011","May 2011","August 2011","January 19, 2011",,"March 19, 2012","Blue Cross Blue Shield Massachusetts, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT01278654"
600,"NCT03561688","Foot Orthotic for Early Stage Rheumatoid Arthritis",,"Completed","No Results Available","Rheumatoid Arthritis|Rheumatoid Arthritis of Foot (Disorder)","Device: Foot orthotics|Device: Standard insole","Change in gait mechanics|Change in foot pressure distribution|Questionnaire - Pain - Visual analog scale|Insole wearing time|Pain - Pressure pain threshold|Pain mapping|Wearable activity monitor","Vendsyssel Hospital|TrygFonden, Denmark|The Danish Rheumatism Association|Aalborg University|King Christian X´Hospital for Rheumatic Diseases","All","18 Years and older   (Adult, Older Adult)","Not Applicable","27","Other|Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","RHN_MBS_01","October 10, 2018","November 1, 2019","December 1, 2019","June 19, 2018",,"March 3, 2020","Aalborg University Hospital, Aalborg, Denmark|King Christian X's Hospital for Rhuematic Diseases, Gråsten, Denmark|Department for Rheumatology, Hjørring, Denmark",,"https://ClinicalTrials.gov/show/NCT03561688"
601,"NCT01672723","Neuropharmacological Basis of Social Connection: The Role of Opioids",,"Completed","Has Results","Psychology, Social","Drug: Naltrexone","Changes in Self-reported Feelings of Connection During Naltrexone (vs. Placebo)|Daily Self-reported Feelings of Social Connection","University of California, Los Angeles","All","18 Years to 35 Years   (Adult)","Not Applicable","34","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","Opioids and Social Cognition","October 2012","February 2014","February 2014","August 27, 2012","January 14, 2016","January 14, 2016","University of California, Los Angeles Department of Psychology, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT01672723"
602,"NCT03440346","Biomarker Research in ADHD: the Impact of Nutrition","BRAIN","Completed","No Results Available","Attention Deficit-Hyperactivity Disorder","Other: Few-foods diet","Change in neural activation patterns during execution of tasks|Change in peripheral blood metabolite concentrations|Change in functional composition of the gut microbiota|Change in ADHD symptom scores|Change in whole brain neural activation patterns during the execution of tasks|Change in whole brain functional connectivity at rest|Change in taxonomic and functional composition of the gut microbiota|Change in metabolite profiles|Change in peripheral blood cell gene expression profiles|Change in a panel of peripheral blood protein biomarkers related to immune, metabolic and neurological status|DNA genotype|Change in DNA methylation profiles|Change in executive function|Change in ADHD symptoms|Change in oppositional defiant disorder symptoms|Change in social behavioural problems|Change in physical complaints|Change in stool frequency|Change in stool type","Wageningen University|ADHD Research Centre","Male","8 Years to 10 Years   (Child)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","NL63851.081.17","February 19, 2018","June 21, 2019","June 21, 2019","February 22, 2018",,"July 1, 2019","Wageningen University, Wageningen, Netherlands",,"https://ClinicalTrials.gov/show/NCT03440346"
603,"NCT01613911","Study of Human Sensory Perception",,"Completed","No Results Available","Epilepsy",,"Reveal induced neuronal activity|Calculate evoked response potentials.","Swedish Medical Center|Weizmann Institute of Science","All","10 Years to 65 Years   (Child, Adult, Older Adult)",,"6","Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","5146S-11","March 2012","November 2014","November 2014","June 7, 2012",,"December 8, 2014","Swedish Medical Center Epilepsy Center, Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT01613911"
604,"NCT02563236","Evaluation of 3D Selection Tasks in Parabolic Flight Conditions: Pointing Task in Augmented Reality User Interfaces","3DPICK","Completed","No Results Available","Healthy Volunteers","Other: Parabolic flight","Gravity induced change in completion time of a pointing task on a virtual keyboard (ms)|Gravity induced change in error rate of the pointing task|Gravity induced change in accuracy (centimeter) of the pointing task","University Hospital, Caen","All","21 Years to 55 Years   (Adult)","Not Applicable","9","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","12-022","March 2012","June 2013","December 2014","September 30, 2015",,"September 30, 2015","Umr Ucbn/Inserm U1075 Comete, Caen CEDEX, Basse-Normandie, France",,"https://ClinicalTrials.gov/show/NCT02563236"
605,"NCT02032290","Assessment of Coronary Flow Reserve by Doppler Flow Wire in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between the Loading Dose of Ticagrelor and Clopidogrel",,"Unknown status","No Results Available","Acute Coronary Syndrome:|Non ST Elevation Myocardial Infarction|ST Elevation Myocardial Infarction|Unstable Angina","Procedure: Assessment of Coronary Flow Reserve|Procedure: Percutaneous coronary intervention|Drug: ticagrelor loading|Drug: Clopidogrel loading","assessment of coronary flow reserve","Azienda Policlinico Umberto I","All","18 Years to 75 Years   (Adult, Older Adult)","Phase 4","88","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","Ticagrelor - Clopidogrel","February 2014","December 2014",,"January 10, 2014",,"January 10, 2014","Massimo Mancone, Rome, Italy",,"https://ClinicalTrials.gov/show/NCT02032290"
606,"NCT00482820","A Clinical Research Studying a Method of Intervention for Children Diagnosed With Anxiety Disorder: Attentional Bias Intervention",,"Completed","No Results Available","Anxiety","Behavioral: attention-bias training","anxiety questionnaire - that are specified in the protocol. mood scale- as described in the protocol attention bias scores- as described in the protocol","Rabin Medical Center","All","7 Years to 12 Years   (Child)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Basic Science","4373","July 2007","September 2012","September 2012","June 5, 2007",,"February 7, 2013",,,"https://ClinicalTrials.gov/show/NCT00482820"
607,"NCT02192138","Pathophysiological Effects of Intrapleural Pressure Changes During Therapeutic Thoracentesis",,"Unknown status","No Results Available","Pleural Effusion|Exudative Pleuritis","Procedure: Therapeutic thoracentesis|Device: Pleural catheter|Device: Pleural manometer","Change in intrapleural pressure|Intrapleural pressure|Volume of withdrawn pleural fluid","Medical University of Warsaw","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","IPU-DIMPA-WUM14(1)","April 2014","March 2018","June 2018","July 16, 2014",,"January 24, 2018","Medical University of Warsaw, Warsaw, Poland",,"https://ClinicalTrials.gov/show/NCT02192138"
608,"NCT02791841","Comparison of Interventions for Developmental Dyslexia",,"Unknown status","No Results Available","Developmental Dyslexia","Behavioral: Rhythmic Reading Training|Behavioral: Visual Hemispheric-Specific Stimulation + Action Video Games|Behavioral: Action Video Games","Text reading|Word reading|Pseudo-word reading|Lexical access|Phonological awareness: phonemic blending|Phonological awareness: phonemic elision|Auditory attention|Rhythm perception and reproduction","Catholic University of the Sacred Heart|IRCCS Eugenio Medea","All","8 Years to 12 Years   (Child)","Not Applicable","33","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","RRT-VHSS-AVG","January 2016","June 2017","April 2018","June 7, 2016",,"January 25, 2018","Unit of Child Psychopathology, Scientific Institute IRCCS 'Eugenio Medea', Bosisio Parini, Italy",,"https://ClinicalTrials.gov/show/NCT02791841"
609,"NCT01945190","Acupuncture for Inflammatory Pain and Central Sensitization - A Pilot Study",,"Completed","No Results Available","Pain|Inflammation","Device: Electroacupuncture","Erythema as measured by Laser Doppler|Heat pain threshold (deg C)|Analgesia to temporal summation of heat pain","University of Vermont|Stanford University","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","15","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","14-079|28064","September 2013","October 2013","October 2013","September 18, 2013",,"October 17, 2013","Stanford University, Stanford, California, United States",,"https://ClinicalTrials.gov/show/NCT01945190"
610,"NCT01680718","Neuropeptides and Social Behavior",,"Completed","No Results Available","Social Psychology","Drug: Intranasal oxytocin|Drug: Intranasal vasopressin|Drug: Intranasal placebo","Speed in social working memory task|Accuracy of deception detection based on self-report|Self-reported perceptions of trust and threat|Self-reported empathy and altruistic behavior","University of California, Los Angeles","All","18 Years to 50 Years   (Adult)","Early Phase 1","160","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","Behavioral Neuropeptides","October 2012","September 2013","September 2013","September 7, 2012",,"May 28, 2015","UCLA Department of Psychology, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT01680718"
611,"NCT00435630","Documenting a Learning Curve and Test-retest Reliability of a Virtual Reality Training Simulator in Laparoscopic Surgery",,"Completed","No Results Available","Education","Other: LapSim training","Establish learning curve for each of seven tasks on the simulator.|Establish test-retest reliability for each of seven tasks on the simulator.","Columbia University","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","29","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)","AAAA7372","July 2004","January 2005","August 2008","February 15, 2007",,"November 21, 2012","Columbia University College of Physicians and Surgeons, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT00435630"
612,"NCT03557710","Devaluing Foods to Change Eating Behavior",,"Recruiting","No Results Available","Overweight and Obesity|Cancer","Behavioral: Devaluing energy-dense foods for cancer-control","Change from Baseline Food Intake at 1 month using dietary assessment tool|Change from Baseline Food Intake at 1 month, Self-Report Questionnaire|Change from Baseline Body Fat Percent at 1 month|Change from Baseline Body Mass Index at 1 month|Change from Baseline Waist-to-Hip Ratio at 1 month|Change from Baseline Food Approach and Avoidance Behavior at 1 month, Self-Report Questionnaire 2|Change from Baseline Food Approach and Avoidance Behavior at 1 month, Self-Report Questionnaire 3|Change from Baseline Cognitive Tendencies at 1 month, Self-Report Questionnaire 1|Change from Baseline Cognitive Tendencies at 1 month, Self-Report Questionnaire 2|Change from Baseline Food-related Habitual Behavior at 1 month, Self-report Questionnaire 1|Change from Baseline Cancer Risk and Healthy Food Craving and Valuation at 1 month, Self-report Questionnaire 2|Change from Baseline Behavioral Response Biases Toward and Away from Cancer Risk and Healthy Foods at 1 month, Behavioral marker, Task 1|Change from Baseline Behavioral Response Biases Toward and Away from Cancer Risk and Healthy Foods at 1 month, Behavioral marker, Task 2|Change from Baseline Cognitive Reappraisal of Food at 1 month, Behavioral marker|Change from Baseline Valuation of Subjective Value of Various Foods at 1 month, Behavioral marker|Change from Baseline Habitual Response to Food at 1 month, Behavioral marker|Change from Baseline Behavioral Response Biases Toward and Away from Cancer Risk and Healthy Foods at 1 month, Neural marker, Task 1|Change from Baseline Behavioral Response Biases Toward and Away from Cancer Risk and Healthy Foods at 1 month, Neural marker, Task 2|Change from Baseline Cognitive Reappraisal of Food at 1 month, Neural marker|Change from Baseline Habitual Response to Food at 1 month, Neural marker|Change from Baseline Valuation of Subjective Value of Various Foods at 1 month, Neural marker","University of Oregon","All","18 Years to 60 Years   (Adult)","Not Applicable","300","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","EPCS24327","May 1, 2018","July 31, 2022","July 31, 2022","June 15, 2018",,"December 9, 2019","University of Oregon, Lewis Integrative Sciences Building, Eugene, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT03557710"
613,"NCT04141904","Tofacitinib in Depression (TIDE)","TIDE","Recruiting","No Results Available","Depression|Inflammation","Drug: Tofacitinib 5 MG [Xeljanz]|Other: Placebo","The effects of tofacitinib on emotional processing using the Facial Expression Recognition Task (FERT)|The effects of tofacitinib on Emotional Memory Task (EMEM) scores|Emotional categorization using the Emotional categorization task (ECAT)|Emotional recall task (EREC)|Brain neural activity|Faces dot probe task (FDOT)|Probabilistic Instrumental Learning Task (PILT)|Auditory Verbal Learning Task (AVLT)|The effects of tofacitinib on cerebral perfusion","University of Oxford|Wellcome Trust|Medical Research Council","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1|Phase 2","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","19/SC/0136","November 2019","September 2021","September 2021","October 28, 2019",,"November 15, 2019","Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04141904"
614,"NCT01066299","Influence of Oxytocin on the Startle Reflex and on Its Modulation",,"Unknown status","No Results Available","Psychiatric Disorders","Drug: Syntocinon®|Drug: inactive nasal spray","Eye blink response to the tones measured as the peak activity of the left musculus orbicularis oculi that will be compared between the active drug and the placebo conditions.|Anxiety ratings assessed with the State-Trait-Inventory that will used as a covariate in the ANOVAs.","University of Zurich|University of Basel|University of Freiburg","Male","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","OXT_PSY1","May 2010","September 2012","December 2012","February 10, 2010",,"November 29, 2011","University Hospital Zurich, Division of Psychiatry and Psychotherapy, Zurich, Switzerland",,"https://ClinicalTrials.gov/show/NCT01066299"
615,"NCT02409862","Faces: Choices Study",,"Withdrawn","No Results Available","Socioemotional Aging","Drug: Oxytocin Spray|Drug: Placebo Spray","The change in choices task between baseline and at week 2|The change in General Trust Measure Questionnaire between baseline and at week 2|The change in Empathy Quotient Questionnaire between baseline and at week 2|The change in Trait Meta-Mood Scale Questionnaire between baseline and at week 2|The change in Inclusion of Community in the Self Scale Questionnaire between baseline and at week 2|Gift basket task|Donation task","University of Florida","Male","18 Years to 85 Years   (Adult, Older Adult)","Phase 2|Phase 3","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","IRB201600718 -A|39-2013 SubStudy","January 1, 2019","August 30, 2019","August 30, 2019","April 7, 2015",,"November 26, 2018","University of Florida, Gainesville, Florida, United States",,"https://ClinicalTrials.gov/show/NCT02409862"
616,"NCT01224704","Water Deprivation Protocol",,"Completed","No Results Available","Obesity","Other: Hypertonic saline infusion|Other: Water deprivation","Water intake|Hormonal response|Thirst rating","National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Institutes of Health Clinical Center (CC)","Male","18 Years to 50 Years   (Adult)","Early Phase 1","75","NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","999911008|11-DK-N008","October 19, 2010","March 28, 2019","March 28, 2019","October 20, 2010",,"March 10, 2020","NIDDK, Phoenix, Phoenix, Arizona, United States",,"https://ClinicalTrials.gov/show/NCT01224704"
617,"NCT04343352","Evaluation of the Efficiency of Mobile Application for Parents of Children With Epilepsy",,"Not yet recruiting","No Results Available","Child|Epilepsy|Education|Mobile Application|Nursing","Other: implementation of mobile epilepsy training program","Change in the knowledge of the applicant group about epilepsy disease|Change in anxiety of the applicant group about epilepsy disease","DILEK SAYIK|Eskisehir Osmangazi University","All","18 Years to 50 Years   (Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","DSAYIK|Ayfer ACIKGOZ","September 2020","December 2020","September 2021","April 13, 2020",,"April 14, 2020",,,"https://ClinicalTrials.gov/show/NCT04343352"
618,"NCT00110539","Effectiveness of an Internet-Based Curriculum in Increasing Health Care Providers' Knowledge of Herbs and Dietary Supplements",,"Completed","No Results Available","Healthy","Behavioral: Complementary and alternative medicine education","Changes in participant knowledge, confidence, and communication practices regarding herbs and dietary supplements|Impact of comfort with using technology on the primary outcomes","National Library of Medicine (NLM)","All","Child, Adult, Older Adult","Not Applicable","1500","NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double","R01LM007709","February 2004",,"December 2004","May 11, 2005",,"May 24, 2012","Northwest Area Health Education Center, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT00110539"
619,"NCT02990676","Exploring Computerised Cognitive Training for People With Huntington's Disease","CogTrainHD","Completed","No Results Available","Huntington's Disease","Behavioral: Computerised cognitive training","Number of participants able to complete the feasibility study as measured by retention rate|Number of participants able to complete computerised HAPPYneuron pro cognitive training as assessed by task performance and the quality of the data generated.|Symbol digit modality test|Stroop tasks on paper of colour and work naming|Categorical verbal fluency (letter and categorical fluency test)|Trail making A and B tests|Digit Span Forward subtest from Weschler's Adult Intelligence Scale (WAIS)|Dual-tasking. Subjects are required to switch their attention between two competing tasks. Subjects will be asked to cross out a series of boxes whilst simultaneously recalling a digit sequence.|Tower of Hanoi|Card sorting task of executive function|Number of participants able to fully complete timed up and go (TUG) motor assessments as assessed by time taken to complete the task|Participant scores in the 'money box test'|MRI scanning results|Participant scores on the Hospital Anxiety and Depression Scale (HADS)|Participant scores on The International Physical Activity Questionnaire (IPAQ)|Participant scores on HD-Pro-TriadTM Questionnaire|Participant scores on the Life-Space Assessment","Cardiff University|Jacque and Gloria Gossweiler Foundation|Health and Care Research Wales","All","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","1535-16|HF-16-1152|210821","January 25, 2017","March 13, 2019","March 13, 2019","December 13, 2016",,"May 10, 2019","Cardiff University, Cardiff, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02990676"
620,"NCT01897025","Combined Transcranial Direct Current Stimulation and Motor Imagery-based Robotic Arm Training for Stroke Rehabilitation",,"Completed","Has Results","Stroke","Device: real-tDCS with MI-BCI","Upper Extremity Component of Fugl-Meyer Assessment|Resting Motor Threshold of Stroke Affected M1 Motor Cortex|Grip Strength|Box and Block Test|MRI Parameters","National University Hospital, Singapore|National University Health System, Singapore|Agency for Science, Technology and Research","All","21 Years to 70 Years   (Adult, Older Adult)","Phase 2","42","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","NIG09may022","January 2011","January 2014","January 2014","July 11, 2013","March 10, 2016","March 10, 2016","National University Hospital, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT01897025"
621,"NCT00158184","Prescription Opioid Effects in Abusers Versus Non-Abusers",,"Completed","Has Results","Opioid-Related Disorders|Substance-Related Disorders","Drug: oxycodone 15 mg|Drug: oxycodone 30 mg|Drug: Placebo 0 mg","Breakpoint|Drug Liking","New York State Psychiatric Institute|National Institute on Drug Abuse (NIDA)","All","21 Years to 45 Years   (Adult)","Phase 2","27","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","#4691|R01DA016759-01","June 2004","June 2009","June 2009","September 12, 2005","July 7, 2017","July 7, 2017","New York State Psychiatric Institute, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT00158184"
622,"NCT02559063","Vision-based Speed of Processing Cognitive Training and Mild Cognitive Impairment",,"Completed","No Results Available","Mild Cognitive Impairment","Behavioral: Vision-based speed of processing training|Behavioral: Mental leisure activities","Attention and processing speed test (UFOV)|Cognitive control and working memory (EXAMINER)|instrumental activities of daily living (TIADL)|mean of functional connectivity in default mode network|mean of structural connectivity in default mode network","University of Rochester|National Institute of Nursing Research (NINR)","All","60 Years and older   (Adult, Older Adult)","Not Applicable","84","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Prevention","1R01NR015452","January 12, 2016","October 9, 2018","July 1, 2019","September 24, 2015",,"October 2, 2019","University of Rochester Memory Care Program, Rochester, New York, United States",,"https://ClinicalTrials.gov/show/NCT02559063"
623,"NCT03515226","Remote Training in Evidence-based Practices for Clinicians Who Work With Migrant Workers",,"Recruiting","No Results Available","Depression","Behavioral: ITS based training|Behavioral: Traditional Training","Learnability|Skill drift|Acceptability of Intervention Measure (AIM)|User Burden Scale|System Usability Scale","University of Washington","All","18 Years and older   (Adult, Older Adult)","Not Applicable","34","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","STUDY00004268","June 30, 2018","June 30, 2020","August 30, 2020","May 3, 2018",,"October 12, 2018","University of Washington Department of Psychiatry and Behavioral Sciences, Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT03515226"
624,"NCT04270214","Conversion to Dysport in Cervical Dystonia Patients",,"Not yet recruiting","No Results Available","Cervical Dystonia","Drug: Dysport Injectable Product","waning effect|objective measures of CD severity","Western University, Canada","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","35","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","115308","April 2020","June 2021","January 2022","February 17, 2020",,"February 21, 2020","London Health Sciences Centre, London, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04270214"
625,"NCT03441737","Aerobic Exercise and Inhibitory Control","AMIAEIC","Unknown status","No Results Available","Smoking Cessation|Inhibition (Psychology)","Behavioral: Exercise|Behavioral: Non-Exercise","Inhibitory Control|Urge to Smoke|Time to First Cigarette","Western University, Canada","All","18 Years to 64 Years   (Adult)","Not Applicable","28","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","1795AM","April 2018","December 2018","March 2019","February 22, 2018",,"February 22, 2018",,,"https://ClinicalTrials.gov/show/NCT03441737"
626,"NCT02415517","Cognitive Training in Heart Failure Study (CogTrain-HF)","CogTrain-HF","Completed","No Results Available","Congestive Heart Failure|Cognitive Impairment","Behavioral: Cognitive training|Behavioral: Test of general knowledge","Training effects|Transfer effects|Changes in quality of life and psychological well-being|Long-term benefits of cognitive training in patients with congestive heart failure.|Compliance with medication","Saarland University|Deutsche Stiftung für Herzforschung","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","107","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","CogTrain-HF","January 2014","June 3, 2019","December 4, 2019","April 14, 2015",,"March 26, 2020","Department of Educational Science, Saarland University, Frankfurt am Main, Hessen, Germany|Clinic for Internal Medicine, Cardioloy, Angioloy, and Internal Intensive Care Medicine, Saarland University Hospital, Homburg, Saarland, Germany",,"https://ClinicalTrials.gov/show/NCT02415517"
627,"NCT02659787","Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology","BED","Completed","Has Results","Depression","Drug: 0.2mg Buprenorphine|Drug: Placebo","Subjective Effects as Assessed by Score on ""Feel Drug"", ""Feel High"", ""Like Drug"", and ""Want More"" Subscales of the Drug Effects Questionnaire Subjective Response With and Without Buprenorphine","University of Chicago","All","18 Years to 35 Years   (Adult)","Not Applicable","38","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","14-0170","June 2016","April 2017","April 2017","January 20, 2016","May 29, 2019","May 29, 2019","University of Chicago, Chicago, Illinois, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/87/NCT02659787/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02659787"
628,"NCT01373372","Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia",,"Withdrawn","No Results Available","Functional Dyspepsia","Drug: Acthrel","Heart rate variability|Stress profile|plasma protein levels|BASC 2 profile|STICSA-C|GI symptom severity scale","Children's Mercy Hospital Kansas City","All","8 Years to 17 Years   (Child)","Not Applicable","0","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","11 05-069","December 2016","December 2016","March 2017","June 15, 2011",,"May 16, 2019","Children's Mercy Hospital and Clinics, Kansas City, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT01373372"
629,"NCT02323048","Acquisition of Responses to a Methamphetamine-associated Cue in Healthy Humans","CAM","Completed","Has Results","Substance Abuse","Drug: methamphetamine|Drug: placebo","Subjective Effects as Assessed by Score on ""Feel Drug"", ""Feel High"", ""Like Drug"", and ""Want More"" Subscales of the Drug Effects Questionnaire","University of Chicago","All","21 Years to 35 Years   (Adult)","Not Applicable","90","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","12-2047","July 2014","November 2014","December 2014","December 23, 2014","July 26, 2018","July 26, 2018",,,"https://ClinicalTrials.gov/show/NCT02323048"
630,"NCT03390218","TAO Outpatient Trial for Anxiety and Depression",,"Unknown status","No Results Available","Anxiety Disorders|Depression","Behavioral: Therapy Assistance Online|Behavioral: Treatment as usual","Outcome Questionnaire-45","TAO Connect, Inc.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","300","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","TAO001","January 15, 2018","November 2018","December 2018","January 4, 2018",,"January 4, 2018","Weber Human Services, Ogden, Utah, United States",,"https://ClinicalTrials.gov/show/NCT03390218"
631,"NCT03627962","Oculomotor Training and Chinese Characters Recognition in Children With Neuromuscular Disease","yes","Completed","No Results Available","Extraocular Muscle Disorder|Neuromuscular Diseases","Other: gaze-directed oculomotor training","adjusted horizontal reading time|saccade accuracy|Chinese characters recognition accuracy of grade-leveled readings","The Hong Kong Polytechnic University","All","6 Years to 8 Years   (Child)","Not Applicable","21","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","HSEARS20160816001","November 1, 2016","April 30, 2017","August 8, 2018","August 14, 2018",,"August 14, 2018","The Hong Kong Polytechnic University, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT03627962"
632,"NCT01815203","Caffein Consumption and Response Inhibition",,"Completed","No Results Available","Eating Behavior|Obesity","Drug: Caffeine|Drug: Placebo","Inhibition control|Food test","Uppsala University","Male","18 Years to 35 Years   (Adult)","Not Applicable","21","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","PH2013a","March 2013","July 2013","August 2013","March 20, 2013",,"September 25, 2013","Uppsala University, Uppsala, Sweden",,"https://ClinicalTrials.gov/show/NCT01815203"
633,"NCT02205983","The Effects of Hydromorphone on Responses to Verbal Tasks","HESS","Completed","Has Results","Healthy","Drug: 2 mg hydromorphone|Drug: 1000 mg Acetaminophen|Drug: 4 mg hydromorphone|Drug: dextrose","Subjective Effects as Assessed by Score on ""Feel Drug"", ""Feel High"", ""Like Drug"", and ""Want More"" Subscales of the Drug Effects Questionnaire","University of Chicago|National Institute on Drug Abuse (NIDA)","All","18 Years to 40 Years   (Adult)","Not Applicable","50","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","UC13-1027|R01DA002812","January 2015","July 2016","September 2016","August 1, 2014","October 9, 2018","October 9, 2018","University of Chicago Hospital, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT02205983"
634,"NCT03343028","Biomarker Establishment for Superior Treatment of PTSD",,"Completed","No Results Available","PTSD","Other: Psychotherapy","Understanding the brain network function-neuroimaging and behavioral with Clinician-Administered PTSD Scale for DSM-5","Stanford University|New Mexico VA Healthcare System","All","18 Years to 60 Years   (Adult)",,"292","Other|U.S. Fed","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","39006","September 2016","September 30, 2019","September 30, 2019","November 17, 2017",,"February 12, 2020","VA Palo Alto Health Care System (VAPAHCS), Palo Alto, California, United States|New Mexico VA Health Care System, Albuquerque, New Mexico, United States",,"https://ClinicalTrials.gov/show/NCT03343028"
635,"NCT01543633","EEG Studies of Induction and Recovery From Propofol Induced General Anesthesia",,"Unknown status","No Results Available","Brain Activity Under Sedation","Drug: Propofol","Localize and track brain activity under propofol sedation.","Massachusetts General Hospital|National Institutes of Health (NIH)","All","18 Years to 36 Years   (Adult)","Not Applicable","20","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2005P001549|5DP1OD003646","August 2005","July 2020","July 2020","March 5, 2012",,"January 12, 2018","Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT01543633"
636,"NCT02792127","Online Program for Social Anxiety",,"Completed","No Results Available","Social Anxiety","Behavioral: Online Program for Social Anxiety","Social Anxiety","University of British Columbia","All","Child, Adult, Older Adult","Not Applicable","101","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","H16-00319","July 2016","December 2017","December 2017","June 7, 2016",,"December 29, 2017",,,"https://ClinicalTrials.gov/show/NCT02792127"
637,"NCT03250663","Eucrisa for Atopic Dermatitis",,"Active, not recruiting","No Results Available","Mild to Moderate Atopic Dermatitis","Behavioral: Online Treatment response|Drug: EUCRISA","Adherence to topical Therapy|Adherence to topical therapy #1|Adherence to topical therapy #2|Adherence to topical therapy #3|Adherence to topical therapy #4","Wake Forest University Health Sciences","All","2 Years to 64 Years   (Child, Adult)","Phase 1","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Health Services Research","IRB00045841","October 1, 2017","August 2020","August 2020","August 16, 2017",,"May 21, 2020","Wake Forest University Heath Sciences, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03250663"
638,"NCT00955110","Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin)",,"Completed","Has Results","Healthy","Drug: Oxymorphone ER|Drug: Oxycodone CR|Drug: Placebo|Drug: Hydromorphone","High VAS - Emax (mm)","Endo Pharmaceuticals|Kendle Early Stage - Toronto","All","18 Years to 55 Years   (Adult)","Phase 4","78","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","EN3202-402","June 2009","September 2009","September 2009","August 7, 2009","July 14, 2011","October 5, 2017","Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT00955110"
639,"NCT03396549","Effect of tDCS Montage on Measures of Appetite",,"Completed","No Results Available","Eating Behavior","Device: new sham tDCS|Device: real tDCS","Eating Behaviors|Detection of target from sham tDCS session.","University of Alabama at Birmingham","All","18 Years to 55 Years   (Adult)","Not Applicable","28","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","IRB-300000049","March 7, 2018","March 14, 2018","March 14, 2018","January 11, 2018",,"May 15, 2018","University of Alabama at Birmingham (UAB), Birmingham, Alabama, United States",,"https://ClinicalTrials.gov/show/NCT03396549"
640,"NCT02051530","Mood, Serotonin and Social Interaction",,"Completed","No Results Available","Mood|Social Behavior","Dietary Supplement: tryptophan depletion","Empathic Accuracy|Behavioral mimicry|Emotional Prosody (EP)|blood|heart rate variability","University of Groningen","All","18 Years to 65 Years   (Adult, Older Adult)","Early Phase 1","40","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","NL451-09-013","April 2012","March 2014","March 2014","January 31, 2014",,"January 30, 2015","University Center Psychiatry, Groningen, Netherlands",,"https://ClinicalTrials.gov/show/NCT02051530"
641,"NCT02533076","The Functional Consequences of the CTNS-deletion for the TRPV1-receptor in Cystinosis Patients",,"Completed","No Results Available","Cystinosis","Other: Challenge agent: capsaicin|Other: Challenge agent: placebo|Device: Mechanical stimulation with Von Frey filaments|Device: Temperature sensitivity measurement with Advanced Thermal Stimulation","Change from baseline of the dermal blood flow response to topical applied capsaicin at 10, 20, 30, 40, 50 and 60 minutes, measured with Laser Doppler Imaging and expressed in % change to baseline|Change from baseline of the skin sensitivity response after topical applied capsaicin at 10, 20, 30, 40, 50 and 60 minutes, measured with the Numerical rating scale and skin sensitivity to mechanical stimulation, measured with Von Frey filaments.|Temperature sensitivity (detection and pain threshold), measured with Advanced Thermal stimulation and expressed in degrees Celsius.","Universitaire Ziekenhuizen Leuven","All","8 Years and older   (Child, Adult, Older Adult)","Early Phase 1","50","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","CCP13-3302-CYST","November 2014","July 2015","July 2015","August 26, 2015",,"August 26, 2015","Centre for Clinical Pharmacology, UZ Leuven, Leuven, Vlaams-Brabant, Belgium",,"https://ClinicalTrials.gov/show/NCT02533076"
642,"NCT04041024","Decision-making and Risk-taking in Bulimia","FaciB","Not yet recruiting","No Results Available","Bulimia Nervosa","Other: tasks and questionnaires","oxygen variation in the brain|Task related parameters|Skin conductance response related to events in the task performed while the signal is being collected|cardiac frequency in beats per minute related to events in the task performed while the signal is being collected|parameters of eye movements extracted from the eye tracking signal is being collected|Eating Disorders Examination (EDE-Q)","Hôpital le Vinatier","All","18 Years to 35 Years   (Adult)","Not Applicable","720","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2018-A01268-47","September 2020","January 2024","January 2025","August 1, 2019",,"June 17, 2020",,,"https://ClinicalTrials.gov/show/NCT04041024"
643,"NCT03451409","Neurobiology of Sensory Phenomena in Obsessive-Compulsive Disorder",,"Recruiting","No Results Available","Obsessive Compulsive Disorder","Other: Tasked based functional MRI (fMRI)|Other: Eye Tracking Device","Brain activation in relation to sensory phenomena severity in patients with OCD","NYU Langone Health","All","18 Years to 60 Years   (Adult)","Not Applicable","100","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","17-01606","May 5, 2018","January 2022","January 2022","March 1, 2018",,"April 24, 2020","New York University School of Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03451409"
644,"NCT02816632","Feedbacks' Influence on Decision Making Processes","Feedbacks","Recruiting","No Results Available","Healthy Volunteers","Other: mRI|Other: Effect of Galvanic Vestibular Stimulation on decision making processes","Behavioral performance (Accuracy)|Behavioral performance (Reaction times)|Neural activity (BOLD signal measured using fMRI) as a function of the nature of the feedback.","Hospices Civils de Lyon","All","18 Years to 45 Years   (Adult)","Not Applicable","180","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","69HCL15_0221|2015-A00623-46","March 30, 2017","March 30, 2023","March 30, 2023","June 28, 2016",,"April 3, 2019","Unité de Neuro-Ophtalmologie Hôpital Neurologique - HOSPICES CIVILS DE LYON, Bron, France",,"https://ClinicalTrials.gov/show/NCT02816632"
645,"NCT04359108","Environmental Localization Mapping and Guidance for Visual Prosthesis Users","SLAM","Not yet recruiting","No Results Available","Retinitis Pigmentosa|Visual Impairment|Visual Prosthesis","Device: Navigation System for Users of a Visual Prosthesis","Accuracy as assessed as ratio of target identification success to total trials|Trial Time as assessed by mean time duration to identify target|Success in psychophysical judgments","Johns Hopkins University|Carnegie Mellon University|National Eye Institute (NEI)","All","20 Years to 70 Years   (Adult, Older Adult)","Not Applicable","35","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","IRB00228932|1R01EY029741-01A1","July 1, 2020","September 30, 2023","September 30, 2023","April 24, 2020",,"June 23, 2020","Johns Hopkins Medicine - Wilmer Eye Institute, Baltimore, Maryland, United States|Johns Hopkins Applied Physics Laboratory, Laurel, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT04359108"
646,"NCT00373399","Effects of Smoked Marijuana on Risk Taking and Decision Making Tasks",,"Completed","Has Results","Marijuana Use Disorder","Drug: Inactive Marijuana (0% THC)|Drug: Low THC marijuana (1.8 %THC)|Drug: High THC marijuana (3.9% THC)","Change From Baseline in Iowa Gambling Task Scores [Objective Measure of Decision Making]","New York State Psychiatric Institute|National Institute on Drug Abuse (NIDA)","All","21 Years to 45 Years   (Adult)","Phase 1","36","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","IRB# 5204|DA-03746","May 2006","March 2008","March 2008","September 8, 2006","October 31, 2018","December 19, 2018","New York State Psychiatric Institute, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT00373399"
647,"NCT03633955","Pilot Imaging Study of Leukemia","REALIZE","Not yet recruiting","No Results Available","Acute Lymphocytic Leukemia|Acute Myeloid Leukemia|Ambiguous Lineage Leukemia or Lymphoma|Myelodysplastic Syndrome","Drug: FLT","FLT SUV identifies leukemia disease|Computer assisted evaluation of leukemia disease|Patient reported outcomes|Blood biomarkers","University of Oklahoma|Emory University","All","4 Years to 80 Years   (Child, Adult, Older Adult)","Phase 1","36","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","OU-SCC-REALIZE","July 2020","April 2022","May 2024","August 16, 2018",,"June 16, 2020","Children's National Health System, Washington, District of Columbia, United States|Emory University, Atlanta, Georgia, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States",,"https://ClinicalTrials.gov/show/NCT03633955"
648,"NCT04196153","A Comparison of Pedicle Screws Placement Accuracy in Thoracolumbar Spine Using Two Guidance Techniques Which Are O-arm Navigation and Standard Cervical Distractor Screws",,"Recruiting","No Results Available","Pedicle Screws|Surgery, Computer-Assisted/Adverse Effects|Bone Screws|Imaging, Three-Dimensional/Methods","Procedure: Pedicle screws instrumentation","Rate screws breach|Screw insertion time|screws revision times|degree of screws breach|Direction of the breach|complications","King Abdullah International Medical Research Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","kashabmo","October 10, 2019","May 2020","July 2020","December 12, 2019",,"December 12, 2019","King Abdulaziz Medical City, Jeddah, Eastern Province, Saudi Arabia",,"https://ClinicalTrials.gov/show/NCT04196153"
649,"NCT01376869","Investigation of the Acute Cognitive, Mood and Autonomic Effects of Hops in Healthy Participants",,"Completed","No Results Available","Mood Modulation|Modulation of Cognition","Dietary Supplement: Hops Extract|Other: Placebo (silica)","Mood|Satiety|Bioavailability of Hops|Cognition","Northumbria University|The New Zealand Institute for Plant and Food Research","All","18 Years to 35 Years   (Adult)","Not Applicable","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","21AO1","June 2011","December 2011","December 2011","June 20, 2011",,"June 25, 2012","Northumbria University, Newcastle upon Tyne, United Kingdom",,"https://ClinicalTrials.gov/show/NCT01376869"
650,"NCT02193854","Teledermatology Solution Through Mobile Phone in Rural Mongolia",,"Completed","No Results Available","Social Distance","Device: Mobile Phone","Comparison between the number of referrals in the control and intervention groups|Satisfaction by physicians and patients by questionnaire","Taipei Medical University|Health Science University of Mongolia","All","18 Years and older   (Adult, Older Adult)","Not Applicable","441","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","TaipeiMU","September 2013","January 2014","January 2014","July 18, 2014",,"July 18, 2014","Shabbir Syed Abdul, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT02193854"
651,"NCT01823146","Oxytocin's Effect on Socioemotional Aging",,"Completed","Has Results","Aging","Drug: Oxytocin spray|Drug: Placebo spray","Extent of Trust Behavior|Meta-Mood|Functional Connectivity (Resting fMRI)","University of Florida","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","106","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","39-2013|UL1TR000064","July 2013","September 2014","September 2014","April 4, 2013","September 17, 2015","August 25, 2016","University of Florida, Gainesville, Florida, United States",,"https://ClinicalTrials.gov/show/NCT01823146"
652,"NCT02965924","Effect of Topical Phenylephrine 2.5% on EVP in Normal Human Eyes",,"Completed","Has Results","Assess Phenylephrine on EVP and IOP","Drug: Phenylephrine 2.5%","Change in Episcleral Venous Pressure (EVP)|Change in Intraocular Pressure (IOP)","Mayo Clinic","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","16-007077","October 2016","October 1, 2018","October 1, 2018","November 17, 2016","October 23, 2019","October 23, 2019","Mayo Clinic in Rochester, Rochester, Minnesota, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/24/NCT02965924/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02965924"
653,"NCT03101826","Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory",,"Recruiting","No Results Available","Prader-Willi Syndrome","Behavioral: Listening Project Protocol","Effect of Intervention on Autonomic regulation|Effect of Intervention on Heart period|Effect of Intervention on Auditory processing|Effect of Intervention on Sensory Sensitivities|Effect of Intervention on Latency to Affect recognition|Effect of Intervention on Accuracy of Affect recognition|Effect of Intervention on Prosody|Effect of Intervention on Disruptive Behavior|Effect of Intervention on Social behavior|Effect of Intervention on Oxytocin|Effect of Intervention on Vasopressin","Indiana University|Latham Centers","All","13 Years to 25 Years   (Child, Adult)","Not Applicable","25","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","1609337519","November 1, 2017","May 2020","May 2020","April 5, 2017",,"February 27, 2019","Latham Centers School, Brewster, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT03101826"
654,"NCT03472729","AGE-ON 2.0: Expanding and Evaluating a Tablet Training Program for Older Adults","AGEON2","Completed","No Results Available","Social Isolation","Other: AGE-ON Workshop","Duke Social Support Index|de Jon Gierveld Loneliness Scale|CASP-12","McMaster University|Social Sciences and Humanities Research Council of Canada","All","60 Years and older   (Adult, Older Adult)","Not Applicable","32","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Other","3670","September 1, 2018","September 1, 2019","January 1, 2020","March 21, 2018",,"February 20, 2020","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03472729"
655,"NCT03958474","Neurobehavioral Mechanisms of Choice in Opioid Use Disorder",,"Recruiting","No Results Available","Opioid Use Disorder","Drug: Oxycodone","Gambling task","Joshua A. Lile, Ph.D.|University of Kentucky","All","18 Years to 50 Years   (Adult)","Early Phase 1","31","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","47844","August 16, 2019","June 30, 2023","June 30, 2023","May 22, 2019",,"August 19, 2019","Laboratory of Human Behavioral Pharmacology, Lexington, Kentucky, United States",,"https://ClinicalTrials.gov/show/NCT03958474"
656,"NCT01174485","Effects of Liposuction and Exercise Training on Metabolism, Lipid Profile and Adiposity in Women",,"Completed","No Results Available","Healthy Subjects","Procedure: exercise","Body composition|Insulin Sensitivity|Total cholesterol, LDL-c, HDL-c, VLDL-c and triacylglycerol plasma levels|Cytokine plasma levels - IL-6, TNF-alpha, IL-10, leptin and adiponectin levels","University of Sao Paulo","Female","20 Years to 36 Years   (Adult)","Early Phase 1","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","EEFEUSP-LIPO","August 2010","April 2011","April 2011","August 3, 2010",,"May 13, 2011","Escola de Educação Física e Esporte da Universidade de São Paulo, São Paulo, SP, Brazil",,"https://ClinicalTrials.gov/show/NCT01174485"
657,"NCT02514226","Evaluation of Periodontal Treatment in Patients With Bronchiectasis",,"Enrolling by invitation","No Results Available","Bronchiectasis|Periodontal Disease","Procedure: supragingival treatment|Procedure: periodontal treatment|Procedure: periodontal treatment and photodynamic therapy|Other: dental hygiene orientation","Microbiological evaluation|Halitosis measurements","University of Nove de Julho|InCor Heart Institute|University of Sao Paulo|Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP #2015/20535-1)","All","35 Years and older   (Adult, Older Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","44769315.0.0000.5511","August 2015","July 2020","December 2020","August 3, 2015",,"July 10, 2018","InCor Heart Institute, Sao Paulo, São Paulo, Brazil",,"https://ClinicalTrials.gov/show/NCT02514226"
658,"NCT04377061","Anemia in Non-celiac Wheat Sensitivity",,"Recruiting","No Results Available","Non-celiac Gluten Sensitivity|Anemia","Diagnostic Test: Evaluation of anemia","Presence, severity and morphologic characteristic of anemia|Possible pathogenic mechanisms","University of Palermo","All","18 Years to 65 Years   (Adult, Older Adult)",,"100","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","ACPM25","January 1, 2020","January 1, 2021","January 1, 2022","May 6, 2020",,"May 7, 2020","Department of Internal Medicine, Giovanni Paolo II Hospital of Sciacca, Sciacca, Agrigento, Italy|Internal Medicine Division of the ""Cervello-Villa Sofia"" Hospital, Palermo, PA, Italy|Department of Internal Medicine, University Hospital of Palermo, Palermo, Italy",,"https://ClinicalTrials.gov/show/NCT04377061"
659,"NCT03213600","Neurostimulation-enhanced Behavioral Remediation of Social Cognition in Schizophrenia","NSOCOG","Withdrawn","No Results Available","Behaviors and Mental Disorders","Device: transcranial Direct Current Stimulation tDCS","Causation Task - testing time based causal judgments|Triangle Task - measuring the extent to which temporal coincidence is used to infer causality in a social situation|EEG Task 1, Time visual oddball task - for measuring electrophysiological markers of active temporal (time) deviance detection|EEG Task 2, Covert visual simultaneity task - an exploratory task designed to model the visual Simultaneity behavioral task|Resting state oscillatory structure","Hôpital le Vinatier","All","18 Years to 45 Years   (Adult)","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","2017-A01042-51","November 1, 2018","September 1, 2019","December 31, 2019","July 11, 2017",,"April 22, 2019","Hopital Le Vinatier, Bron, France",,"https://ClinicalTrials.gov/show/NCT03213600"
660,"NCT02769143","Effects of Whole Body Vibration and Pilates on Bone Mineral Density in Postmenopausal Women",,"Completed","No Results Available","Bone Mineral Density Quantitative Trait Locus 3","Other: Whole-Body Vibration|Other: Pilates","Bone mineral density|Muscle strength|Flexibility|Postural balance|The Timed Up and Go test (TUG)|Fear Falls|Quality of life","Universidade Norte do Paraná","Female","40 Years to 75 Years   (Adult, Older Adult)","Not Applicable","51","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","1.032.182","May 2016","November 2016","December 2016","May 11, 2016",,"November 6, 2017","Universidade Norte do Paraná, Londrina, Paraná, Brazil",,"https://ClinicalTrials.gov/show/NCT02769143"
661,"NCT04208425","Promoting Resilience in Teens With ASD","PRITA","Recruiting","No Results Available","Autism Spectrum Disorder","Behavioral: Project Personality|Behavioral: Sharing Feelings Intervention","Children's Depression Inventory-2 (CDI-2)|Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2)|Brief Symptom Inventory 18 (BSI-18)|Multidimensional Anxiety Scale for Children-2 (MASC-2)|Primary Control Scale for Children (PCSC)|Secondary Control Scale for Children (SCSC)|Social Responsiveness Scale-2 (SRS-2)|The Self Perception Profile for Children/ Adolescents (SPPC/A) self-report|Implicit Personality Theory Questionnaire (ITPQ)","Stony Brook University|Society of Clinical Child & Adolescent Psychology|Autism Research Institute","All","11 Years to 16 Years   (Child)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","IRB2019-00280|AWD00001042|AWD00001244","January 7, 2019","December 2021","March 2022","December 23, 2019",,"March 18, 2020","Stony Brook University, Stony Brook, New York, United States",,"https://ClinicalTrials.gov/show/NCT04208425"
662,"NCT01785121","Increasing Exercise Capacity of Patients With Heart Failure by Wii Gaming","HF-Wii","Completed","No Results Available","Heart Failure","Behavioral: Structured access to a Wii game computer (Wii)|Behavioral: Motivational support only","change in 6 minute walk test|Muscle function|Exercise Motivation|Daily Physical Activity|Exercise Self-Efficacy|Perceived Physical Effort|Heart Failure Symptoms|Health Related Quality of Life|Global Well-Being|Readmission|Costs|Experiences of patients|change in 6 minute walk","Linkoeping University|The Swedish Research Council|The Swedish Heart and Lung Association|Swedish Heart Lung Foundation|Vardalinstitutet The Swedish Institute for Health Sciences|Medical Research Council of Southeast Sweden|Swedish National Science Council/Swedish research council for health, working life and welfare","All","18 Years and older   (Adult, Older Adult)","Not Applicable","605","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","HF-Wii","September 2013","April 2018","April 2018","February 7, 2013",,"April 3, 2019","University of California, Irvine, California, United States|Center of Internal Medicine Elsterwerda, Elsterwerda, Germany|Rabin Medical Center, Petah Tikva, Israel|Villa delle Querce hospital, Nemi, Italy|Maastricht University Medical Center, Maastricht, Netherlands|Länssjukhuset Ryhov hospital, Jönköping, Sweden|University hospital Linköping, Linköping, Sweden|Vrinnevi Hospital, Norrköping, Sweden|Nyköpings lasarett hospital, Nyköping, Sweden|Karolinska University Hospital Huddinge, Stockholm, Sweden",,"https://ClinicalTrials.gov/show/NCT01785121"
663,"NCT02916849","A Feasibility Study of a Mobile Application Intervention to Promote Strength and Balance Exercises in Older People",,"Completed","No Results Available","Accidental Falls","Other: Safe Step|Other: OEP","Adherence|Change: Attitudes to Falls-Related Interventions Scale (AFRIS)|Change: Behavioural Regulation In Exercise Questionnaire (BREQ-2)|Change: Iconographical Falls Efficacy Scale (Icon-FES)|Change: Activity Specific Balance Confidence Scale (ABC)|Change: Late-Life Function and Disability Instrument (LLFDI)|Change: Short Physical Performance Battery|Change: 30 second chair-stand|Usability of the programs|Uptake","Umeå University|The Swedish Research Council|Forte|Glasgow Caledonian University","All","70 Years and older   (Older Adult)","Not Applicable","69","Other|Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","SafeStep","September 2016","March 31, 2017","March 31, 2017","September 28, 2016",,"December 15, 2017","Caring Science Buildning, Umeå University, Umeå, Sweden",,"https://ClinicalTrials.gov/show/NCT02916849"
664,"NCT03871751","Home-based SSP on Individuals With PWS",,"Recruiting","No Results Available","Prader-Willi Syndrome","Behavioral: Safe and Sound Protocol","Change from baseline in sensory sensitivities at 1 week|Change from baseline in disruptive behavior at 1 week|Change from baseline in social behavior at 1 week|Change from baseline in Foundational Abilities (balance, gross & fine motor control, sensory, social/emotional, auditory/language and attention/organization and sleep) at 1 week|Change from baseline in prosody at 1 week","Indiana University|Integrated Listening Systems","All","3 Years to 17 Years   (Child)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","1807300643","April 8, 2019","October 2020","October 2020","March 12, 2019",,"February 11, 2020","Integrated Listening Systems, Aurora, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT03871751"
665,"NCT03717727","Gamification in Knee Replacement Rehabilitation","BEE-RCT","Recruiting","No Results Available","Knee Osteoarthritis","Other: Exergame|Other: Control","Change in Function and pain related to knee|Change in Mobility|Change in Walking|Change in Lower extremity performance|Change in Muscle strength|Change in Knee range of motion|Change in knee pain (VAS)|Change in Disability|Change in Pain|Change in other symptoms such as swelling, restricted range of motion and mechanical symptoms|Change in quality of life (QOL)|Change in activities of daily living (ADL) Function|Change in Sport and Recreation Function","University of Jyvaskyla|Turku University Hospital|Turku University of Applied Sciences|Jyväskylä Central Hospital|University of Oulu","All","60 Years to 75 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","T226/2018","November 27, 2018","September 30, 2020","December 31, 2020","October 24, 2018",,"February 27, 2019","Central Finland Central Hospital, Jyväskylä, Finland|University of Jyväskylä, Jyväskylä, Finland|Turku University Hospital, Turku, Finland|Turku University of Applied Sciences, Turku, Finland",,"https://ClinicalTrials.gov/show/NCT03717727"
666,"NCT02000492","Frequent Ballgames Training for 9-11 Year Old Schoolchildren",,"Completed","No Results Available","Body Composition|Echocardiography","Behavioral: Football|Behavioral: Running|Behavioral: Circuit training","Cardiac function|Body composition|Cognitive effect","University of Copenhagen|University Hospital, Gentofte, Copenhagen","All","9 Years to 11 Years   (Child)","Not Applicable","423","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","H-3-2013-038|18172","September 2013","June 2016",,"December 4, 2013",,"October 26, 2016","Municipality of Frederikssund, Frederikssund, Denmark",,"https://ClinicalTrials.gov/show/NCT02000492"
667,"NCT04074382","FIT Study (Functional Outcomes In Trauma Study)",,"Not yet recruiting","No Results Available","Patient Reported Outcome Measures|Recovery of Function|Rehabilitation|Disability Evaluation|Trauma Centers|Trauma Severity Indices|Advanced Trauma Life Support Care|Multiple Trauma/Injuries|Wounds and Injuries|Orthopedic Disorder|Surgery","Other: Online Questionnaires|Other: Qualitative Interviews","Physical Component Score of SF-36v2 - PROM|Trauma and Outcomes Profile (TOP) - PROM|HADS: Hospital Anxiety and Depression Score - PROM|EQ-5D: Euroqol 5 Dimensions Scale|Leeds Trauma Questionnaire - PROM/PREM|Qualitative Interview Outcomes","The Leeds Teaching Hospitals NHS Trust","All","18 Years to 65 Years   (Adult, Older Adult)",,"440","Other","Observational","Observational Model: Cohort|Time Perspective: Other","OR19/123401|257064|19/YH/0280","September 2019","September 2021","January 2031","August 30, 2019",,"August 30, 2019","Leeds teaching Hospitals, Leeds, West Yorkshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04074382"
668,"NCT04270448","Effects of Feedback on Learning of a Motor Sequence Task",,"Recruiting","No Results Available","Adult","Behavioral: Motor Sequence Task","Response Time|Task Confidence|Peak Velocity|Total Path Distance|Time to Peak Velocity|Perceived Competence|Perceived Interest/Enjoyment|Positive Affect","University of South Carolina","All","18 Years to 40 Years   (Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","Pro00095119","February 5, 2020","December 2020","December 2020","February 17, 2020",,"March 31, 2020","University of South Carolina, Columbia, South Carolina, United States",,"https://ClinicalTrials.gov/show/NCT04270448"
669,"NCT02680730","The Listening Project at the ADD Centre and Biofeedback Institute of Toronto",,"Recruiting","No Results Available","Auditory Perceptual Disorders|Stress Disorder","Behavioral: Listening Project Protocol","Change from baseline in auditory hypersensitivity at 1 week, and at 1 month|Change from baseline in state regulation at 1 week, and at 1 month|Change from baseline in auditory processing at 1 week, and at 1 month|Change from baseline in social behavior at 1 week, and at 1 month|Change from baseline in middle ear transfer function at 1 week, and at 1 month|Change from baseline in prosody at 1 week, and at 2 months|Change from baseline in attention at 1 week, and at 2 months|Change from baseline in attention (task) at 1 week, and at 2 months","University of North Carolina, Chapel Hill|ADD Centre© and Biofeedback Institute of Toronto©","All","7 Years to 55 Years   (Child, Adult)","Not Applicable","30","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","15-1954","September 1, 2018","August 2020","August 2020","February 11, 2016",,"October 4, 2019","ADD Centre and Biofeedback Institute of Toronto, Mississauga, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02680730"
670,"NCT02386670","Prevention of Alzheimer's Disease With CR Plus tDCS in Mild Cognitive Impairment and Depression (PACt-MD)","PACt-MD","Active, not recruiting","No Results Available","Mild Cognitive Impairment|Major Depressive Disorder, Recurrent, In Remission|Major Depressive Disorder, Single Episode, in Full Remission","Other: tDCS + CR|Other: sham tDCS + sham CR","Change in cognitive scores over time|Percentage of subjects who remain free of MCI or dementia over time","Centre for Addiction and Mental Health|Brain Canada|Applied Health Research Centre|Queen's University|Baycrest Centre for Geriatric Care|St. Michael's Hospital, Toronto|Sunnybrook Health Sciences Centre|University Health Network, Toronto","All","60 Years and older   (Adult, Older Adult)","Not Applicable","375","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","041-2014","January 2015","June 2022","December 2022","March 12, 2015",,"July 7, 2020","Baycrest Centre for Geriatric Care, Toronto, Ontario, Canada|Centre for Addiction and Mental Health, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Sunnybrook Heath Sciences Centre, Toronto, Ontario, Canada|University Health Network, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02386670"
671,"NCT02680522","Safety Study to Autonomic Rehabilitation o Parkinson's Disease",,"Completed","No Results Available","Parkinson Disease","Other: Exercise","Heart Rate Variability","Universidade Metodista de Piracicaba","All","45 Years to 70 Years   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","35683614.5.0000.5173","January 2014","January 2016","January 2016","February 11, 2016",,"February 11, 2016","Universidade da Amazônia, Belém, Pará, Brazil",,"https://ClinicalTrials.gov/show/NCT02680522"
672,"NCT02298361","IMPACCT for Kids' Care","IMPACCT","Completed","Has Results","Insurance Status/Stability","Other: Health insurance outreach IT tools","Percent of Study Period Covered by Medicaid|Proportion of Patients Who Gained Medicaid Coverage|Proportion of Patients Who Lost Medicaid Coverage","Ochin, Inc.|Oregon Health and Science University","All","up to 19 Years   (Child, Adult)",,"27251","Other","Observational","Time Perspective: Prospective","PCORI Award (308)","March 2013","February 2016","February 2016","November 21, 2014","June 2, 2016","June 2, 2016",,,"https://ClinicalTrials.gov/show/NCT02298361"
673,"NCT02064257","The Listening Project: Tuning Into Change",,"Completed","No Results Available","Auditory Perceptual Disorders|Stress Disorder","Behavioral: Listening Project Protocol","Auditory hypersensitivity|Autonomic state regulation|Auditory processing|social behavior|Middle ear muscle transfer function","University of North Carolina, Chapel Hill|Australian Childhood Foundation","All","7 Years to 14 Years   (Child)","Not Applicable","43","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","13-2304","October 2014","September 2019","September 2019","February 17, 2014",,"October 7, 2019","Child Trauma Service Unit, Australian Childhood Foundation, Ringwood, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT02064257"
674,"NCT03561727","Risk Factors for Development of Incisional Hernia in Transverse Incisions",,"Recruiting","No Results Available","Incisional Hernia|Malignancy","Procedure: Mass closure technique|Procedure: Layered closure technique","Incisional hernia|Quality of life|Surgical site infection|Severe postoperative morbidity|Duration of hospitalization","Medical University of Warsaw|National Science Centre, Poland","All","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","392","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","1WB1/3D179|2017/26/D/NZ5/00733","September 1, 2018","May 30, 2021","May 30, 2021","June 19, 2018",,"December 3, 2019","Department of General, Transplant and Liver Surgery, Warsaw, Mazowieckie, Poland",,"https://ClinicalTrials.gov/show/NCT03561727"
675,"NCT02301741","Using an Interactive Game to Reduce Fear and Increase Spine Motion in Low Back Pain",,"Completed","No Results Available","Low Back Pain","Behavioral: Game","Lumbar spine flexion changes|Expectation of pain changes|Expectation of harm changes|Lumbar spine flexion change as a function of altered movement gain","Ohio University","All","18 Years to 50 Years   (Adult)","Not Applicable","53","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Basic Science","R21AR064430-01A1","January 2015","April 2016","April 2016","November 26, 2014",,"June 13, 2016","Ohio University, Athens, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT02301741"
676,"NCT02427672","The Effect of Prefrontal Cortex Stimulation on Antisocial and Aggressive Behavior",,"Completed","Has Results","Antisocial Behavior|Aggression","Device: Transcranial direct current stimulation|Device: Sham transcranial direct current stimulation","Change in Antisocial Behavior Inclinations at 24 Hours|Number of Pins Inserted Into a Virtual Voodoo Doll at 24 Hours","University of Pennsylvania","All","18 Years and older   (Adult, Older Adult)","Not Applicable","84","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","821313","March 2015","December 2017","December 2018","April 28, 2015","August 28, 2019","August 28, 2019","University of Pennsylvania, Philadelphia, Pennsylvania, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/72/NCT02427672/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02427672"
677,"NCT02706990","Fluoroscopic Analysis of Total Knee Replacement With a Kinematic Retaining or a Posterior Stabilized Design",,"Completed","No Results Available","Total Knee Replacement","Device: Physica KR|Device: Physica PS","Assessment of the roll-back mechanism measured with the tibio-femoral contact points at different degrees of flexion","Limacorporate S.p.a","All","Child, Adult, Older Adult","Not Applicable","34","Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","K-10","January 2016","March 2016","March 2016","March 11, 2016",,"March 7, 2017","Ospedale San Camillo, Trento, Italy",,"https://ClinicalTrials.gov/show/NCT02706990"
678,"NCT01312610","Orange Juice Consumption and Cognitive Function","OJOC","Completed","No Results Available","Nerve Degeneration","Dietary Supplement: High flavanone orange juice|Dietary Supplement: Control orange juice","Executive function - Attention|Plasma flavanones|Blood pressure","University of Reading","All","60 Years to 75 Years   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","UReading_2010_OJOC","September 2010","August 2011","September 2011","March 10, 2011",,"November 23, 2011","University of Reading, Reading, Berkshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT01312610"
679,"NCT00164437","CD-ROM Intervention for Prostate Cancer Screening",,"Completed","No Results Available","Prostate Cancer","Behavioral: educational CD-ROM","prostate cancer knowledge,|ability to make an informed decision about prostate cancer screning,|decisional conflict,|realistic expectations|costs","Centers for Disease Control and Prevention|University of Colorado, Denver","Male","45 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","554","U.S. Fed|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Educational/Counseling/Training","CDC-NCCDPHP-4020|U48/CCU815787","September 2002",,"September 2004","September 14, 2005",,"September 14, 2005","University of Colorado Health Sciences Center, Denver, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT00164437"
680,"NCT02482571","Metabolic Changes in the Activated Human Visual Cortex During Mild Hypoxia",,"Completed","Has Results","Brain Hypoxia","Device: Mild Hypoxia","Change in Glutamate Concentration During a Visual Stimulus Measured by fMRS at Normoxia|Change in Glutamate Concentration During a Visual Stimulus Measured by Functional MRS at Hypoxia|Brain Activity Measured by Blood Oxygenation Level Dependent (BOLD) Signal at Normoxia|Brain Activity Measured by Blood Oxygenation Level Dependent (BOLD) Signal at Hypoxia","University of Minnesota","Male","18 Years to 40 Years   (Adult)","Not Applicable","25","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","201503M65382","August 13, 2015","September 26, 2016","September 26, 2016","June 26, 2015","May 24, 2018","March 19, 2019","Center for Magnetic Resoance Research, University of Minnesota, Minneapolis, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT02482571"
681,"NCT03163004","Implementation of Standing Desks at School",,"Completed","No Results Available","Health Behavior","Behavioral: Implementation of standing desks","Decrease in children's sedentary time during school hours|Possible decrease in TV time on week- and weekend days|Possible decrease in computer time on week- and weekend days|Increase in the number of breaks in sedentary activities|Improvement of determinants related to breaking up sedentary activities|Improvement in school well-being","University Ghent","All","9 Years to 18 Years   (Child, Adult)","Not Applicable","343","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","FWO13/PDO/191 second term","October 1, 2016","June 30, 2017","June 30, 2017","May 22, 2017",,"October 24, 2017","Ghent University, Department of Movement and Sports Sciences, Ghent, Belgium",,"https://ClinicalTrials.gov/show/NCT03163004"
682,"NCT01705015","Organ Transplantation Rehabilitation: Effect of Bedside Exercise Device and Activity Reinforcement",,"Unknown status","No Results Available","Heart Transplantation|Liver Transplantation","Behavioral: direct feedback about exercise|Behavioral: PLacebo","A.Level of independence for walking 150 feet and the ratio of subjects who achieve independence in walking 150 feet. B. Walking speed for 50 feet. C. 6-minute walk test. D. Findings of cardiopulmonary exercise testing|A.Total amount of exercise. B.Short Form-36. C. Length of stay in the intensive care unit and hospital. D.Rate of rehospitalization. E.Adverse responses and complications related to exercise.","National Taiwan University Hospital|National Science Council, Taiwan","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","110","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","NSC101-2314-B-002-006-MY3","September 2012","August 2015",,"October 12, 2012",,"October 16, 2012","National Taiwan University Hospital, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT01705015"
683,"NCT01434862","Pramlintide Combined With Model Predictive Control Algorithm","ALM002","Terminated","No Results Available","Type 1 Diabetes Mellitus","Drug: Closed loop with pramlintide|Device: Closed loop without pramlintide|Drug: Open loop with pramlintide","Percent of Blood glucose tests within target range of 70 to 180 mg/dl|Percent of Continuous Glucose Monitoring (CGM) System estimated blood glucose within target range of 70 to 180 mg/dl","University of Virginia|The Paul Manning Foundation","All","21 Years to 65 Years   (Adult, Older Adult)","Not Applicable","2","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","15401","February 2011","February 2012","February 2012","September 15, 2011",,"May 1, 2014","University of Virginia, Center for Diabetes Technology, Charlottesville, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT01434862"
684,"NCT03884985","Eye Movements, Visual Perception and Attention",,"Recruiting","No Results Available","Vision","Other: Visual stimulation","Average Performance in Visual tasks|Microsaccades rate","University of Rochester|National Eye Institute (NEI)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","RSRB00069578|R01EY029788-01","January 1, 2015","February 1, 2023","February 1, 2023","March 21, 2019",,"March 16, 2020","University of Rochester, Rochester, New York, United States",,"https://ClinicalTrials.gov/show/NCT03884985"
685,"NCT02398422","The Listening Project at Reiss-Davis/Vista Del Mar Child and Family Services",,"Completed","No Results Available","Auditory Perceptual Disorders|Stress Disorder","Behavioral: Listening Project Protocol","Change from baseline in auditory hypersensitivity at 1 week, and at 2 months|Change from baseline in state regulation at 1 week, and at 2 months|Change from baseline in auditory processing at 1 week, and at 2 months|Change from baseline in social behavior at 1 week, and at 2 months|Change from baseline in middle ear transfer function at 1 week, and at 2 months","University of North Carolina, Chapel Hill|Reiss-Davis Child Study Center of Vista Del Mar","All","6 Years to 17 Years   (Child)","Not Applicable","15","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","14-3268","October 2015","December 2018","December 2018","March 25, 2015",,"November 13, 2019","Reiss-Davis / Vista del Mar Child and Family Services, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT02398422"
686,"NCT03230253","Effects and Mechanism of Two Hybrid Exercise-cognitive Trainings in Mild Ischemic Stroke With Cognitive Decline",,"Recruiting","No Results Available","Stroke Patients With Cognitive Decline","Behavioral: Sequential training|Behavioral: Dual training|Behavioral: Control training","fMRI (change is being assessed)|Serum BDNF level|Antioxidative marker|Glucose indicator|Plasma lipid level|Montreal Cognitive Assessment (MoCA)|Wechsler Memory Scale - Third Edition (WMS-III)|Wechsler Adult Intelligence Scale - Third Edition (WAIS-III)|Useful Field of View (UFOV)|Stroop Color-Word test|Dual-task test|Time up and go test (TUG)|Six-minute walk test (6MWT)|International Physical Activity Questionnaires (IPAQ)|Fugl-Meyer Assessment (FMA)|Rivermead Mobility Index (RMI)|Muscle strength|Mobility level|Functional Independence Measure (FIM)|Lawton Instrumental Activities of Daily Living Scale (Lawton LADL)|Stroke Impact Scale (SIS)|Caregiver Burden Scale (CB scale)|EuroQol-5D questionnaire (EQ-5D)","Chang Gung Memorial Hospital","All","20 Years to 80 Years   (Adult, Older Adult)","Not Applicable","75","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","KMUHIRB-F(II)-20170040","April 19, 2018","July 31, 2020","July 31, 2020","July 26, 2017",,"June 24, 2020","Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan",,"https://ClinicalTrials.gov/show/NCT03230253"
687,"NCT04293705","Pediatric Ataxias and Rehabilitation of Behavioral Problems (TOPS)","TOPS","Recruiting","No Results Available","Acquired Brain Injury|Congenital Brain Damage","Device: Teen On-line Problem Solving","Behavior Rating Inventory of Executive Function Second Edition (BRIEF 2) - parent form - baseline|Behavior Rating Inventory of Executive Function Second Edition (BRIEF 2) - parent form - change at 6 months|Behavior Rating Inventory of Executive Function Second Edition (BRIEF 2) - parent form - change at 12 months|Behavior Rating Inventory of Executive Function Second Edition (BRIEF 2) - self report form - baseline|Behavior Rating Inventory of Executive Function Second Edition (BRIEF 2) - self report form - change at 6 months|Behavior Rating Inventory of Executive Function Second Edition (BRIEF 2) - self report form - change at 12 months|Child Behavior Checklist 6-18 (CBCL 6-18) - baseline|Child Behavior Checklist 6-18 (CBCL 6-18) - change at 6 months|Child Behavior Checklist 6-18 (CBCL 6-18) - change at 12 months|Youth Self-Report 11-18 (YSR 11-18) - baseline|Youth Self-Report 11-18 (YSR 11-18) - change at 6 months|Youth Self-Report 11-18 (YSR 11-18) - change at 12 months|Back Anxiety Inventory (BAI) - baseline|Back Anxiety Inventory (BAI) - change at 6 months|Back Anxiety Inventory (BAI) - change at 12 months|Symptom Checklist 90 (SCL-90) - baseline|Symptom Checklist 90 (SCL-90) - change at 6 months|Symptom Checklist 90 (SCL-90) - change at 12 months|Parenting Stress Index (PSI) - Short Form - baseline|Parenting Stress Index (PSI) - Short Form - change at 6 months|Parenting Stress Index (PSI) - Short Form - change at 12 months|Jansari Assessment of Executive Functioning - Adolescents (JEF-A) - baseline|Jansari Assessment of Executive Functioning - Adolescents (JEF-A) - change at 6 months|Jansari Assessment of Executive Functioning - Adolescents (JEF-A) - change at 12 months|A Developmental NEuroPSYchological Assessment-II (NEPSY-II) (Theory of Mind and Emotion Recognition subscales) - baseline|A Developmental NEuroPSYchological Assessment-II (NEPSY-II) (Theory of Mind and Emotion Recognition subscales) - change at 6 months|A Developmental NEuroPSYchological Assessment-II (NEPSY-II) (Theory of Mind and Emotion Recognition subscales) - change at 12 months","IRCCS Eugenio Medea","All","11 Years to 19 Years   (Child, Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","350","February 16, 2018","September 27, 2020","September 27, 2020","March 3, 2020",,"March 3, 2020","Scientific Institute IRCCS E. Medea, Bosisio Parini, Lecco, Italy",,"https://ClinicalTrials.gov/show/NCT04293705"
688,"NCT03143764","Cardiorespiratory Fitness Using Electrically Assisted Bicycles",,"Completed","No Results Available","Diabetes Mellitus, Type 2","Behavioral: Commuting with electrically assisted bicycles","examine cycling time|examine cycling distance|examine changes in cardiorespiratory fitness","University of Bergen|The GC Rieber Funds|Bergen Council|Helse Stavanger HF|Kristiansand Zoo and Amusement park|National Oilwell Varco Norway AS|General Practitioner-scholarship from the Norwegian Medical Association.|Department of Global Public Health and Primary Care, University of Bergen|Department of Education and Sports Science, University of Stavanger|Department of Sports and Physical Activity, Bergen University College","All","18 Years to 67 Years   (Adult, Older Adult)","Not Applicable","25","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","UBergenElsykkel","September 1, 2014","June 15, 2015","December 1, 2016","May 8, 2017",,"May 8, 2017","Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway|Department of Public Health, Sport and Nutrition, University of Agder, Kristiansand, Norway|Department of Education and Sports Science, University of Stavanger, Stavanger, Norway",,"https://ClinicalTrials.gov/show/NCT03143764"
689,"NCT03141281","Intervention Comparative Effectiveness for Adult Cognitive Training","ICE-ACT","Completed","No Results Available","Cognitive Aging","Behavioral: BrainHQ|Behavioral: Rise of Nations|Behavioral: IADL Training|Behavioral: Active Control","Fraud Detection post training|Driving Simulator Hazard Perception post training|Self-reported IADL post training|Speed of Processing post training|Knowledge about Driving post training|Knowledge about Finances and Fraud post training|Fraud Detection at one year|Driving Simulator Hazard Perception at one year|Self-reported IADL task at one year|Speed of Processing at one year|Knowledge about driving at one year|Knowledge about Finances and Fraud at one year|Change in Technology Proficiency post training|Change in Technology Proficiency at one year|Change in Numeracy post training|Change in Numeracy at one year|Change in Reasoning Ability post training|Change in Reasoning Ability at one year|Change in Memory Ability post training|Change in Memory Ability at one year|Change in Miami IADL task post training|Change in Miami IADL task at one year","Florida State University","All","65 Years and older   (Older Adult)","Not Applicable","238","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science","2017.20622","September 20, 2017","September 3, 2019","September 3, 2019","May 5, 2017",,"September 9, 2019","Florida State University, Tallahassee, Florida, United States","""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/81/NCT03141281/ICF_000.pdf|""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/81/NCT03141281/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT03141281"
690,"NCT02783794","BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer",,"Completed","No Results Available","Metastatic Breast Cancer|Stage IV Breast Cancer","Drug: BP-C1|Drug: Placebo","Change (%) in the sum of diameters of target lesions|Number of target lesions|Number of non-target lesions|Treatment response|Karnofsky Performance Status (KPS) score|Changes in the scores of the general questionnaire EORTC QLQ-C30 (""Physical activity problem last week"", ""Discomfort last week"", ""Health and quality of life"")|Changes in three separate scores of the specific questionnaire EORTC QLQ-BR23 (""Breast cancer treatment problem last week"", ""Sexual interest and activity last four weeks"", ""Breast cancer related pain and discomfort last week"")|Change in Maximum Common Toxicity Criteria (CTC) score|Sum CTC score|Number of registered adverse events","Meabco A/S|Meddoc|Norwegian University of Life Sciences","Female","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","36","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","BMC2011-1","December 24, 2012","February 28, 2014","February 28, 2014","May 26, 2016",,"October 10, 2019","Russian Oncological Research Centre n.a. N.N. Blokhin, Russian Academy of Medical Science (RAMS), Moscow, Russian Federation|State Budgetary Institution of Nizhniy Novgorod Region ""Oncology Dispensary of Nizhniy Novgorod"" (Branch nr.1), Nizhniy Novgorod, Russian Federation|St. Petersburg State Budgetary Health Organization, City Clinical Oncology Dispensary, St Petersburg, Russian Federation|Leningrad Regional Oncological Centre, St. Petersburg, Russian Federation|Siriraj Hospital, Mahidol University, Bangkok, Thailand|Udon Thani Cancer Hospital, Udon Thani, Thailand",,"https://ClinicalTrials.gov/show/NCT02783794"
691,"NCT02668926","Endocrine and Emotional Effects of Lisdexamfetamine and d-Amphetamine.","LisDex","Completed","No Results Available","Healthy","Drug: Lisdexamfetamine, d-amphetamine, Placebo|Drug: d-amphetamine, Placebo, Lisdexamfetamine|Drug: Placebo, Lisdexamfetamine, d-amphetamine","Effects of lisdexamphetamine and d-Amphetamine on circulating steroidal hormones|Subjective effects of lisdexamphetamine and d-amphetamine|Effects of lisdexamphetamine and d-Amphetamine on emotion recognition and empathy","University Hospital, Basel, Switzerland","All","18 Years to 45 Years   (Adult)","Phase 1","24","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","EKNZ 2015-00015","May 2016","June 2016","December 2016","January 29, 2016",,"December 11, 2018","University Hospital Basel, Basel, Basel Stadt, Switzerland",,"https://ClinicalTrials.gov/show/NCT02668926"
692,"NCT04276779","Effects of Alcohol and Mood on Attention",,"Not yet recruiting","No Results Available","Suicidal Ideas","Drug: Alcohol administration|Other: Placebo administration|Behavioral: Positive mood induction|Behavioral: Negative mood induction","Modified Suicide Stroop Task|Brief Hopelessness Measure (Brief-H-Neg)","University of Alabama at Birmingham","All","21 Years to 65 Years   (Adult, Older Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","GRANT13018273","November 2020","November 2024","November 2024","February 19, 2020",,"February 19, 2020",,,"https://ClinicalTrials.gov/show/NCT04276779"
693,"NCT00643266","Recollection Training in Healthy Older Adults and Older Adults With Amnestic Mild Cognitive Impairment",,"Completed","No Results Available","Amnestic Mild Cognitive Impairment|Aging","Behavioral: Recollection Training|Behavioral: Control","Recollection estimates|Brain activation as assessed by functional magnetic resonance imaging|Transfer to other recollection-dependent task and to subjective memory measures","Baycrest","All","65 Years to 90 Years   (Older Adult)","Not Applicable","91","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Basic Science","RecollectionTraining|CIHR MOP 67015|ASC 08 95","February 2008","August 2013","August 2013","March 26, 2008",,"November 16, 2018","Baycrest, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT00643266"
694,"NCT03662425","the Effects of Oxytocin on Negative Symptoms and Cognitive Tasks in Schizophrenia and it's Possible Mechanisms.",,"Recruiting","No Results Available","Schizophrenia","Drug: Oxytocin|Drug: Saline","The Positive and Negative Syndrome Scale (PANSS)|The Clinical Assessment Interview for Negative Symptoms (CAINS)|Reinforcement Learning Task|The Temporal Experience of Pleasure Scale (TEPS)|Interpersonal Reactivity Index (IRI)|Toronto Alexithymia Scale (TAS)","Shanghai Mental Health Center|Chinese Academy of Sciences","Male","18 Years to 55 Years   (Adult)","Not Applicable","104","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","KLMH2018K02","July 21, 2018","December 2020","December 2020","September 7, 2018",,"December 9, 2019","Shanghai Mental Health Center, Shanghai, Shanghai, China",,"https://ClinicalTrials.gov/show/NCT03662425"
695,"NCT02249299","Experimental Medicine in ADHD - Cannabinoids","EMA-C","Unknown status","No Results Available","Attention Deficit Hyperactivity Disorder (ADHD)","Drug: Sativex Oromucosal Spray|Drug: Placebo","Change in performance on the QB Test using the average of 3 weighted indexes: 'activity' 'inattention' and 'impulsivity'|ADHD symptoms of inattention, hyperactivity-impulsivity and emotional lability|Self-report behavioural questionnaire|Self-report behavioural questionnaires|Change in cognitive performance","King's College London|South London and Maudsley NHS Foundation Trust","All","18 Years to 55 Years   (Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","EMA-C","August 2014","August 2015","December 2015","September 25, 2014",,"September 25, 2014","Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02249299"
696,"NCT04254302","Using Telerehabilitation to Support Families of Children With Motor Difficulties Aged 3-8 Years Old","WeCare","Recruiting","No Results Available","Motor Disorders","Other: WECARE web platform","Canadian Occupational Performance Measure (COPM)|Pediatric Evaluation of Disability Inventory - computer adaptive test (PEDI-CAT)|Parental Knowledge and Skills Questionnaire (PKSQ)|Parental Stress Scale (PSS)|Six Dimension Short-Form Health Survey (SF-6D)|Health-Related Quality of Life Utility Measure for Pre-School Children (HuPS)","Université de Sherbrooke|Canadian Institutes of Health Research (CIHR)","All","3 Years to 8 Years   (Child)","Not Applicable","118","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","2020-3429","February 20, 2020","June 1, 2021","June 1, 2021","February 5, 2020",,"February 21, 2020","Centre de recherche du CHUS, Sherbrooke, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT04254302"
697,"NCT01294813","Bronchoscopy and Electric Impedance Tomography (EIT) Pilot Study","Broncho-EIT","Unknown status","No Results Available","Electric Impedance Tomography|Bronchoscopy|Change in Lung Impedance Due to Ventilation|Recruitment|Improvement the Treatment of the Patient","Device: Electrical Impedance Tomography (EIT)","Comparison of the change in lung impedance due to ventilation before and after bronchoscopy by EIT measurements","RWTH Aachen University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","Bronchoscopy- EIT","January 2011","April 2011","April 2011","February 14, 2011",,"February 16, 2011","Faculty Medical Clinic 1, University Hospital Aachen, Aachen, Nordrhein-Westfalen, Germany",,"https://ClinicalTrials.gov/show/NCT01294813"
698,"NCT01484834","Comparison of Interventions to Promote Health in Workers",,"Completed","Has Results","Health Behavior","Behavioral: Exercise and Education|Behavioral: Exercise|Behavioral: Educational Intervention|Other: Control Company","Quality of Life|Physical Activity Level|Occupational Environment|Changes in Disease Prevalence|Pain Perception","Universidade Metodista de Piracicaba","All","18 Years to 50 Years   (Adult)","Not Applicable","190","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","UMetodistaPiracicaba-2011","August 2011","November 2011","November 2011","December 2, 2011","August 15, 2017","August 15, 2017","Universidade Metodista de Piracicaba, Piracicaba, São Paulo, Brazil",,"https://ClinicalTrials.gov/show/NCT01484834"
699,"NCT04280523","TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH","TYEGER","Not yet recruiting","No Results Available","Pulmonary Arterial Hypertension","Drug: ESR-specific PET scan","To correlate lung ESR density with pulmonary vascular resistance (PVR)|Survival at one year","Vanderbilt University Medical Center","All","13 Years and older   (Child, Adult, Older Adult)","Phase 2","40","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","191946","August 20, 2020","October 2024","October 2024","February 21, 2020",,"April 24, 2020","Vanderbilt University Medical Center, Nashville, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT04280523"
700,"NCT04273841","Impact of Sleep Deprivation and Caffeine in Medical Professionals",,"Recruiting","No Results Available","Sleep Deprivation|Performance","Dietary Supplement: Military Energy Gum|Dietary Supplement: Placebo Gum","Psychomotor Vigilance Task|Clinical Reasoning Questions|Actigraphy|Polysomnography|Structural Brain Scan-functional MRI","Walter Reed Army Institute of Research (WRAIR)","All","18 Years to 50 Years   (Adult)","Not Applicable","42","U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","WRAIR #2311","July 6, 2017","October 12, 2021","October 12, 2021","February 18, 2020",,"February 18, 2020","WRAIR Sleep Research Center, Silver Spring, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT04273841"
701,"NCT01937910","Neuroplastic Change in Myelin of the Brain","Myelin","Unknown status","No Results Available","Stroke","Behavioral: TRAIT Task","Change in Myelin water fraction|Change in Fractional anisotropy","University of British Columbia|Canadian Institutes of Health Research (CIHR)","All","40 Years to 75 Years   (Adult, Older Adult)","Not Applicable","88","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science","H13-01952","September 2014","September 2017","September 2018","September 10, 2013",,"January 10, 2017","University of British Columbia, Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT01937910"
702,"NCT02089672","RF Lesion Monitoring With 8mm IntellaTip MiFi XP",,"Completed","No Results Available","Atrial Flutter|Arrhythmia","Device: Catheter ablation","Total bipolar electrogram amplitude using tip to ring and pin to pin configurations|Total number of seconds per isthmus ablation spent in excess of the post-hoc identified complete lesion time.","Emory University|Boston Scientific Corporation","All","18 Years and older   (Adult, Older Adult)",,"30","Other|Industry","Observational","Observational Model: Case-Only|Time Perspective: Retrospective","IRB00069674|ISRCRM90003","April 2014","November 2015","November 2015","March 18, 2014",,"November 17, 2015","Emory University Hospital, Atlanta, Georgia, United States",,"https://ClinicalTrials.gov/show/NCT02089672"
703,"NCT02632838","Improve Hypertension Monitoring and Self-management by Using mHealth",,"Completed","Has Results","Hypertension","Device: iHealth BP7-Wireless Blood Pressure Wrist Monitor,","Blood Pressure (BP) Change|Blood Pressure Monitoring Adherence","Rutgers, The State University of New Jersey","All","18 Years to 64 Years   (Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","Pro20150001419","January 2016","September 2017","November 2017","December 17, 2015","June 19, 2018","June 19, 2018","Peijia Zha, Newark, New Jersey, United States","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/38/NCT02632838/Prot_000.pdf|""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/38/NCT02632838/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT02632838"
704,"NCT01957800","Weight Loss and Healthy Diet Through Mobile Phone-enabled Social Interactions",,"Completed","No Results Available","Overweight|Obese","Behavioral: Website|Behavioral: Usual Care","Body Weight","Milton S. Hershey Medical Center|Penn State University","All","21 Years to 65 Years   (Adult, Older Adult)","Not Applicable","102","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","43474EP","October 2013","November 2014","November 2014","October 8, 2013",,"September 1, 2015","Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT01957800"
705,"NCT01010009","The Cognitive and Cerebral Blood Flow Effects of Resveratrol",,"Completed","Has Results","Cognitive and Cerebral Blood Flow Effects of Resveratrol","Dietary Supplement: Trans- resveratrol|Other: Placebo (silica)","Modulation of Levels of Total Haemoglobin|Modulation of Deoxygenated Levels of Haemoglobin|Number of Participants With Significant Modulation of Cognitive Performance","Northumbria University","All","18 Years to 35 Years   (Adult)","Not Applicable","24","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","22P2","June 2008","March 2009","March 2009","November 9, 2009","April 18, 2011","May 23, 2012","Northumbria University, Newcastle upon Tyne, United Kingdom",,"https://ClinicalTrials.gov/show/NCT01010009"
706,"NCT03637452","Baby Albert: Electronic Cigarette Pharmacokinetics (PK) and Abuse Liability",,"Recruiting","No Results Available","Tobacco Use",,"Nicotine delivery measured by serum (blood) nicotine|Proportion of puffs earned and allocated to each product in three hypothetical tobacco regulatory scenarios","University of Oklahoma","All","18 Years to 99 Years   (Adult, Older Adult)",,"30","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","8988","November 12, 2018","May 31, 2019","May 31, 2019","August 20, 2018",,"May 9, 2019","University of Oklahoma Health Sciences Center Tobacco Research Center, Oklahoma City, Oklahoma, United States",,"https://ClinicalTrials.gov/show/NCT03637452"
707,"NCT04279158","Attention Modulation of Local and Global Inhibition Mechanisms","MILGattention","Not yet recruiting","No Results Available","Optical Phenomena","Behavioral: experience 1 ""The negative priming task""|Behavioral: experience 2 ""Stop signal task""|Behavioral: experience 3 ""Anti-saccades""","error rate|reaction time","Hospices Civils de Lyon","All","8 Years to 75 Years   (Child, Adult, Older Adult)","Not Applicable","120","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","69HCL19_0728|2019-A03055-52","September 2020","September 2026","September 2026","February 21, 2020",,"April 9, 2020","Centre de Recherche en Neuroscience de Lyon, Bron, France",,"https://ClinicalTrials.gov/show/NCT04279158"
708,"NCT03924765","Assistive Hip Exoskeleton Study for Stroke",,"Recruiting","No Results Available","Lower Limb Injury|Stroke","Device: Powered hip exoskeleton","Walking Speed","Georgia Institute of Technology","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","5","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","H19179","July 24, 2019","December 31, 2021","April 30, 2023","April 23, 2019",,"March 17, 2020","Exoskeleton and Prosthetic Intelligent Controls Lab, Atlanta, Georgia, United States",,"https://ClinicalTrials.gov/show/NCT03924765"
709,"NCT03924752","Assistive Hip Exoskeleton Study",,"Recruiting","No Results Available","Lower Limb Injury","Device: Powered hip exoskeleton","Walking Speed","Georgia Institute of Technology","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","H19178","August 14, 2019","December 31, 2020","April 30, 2022","April 23, 2019",,"August 20, 2019","Exoskeleton and Prosthetic Intelligent Controls Lab, Atlanta, Georgia, United States",,"https://ClinicalTrials.gov/show/NCT03924752"
710,"NCT02463136","Fmri-based Neurofeedback With Anxious Adolescents Study","NF-AA","Unknown status","No Results Available","Anxiety","Behavioral: questionnaires|Device: Functional magnetic resonance imaging w neurofeedback","Proof of concept for using NF in anxious adolescents|Improved emotion regulation skills (questionnaires, behavioural tasks)|Successful reduction in anxious mood (questionnaire)|Demographics (Demographic questionnaire)|Thought control abilities (questionnaire)|IQ levels (Wechsler Abbreviated Intelligence Scale)|Emotion regulation skills (Cognitive Emotion Regulation Questionnaire)|Mood and feelings (Moods and feelings questionnaire)|Debriefing interview questionnaire","University of Oxford|King's College London|Cardiff University","Female","14 Years to 17 Years   (Child)","Phase 1","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","MSD-IDREC-C2-2013-014","November 2015","October 2017","October 2017","June 4, 2015",,"November 10, 2016","University of Oxford, Oxford, Oxfordshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02463136"
711,"NCT03010189","Actigraphy and Nocturnal Heartrate Variability in Cluster Headache Patients",,"Completed","No Results Available","Cluster Headache|Sleep","Device: Actigraphy|Device: Heart-rate variability monitoring|Device: Pupillometry","Change in pupillary average contraction velocity|Change in total sleep time|Change in sleep efficiency|Change in wake after sleep onset|Change in LF/HF ratio","Nordlandssykehuset HF|University of Tromso","All","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2015/1789(REK)","January 2017","December 2018","December 2018","January 4, 2017",,"March 21, 2019","Nordland Hospital Trust, Bodo, Nordland, Norway",,"https://ClinicalTrials.gov/show/NCT03010189"
712,"NCT03943706","E-Cigarette and Cigarette Nicotine Delivery and Abuse Liability in Cigarette Smokers and Dual Users",,"Not yet recruiting","No Results Available","Tobacco Use",,"Nicotine delivery measured by serum (blood) nicotine|Proportion of puffs earned and allocated to each product in three hypothetical tobacco regulatory scenarios","University of Oklahoma","All","18 Years to 50 Years   (Adult)",,"40","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","8841","June 1, 2019","December 1, 2019","December 1, 2019","May 9, 2019",,"May 9, 2019","University of Oklahoma Health Sciences Center Oklahoma Tobacco Research Center, Oklahoma City, Oklahoma, United States",,"https://ClinicalTrials.gov/show/NCT03943706"
713,"NCT01831622","Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder",,"Completed","No Results Available","Attention Deficit-Hyperactivity Disorder","Drug: Ritalin|Drug: Placebo","Effect of ADHD medication on decision making","Mats Fredriksen|The Research Council of Norway|The Hospital of Vestfold|Norwegian Institute of Public Health|University of Oslo","All","18 Years to 40 Years   (Adult)","Phase 4","131","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science","2012-005246-38|2012/1105-8|2011/1585-10","June 2013","June 2015","June 2015","April 15, 2013",,"December 2, 2015","Department of Psychology, University of Oslo, Oslo, Norway|Adult ADHD diagnostic clinic, Vestre Viken Hospital Trust, Tønsberg, Norway",,"https://ClinicalTrials.gov/show/NCT01831622"
714,"NCT00819949","Effect of Robot-assisted Gait Training on Freezing of Gait in Parkinson's Disease",,"Completed","No Results Available","Parkinson's Disease","Device: Lokomat","Freezing of Gait","US Department of Veterans Affairs|VA Office of Research and Development","All","18 Years to 85 Years   (Adult, Older Adult)","Phase 1|Phase 2","20","U.S. Fed","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science","B4125-K","October 2008","October 2010","October 2010","January 9, 2009",,"September 20, 2013","Providence VA Medical Center, Providence, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT00819949"
715,"NCT02193906","Neuropsychological Profile of a Patient's Group With Multiple Sclerosis and Effect of a Cognitive Rehabilitation Program","MS_Rehab","Unknown status","No Results Available","Cognitive Dysfunction","Other: Cognitive training|Other: Placebo task","Effect of an intensive cognitive rehabilitation program in neuropsychological performance of a population of patients with multiple sclerosis or clinical isolated syndrome.|Neuropsychological profile of a population of patients with multiple sclerosis or clinical isolated syndrome.|Percentage of patients with Cognitive Dysfunction|Relation between Expended Disability Status Scale score and cognitive dysfunction.|Impact of depression on neuropsychological performance.|Relation between cognitive dysfunction and the 9-hole peg test.|Relation between cognitive dysfunction and the 25-foot walk test.","Aveiro University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","75","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","MSR-2013","December 2012","June 2013","December 2014","July 18, 2014",,"July 18, 2014",,,"https://ClinicalTrials.gov/show/NCT02193906"
716,"NCT01433666","Roflumilast and Cognition","EEGrofl","Completed","No Results Available","Dementia","Drug: roflumilast (EU: Daxas, USA: Daliresp)|Drug: Placebo|Drug: roflumilast","Number of words remembered on Verbal learning task","Maastricht University Medical Center|ZonMw: The Netherlands Organisation for Health Research and Development","All","18 Years to 35 Years   (Adult)","Phase 2","22","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","METC11-3-035|ZonMw (the Netherlands)|2011-002070-23","September 2011","July 2012","September 2013","September 14, 2011",,"January 2, 2020","Maastricht University, Faculty of Psychology and Neuroscience, Maastricht, Limburg, Netherlands",,"https://ClinicalTrials.gov/show/NCT01433666"
717,"NCT01484457","Controlled Insulin Delivery: Combining Technology With Treatment",,"Completed","No Results Available","Diabetes Mellitus, Type 1","Device: Closed-loop session","Restoration of Euglycemia|Average percent-of-time-in-range (80 - 180 mg/dL)","Sansum Diabetes Research Institute|Juvenile Diabetes Research Foundation|Schneider Children's Medical Center, Israel","All","18 Years and older   (Adult, Older Adult)","Early Phase 1","19","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","JDRF 22-2009-796","July 2008","January 2010","January 2010","December 2, 2011",,"June 7, 2012","Sansum Diabetes Research Institute, Santa Barbara, California, United States|Schneider Children's Medical Center of Israel, Petah Tikva, Israel",,"https://ClinicalTrials.gov/show/NCT01484457"
718,"NCT00258869","Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests",,"Unknown status","No Results Available","Sepsis|Septicemia|Sepsis Syndrome|Shock, Septic|Community Acquired Pneumonia",,"Death|Septic Shock|Severe Sepsis|Time to death|Time to severe sepsis|Severe sepsis|Time to septic shock|Septic shock|Cryptic shock (ScvO2<65 or Lactate >2.5 and MAP >65 mmHg [>18 years of age] or SBP >90 [<18 years of age])|Time to Cryptic shock (ScvO2<65 or Lactate >2.5 and MAP >65 mmHg [>18 years of age] or SBP >90 [<18 years of age])|Hospitalization|Length of hospital stay|ICU admission|Length of ICU admission|Disposition|Renal dysfunction|Respiratory dysfunction|Hematology dysfunction|Metabolic dysfunction|Renal SOFA score|Lung SOFA score|Coagulation SOFA score|Liver SOFA score|CVS SOFA score|Time to respiratory SOFA Score|Time to coagulation SOFA score|Time to liver SOFA score|Time to CVS SOFA score|Time to Renal SOFA score|DIC score >5 (modified ISTH scoring system)|Time to DIC score > 5|Development of ALI|Development of ARDS|Time to ALI|Time to ARDS|Ventilator|Ventilator days|MELD score|Effect of early goal directed therapy on primary and secondary end-points|Effect of Activated Protein C on primary and secondary end-points|Effect of stress-dose corticosteroids on primary and secondary end-points|Effect of intensive glycemic control on primary and secondary end-points|APACHE II score|PRISM III score|SOFA score|CAP mortality|CAP and severe sepsis|CAP and septic shock|Severe CAP (ATS criteria)|Severe CAP (BTS criteria)|Pneumococcal sepsis|Staphylococcus aureus sepsis|Gram negative rod sepsis|Fungal sepsis|SeptiFast result|Microbiologic culture result|Urinary legionella antigen|Microbiologic culture|CAP, time to death|CAP, mortality|CAP, time to severe sepsis|CAP, severe sepsis|CAP, time to septic shock|CAP, septic shock|Time to severe CAP (ATS and BTS criteria)|Severe CAP (ATS and BTS criteria)|CAP, mechanical ventilation|CAP, time to mechanical ventilation|CAP, length of mechanical ventilation|CAP, SOFA respiratory score > 2|CAP, respiratory component of severe sepsis criteria|CAP, hospitalized|CAP, length of hospitalization|CAP, ICU admission|CAP, length of ICU stay|CAP, Disposition|CAP, ALI|CAP, ARDS|CAP, time to ARDS|CAP, time to ALI|CAP, PORT score","National Center for Genome Resources|National Institute of Allergy and Infectious Diseases (NIAID)|Duke University|Henry Ford Hospital|Durham VA Medical Center|Pfizer|Hoffmann-La Roche","All","6 Years and older   (Child, Adult, Older Adult)",,"1200","Other|NIH|U.S. Fed|Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","0001|U01AI066569","December 2005","July 2010","July 2010","November 28, 2005",,"November 9, 2010","Henry Ford Hospital, Detroit, Michigan, United States|Duke University Medical Center, Durham, North Carolina, United States|Durham VA Medical Center, Durham, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT00258869"
719,"NCT02714426","A 14 Week Study of Mindfulness Effects on Attentional Control in Older Adults","MACS","Completed","Has Results","Cognitive Aging","Behavioral: Mindfulness-inspired treatment|Other: Brain health","Performance in Attention Network Task Conflict Monitoring Over 14 Weekly Measurements|Performance in Useful Field of View Over 14 Weekly Measurements|Performance in Stroop Interference Over 14 Weekly Measurements","University of Florida|National Institute on Aging (NIA)","All","65 Years and older   (Older Adult)","Not Applicable","42","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science","IRB02-2016-U-0277-N|1F31AG051356-01A1|IRB201800586","November 2016","February 28, 2018","February 28, 2018","March 21, 2016","February 21, 2019","March 7, 2019","The Vital Laboratory at the The Village, Gainesville, Florida, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/26/NCT02714426/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02714426"
720,"NCT01046630","Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects",,"Completed","No Results Available","Depression","Drug: AZD6765|Drug: Ketamine|Drug: Placebo","Measurements of BOLD signal in the brain area BA25|Measurements of symptoms of depression using Montgomery-Asberg Depression Rating Scale and Beck Depression Inventory total score|Responses on a computer based battery of behavioral tasks|Pharmacokinetics of AZD6765","AstraZeneca|University of Manchester|University of Oxford","All","18 Years to 45 Years   (Adult)","Phase 1","128","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","D2285C00001","December 2009","March 2011","March 2011","January 12, 2010",,"October 13, 2014","Research Site, Manchester, United Kingdom|Research Site, Oxford, United Kingdom",,"https://ClinicalTrials.gov/show/NCT01046630"
721,"NCT00603070","Electronic Prescribing and Electronic Transmission of Discharge Medication Lists",,"Completed","No Results Available","Medication Errors","Other: E-prescribing system|Other: Electronic transmission of medication discharge lists","Prescription medication errors|Medication discrepancies (as detected on a comparison between inpatient and outpatient medical records)|Patient adverse drug events (as determined by patient telephone interview and medical record review)|Human-Computer interactions as measured by physician interview and direct observation of physician work","Weill Medical College of Cornell University|Agency for Healthcare Research and Quality (AHRQ)|New York Presbyterian Hospital|Columbia University|Oregon Health and Science University","All","Child, Adult, Older Adult",,"130","Other|U.S. Fed","Observational","Observational Model: Cohort|Time Perspective: Prospective","R18HS017029-01","March 2008","March 2011","March 2011","January 28, 2008",,"February 20, 2012","Weill Cornell Internal Medicine Associates, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT00603070"
722,"NCT02228031","Oxytocin, Emotions and Mirror Neurons",,"Completed","No Results Available","Social Cognition|Expressed Emotion","Drug: Oxytocin|Other: Placebo","EEG mu rhythm suppression","University of Maryland, Baltimore|University of Maryland, College Park","Male","18 Years to 30 Years   (Adult)","Early Phase 1","44","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","HP-00059904","October 2014","August 2016","August 2016","August 28, 2014",,"August 19, 2019","Child Development Lab, University of Maryland, College Park, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT02228031"
723,"NCT01939041","Efficacy of Unilateral Versus Bilateral Approach to Robot-Assisted Rehabilitation in Patients With Subacute Stroke",,"Withdrawn","No Results Available","Subacute Stroke","Device: InMotion3 (IMT)|Device: Bi-Manu-Track (BMT)|Behavioral: Control intervention (CI)","Change of Kinematic analysis|Changes of Fugl-Meyer Assessment (FMA)|Changes of Modified Ashworth Scale (MAS)|Changes of MyotonPRO|Changes of Medical Research Council scale (MRC)|Changes of the Jamar dynamometer|Changes of Action Research Arm Test (ARAT)|Changes of Motor Activity Log (MAL)|Changes of ABILHAND Questionnaire|Change of Accelerometers|Changes of Adelaide Activities Profile (AAP)|Change of inflammatory markers|Change of oxidative stress markers|Change of erythrocyte deformability|Change of blood glucose indicators","Chang Gung Memorial Hospital","All","20 Years to 75 Years   (Adult, Older Adult)","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","101-5194A3","August 1, 2013","February 20, 2017","February 20, 2017","September 11, 2013",,"May 19, 2017","Chang Gung Memorial Hospital, Kwei-Shan, Tao-Yuan, Taiwan",,"https://ClinicalTrials.gov/show/NCT01939041"
724,"NCT03058172","Study of Olfaction / Vision Interactions in Expert and Novice Populations",,"Unknown status","No Results Available","Healthy","Other: Odor presentation (for participants' perception)|Other: Image presentation (for participants' perception)","Brain activity|Genotyping|Olfactory abilities|Perception|Response times","Hospices Civils de Lyon","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","120","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","69HCL16_0685","April 15, 2016","March 15, 2019","April 15, 2019","February 20, 2017",,"February 23, 2018","Infirmerie Protestante, Caluire et Cuire, France",,"https://ClinicalTrials.gov/show/NCT03058172"
725,"NCT02252666","Exploring the Use of Non-invasive Neuromodulation Combined With Exercise in People With Advanced Multiple Sclerosis (MS)",,"Completed","Has Results","Multiple Sclerosis","Device: Neuromodulation Rehabilitation","Trunk Impairment Scale (TIS)|Static Standing Balance Test|Impact of Visual Impairment Scale (IVIS)|Medical Outcomes Study (MOS) Pain Effects Scale (PES)|Bladder Control Scale (BLCS)|Bowel Control Scale (BWCS)|Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)|Walking Distance|Walking Speed|12-item MS Walking Scale (MSWS-12)|Box & Blocks (B&B) Assessment - Right|Box & Blocks (B&B) Assessment - Left|Multiple Sclerosis Impact Scale (MSIS-29) - Physical|Multiple Sclerosis Impact Scale (MSIS-29) - Psychological|Modified Fatigue Impact Scale (MFIS)|Gross Motor Function Measure (GMFM)|Slump Test|Modified Rivermead Mobility Index","University of Wisconsin, Madison","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","6","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2013-1060","March 2014","January 2017","June 28, 2017","September 30, 2014","June 28, 2019","July 9, 2019","TCNL, 455 Science Drive, Suite 165, Madison, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT02252666"
726,"NCT01623947","Effects of Sustamine(TM) on Cycling Time Trial Performance",,"Unknown status","No Results Available","Healthy","Dietary Supplement: Placebo Beverage|Dietary Supplement: 2.8 g Sustamine Beverage|Dietary Supplement: 19.6 g Sustamine Beverage","Improved Time Trial Performance|Improved Mental Function","University of Texas at Austin|Kyowa Hakko Bio Co., Ltd.","All","20 Years to 45 Years   (Adult)","Not Applicable","14","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","2012-03-0043","June 2012","October 2012","May 2013","June 20, 2012",,"April 19, 2013","The University of Texas at Austin, Austin, Texas, United States",,"https://ClinicalTrials.gov/show/NCT01623947"
727,"NCT03964350","Behavior Brain Responses","BBR","Recruiting","No Results Available","Alcohol Drinking|Drinking Behavior|Physiological Effects of Drugs|Central Nervous System Depression","Drug: Ethanol|Other: Placebo","Change in Subjective Effects as Assessed by Score on ""Feel Drug"", ""Feel High"", ""Like Drug"", and ""Want More"" Subscales of the Drug Effects Questionnaire","University of Chicago","Male","21 Years to 35 Years   (Adult)","Early Phase 1","30","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","IRB19-0293","May 28, 2019","July 1, 2020","November 1, 2020","May 28, 2019",,"June 13, 2019","University of Chicago, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT03964350"
728,"NCT04287166","Early Remote At-risk Diagnosis for Cerebral Palsy in Follow-up Clinics for High-risk Infants",,"Not yet recruiting","No Results Available","Cerebral Palsy",,"Scorable video for remote GMA|Correlation of computer software data between standard video set-up and handheld smartphone video.|Predictability of GMA and computer-based assessment for development of CP","St. Olavs Hospital|Alesund Hospital|Levanger Hospital","All","up to 2 Months   (Child)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","REK 62240","August 1, 2020","January 2025","January 2025","February 27, 2020",,"February 27, 2020","Department of Pediatrics, Nord-Trøndelag Hospital Trust, Levanger, Norway|Department of Pediatrics, St. Olav's Hospital Trust, Trondheim, Norway|Department of Pediatrics, Møre and Romsdal Hospital Trust, Ålesund, Norway",,"https://ClinicalTrials.gov/show/NCT04287166"
729,"NCT03464292","Spinal and Supra-Spinal Pain Mechanisms in Patients With Fibromyalgia",,"Recruiting","No Results Available","Fibromyalgia|Pain","Drug: Capsaicin Patch 8% or 0.1% Capsaicin Cream|Other: Vehicle Patch","Progression of Temporal Summation of Second Pain","University of Florida","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2","160","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science","IRB201800479|OCR17639","April 16, 2018","April 2021","April 2021","March 14, 2018",,"April 7, 2020","University of Florida, Gainesville, Florida, United States",,"https://ClinicalTrials.gov/show/NCT03464292"
730,"NCT04040257","A Team-based Approach to Improve Knowledge and Judgment Performance in Electronic Fetal Monitoring",,"Completed","No Results Available","Electronic Fetal Monitoring","Behavioral: Team-based approach","The Perinatal Quality Foundation Fetal Monitoring Credentialing (PQF/FMC) Judgement|The Perinatal Quality Foundation Fetal Monitoring Credentialing (PQF/FMC) Knowledge","Yale University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","92","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","2000023716","December 12, 2018","April 12, 2019","April 22, 2019","July 31, 2019",,"July 31, 2019","Yale-New Haven Hospital, New Haven, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT04040257"
731,"NCT01242501","Brief HIV Prevention Counseling for STI Patients in South Africa",,"Completed","No Results Available","Sexually Transmitted Infections","Behavioral: 60 Minute HIV/STI risk reduction counseling|Behavioral: 20-Min education session","Chart abstracted sexually transmitted infections|Sexual behavior change","University of Connecticut|Human Sciences Research Council","All","18 Years and older   (Adult, Older Adult)","Phase 2","617","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","H05-113","August 2005","August 2010","August 2010","November 17, 2010",,"November 17, 2010","University of Connecticut, Storrs, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT01242501"
732,"NCT02470026","Noradrenergic Activity, Cognition and Major Depressive Disorder","YohCog","Completed","No Results Available","Major Depressive Disorder|Early Life Trauma","Drug: yohimbine|Drug: placebo","behavioral responses in two different conditions of noradrenergic stimulation|physiological responses in two different conditions of noradrenergic stimulation","Charite University, Berlin, Germany","All","18 Years to 60 Years   (Adult)","Not Applicable","131","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","KU3106/2-1","June 2014","November 2017","October 2018","June 12, 2015",,"May 23, 2019","Charite University, Berlin, Germany",,"https://ClinicalTrials.gov/show/NCT02470026"
733,"NCT03514186","The Intensive Comprehensive Aphasia Program (ICAP)",,"Active, not recruiting","No Results Available","Aphasia|Stroke","Behavioral: Speech and Language Therapy","Language Quotient of the Western Aphasia Battery-Revised (WAB-R LQ)|Assessment for Living with Aphasia (ALA)|The Communication Confidence Rating Scale for Aphasia (CCRSA)|The Communicative Effectiveness Index (CETI)","Shirley Ryan AbilityLab|Northwestern University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","56","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","81035","July 15, 2015","March 2019","December 2020","May 2, 2018",,"January 21, 2020","Shirley Ryan AbilityLab, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT03514186"
734,"NCT02885961","The Coagulation Cascade in Idiopathic Pulmonary Fibrosis",,"Unknown status","No Results Available","Idiopathic Pulmonary Fibrosis|IPF|Interstitial Lung Disease","Drug: Dabigatran|Radiation: FDG PET scan","Demonstrate a change in FDG (18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose) avidity|Demonstrate changes in various coagulation factors","University College, London","All","40 Years to 80 Years   (Adult, Older Adult)","Not Applicable","12","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","IRAS191454","August 2016","August 2017",,"September 1, 2016",,"September 1, 2016",,,"https://ClinicalTrials.gov/show/NCT02885961"
735,"NCT04296708","ExerCube Training on Executive Functions in Young Athletes",,"Active, not recruiting","No Results Available","Effects of Exergaming on Cognitive Functions in Young Athleten","Other: Exergame Training","FitLight|Test for Attentional Performance|Situation Motivation Scale|Flow Short Scale|Physical Activity Enjoyment Scale|Warwick-Edinburgh Mental Well-being Scale","Swiss Federal Institute of Technology","All","15 Years to 20 Years   (Child, Adult)","Not Applicable","32","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","EK 2019-N-161","January 1, 2020","April 17, 2020","April 17, 2020","March 5, 2020",,"March 5, 2020","Institute of Human Movement Sciences and Sport, ETH Zurich, Zürich, Switzerland",,"https://ClinicalTrials.gov/show/NCT04296708"
736,"NCT02160717","Risk of Diabetes in Young Turner Syndrome Patients",,"Completed","No Results Available","Turner Syndrome",,"Beta-Cell Function measured as Disposition Index","Children's Hospital Medical Center, Cincinnati|National Center for Advancing Translational Science (NCATS)","Female","6 Years to 22 Years   (Child, Adult)",,"120","Other|NIH","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","CCHMC-906|UL1TR000077","May 2014","June 2017","June 2017","June 11, 2014",,"August 23, 2017","Children's Hospital Medical Center, Cincinnati, Cincinnati, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT02160717"
737,"NCT01780519","The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms",,"Completed","No Results Available","Alzheimer's Disease (AD)","Drug: lorazepam","Groton Maze Learning Test (GMLT) score|Auditory Verbal Learning Test (AVLT) Long-term memory score|Two Back Test (TBK)","Mayo Clinic","All","50 Years to 80 Years   (Adult, Older Adult)","Phase 1","57","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","12-006469","January 2013","September 2016","September 2016","January 31, 2013",,"November 10, 2016","Mayo Clinic, Scottsdale, Arizona, United States",,"https://ClinicalTrials.gov/show/NCT01780519"
738,"NCT02086526","Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)",,"Completed","No Results Available","Polycystic Ovary Syndrome","Drug: Metformin","Change in Insulin Sensitivity (SI) after 3 Months of Metformin Therapy|Change in Peripheral Flow-Mediated Vasodilatation after 3 Months of Metformin Therapy","Mayo Clinic|Abbott Medical Devices","Female","18 Years to 50 Years   (Adult)","Phase 1","68","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","13-000692|UL1TR000135","March 2014","November 20, 2016","November 20, 2016","March 13, 2014",,"March 19, 2018","Mayo Clinic in Rochester, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT02086526"
739,"NCT02857829","The Effects of a Combination of Nootropic Ingredients on Cognition in Healthy Young Volunteers",,"Completed","No Results Available","Biomedical Enhancement","Dietary Supplement: CAF+|Dietary Supplement: Caffeine-alone|Other: Placebo","Verbal Memory: Immediate recall score|Verbal Memory: Delayed recall score|Working memory|Response inhibition and focused attention|Complex-scanning and visual tracking|Simple and -choice reaction time","Nootrobox, Inc.","All","18 Years to 35 Years   (Adult)","Not Applicable","21","Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","Nootrobox_Maastricht","March 1, 2017","March 24, 2017","March 24, 2017","August 5, 2016",,"December 22, 2017","Maastricht University, Maastricht, Netherlands",,"https://ClinicalTrials.gov/show/NCT02857829"
740,"NCT02535910","Effect of vitaminD3 or 25(OH)D3 Fortified Dairy on Vitmain D Status and CVD Risk Markers",,"Unknown status","No Results Available","Hypovitaminosis D|Cardiovascular Diseases","Dietary Supplement: vitamin D3|Dietary Supplement: 25(OH) D3|Dietary Supplement: Control","Change from baseline in the concentrations of vitamin D3, 25(OH)D3, 1, 25(OH)2D3 of the blood|Change from baseline in the concentrations of vitamin D3 and 25(OH)D3 of the chylomicron|change from baseline in vascular reactivity measured by Endo-PAT|change from baseline in vascular reactivity measured by digital volume pulse (DVP)|change from baseline in plasma lipids (primarily triacylglycerol, apolipoprotein B, apolipoprotein B-48, apolipoprotien B-100, total-cholesterol, HDL-cholesterol, non-esterified fatty acids)|change from baseline in markers of insulin resistance (glucose and insulin)|change from baseline in nitric oxide|change from baseline in inflammatory markers (tumor necrosis factor alpha, C-reactive protein and interleukin 6) of the blood|change from baseline in blood pressure|change from baseline in cognitive test","University of Reading","Male","30 Years to 65 Years   (Adult, Older Adult)","Not Applicable","18","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","VitD","August 2015","December 2015","May 2016","August 31, 2015",,"September 24, 2015","Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading, Reading, Berkshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02535910"
741,"NCT00584948","Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome",,"Completed","Has Results","Fragile X-Associated Tremor/Ataxia Syndrome|Fragile X Premutation Carriers","Drug: Memantine|Drug: Placebo","Change From Baseline in Executive Functioning as Measured by the Behavioral Dyscontrol Scale II (BDS-II)|Change From Baseline in Intention Tremor as Measured by the CATSYS Tremor Scale","University of California, Davis|National Institute on Aging (NIA)|Forest Laboratories","All","30 Years to 80 Years   (Adult, Older Adult)","Not Applicable","94","Other|NIH|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","200715426-1|1RL1AG032115-01","September 2007","September 2012","September 2012","January 2, 2008","April 10, 2017","May 30, 2017","UC Davis MIND Institute, Sacramento, California, United States|University of Colorado Health Sciences Center, Aurora, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT00584948"
742,"NCT02240095","Increasing Medical and Nursing Students Searching of Current Best Evidence to Answer Clinical Questions","MPFS-2","Completed","No Results Available","Medical and Nursing Students' Evidence Retrieval Skills","Behavioral: Intervention A - Online Clinical Questions Recorder|Behavioral: Intervention B - Online Evidence Retrieval Coach|Behavioral: Intervention C - Online Audit and Feedback","Utilization of evidence-based resources on MPFS as measured by rate of searches/month/user|Utility (satisfaction in meeting users' information needs) as assessed by the Impact Assessment Measure questionnaire|Use (application of evidence in practice) as assessed by the Impact Assessment Measure questionnaire|Perceived Usefulness in patient care and outcomes as assessed by the Impact Assessment Measure questionnaire","McMaster University|Canadian Institutes of Health Research (CIHR)","All","Child, Adult, Older Adult","Not Applicable","960","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Investigator)|Primary Purpose: Other","FRN86465-B|FRN86465","September 2014","October 22, 2017","October 22, 2017","September 15, 2014",,"October 25, 2017","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02240095"
743,"NCT02038439","Multifaceted Online Interventions to Increase Clinicians Searching of Current Best Evidence to Answer Clinical Questions","MPFS","Completed","No Results Available","Physicians Evidence Retrieval Skills","Behavioral: Intervention A - Online Clinical Questions Recorder|Behavioral: Intervention B - Online Evidence Retrieval Coach|Behavioral: Intervention C - Online Audit and Feedback","Utilization of evidence-based resources on MPFS as measured by rate of searches/month/user|Utility (satisfaction in meeting users' information needs) as assessed by the Impact Assessment Measure questionnaire|Use (application of evidence in practice) as assessed by the Impact Assessment Measure questionnaire|Perceived Usefulness in patient care and outcomes as assessed by the Impact Assessment Measure questionnaire","McMaster University|Canadian Institutes of Health Research (CIHR)","All","Child, Adult, Older Adult","Not Applicable","908","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Investigator)","FRN86465","January 2014","October 2014","October 2014","January 16, 2014",,"April 8, 2015","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02038439"
744,"NCT03294148","Mind-body Treatments for Chronic Back Pain",,"Active, not recruiting","No Results Available","Chronic Pain|Back Pain Lower Back Chronic|Back Pain, Low","Other: Open-Label Placebo Treatment for Chronic Back Pain|Behavioral: Psychotherapy Treatment for Chronic Back Pain","Change in Brief Pain Inventory—short form (BPI-SF)|Change in Positive and Negative Affect Scale short form (PANAS-SF)|Change in PROMIS short forms|Change in Tampa Scale of Kinesiophobia (TSK)|Change in Pain Catastrophizing Questionnaire (PCS)|Change in Timeline Follow-Back Measure for alcohol and drug use (TLFB)|Change in Patient Global Impression of Change (PGIC) scale|Change in Treatment satisfaction questionnaire|Change in Oswestry Low Back Pain Disability Questionnaire (OLBPD)","University of Colorado, Boulder|The Therapeutic Encounter Foundation|The Radiological Society of North America|The Psychophysiologic Disorders Society.|National Institutes of Health (NIH)","All","21 Years to 70 Years   (Adult, Older Adult)","Not Applicable","151","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","16-0544","August 7, 2017","November 25, 2018","November 26, 2019","September 26, 2017",,"December 19, 2018","University of Colorado Boulder, Boulder, Colorado, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/48/NCT03294148/Prot_SAP_004.pdf|""Informed Consent Form: Placebo"", https://ClinicalTrials.gov/ProvidedDocs/48/NCT03294148/ICF_005.pdf|""Informed Consent Form: Control"", https://ClinicalTrials.gov/ProvidedDocs/48/NCT03294148/ICF_006.pdf|""Informed Consent Form: Psychotherapy"", https://ClinicalTrials.gov/ProvidedDocs/48/NCT03294148/ICF_007.pdf","https://ClinicalTrials.gov/show/NCT03294148"
745,"NCT04090060","The Prevent Anal Cancer Palpation Study",,"Suspended","No Results Available","Anal Cancer","Behavioral: Practice Self-/Companion Exams|Behavioral: Control Arm","Concordance between self-examination and clinician examination|Concordance between companion examination and clinician examination|Number of persons who practice the self examination|Number of persons who practice the companion examination|Measuring the difference between Chicago and Houston self-exam concordance.|Measuring the difference between Chicago and Houston companion exam concordance.|Waist circumference for persons doing self-examinations","Medical College of Wisconsin|University of Chicago|Baylor College of Medicine|The University of Texas Health Science Center, Houston|Gordon Crofoot MD PA","Male","25 Years and older   (Adult, Older Adult)","Not Applicable","800","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening","PRO00033000","December 9, 2019","September 30, 2022","September 1, 2023","September 16, 2019",,"April 3, 2020","University of Chicago, Chicago, Illinois, United States|Baylor College of Medicine, Houston, Texas, United States|University of Texas Health Sciences Center, Houston, Texas, United States|Gordon Crofoot MD, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT04090060"
746,"NCT04101968","The GBA Multimodal Study in Parkinson's Disease",,"Recruiting","No Results Available","Parkinson Disease|GBA Gene Mutation|Gaucher Disease","Diagnostic Test: PET scan|Diagnostic Test: neuroQWERTY","Acetylcholinesterase activity|Tau protein deposition|Dopaminergic denervation|neuroQWERTY index","Pacific Parkinson's Research Centre|University of British Columbia|University of Washington|Oregon Health and Science University|Simon Fraser University|Michael J. Fox Foundation for Parkinson's Research|Silverstein Foundation|Weston Brain Institute","All","18 Years to 80 Years   (Adult, Older Adult)",,"25","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","16451","May 1, 2019","April 30, 2021","April 30, 2021","September 24, 2019",,"September 24, 2019","Oregon Health & Science University, Portland, Oregon, United States|University of Washington, Seattle, Washington, United States|Pacific Parkinson's Research Centre   University of British Columbia, Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT04101968"
747,"NCT02172859","Dietary Influence on Serotonin in Cognitive and Emotional Functioning in Women","P2B_UK","Completed","No Results Available","Healthy","Dietary Supplement: lumiVida™|Dietary Supplement: Placebo","Change from baseline in measures of mood (MAPS scale) at day 19|Change from baseline in sleep diaries until day 19|Change from baseline in ""Simple Reaction Time (SRT)"" at day 19|Change from baseline in the ""Rotary Pursuit Task"" at day 19|Change from baseline in ""Verbal Recognition Memory test (VRM)"" at day 19|Change from baseline in ""Match To Sample Visual search (MTS)"" at day 19|Change from baseline in ""Rapid Visual Information Processing task (RVIP)"" at day 19|Change from baseline in ""Affective Go/No-Go"" at day 19|Change from baseline in ""Emotion Recognition Task"" at day 19|Change from baseline in ""Driving Hazard Perception Test"" at day 19|Genetic evaluation of genotypes of the serotonin transporter protein (5HTTP)|Change from baseline in plasma TRP/LNAA ratio at day 19","DSM Nutritional Products, Inc.","Female","45 Years to 65 Years   (Adult, Older Adult)","Phase 2","59","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","P2B-05","November 2010","July 2011","July 2011","June 24, 2014",,"June 24, 2014","School of Human & Life Sciences, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02172859"
748,"NCT03206463","Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder","THC-BD","Active, not recruiting","No Results Available","Delta-9-Tetrahydroncannabinol|Bipolar Disorder|Healthy Controls","Drug: 4 mg Delta-9-THC|Drug: Placebo|Drug: 2 mg Delta-9-THC","Change in Verbal memory|Change in Executive functioning|Attention|Working memory|Mood|Psychotic-type experiences|Anxiety symptoms|Impulsivity","Yale University","All","18 Years to 55 Years   (Adult)","Phase 1","40","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","2000020272","August 1, 2017","July 2020","July 2020","July 2, 2017",,"November 27, 2019","Biological Studies Unit, VA Connecticut Healthcare System, West Haven, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT03206463"
749,"NCT01048944","Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers",,"Completed","Has Results","Nicotine Dependence","Drug: Bupropion SR|Drug: Nicotine Patch|Drug: Placebo Patch and Placebo Pill","Changes in Log Brain-wave (EEG) Activity (Power [Microvolts Squared]) From Pre-quit Baseline to 66 Days Post-quit, Assessed at 3, 24, 45, and 66 Days Post-quit.|Changes in Log of Smoking Withdrawal Scores (Mood, and Depressive Symptoms) From Baseline Across 66 Days of Abstinence","Southern Illinois University Carbondale|National Institute on Drug Abuse (NIDA)","All","18 Years to 55 Years   (Adult)","Phase 4","197","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","NIH/NIDA-2R01DA012289|2R01DA012289","June 2005","January 2013","January 2013","January 14, 2010","November 25, 2014","November 25, 2014","Southern Illinois University, Carbondale, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT01048944"
750,"NCT03375658","Evaluation of the Patient Deterioration Warning System","PDWS","Recruiting","No Results Available","Patient Transfer to Intensive Care Unit (Procedure)|Respiratory Arrest (Disorder)|Cardiac Arrest (Disorder)|Patient Died in Hospital (Finding)","Other: PDWS Intervension","In-hospital deterioration|Economic effect of PDWS|Acceptance of novel patient monitoring system|Reduction in length of stay|Monitoring load effect","University of Southern Denmark|Odense University Hospital|Hospital of South Western Jutland","All","18 Years and older   (Adult, Older Adult)","Not Applicable","10500","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","PDWS","May 18, 2018","April 8, 2019","December 31, 2019","December 18, 2017",,"June 26, 2019","Odense University Hospital, Odense, Fyn, Denmark|Hospital of South Western Jutland, Esbjerg, Jylland, Denmark",,"https://ClinicalTrials.gov/show/NCT03375658"
751,"NCT01550237","Curative Image Guided Radiotherapy for Prostate Cancer","RIC","Active, not recruiting","No Results Available","Prostatic Neoplasms","Radiation: radiotherapy daily verification reduced safety margins|Radiation: radiotherapy weekly verification standard safety margins","Acute rectal side effects|Freedom from biochemical failure|Overall survival|Cancer specific survival|Late genitourinary and rectal side effects|Acute genitourinary side effects|quality of life","St. Olavs Hospital|Norwegian University of Science and Technology|Alesund Hospital","Male","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","260","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2011/710","October 2012","September 2015","September 2025","March 9, 2012",,"February 12, 2020","St Olavs Hospital, Trondheim, Norway|Ålesund Sykehus, Ålesund, Norway",,"https://ClinicalTrials.gov/show/NCT01550237"
752,"NCT01651793","Effect of Phytochemicals From Theobroma Cacao on Mental Energy",,"Completed","Has Results","Mental Fatigue","Other: Caffeinated cocoa|Other: Cocoa|Other: Caffeine|Other: Placebo","Correct Responses on Serial 7 Subtraction Task|Performance on Bakan Task|Vigor Symptoms (Profile of Mood State)","University of Georgia|The Hershey Company","All","18 Years to 34 Years   (Adult)","Not Applicable","24","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","Study of cocoa-like beverages","July 2012","June 2014","June 2014","July 27, 2012","June 25, 2018","June 25, 2018","University of Georgia, Athens, Georgia, United States",,"https://ClinicalTrials.gov/show/NCT01651793"
753,"NCT02521935","Conventionally vs. Digitally Fabricated Complete Dentures: Clinical Treatment Outcome Differences",,"Withdrawn","No Results Available","Mouth, Edentulous","Device: Complete traditional dentures|Device: Complete CADCAM dentures","the overall comparison of functional assessment of digitally fabricated dentures to traditionally fabricated dentures|comparison of functional assessment of digitally fabricated dentures to traditionally fabricated dentures|comparison of patient satisfaction between digital dentures and traditional dentures|bite force comparison between digital dentures and traditional dentures","University of North Carolina, Chapel Hill|Global Dental Science, LLC","All","18 Years to 99 Years   (Adult, Older Adult)","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","14-1811","January 2017","January 2018","January 2020","August 13, 2015",,"April 27, 2017","University of North Carolina School of Dentistry Student Clinics, Chapel Hill, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT02521935"
754,"NCT03386188","Role of the Posterior Parietal Cortex in the Processing of Sensory Information","CORTEX","Recruiting","No Results Available","Healthy Subject","Device: Transcranial Magnetic Stimulation (TMS)|Device: Electrical Muscle Activity (EMG)","Afferent induced facilitation|Interaction between long latency afferent inhibition and long latency intracortical inhibition (LICI)","University Hospital, Lille","All","18 Years to 40 Years   (Adult)","Not Applicable","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2014_32|2014-A01507-40","January 2016","January 18, 2021","July 18, 2021","December 29, 2017",,"February 15, 2019","Hôpital Roger Salengro, CHRU de Lille, Lille, France",,"https://ClinicalTrials.gov/show/NCT03386188"
755,"NCT02973308","The Inter and Intra Reliability of Cardiopulmonary Exercise Testing in Abdominal Aortic Aneurysm Patients","CPEX","Completed","No Results Available","Abdominal Aortic Aneurysm","Other: Observer","Anaerobic threshold|Minute ventilation|Respiratory exchange ratio|Total time of exercise|Quality of life Questionnaire|Time to anaerobic threshold|Maximal oxygen uptake","Hull University Teaching Hospitals NHS Trust|University of Hull","All","45 Years and older   (Adult, Older Adult)","Not Applicable","24","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Basic Science","199037","July 3, 2016","March 31, 2017","June 14, 2017","November 25, 2016",,"July 1, 2019","Academic Vascular Surgery Unit, Vascular Laboratory, Alderson House, Hull Royal Infirmary, Hull, East Riding Of Yorkshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02973308"
756,"NCT01908361","Hybrid Approach to Unilateral vs. Bilateral Upper Limb Rehabilitation in Subacute and Chronic Stroke",,"Withdrawn","No Results Available","Cerebrovascular Accident","Behavioral: Unilateral Hybrid (InMotion3 plus CIT) Intervention|Behavioral: Bilateral Hybrid (BMT plus BAT) Intervention|Behavioral: Conventional Rehabilitation","Change in Fugl-Meyer Assessment (FMA)|Change in Wolf Motor Function Test (WMFT)|Change in MyotonPro|Change in 10-Meter Walk Test (10MWT)|Change in Actigraphy|Change in Functional Independence Measure (FIM)|Change in Motor Activity Log (MAL)|Change in ABILHAND Questionnaire|Change in Nottingham Extended Activities of Daily Living Scale (NEADL)|Change in Stroke Impact Scale Version 3.0 (SIS 3.0)|Change in Physiologic Response Measures (Biomarkers)|Change in Kinematic analysis","Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","All","20 Years to 80 Years   (Adult, Older Adult)","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","02-M04-022","January 2014","December 2018","December 2018","July 25, 2013",,"August 7, 2014","Buddhist Tzu Chi General Hospital Taipei Branch, New Taipei City, Taiwan",,"https://ClinicalTrials.gov/show/NCT01908361"
757,"NCT02755493","Quantifying and Developing Countermeasures for the Effect of Fatigue-Related Stressors on Automation Use and Trust During Robotic Supervisory Control",,"Completed","No Results Available","Sleep Deprivation","Behavioral: Sleep deprivation","Performance metrics on simulated robotic tasks - time|Performance metrics on simulated robotic tasks - number complete|Performance metrics on simulated robotic tasks - resources uses","Brigham and Women's Hospital|National Space Biomedical Research Institute","All","18 Years to 40 Years   (Adult)","Not Applicable","22","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","HFP04201","April 2016","May 31, 2017","May 31, 2018","April 29, 2016",,"July 11, 2018","Brigham and Women's Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02755493"
758,"NCT03645122","Altered Connections in the Spinal Cord to Reduce Hand Impairment After Stroke",,"Recruiting","No Results Available","Stroke|Central Nervous System Haemorrhage|Post-stroke|Cerebrovascular Accident","Procedure: Stimulation","Corticospinal Transmission|Motor output","VA Office of Research and Development|University of Pittsburgh","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","48","U.S. Fed|Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","B2837-W|Pro00002490","February 4, 2019","October 31, 2021","October 31, 2023","August 24, 2018",,"February 21, 2020","VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03645122"
759,"NCT03639116","Spinal Plasticity to Reduce Hand Impairment After Stroke",,"Recruiting","No Results Available","Stroke|Central Nervous System Haemorrhage|Hemiparesis|Post-stroke|Cerebrovascular Accidents","Procedure: Stimulation","Corticospinal Transmission (evoked potentials will be recorded via electromyography.)|Motor Output","University of Pittsburgh","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","36","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","PRO16110467","February 28, 2017","February 2021","February 2022","August 20, 2018",,"December 4, 2019","University of Pittsburgh, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03639116"
760,"NCT03064542","The Role of Thyroid Status in Regulating Brown Adipose Tissue Activity, White Adipose Tissue Partitioning and Resting Energy Expenditure","TRIBUTE","Active, not recruiting","No Results Available","Hyperthyroidism","Drug: carbimazole (CMZ) or thiamazole (TMZ)","Thyroid function test (serum free thyroxine (FT4) and serum thyroid stimulating hormone (TSH).|Fat volume- Brown adipose tissue (BAT)|Fat volume- White adipose tissue (WAT)|Energy expenditure|Body composition|Infrared thermography (IRT)","Clinical Nutrition Research Centre, Singapore|Agency for Science, Technology and Research","All","21 Years to 50 Years   (Adult)",,"30","Other","Observational","Observational Model: Cohort|Time Perspective: Other","2015/00718","August 18, 2017","January 14, 2020","January 14, 2020","February 27, 2017",,"July 30, 2019","Tan Tock Seng Hospital, Endocrinology Clinic, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT03064542"
761,"NCT02053207","Feasibility Study of Preoperative Cognitive Training in Cardiac Surgical Patients","Cog-Train","Unknown status","No Results Available","Postoperative Cognitive Dysfunction","Behavioral: Cog-Train Intervention","Training performance gain|Adherence to training regimen|Recruitment and retention|Satisfaction and acceptability|Side-effects","Papworth Hospital NHS Foundation Trust|Medical Research Council Cognition and Brain Sciences Unit","All","60 Years and older   (Adult, Older Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","P01907","January 2018","November 2018","December 2018","February 3, 2014",,"December 2, 2017","Papworth Hospital NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02053207"
762,"NCT01942356","Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor",,"Completed","No Results Available","Acute Cholecystitis|Chronic Cholecystitis","Procedure: TIVA - Hypotension|Procedure: TIVA - Hypertension|Procedure: TIVA - Bradycardia|Procedure: TIVA - Tachycardia|Procedure: INH - Hypotension|Procedure: INH - Hypertension|Procedure: INH - Bradycardia|Procedure: INH - Tachycardia","Time to discharge from PACU|Post operative Nausea and/or vomiting|Visual Analog Scale Pain score|ALDRETE Sedation Score|Time to extubation","The University of Texas Health Science Center at San Antonio","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","4","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)","HSC20130047H","September 2013","April 2014","August 2014","September 13, 2013",,"January 27, 2015","University Hospital, San Antonio, Texas, United States",,"https://ClinicalTrials.gov/show/NCT01942356"
763,"NCT02102763","Greek Childhood Obesity (GRECO) Study","GRECO","Completed","No Results Available","Overweight|Obesity|Dietary Habits|Physical Activity|Blood Pressure",,"Overweight and obesity prevalence in a representative sample of primary schoolchildren aged 10-12 years old|Dietary intake assessment|Assessment of eating behaviors|Assessment of physical activity and inactivity levels","Agricultural University of Athens|General Secretariat of Consumers-Greek Ministry of Development|Hellenic Association of Food and Beverage Companies|Coca Cola Hellas|Coca Cola Hellenic Bottling Company|Cereal Partners Hellas|FAGE S.A.|Unilever Hellas|Nestle Hellas|Kraft Foods Hellas|European Union and Greek national funds - Research Funding Program: Heraclitus II.","All","10 Years to 12 Years   (Child)",,"5000","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","AgriculturalUA","October 2008","May 2009","May 2009","April 3, 2014",,"April 8, 2014","Department of Food Science and Human Nutrition, Agricultural University of Athens, Athens, Attica, Greece",,"https://ClinicalTrials.gov/show/NCT02102763"
764,"NCT04448483","Clinical Study for Upper Limb Motor Restoration in Chronic Stroke Patients Using Personalized Neuro-technologies","AVANCER","Not yet recruiting","No Results Available","Stroke, Cerebral","Device: Paretic upper limb functional electric stimulation|Device: Non-invasive transcranial current stimulation","Change in functional improvement of upper limbs along training sessions|Change in speed and coordination of the affected side|Change in sensorimotor status in the two upper limbs|Action Reach Arm Test (ARAT)|Fatigue Visual Analog Scale (VAS)|Rivermead Assessment of Somatosensory Performance (RASP)|Brain stimulation effectiveness in BCI-aided motor therapy","Wyss Center for Bio and Neuroengineering|Ecole Polytechnique Fédérale de Lausanne","All","18 Years and older   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","AVANCER","June 30, 2020","March 31, 2022","December 31, 2022","June 26, 2020",,"June 26, 2020",,,"https://ClinicalTrials.gov/show/NCT04448483"
765,"NCT02037438","Sustainable Methods, Algorithms, and Research Tools for Delivering Optimal Care Study","SMART DOCS","Completed","Has Results","Obstructive Sleep Apnea of Adult|Insomnia|Circadian Rhythm Sleep Disorder|Sleep Related Movement Disorders|Narcolepsy and Hypersomnia|Parasomnia","Other: CONV care for the diagnosis and treatment of sleep disorders|Other: PCCM for the diagnosis and treatment of sleep disorders","Change in CGCAHPS Global Rating After 12 Months|Change in SF-36 Version 2 Health Survey Vitality Score After 12 Months|Change in CGCAHPS Provider Communication After 12 Months|Change in CGCAHPS Health Information Technology Measure #1 After 12 Months|Change in CGCAHPS Health Information Technology Measure #3 After 12 Months","Stanford University|Patient-Centered Outcomes Research Institute","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1836","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","CE-12-11-4137|SPO #: 105981","January 2014","May 2016","May 2016","January 16, 2014","March 4, 2019","March 4, 2019","Stanford Sleep Clinic, Stanford University Center for Sleep Science and Medicine, Redwood City, California, United States",,"https://ClinicalTrials.gov/show/NCT02037438"
766,"NCT03084822","Cardiovascular Health Promotion Among African-Americans by FAITH!","FAITH!","Completed","No Results Available","Cardiovascular Diseases|Prevention|Physical Activity|Diet Modification|Diabetes|Hypertension|High Cholesterol|Pre Diabetes|Smoking Cessation|Obesity","Behavioral: FAITH! App digital intervention","Diet (fruit/vegetable intake using adaptation of NIH Eating at America's Table Quick Food Scan Screener)|Physical activity (using the International Physical Activity Questionnaire (IPAQ))|Diet self-efficacy (using Self-Efficacy and Eating Habits Survey)|Physical activity self-efficacy (using Self-Efficacy and Exercise Habits Survey)|Intervention feasibility|BMI|Blood Pressure|Fasting Cholesterol|Fasting glucose|Smoking (using adaptation of Global Adult Tobacco Survey)|Life's Simple 7 Composite Score|Cardiovascular health knowledge","Mayo Clinic|Mayo Clinic Clinic Center for Innovation|Mayo Clinic Center for Clinical and Translational Science (CCaTS)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","16-000353","March 2016","June 2017","June 2018","March 21, 2017",,"July 24, 2018",,,"https://ClinicalTrials.gov/show/NCT03084822"
767,"NCT02235350","Action Observation Treatment (AOT) as a Rehabilitation Tool","AOT","Unknown status","No Results Available","Stroke, Acute Hemiplegia, Apraxia","Other: Action Observation Treatment (AOT)|Other: Observation of videos with no motor content (MNO)","Fugl-Meyer Assessment of Motor Recovery after Stroke (FMA), (L Jääskö 1975)|Functional Independence Measure (FIM), (Hamilton, 1987)|FMA|FIM|Functional Magnetic Resonance (fMRI)|fMRI","Neuromed IRCCS","All","18 Years to 85 Years   (Adult, Older Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Health Services Research","neuromedbuccino01","June 2014","September 2014","June 2015","September 9, 2014",,"September 10, 2014","Neuromed IRCCS, Istituto Neurologico Mediterraneo, Pozzilli, Isernia, Italy",,"https://ClinicalTrials.gov/show/NCT02235350"
768,"NCT04090541","Effects of Elastic Therapeutic Tapes on Performance With Healthy Subjects",,"Completed","No Results Available","Sports Physical Therapy|Sports Performance","Other: Rigid Tape|Other: Kinesiology Tape|Other: Biomechanical Tape","Change From Vertical Jump With Each Taping Application|Change From Muscle Strength With Each Taping Application|Change From Active Range Of Motion With Each Taping Application","Bahçeşehir University","All","18 Years to 24 Years   (Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","52","November 3, 2016","January 12, 2017","January 12, 2017","September 16, 2019",,"September 16, 2019","Bahçeşehir University, İstanbul, Beşiktaş, Turkey",,"https://ClinicalTrials.gov/show/NCT04090541"
769,"NCT04050267","Effects of Low Concentrations of Nitrous Oxide",,"Completed","No Results Available","Nitrous Oxide Poisoning","Drug: Nitrous Oxide|Other: Placebo - air","Cognitive test results|Reaction Time","Czech Technical University in Prague","All","18 Years to 30 Years   (Adult)","Not Applicable","16","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","VentRes-2019-02-KR","April 25, 2019","April 29, 2019","April 29, 2019","August 8, 2019",,"August 9, 2019","Czech Technical University, Praha, Czechia",,"https://ClinicalTrials.gov/show/NCT04050267"
770,"NCT03036657","Local Effects of Acupuncture and Nerve Conduction Studies",,"Recruiting","No Results Available","Carpal Tunnel Syndrome","Device: MAC acupuncture needles|Device: Electrostimulator 6c.Pro, Pantheon Research, Venice, CA","Change in Cold Detection Threshold (CDT) post-acupuncture compared to pre-acupuncture|Change in Vibration Detection Threshold (VDT) post-acupuncture compared to pre-acupuncture|Change in Median and Ulnar nerve CMAP amplitude post-acupuncture compared to pre-acupuncture.|Change in Median and Ulnar SNAP amplitude post-acupuncture compared to pre-acupuncture|Change in Median and Ulnar nerve distal motor latency post-acupuncture compared to pre-acupuncture|Change in Median and Ulnar nerve distal sensory latency post-acupuncture compared to pre-acupuncture|Change in Median and Ulnar nerve nerve conduction velocities (NCV) post-acupuncture compared to pre-acupuncture","Oregon Health and Science University","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Other","IRB00008949","October 2015","May 2020","September 2020","January 30, 2017",,"March 4, 2020","Oregon Health & Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT03036657"
771,"NCT03818217","Effects of a Robot on Physical and Psychosocial Outcomes of Persons With Dementia and Their Social Environment at Home",,"Enrolling by invitation","No Results Available","Dementia","Device: Coach Pepper group|Device: Tablet group","Change of motivation (persons with dementia)|Change of care burden (relatives)|Change of quality of life (persons with dementia, relatives): The ""Dementia Quality of Life Instrument""|Change of care dependency (persons with dementia)|Change of mobility (persons with dementia)|Change of cognition (persons with dementia)|Change of depression (persons with dementia, relatives)|Technology acceptance (persons with dementia, relatives, dementia trainers, professional caregivers)|Change of usability/acceptance (persons with dementia): semi-structured observation|Change of affect (relatives)|Change of behavioral problems (persons with dementia)","Medical University of Graz|Joanneum Research Forschungsgesellschaft mbH|Sozialverein Deutschlandsberg|Humanizing Technologies GmbH","All","Child, Adult, Older Adult","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","30-401ex17/18","May 6, 2019","March 6, 2020","March 6, 2020","January 28, 2019",,"July 19, 2019","Medical University of Graz, Graz, Austria",,"https://ClinicalTrials.gov/show/NCT03818217"
772,"NCT04069429","Radiation Dose in Humans From Orally Administered Tc99m-Heparin",,"Recruiting","No Results Available","Eosinophilic Esophagitis","Radiation: Computerized Tomography scan|Radiation: Single Photon Emission Computed Tomography scans|Drug: Technetium Tc 99M|Radiation: Planar Images|Procedure: Esophagogastroduodenoscopy","Biodistribution of Tc99m-heparin|Calculation of organ doses","University of Utah","All","18 Years to 70 Years   (Adult, Older Adult)","Early Phase 1","17","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","IRB_00058734","July 2016","December 2020","January 2021","August 28, 2019",,"October 8, 2019","University of Utah, Salt Lake City, Utah, United States",,"https://ClinicalTrials.gov/show/NCT04069429"
773,"NCT02758015","Effect of Betaine and Food on Gastric pH",,"Completed","No Results Available","Healthy","Other: Standardized Meal|Dietary Supplement: Betaine Hydrochloride 1500mg|Dietary Supplement: Betaine Hydrochloride 3000mg|Dietary Supplement: Betaine Hydrochloride 4500mg","Change in Gastric pH After Administration of Standardized Meal|Change in Gastric pH After Administration of Standardized Meal and Betaine hydrochloride","University of California, San Francisco","All","18 Years to 64 Years   (Adult)","Not Applicable","9","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","16-18635","June 2016","March 26, 2018","March 26, 2018","May 2, 2016",,"January 23, 2020","Clinical Research Center, UCSF, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT02758015"
774,"NCT01708577","UMIC Validation Study",,"Completed","No Results Available","Healthy","Device: Validation of the IPANEMA - measurement system","Determination of vital signs out of a portable measuring system for monitoring performance of athletes during exercise|Determination of vital signs out of a new textile integrated and portable measurement system during training and competition conditions in comparision to parallel measurements with the reference devices","RWTH Aachen University","All","18 Years to 35 Years   (Adult)","Not Applicable","12","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","11-111|EK 180/11","July 2011","March 2012","May 2012","October 17, 2012",,"November 14, 2012","Internal Medicine I, University Hospital, Aachen, North Rhine-Westphalia, Germany",,"https://ClinicalTrials.gov/show/NCT01708577"
775,"NCT04292093","Efficacy Study of a Neuropsychological Rehabilitation Intervention for Children With Non-symptomatic Epilepsy",,"Not yet recruiting","No Results Available","Epilepsy","Behavioral: Home rehabilitation training|Behavioral: Home control activity","NEPSY-II Neuropsychological Battery|Wechsler Intelligence Scale for Children Fourth Edition (WISC-IV)|NEPSY-II Neuropsychological Battery (change)|Child Behavior Checklist (CBCL) (parent compiled for 6-18 years old participants)|Youth Self Report (CBCL self-report version for 11-18 years old participants)|The Children's Quality of Life (TACQOL)|Behavior Rating Inventory of Executive Function (BRIEF-2) (parent compiled for 5-10 years old participants; self-report version for 11-18 years old participants)|Theta/beta ratio|Child Behavior Checklist CBCL (change)|The Children's Quality of Life TACQOL (change)|Behavior Rating Inventory of Executive Function (BRIEF-2) (change)|Theta/beta ratio (change)|Ad-hoc compliance to treatment questionnaire","IRCCS Eugenio Medea","All","7 Years to 18 Years   (Child, Adult)","Not Applicable","48","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Investigator)|Primary Purpose: Treatment","769","May 1, 2020","February 28, 2022","February 28, 2022","March 2, 2020",,"March 26, 2020",,,"https://ClinicalTrials.gov/show/NCT04292093"
776,"NCT03514823","Respiratory Muscle Contribution to Blood Pressure During Exercise",,"Recruiting","No Results Available","Respiratory Muscle|Blood Pressure|Exercise Capacity|Sympathetic Nerve Activity","Other: Inspiratory Muscle Training (IMT)|Other: No Inspiratory Muscle Training (IMT)","VO2 max test|Blood Pressure","Mayo Clinic|National Heart, Lung, and Blood Institute (NHLBI)","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","80","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","17-011100|5R01HL126638-03","August 1, 2018","June 1, 2020","June 1, 2020","May 2, 2018",,"November 6, 2019","Mayo Clinic, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT03514823"
777,"NCT02706964","Imaging the Patterns of Breast Cancer Early Metastases","BCMetPats","Active, not recruiting","No Results Available","Breast Cancer","Device: Positron emission tomography/x-ray computed tomography|Device: Magnetic resonance imaging|Device: x-ray computed tomography (CT)","Proportion of patients with oligometastatic presentation|Histogram of the number and size of metastases at first presentation.|Measure time to first instance of metastatic presentation.|Measure the growth rates of metastases in each of the target organs.|Measure the incidence of metastatic spread to each target organ.|Prognosis for oligometastases based on patient and tumor factors.|Local control outcomes of treatment of metastases|Acute and late clinical side effects for ablative local therapy of the metastases|Patterns of secondary recurrence","University of Florida|Florida Academic Cancer Center Alliance","Female","18 Years to 110 Years   (Adult, Older Adult)","Not Applicable","13","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","IRB201500683","April 2016","January 2018","March 2021","March 11, 2016",,"March 17, 2020","Department of Radiation Oncology Davis Cancer Pavilion, Gainesville, Florida, United States|University of Miami, Sylvester Comprehensive Cancer Center, Miami, Florida, United States",,"https://ClinicalTrials.gov/show/NCT02706964"
778,"NCT01764568","Contrasting Group Therapy Methods for Psychosis","MCT","Recruiting","No Results Available","Psychosis|Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder","Behavioral: Metacognitive Training (MCT)|Behavioral: Cognitive Remediation (CR)","Delusion Severity|Symptom Ratings|Cognitive Function|Cognitive Bias|Insight|Psychosocial/Everyday Functioning|Feasibility and acceptability","University of British Columbia|Vancouver Coastal Health Research Institute|Vancouver General Hospital|Vancouver Coastal Health|VGH and UBC Hospital Foundation","All","19 Years to 60 Years   (Adult)","Not Applicable","225","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","H12-01968|F11-02233","January 2013","September 2019","September 2020","January 9, 2013",,"October 30, 2018","UBC Hospital - Detwiller Pavilion, Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT01764568"
779,"NCT02217527","Test of Novel Drug for Smoking Cessation","UH3-P2","Completed","Has Results","Smoking Cessation","Drug: Active JNJ Drug|Drug: Placebo pill","Quit Status|Minnesota Nicotine Withdrawal Scale (MNWS) During Attempt to Quit on Active JNJ Drug and on Placebo|Cognitive Function on Continuous Performance Task (CPT) for Those With CO<10 During First Assessment Day (Mon) of Attempt to Quit Smoking During Both JNJ and Plac Quit Periods","Chengappa, K.N. Roy, MD|National Institutes of Health (NIH)|University of Pittsburgh","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 2","36","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","UH3-PRO14070319|UH3TR000958","November 2014","July 2017","January 2018","August 15, 2014","August 15, 2018","August 15, 2018","Univ of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/27/NCT02217527/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02217527"
780,"NCT04247828","Adaptive and Individualized AAC",,"Active, not recruiting","No Results Available","Communication Disorders","Device: Adaptive and individualized communication interface (AAC device)|Device: Generic communication interface (AAC device)","Time-to-target cursor metrics|Cursor path-to-target metrics|Self-report for AAC fatigability and satisfaction","Altec Inc.|Madonna Rehabilitation Hospital","All","12 Years and older   (Child, Adult, Older Adult)","Not Applicable","15","Industry|Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","AAC Phase I","January 6, 2020","August 2020","August 2020","January 30, 2020",,"April 28, 2020","Altec Inc., Natick, Massachusetts, United States|Madonna Rehabilitation Hospital Institute for Rehabilitation Science and Engineering, Lincoln, Nebraska, United States",,"https://ClinicalTrials.gov/show/NCT04247828"
781,"NCT00799487","CONCERTA Lab School Study",,"Completed","Has Results","Attention Deficit Hyperactivity Disorder","Drug: CONCERTA (methylphenidate HCl) or placebo","Hour 4 Permanent Product Math Test Attempted Score (PERMP-Attempted)|Hour 4 Permanent Product Math Test Correct Score (PERMP-Correct)|Hour 4 Swanson, Kotkin, Alger, M-Flynn and Pelham Scale for Deportment (SKAMP-Deportment)|Hour 4 Swanson, Kotkin, Alger, M-Flynn and Pelham Scale for Attention (SKAMP-Attention)|Hour 4 Swanson, Kotkin, Alger, M-Flynn and Pelham Scale for Composite (SKAMP-Composite)|Hour 5.5 Test of Variables of Attention (TOVA) ADHD Score|Hour 5.5 Test of Variables of Attention (TOVA) Reaction Time (Msec)|Hour 5.5 Test of Variables of Attention(TOVA) Reaction Time Variability (Standard Deviation in Milliseconds (Msecs))|Hour 5.5 Wide Range Assessment of Memory and Learning (WRAML-2) Finger Windows Backwards|Hour 5.5 Wide Range Assessment of Memory and Learning (WRAML-2) Finger Windows Forwards|Hour 5.5 Test of Variables of Attention (TOVA) Commissions|Hour 5.5 Wechsler Intelligence Scale for Children - 3rd ed. (WISC-III-PI) Digit Span Backwards|Hour 8.75 Gray Silent Reading Test (GSRT)|Hour 7.5 Test of Handwriting Skills (Revised) (THS-R)|Hour 3.5 Dynamic Indicators of Basic Early Literacy Skills (DIBELS)|Hour 5.5 Wechsler Intelligence Scale for Children - 3rd ed. (WISC-III-PI) Digit Span Forwards|Hour 5.5 Test of Variables of Attention (TOVA) Omissions|Hour 3.0 Grammar Task|Hour 8.75 Packet Activity - Short Story With Questions for Comprehension|Hour 8.75 Packet Activity - Identiy Root Word|Hour 8.75 Packet Activity - Alphabetize List of Words|Hour 8.75 Packet Activity - Identify Multiple Meanings for Words|Hour 8.75 Packet Activity - Complete Sentences Using Words Provided|Hour 8.75 Packet Activity - Word Search|Hour 8.75 Packet Activity - Decode the Mystery Sentence","Ortho-McNeil Janssen Scientific Affairs, LLC","All","9 Years to 12 Years   (Child)","Phase 4","89","Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","CR015118|2015-001042-28","January 2, 2009","June 26, 2009","June 26, 2009","December 1, 2008","October 1, 2010","March 12, 2020","Little Rock, Arkansas, United States|Las Vegas, Nevada, United States|Durham, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT00799487"
782,"NCT03595293","fNIRs-based Neurofeedback to Reduce Relapse in pOUD/AUD",,"Not yet recruiting","No Results Available","Alcohol Use Disorder|Alcoholism|Prescription Drug Dependence|Opioid-use Disorder|Neurofeedback","Device: fNIRs-based Neurofeedback|Device: Sham feedback","Improved capacity to increase neural activity in response to alcohol/pill cues in the rDLPFC measured by the change in the blood-oxygen level dependent (BOLD) signal|Increase in fNIRs signal response to pill/alcohol cues from pre-to-post neurofeedback sessions.|Higher levels of abstinence 90-days post-residential treatment completion as assessed by the 7-day timeline followback questionnaires.|Change in self-reported self-efficacy from pre-to-post neurofeedback sessions assessed via the brief situational confidence questionnaire.|Change in self-reported craving from pre-to-post neurofeedback sessions assessed via a 100-point craving visual analog scale.","Milton S. Hershey Medical Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","8203","June 2020","December 2020","March 2021","July 23, 2018",,"April 8, 2020",,,"https://ClinicalTrials.gov/show/NCT03595293"
783,"NCT02379728","Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth",,"Completed","Has Results","Sleep|Pregnancy|Stillbirth|Infant, Low Birth Weight|Infant, Small for Gestational Age|Infant, Very Low Birth Weight|Fetal Growth Retardation|Fetal Hypoxia","Device: PrenaBelt|Device: Body Position Sensor|Device: sham-PrenaBelt","Birthweight of Baby|Birthweight Centile|Gestational Age at Delivery|Mode of Delivery|Sex of Newborn (Male/Female)|Stillbirth|Low Birthweight|Small for Gestational Age|Preterm Delivery|Received ≥ 1 Obstetrical Diagnosis During Labor/Delivery","Allan Kember|Korle-Bu Teaching Hospital, Accra, Ghana|Grand Challenges Canada|Innovative Canadians for Change|Global Innovations for Reproductive Health and Life|Kaishin Chu Design|IWK Health Centre","Female","18 Years to 35 Years   (Adult)","Not Applicable","200","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","GCC-S7-0629-01-10-ACC|FDA/CT/152","September 2015","June 2016","June 2016","March 5, 2015","April 2, 2020","April 2, 2020","Korle Bu Teaching Hospital, Accra, Greater Accra, Ghana",,"https://ClinicalTrials.gov/show/NCT02379728"
784,"NCT00799409","Lab School Day Study for CONCERTA of Older Children With ADHD",,"Completed","Has Results","Attention Deficit Hyperactivity Disorder","Drug: Placebo/ CONCERTA (methylphenidate HCl)|Drug: CONCERTA (methylphenidate HCl) / Placebo","Hour 4 Permanent Product Math Test Attempted Score (PERMP-Attempted)|Hour 4 Permanent Product Math Test Correct Score (PERMP-Correct)|Hour 4 Swanson, Kotkin, Alger, M-Flynn and Pelham Scale for Deportment (SKAMP-Deportment)|Hour 4 Swanson, Kotkin, Alger, M-Flynn and Pelham Scale for Attention (SKAMP-Attention)|Hour 4 Swanson, Kotkin, Alger, M-Flynn and Pelham Scale for Composite (SKAMP-Composite)|Hour 5.5 Test of Variables of Attention (TOVA) ADHD Composite Cutoff Score|Hour 5.5 Test of Variables of Attention (TOVA) Reaction Time Standard Score|Hour 5.5 Test of Variables of Attention (TOVA) Reaction Time Variability Standard Score|Hour 5.5 Wide Range Assessment of Memory and Learning (WRAML-2) Finger Windows Backwards|Hour 5.5 Wide Range Assessment of Memory and Learning (WRAML-2) Finger Windows Forwards|Hour 5.5 Test of Variables of Attention (TOVA) Commissions Standard Score|Hour 5.5 Wechsler Intelligence Scale for Children - 3rd ed. (WISC-III-PI) Digit Span Backwards|Hour 8.75 Gray Silent Reading Test (GSRT) Reading Quotient|Hour 7.5 Test of Handwriting Skills (Revised) (THS-R) Standard Score|Hour 3.5 Dynamic Indicators of Basic Early Literacy Skills (DIBELS)|Hour 5.5 Wechsler Intelligence Scale for Children - 3rd ed. (WISC-III-PI) Digit Span Forwards|Hour 5.5 Test of Variables of Attention (TOVA) Omissions Standard Score|Hour 3.0 Grammar Task|Hour 8.75 Packet Activity Short Story With Questions for Comprehension|Hour 8.75 Packet Activity Identify Root Word|Hour 8.75 Packet Activity Alphabetize List of Words|Hour 8.75 Packet Activity Identify Multiple Meanings for Words|Hour 8.75 Packet Activity Complete Sentences Using Words Provided|Hour 8.75 Packet Activity Word Search|Hour 8.75 Packet Activity Decode the Mystery Sentence","Ortho-McNeil Janssen Scientific Affairs, LLC","All","9 Years to 12 Years   (Child)","Phase 4","78","Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","CR015046","December 2008","June 2009","June 2009","November 27, 2008","January 20, 2011","May 9, 2014","Irvine, California, United States|Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT00799409"
785,"NCT02411227","Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE) as an Adjunctive Intervention for Traumatic Brain Injury",,"Completed","No Results Available","Traumatic Brain Injury","Behavioral: VR Driving","VR Driving, Cognitive test, and Symptoms|MRI, Phenotyping, &amp; Driving evals","National Institutes of Health Clinical Center (CC)|The Center for Neuroscience and Regenerative Medicine (CNRM)|Uniformed Services University of the Health Sciences","All","18 Years and older   (Adult, Older Adult)","Phase 2","37","NIH|Other|U.S. Fed","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","150103|15-CC-0103","April 7, 2015","July 20, 2017","July 20, 2017","April 8, 2015",,"July 8, 2020","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT02411227"
786,"NCT03422770","Ultrasonic Markers for Myocardial Fibrosis and Prognosis in Aortic Stenosis",,"Recruiting","No Results Available","Aortic Valve Stenosis|Myocardial Fibrosis","Diagnostic Test: Echocardiography|Diagnostic Test: MRI|Diagnostic Test: Blood test|Diagnostic Test: ECG and Holter-ECG|Diagnostic Test: 6 min walking test","Cardiovascular morbidity and mortality|All cause mortality|Time of first re-hospitalisation|Cardiac systolic function|Cardiac diastolic function","Norwegian University of Science and Technology|St. Olavs Hospital|Oslo University Hospital","All","18 Years to 90 Years   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic","2017/1068","January 9, 2018","January 2021","January 2021","February 6, 2018",,"February 20, 2020","Department of Circulation and Medical Imaging, Trondheim, Norway",,"https://ClinicalTrials.gov/show/NCT03422770"
787,"NCT03643640","Evaluating a Novel Web-based Intervention for Breast Cancer Survivors","OPTIMUNE","Active, not recruiting","No Results Available","Breast Cancer","Behavioral: Optimune|Other: Care-As-Usual","Determination of Quality of Life using the WHOQOL-BREF|Determination of Physical Activity using the International Physical Activity Questionnaire|Determination of Diet Quality using the Food Quality Questionnaire|Determination of cancer-related fatigue using the Brief Fatigue Inventory Questionnaire|Determination of cancer-related emotional stress|Determination of depression|Determination of anxiety|Determination of fear of progression|Determination of insomnia|Determination of usefulness of the program|Determination of Negative Effects","Technical University of Dortmund|University of Leipzig|Gaia AG","Female","30 Years to 70 Years   (Adult, Older Adult)","Not Applicable","360","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","Optimune Trial Add-on","September 1, 2018","June 1, 2020","September 1, 2020","August 23, 2018",,"March 6, 2020","Technical University of Dortmund, Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany|University Medical Center Leipzig, Department of Medical Psychology and Medical Sociology, Section Psychosocial Oncology, Leipzig, Germany",,"https://ClinicalTrials.gov/show/NCT03643640"
788,"NCT03448250","Evaluating a Novel Web-based Intervention for Breast Cancer Survivors","OPTIMUNE","Recruiting","No Results Available","Breast Cancer","Behavioral: Optimune|Other: Care-As-Usual","concentration of C-reactive protein (CRP)|circulating Interleukin (IL) 6|circulating Tumor necrosis factor (TNF)-α|stimulated IL-6|stimulated TNF-α|Plasma Concentrations of Cytokines|Concentration of secreted Cytokines after Phorbol-12-myristate-13-acetate (PMA) stimulation of peripheral blood mononuclear cells|Concentration of secreted Cytokines after Lipopolysaccharide (LPS) Stimulation of peripheral blood mononuclear cells|Circulating numbers of Lymphocytes, Monocytes, Granulocytes|Phenotypic analysis of T and NK cell subsets|Cortisol awakening response (CAR)|Determination of cancer-related fatigue using the Brief Fatigue Inventory Questionnaire|Determination of cancer-related emotional stress|Determination of depression|Determination of anxiety|Determination of fear of progression|Determination of usefulness of the program|Determination of Negative Effects","Technical University of Dortmund|University of Leipzig|Gaia AG","Female","30 Years to 70 Years   (Adult, Older Adult)","Not Applicable","150","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","Optimune Trial","March 16, 2018","September 2020","March 2021","February 28, 2018",,"September 17, 2019","Technical University of Dortmund, Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany|University Medical Center Leipzig, Department of Medical Psychology and Medical Sociology, Section Psychosocial Oncology, Leipzig, Germany",,"https://ClinicalTrials.gov/show/NCT03448250"
789,"NCT03232086","Responses to Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Adults","RECAP","Active, not recruiting","No Results Available","Exposure to Pollution","Other: Clean Air|Other: PM2.5","Changes in heart rate variability|Forced expired volume in the first second (FEV1)|Forced Vital Capacity|Index of inflammatory markers","Environmental Protection Agency (EPA)","All","18 Years to 35 Years   (Adult)","Not Applicable","20","U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","16-1548","January 16, 2017","January 20, 2019","July 16, 2020","July 27, 2017",,"January 28, 2020","U.S. EPA Human Studies Facility, Chapel Hill, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03232086"
790,"NCT03961464","The Effect of D-cycloserine on Emotional Processing",,"Completed","No Results Available","Cycloserine|Healthy Volunteer","Drug: d-cycloserine|Drug: Placebo","Performance in a facial expression recognition task|Performance in an emotional recall task|Performance in an autobiographical memory task|Performance in an emotional categorisation task|Performance in an emotional faces dot probe task|Performance in an emotional recognition task|Performance in a cognitive stress task","University of Oxford","All","18 Years to 40 Years   (Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science","R57491/RE001","August 10, 2018","December 5, 2018","December 5, 2018","May 23, 2019",,"May 23, 2019","University of Oxford, Oxford, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03961464"
791,"NCT03672942","Communication Skills vs. Mindfulness for IPV",,"Not yet recruiting","No Results Available","Domestic Violence|Domestic Abuse|Family Conflict|Aggression","Behavioral: Communication Skills Training|Behavioral: Mindfulness|Behavioral: Placebo","Observed aggression|TAPS aggression paradigm","University of Houston","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","STUDY00000975","September 15, 2019","September 15, 2021","September 15, 2022","September 17, 2018",,"April 18, 2019",,,"https://ClinicalTrials.gov/show/NCT03672942"
792,"NCT03268590","Neuroimaging During Pure Oxygen Breathing",,"Completed","Has Results","Hyperoxia|Hypoxia, Brain|Neurobehavioral Manifestations","Drug: Oxygen","Cerebral Blood Flow|Cortical Network Activity|Cognitive Performance","Case Western Reserve University","All","18 Years to 60 Years   (Adult)","Phase 4","33","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","CON215044|FA8650-12-D6280 TO0052","October 2, 2017","May 2, 2018","May 9, 2018","August 31, 2017","November 13, 2019","November 13, 2019","Case Western Reserve University, Cleveland, Ohio, United States","""Study Protocol and Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/90/NCT03268590/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03268590"
793,"NCT03861078","The Effect of Electronic Cigarette Liquid Characteristics in Smokers.",,"Active, not recruiting","No Results Available","Electronic Cigarettes","Other: Own Brand Cigarette|Other: ECIG 15 mg nicotine, sweetened|Other: ECIG 15 mg nicotine, unsweet|Other: ECIG 0 mg nicotine, sweetened|Other: ECIG 0 mg nicotine, unsweet","Plasma Nicotine Concentration|Progressive Ratio Task|Hughes-Hatsukami Questionnaire|Positive and Negative Affect Schedule|Drug Effects Questionnaire|Heart rate|Puff volume|Puff Duration|Inter puff interval|Flow rate","Virginia Commonwealth University|National Institute on Drug Abuse (NIDA)","All","21 Years to 55 Years   (Adult)","Not Applicable","70","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","HM20015258|U54DA036105|F31DA047018","February 17, 2020","June 2021","June 2021","March 4, 2019",,"March 25, 2020","Clinical Behavioral Pharmacology Laboratory, Richmond, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT03861078"
794,"NCT02270294","Acute Effects of Thai Traditional Massage on Cerebrovascular Reactivity in Ischemic Stroke Patients",,"Completed","No Results Available","Ischemic Stroke","Other: Thai traditional massage|Other: No massage","Change from baseline in cerebrovascular reactivity|Change from baseline in stress indicators|Change from baseline in Peripheral arterial stiffness|Change from baseline in blood chemistry","Chulalongkorn University","All","50 Years to 80 Years   (Adult, Older Adult)","Not Applicable","14","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","SPSC-3","October 1, 2014","October 31, 2015","August 3, 2016","October 21, 2014",,"April 3, 2018","Faculty of Sports Science, Chulalongkorn University, Pathumwan, Bangkok, Thailand",,"https://ClinicalTrials.gov/show/NCT02270294"
795,"NCT04334265","Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019",,"Recruiting","No Results Available","COVID-19","Drug: Anluohuaxian","Changes in high-resolution computer tomography of the lung|Change in 6-minute walking distance|Changes in compound physiological index|Changes in the scores of the St. George's Hospital Respiratory Questionnaire|Changes in modified British Medical Research Council Dyspnea Scale (mMRC) scores|Changes in vital capacity of the lung","Peking University First Hospital","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","750","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2020 research 110","April 1, 2020","June 1, 2020","December 1, 2020","April 6, 2020",,"April 24, 2020","The Second People's Hospital of Fuyang, Fuyang, Anhui, China|Ezhou Central Hospital, Wuhan, Hubei, China|Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China|Jinyintan Hospital of Wuhan, Wuhan, Hubei, China|Tongji Hospital of Huazhong University of Science and Technology, Wuhan, Hubei, China|West Hospital Union Hospital Huazhong University of Science and Technology, Wuhan, Hubei, China|Wuhan Pulmonary Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China|Wenzhou Medical University Affiliated First Hospital, Wenzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04334265"
796,"NCT01022086","Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab",,"Unknown status","No Results Available","Stage I-IV Breast Cancer (Neo-adjuvant, Adjuvant, Locally Advanced and Metastatic)","Procedure: Cardiac MRI|Biological: Biomarker Testing","To compare CMR with MUGA scans for determining LVEF and LV volumes in breast cancer patients treated with trastuzumab.|To examine the association between changes in biomarker levels and changes in cardiac structure and function as measured by CMR in breast cancer patients receiving trastuzumab.","St. Michael's Hospital, Toronto|Hoffmann-La Roche","All","18 Years and older   (Adult, Older Adult)",,"50","Other|Industry","Observational","Observational Model: Other|Time Perspective: Prospective","Cardiac CMR","November 2009","December 2019","December 2019","December 1, 2009",,"July 12, 2017","Odette Cancer Centre/Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT01022086"
797,"NCT04052399","Improving Insulin Sensitivity by Non-invasive Brain Stimulation in Persons With Insulin Resistance",,"Recruiting","No Results Available","Insulin Resistance|Transcranial Direct Current Stimulation","Device: anodal transcranial direct current stimulation|Device: cathodal transcranial direct current stimulation|Device: transcranial direct current stimulation","Caloric intake (kcal)|Change in subjective feeling of hunger and food craving|Response inhibition|Tastiness and healthiness rating of food stimuli|Food choice","University Hospital Tuebingen|German Center for Diabetes Research","All","20 Years to 60 Years   (Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","243/2019BO1","November 4, 2019","December 31, 2020","December 31, 2021","August 9, 2019",,"May 14, 2020","University Clinic Tübingen, Tübingen, Germany",,"https://ClinicalTrials.gov/show/NCT04052399"
798,"NCT03603197","BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer",,"Completed","No Results Available","Metastatic Breast Cancer|Stage IV Breast Cancer","Drug: BP-C1|Drug: Placebo","Change (%) in the sum of diameters of target lesions|Number of target lesions|Treatment response|Karnofsky Performance Status (KPS) score|Separate scores of the general questionnaire EORTC QLQ-C30|Separate scores of the specific questionnaire EORTC QLQ-BR23|Maximum Common Toxicity Criteria (CTC) score|Change in the Sum CTC score|Number of registered adverse events","Meabco A/S|Meddoc|Norwegian University of Life Sciences","Female","18 Years to 80 Years   (Adult, Older Adult)","Phase 2","38","Industry|Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","MBC-BPC1/IIB","June 5, 2014","August 30, 2016","August 30, 2016","July 27, 2018",,"October 7, 2019","Udon Thani Cancer Hospital, Udon Thani, Udon Thani Province, Thailand|Siriraj Hospital, Mahidol University, Bangkok, Thailand|Lampang Cancer Center, Lampang, Thailand|Ubon Ratchanthani Cancer Hospital, Ubon Ratchathani, Thailand",,"https://ClinicalTrials.gov/show/NCT03603197"
799,"NCT03517371","Walking and mHealth to Increase Participation in Parkinson Disease","WHIPPD","Recruiting","No Results Available","Parkinson Disease","Other: mHealth delivered exercise program|Other: Exercise only","Walking Activity|Walking Intensity|Walking Capacity","Boston University Charles River Campus|Washington University School of Medicine","All","18 Years and older   (Adult, Older Adult)","Not Applicable","148","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","1R01HD092444","February 4, 2019","May 31, 2023","May 31, 2023","May 7, 2018",,"February 10, 2020","Center for Neurorehabilitation, College of Health & Rehabilitation Sciences, Sargent College, Boston University, Boston, Massachusetts, United States|Washington University St. Louis, Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT03517371"
800,"NCT02800655","Digital Health Feedback System for Longitudinal Measurement of Medication Adherence During Anti-Retroviral (ARV)Therapy",,"Recruiting","No Results Available","HIV","Device: Digital Health Feedback System","Medication taking adherence|The persistence of sensor-enabled ingestions|Participants will be classified into groups according to the accurate measurement of adherence|Medication behavior during IS-ARV use","University of California, San Diego|National Institute of Mental Health (NIMH)|Gilead Sciences|ViiV Healthcare|GlaxoSmithKline|Proteus Digital Health, Inc.","All","18 Years and older   (Adult, Older Adult)","Phase 4","100","Other|NIH|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","160521|R01MH110057","June 2016","June 2020","June 2020","June 15, 2016",,"June 5, 2020","Family Health Centers of San Diego, San Diego, California, United States|UCSD AntiViral Research Center, San Diego, California, United States",,"https://ClinicalTrials.gov/show/NCT02800655"
801,"NCT02179593","Effectiveness of SARPE With 3 and 2-Segment Technique: A Randomized Clinical Trial","3S/2S_SARPE","Unknown status","No Results Available","Maxillary Hypoplasia","Other: 2-Segment SARPE|Other: 3-Segment SARPE","Quality of Life|Maxillary symmetry|Stability of dental and osseous structures|Nasal and paranasal topographic changes","Federal University of São Paulo","All","17 Years to 50 Years   (Child, Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)","464.869","September 2013","August 2016","December 2016","July 2, 2014",,"March 16, 2016","Federal University of Sao Paulo, Sao Paulo, Brazil",,"https://ClinicalTrials.gov/show/NCT02179593"
802,"NCT01558193","The Impact of Supplementation With Multi-vitamins/Minerals, With and Without Fatty Acids, on Impulsivity and Aggression",,"Completed","No Results Available","Aggression","Dietary Supplement: Placebo|Dietary Supplement: Multi-vitamin/mineral|Dietary Supplement: Docosahexaenoic acid|Dietary Supplement: DHA plus vitamins/minerals","Go Stop Impulsivity Paradigm|Rosenzweig Picture Frustration Test|Buss Perry Aggression Scale|Perceived Stress Scale|Single Key Impulsivity Paradigm|General Health Questionnaire","Swansea University","Male","18 Years to 35 Years   (Adult)","Not Applicable","202","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","DB-0123-DHAVM","March 2011","July 2011","July 2011","March 20, 2012",,"May 5, 2017","Swansea University, Swansea, Wales, United Kingdom",,"https://ClinicalTrials.gov/show/NCT01558193"
803,"NCT00859261","Two Dimensional (2D) Silicon Transducer-Compression Plates for Breast Ultrasound",,"Completed","No Results Available","Breast Tumor|Breast Cysts","Procedure: Experimental 3D Breast Ultrasound imaging|Procedure: Experimental Photoacoustic Imaging","To prove the significance/capability of 3D Ultrasound imaging in comparison to current mammographic imaging.","University of Michigan|National Institutes of Health (NIH)|National Cancer Institute (NCI)","Female","30 Years to 80 Years   (Adult, Older Adult)","Not Applicable","21","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic","HUM 15464|2R01CA091713|R01CA115267","March 2009","February 2015","February 2015","March 11, 2009",,"May 5, 2016","University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT00859261"
804,"NCT01800253","The Effects of Acute Total Sleep Deprivation Versus Normal Sleep on Metabolism",,"Completed","No Results Available","Sleep Deprivation|Sleep","Behavioral: Inhibitory task|Procedure: Blood samples|Procedure: Tissue samples|Procedure: Oral glucose tolerance test|Behavioral: Portion Size Task","Gene expression and DNA methylation|Circulating hormone and neuromolecular levels|Appetitive evaluation|Portion Size Task|Inhibitory task","Uppsala University","Male","18 Years to 28 Years   (Adult)","Not Applicable","17","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","SleepMetaJCCB2013","March 2013","October 2013","October 2013","February 27, 2013",,"December 9, 2013","Department of Neuroscience, Uppsala University, Uppsala, Sweden",,"https://ClinicalTrials.gov/show/NCT01800253"
805,"NCT02529020","Jaw Clenching on Anaerobic Ability and Ventilatory Flows",,"Completed","No Results Available","Mouth Breathing","Device: Mouthguard|Device: No mouthguard","Changes in performance in Wingate test|Changes in performance dynamics airflow measurements.","University Ramon Llull","Male","19 Years to 30 Years   (Adult)","Not Applicable","30","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Single (Investigator)|Primary Purpose: Basic Science","mou01","May 2014","July 2015","August 2015","August 19, 2015",,"August 19, 2015",,,"https://ClinicalTrials.gov/show/NCT02529020"
806,"NCT02731495","Effect of Epigallocatechin -3-gallate Supplementation in Traumatic Brain Injury Patients",,"Completed","No Results Available","Traumatic Brain Injury","Dietary Supplement: EGCG|Dietary Supplement: Placebo (deionized water)","Glasgow Coma Scale (GCS)|Duration of mechanical ventilation|ICU stay|Serum S100 level","National Nutrition and Food Technology Institute|Tehran University of Medical Sciences","Male","16 Years to 65 Years   (Child, Adult, Older Adult)","Phase 2|Phase 3","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","24513540293","March 2015","November 2015","January 2016","April 7, 2016",,"June 7, 2016","NNFTRI clinic, Tehran, Iran, Islamic Republic of",,"https://ClinicalTrials.gov/show/NCT02731495"
807,"NCT02999516","Complex Motor Learning With Motor Imaginary",,"Unknown status","No Results Available","Learning Disturbance","Other: Motor imaginary|Other: Non Motor imaginary|Other: tDCS|Other: tDCS sham|Other: Neurofeedback|Other: Neurofeedback sham","Time","Centro Universitario La Salle","All","18 Years to 29 Years   (Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science","CULaSalle","December 2016","June 2018","December 2018","December 21, 2016",,"July 31, 2018","Centro Superior de Estudios Universitarios La Salle, Madrid, Spain",,"https://ClinicalTrials.gov/show/NCT02999516"
808,"NCT00178165","Coordinating Center for Enhancing ADRD Caregiving",,"Completed","No Results Available","Dementia|Alzheimer Disease","Procedure: Skill Training Condition – problem solving training|Procedure: REACH for TLC (Telephone Linked Computer) system","The outcomes were assessed 6 months after randomization and included a measure of burden and a measure of depression. Caregiver burden was assessed using the Revised Memory and Behavior Problem Checklist (RMBPC).|Emotional distress was determined by the Center for Epidemiological Studies Depression Scale (CES-D) a global measure of depression.|Long-term care placement of dementia patients and caregiver health and well-being|Use of cognitive enhancement medication|Clinical significance of caregiver interventions in diverse populations","University of Pittsburgh|National Institute on Aging (NIA)|National Institute of Nursing Research (NINR)","All","21 Years and older   (Adult, Older Adult)","Not Applicable","1200","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","AG13305-01|NR13269|AG13313|AG13297|AG13289|AG13265|AG13255|AG13305","September 1996",,"November 2001","September 15, 2005",,"September 15, 2005","University of Alabama at Birmingham, Birmingham, Alabama, United States|Stanford University and Veterans Affairs, Menlo Park, California, United States|University of Miami at Miami, Center on Adult Development and Aging, Miami, Florida, United States|Thomas Jefferson University at Philadelphia, Center for Applied Research on Aging and Health, Philadelphia, Pennsylvania, United States|University of Tennessee Health Science Center, Memphis, Tennessee, United States",,"https://ClinicalTrials.gov/show/NCT00178165"
809,"NCT04386941","Greenlight Vaporization vs Xpeeda Vaporesection",,"Recruiting","No Results Available","Benign Prostatic Hyperplasia|Lower Urinary Tract Symptoms","Procedure: Xpeeda Fibre Laser Vaporesection of the Prostate|Procedure: Greenlight XPS Vaporization of the Prostate","International Prostate Symptom Score (IPSS)|Quality of life (QOL) Due to Urinary Symptoms|Peak flow rate (Qmax)|Post-void residual urine volume (PVR)|Prostate specific antigen (PSA)|Rates of intraoperative adverse events|Degree of prostatic size change measured by transrectal ultrasound (TRUS)|International index of erectile function-5 (IIEF-5)","Thunder Bay Regional Research Institute|Northern Ontario School of Medicine|Thunder Bay Regional Health Sciences Centre","Male","50 Years and older   (Adult, Older Adult)","Not Applicable","92","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Diagnostic","RP-582","July 31, 2019","July 10, 2022","July 31, 2022","May 13, 2020",,"May 13, 2020","Thunder Bay Regional Health Sciences Centre/Thunder Bay Regional Health Research Institute, Thunder Bay, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04386941"
810,"NCT03479541","Can Early Initiation of Rehabilitation With Wearable Sensor Technology Improve Outcomes in mTBI?",,"Recruiting","No Results Available","Mild Traumatic Brain Injury|Balance; Distorted|Gait, Unsteady|Quality of Life|Veterans","Behavioral: Rehabilitation","Dizziness Handicap Inventory|Automated Neuropsychological Assessment Metrics|Neurobehavioral Symptom Inventory|Quality of Life After Brain Injury|Patient Global Impression of Change Scale|Walking|Complex Navigation Task|Central SensoriMotor Integration Test|Auditory Processing|Static a Visual Acuity|Dynamic Visual Acuity|Contrast Sensitivity|Vestibular and ocular-motor test (VOMs)-instrumented|Mini-Balance Evaluation Systems Test|Return to Activity Question|Modified Balance Error Scoring System (mBESS)","Oregon Health and Science University|United States Department of Defense","All","18 Years to 60 Years   (Adult)","Not Applicable","160","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","DOD2","July 15, 2018","September 30, 2021","September 30, 2021","March 27, 2018",,"March 3, 2020","Oregon Health & Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT03479541"
811,"NCT04144647","The Relationship Between Dual-task Gait Performance, Physical Activity Levels, Sleep and Aging in Healthy Adults",,"Recruiting","No Results Available","Healthy|Adults","Other: Single testing session","Functional Gait Assessment|Functional Gait Dual-Task Test|Mini-Balance Evaluation Systems Test|Cambridge Neuropsychological Test Automated Battery|Standard pure tone audiometry|Speech in Babble Test|Axivity Wrist Band 3-Axis logging accelerometer|Activity-specific Balance Confidence Scale|Hospital Anxiety and Depression Scale|Pittsburgh Sleep Quality Index|Epworth Sleepiness Scale|EQ-5D-5L|Situational Vertigo Questionnaire|Dizziness Handicap Inventory|Cognitive and Behavioural Symptom Questionnaire","King's College London","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening","LRS-18/19-8994","February 25, 2019","September 2020","December 2020","October 30, 2019",,"April 24, 2020","Centre for Human and Applied Physiological Sciences, King's College London, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04144647"
812,"NCT02403427","The Expert System VoiceDiab in Children With Diabetes","VoiceDiab","Unknown status","No Results Available","Type 1 Diabetes Mellitus With Hyperglycemia|Type 1 Diabetes Mellitus With Hypoglycaemia","Device: VoiceDiab expert system","postprandial glucose|AUC|PPGE- postprandial glucose excursion|hypoglycemia|LBGI|Glucose variability parameters","Instytut Diabetologii Sp. z o.o.|Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences|National Centre for Research and Development","All","3 Years to 18 Years   (Child, Adult)","Not Applicable","42","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","PBS1/B9/13/2012-I","March 2015","September 2015","December 2015","March 31, 2015",,"May 7, 2015","Ewa Pankowska, Warsaw, Poland",,"https://ClinicalTrials.gov/show/NCT02403427"
813,"NCT01902069","The Gut-brain Axis in Food Reward and Alcohol Consumption",,"Completed","No Results Available","Impulsivity|Alcohol Consumption","Dietary Supplement: Phospholean|Dietary Supplement: Placebo","Fat and sweet preference|Impulsivity|Alcohol consumption","Yale University|National Institute on Alcohol Abuse and Alcoholism (NIAAA)","All","21 Years to 45 Years   (Adult)","Not Applicable","29","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","1305012106|5P50AA012870","July 2013","November 2014","November 2014","July 17, 2013",,"April 3, 2020","John B Pierce Laboratory, New Haven, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT01902069"
814,"NCT04198675","Effects of Preventive Physiotherapy Practices on Posture and Work-Related Functions in Office Workers",,"Active, not recruiting","No Results Available","Work-related Musculoskeletal Disorders|Office Workers","Behavioral: Supervised EMG Biofeedback Exercise Training Group|Behavioral: Home-Based Exercise Training Group|Behavioral: Posture Training/Ergonomic Regulations Group","Maximal Voluntary Isometric Contraction (MVIC)|Muscle Activation of Upper Trapezius|Cervical Range of Motion (CROM) / Forward Head Posture|Constant-Murley Score (CMS)|Rapid Upper Limb Assessment (RULA)|The Disabilities of the Arm, Shoulder and Hand Score (DASH)|The Disabilities of the Arm, Shoulder and Hand Score Work Module (DASH-W)|Neck Disability Index (NDI)|Neck Pain and Disability Scale (NPAD)","Marmara University|Hacettepe University","All","22 Years to 40 Years   (Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","09.2018.282","August 26, 2019","December 2019","April 2020","December 13, 2019",,"December 26, 2019","Marmara University Faculty of Health Sciences, Maltepe, Istanbul, Turkey",,"https://ClinicalTrials.gov/show/NCT04198675"
815,"NCT02784262","Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis",,"Completed","No Results Available","Chronic Disease|Nasal Polyposis|Rhinitis","Drug: botox injection Multiguide","adverse events|change in symptom index on a visual analog scale nasal obstruction/running nose|change in sinonasal quality of life assessed with the sino-nasal outcome test 22 (SNOT-22)|change in nose-sinus related quality of life assessed with a visual analog scale (VAS)|change in the geometrics of the nose assessed by acoustic rhinometry|change in air flow in the nose measured by peak nasal inspiratory flow (PNIF)|change in polyp mass assessed by magnetic resonance imaging (MRI)|change in polyp mass assessed by computer tomography (CT)|change in quality of life expressed by Patients' Global Impression of Change (PGIC)","Norwegian University of Science and Technology|St. Olavs Hospital","All","18 Years to 70 Years   (Adult, Older Adult)","Phase 2","11","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","011015-01|2015-004377-33","October 2016","September 4, 2018","December 2018","May 27, 2016",,"March 18, 2019","St Olavs Hospital, Trondheim, Norway",,"https://ClinicalTrials.gov/show/NCT02784262"
816,"NCT01855867","HIV Non-Occupational Post-Exposure Prophylaxis","QUAD","Completed","No Results Available","Human Immunodeficiency Virus","Drug: Coformulated Elivitegravir (150mg), Combicistat (150mg), Emtricitabine (200mg), Tenofovir DF (300mg)","Safety and Tolerability - as measured by number of participants with adverse events, the severity of adverse events and frequency of adverse events|Awareness and attitudes around non-occupational post-prophylaxis|Awareness and attitudes around HIV pre-exposure prophylaxis|Adherence compared to other nPEP regimens studied at Fenway Health or from literature review.","Kenneth H. Mayer, MD|Gilead Sciences|Fenway Community Health","All","18 Years and older   (Adult, Older Adult)","Phase 4","100","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","QUAD|IND: 116,967","May 2013","April 2014","April 2016","May 17, 2013",,"January 26, 2017","Fenway Community Health, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT01855867"
817,"NCT03064919","Developing Novel Methods to Teach Children to Recognize Internal Signals of Hunger","CTSI","Completed","No Results Available","Pediatric Obesity","Behavioral: Curriculum Testing","Energy Compensation measured by compensation score.|Eating in the Absence of Hunger after a buffet meal: Food Intake weighed in grams and calories.|Energy intake at a buffet meal|Nutrition knowledge test for children|Liking of foods|Wanting of foods|Fullness feelings|Height|Weight|Body mass index|BMI percentile|BMI z-score|Child Eating Behavior Questionnaire|Pubertal development Questionnaire|Family demographics|Child feeding Questionnaire|Infant Feeding Questionnaire|Child Behavior|Parent Eating Competence|Division of Responsibility in Child Feeding Questionnaire|Nutrition Steps Questionnaire|Caregiver Feeding Style Questionnaire","Penn State University","All","4 Years to 5 Years   (Child)","Not Applicable","32","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","Hunger and Fullness","June 25, 2015","November 2, 2018","November 2, 2018","February 27, 2017",,"July 18, 2019","The Pennsylvania State University, University Park, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03064919"
818,"NCT03286686","Sensori-motor and Perceptual Functions of the PPC.","PPCfonctions","Recruiting","No Results Available","Healthy Volunteers|Optic Ataxia","Behavioral: point targets|Behavioral: tactile stimulation|Behavioral: visual images","response error - number of pointing error|response error -measure of reaction times|response error - percentage of right responses","Hospices Civils de Lyon","All","18 Years to 75 Years   (Adult, Older Adult)","Not Applicable","155","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","69HCL17_0341|2017-A02562-51","February 22, 2018","February 22, 2024","February 22, 2024","September 18, 2017",,"August 8, 2019","U1028 INSERM - CNRS UMR 5292 Equipe ImpAct, Bron, France",,"https://ClinicalTrials.gov/show/NCT03286686"
819,"NCT03892291","Objective Dual-task Turning Measures for Return-to-duty Assessments","reTURN","Recruiting","No Results Available","Mild Traumatic Brain Injury|Gait|Balance|Veterans|Mobility",,"Illinois Agility Assessment|Walk and Turn|Custom Turns Course|Civilian Ambulatory Task|Simulated Urban Combat Patrol|Neurobehavioral Symptom Inventory|Dizziness Handicap Inventory|Quality of Life after Brain Injury|Post-Traumatic Stress Disorder Checklist|Ohio State University TBI Identification Method|Automated Neuropsychological Assessment Metric|Vestibular Ocular Motor Screening|Revised HiMAT|Functional Gait Assessment","Oregon Health and Science University|Courage Kenny Research Center|University of Utah|Fort Sam Houston|Warrior Recovery Center|Madigan Army Medical Center","All","18 Years to 50 Years   (Adult)",,"140","Other|U.S. Fed","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","18749|W81XWH1820049","September 1, 2018","September 2022","September 2022","March 27, 2019",,"June 19, 2019","Warrior Recovery Clinic, Fort Carson, Colorado, United States|Courage Kenny Research Center, Minneapolis, Minnesota, United States|Oregon Health & Science University, Portland, Oregon, United States|Fort Sam Houston, San Antonio, Texas, United States|University of Utah, Salt Lake City, Utah, United States|Madigan Army Medical Center, Lakewood, Washington, United States",,"https://ClinicalTrials.gov/show/NCT03892291"
820,"NCT03648892","Brain Dopamine Function in Human Obesity",,"Recruiting","No Results Available","Obesity|Healthy Volunteers|Overweight","Drug: [c11] raclopride|Drug: [18F]fallypride","To determine if D2BP is related to BMI and whether there is a linear or quadratic relationship.|To determine correlations between D2BP, as measured by [18F]fallypride and [11C]raclopride time-activity curves.|To determine the effect of palatable meal consumption on D2BP in individuals with a wide BMI range. Binding potential estimates will be estimated within subjects using [11C]raclopride|Investigate the associations between brain dopamine D2BP and neural bases of food perception and preference|Investigate the metabolic and endocrine correlates of brain dopamine D2BP and neural bases of food perception and preference.|Investigate the behavioral correlates of brain dopamine D2BP such as free-living physical activity, ad libitum meal consumption, and body weight changes over a one year period.","National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Institutes of Health Clinical Center (CC)","All","18 Years to 45 Years   (Adult)","Not Applicable","100","NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","180132|18-DK-0132","September 21, 2018","December 31, 2021","December 31, 2021","August 28, 2018",,"July 9, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT03648892"
821,"NCT01612169","Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users","CTN0049","Completed","No Results Available","HIV|AIDS|Substance Abuse|Inpatient","Behavioral: Patient Navigation (PN) Group|Behavioral: Patient Navigator Plus Contingency Management (PN+CM) Group","HIV Viral Suppression|HIV Secondary Outcomes|Substance Use Related Secondary Outcomes|Mediators and Moderators of Outcomes","Columbia University|Jackson Health System|Grady Health System|Johns Hopkins University|Boston Medical Center|Hahnemann University Hospital|Rush University Medical Center|PARKLAND HEALTH AND HUMAN SERVICES|University of Pittsburgh|University of California, Los Angeles|University of Alabama at Birmingham|St. Luke's-Roosevelt Hospital Center|National Institute on Drug Abuse (NIDA)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","801","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","AAAK1709|U10DA013720-11","July 2012","June 2015","June 2015","June 5, 2012",,"March 14, 2016","University Hospital At University of Alabama, Birmingham (Uab), Birmingham, Alabama, United States|Los Angeles County Harbor-UCLA Medical Center, Torrance, California, United States|Jackson Memorial Hospital, Miami, Florida, United States|University of Miami, Miami, Florida, United States|Grady Memorial Hospital, Atlanta, Georgia, United States|Stroger Cook County Hospital/Rush University Medical Center, Chicago, Illinois, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Saint Luke's Roosevelt Hospital Center, New York, New York, United States|Hahnemann University Hospital, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center (Upmc), Pittsburgh, Pennsylvania, United States|Parkland Health and Human Services, Dallas, Texas, United States",,"https://ClinicalTrials.gov/show/NCT01612169"
822,"NCT02587494","Cardiac Catheterization in Cardiac Arrest",,"Unknown status","No Results Available","Out of Hospital Cardiac Arrest","Procedure: Cardiac catheterization","Composite of death and poor neurologic outcomes ( Cerebral Performance Category [CPC] score 3-5).|Death|CPC score|Acute kidney injury- creatinine levels|Myocardial infarction - according to cardiac troponin levels|Stent thrombosis by pathology or angiography|Bleeding - according to Hb levels|Composite of death and poor neurologic outcome|Stroke - imaging or pathology|Heart failure (NYHA 3-4)|Estimated cost per patient according to length of stay and procedures performed","Lawson Health Research Institute","All","18 Years and older   (Adult, Older Adult)","Not Applicable","75","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","106834","December 2017","December 2018","December 2018","October 27, 2015",,"August 23, 2017","London Health Sciences Centre, London, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02587494"
823,"NCT03391505","Acute Effects of Physical Activity On Memory, Cognitive Performance and Brain Activity",,"Unknown status","No Results Available","Mental Health Wellness 1","Behavioral: Small-sided soccer game|Behavioral: Walking soccer game|Behavioral: Rest group watching soccer","Event-related brain potentials (P300)|Cognitive Response Speed Performance|Cognitive Response Accuracy Performance|Long-term Memory Accuracy Performance|Height|Weight|Fat Percentage|Lean Body Mass|Fitness Status|Maximal Heart Rate|Flow|Motivation|Enjoyment|Intervention intensity","University of Southern Denmark|University of Copenhagen","All","10 Years to 14 Years   (Child)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","59349 to H-16026885","March 5, 2018","May 30, 2018","May 30, 2018","January 5, 2018",,"February 26, 2018","University of Southern Denmark, Odense, Denmark",,"https://ClinicalTrials.gov/show/NCT03391505"
824,"NCT01823263","Metabolic and Cognitive Parameters Following Partial Sleep Deprivation",,"Unknown status","No Results Available","Sleep Deprivation|Sleep","Behavioral: Portion Size Task|Procedure: Blood sample|Procedure: Interference task|Behavioral: Memory tasks|Behavioral: Intake task|Behavioral: Working memory function task","Memory tasks|Circulating hormone levels|Intake task|Working memory function task|Portion Size Task","Uppsala University","Male","20 Years to 28 Years   (Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","SleepPartialJCCB2013","April 2013","March 2015","March 2015","April 4, 2013",,"December 2, 2014","Department of Neuroscience, Uppsala University, Uppsala, Sweden",,"https://ClinicalTrials.gov/show/NCT01823263"
825,"NCT02258438","Effect of Breaking up Prolonged Sitting on Metabolic Flexibility",,"Recruiting","No Results Available","Health Behavior","Behavioral: Uninterrupted sitting|Behavioral: Sitting + 1 bout of activity|Behavioral: Sitting + microbursts of activity","Total substrate oxidation|Postprandial plasma insulin and glucose response|Dietary fat oxidation","University of Colorado, Denver","All","19 Years to 45 Years   (Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","14-0429|UL1TR001082","October 8, 2014","September 2017","December 2020","October 7, 2014",,"January 18, 2020","University of Colorado Hospital, Aurora, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT02258438"
826,"NCT03522220","Augmentation of Neuronal Network Plasticity in Schizophrenia","SCZ","Unknown status","No Results Available","Schizophrenia|Healthy","Behavioral: 3D navigation video game intervention|Behavioral: video game intervention without 3D navigation|Behavioral: No 3D navigation","T1 - MRI|Cognition - Spatial Orientation|Positive & Negative Symptoms in patients|Resting State fMRI|Spectroscopy - glutamate|Diffusion Tensor Imaging (DTI)|Biomarkers (BDNF & interleukin 1 & 6)","Universitätsklinikum Hamburg-Eppendorf","All","18 Years to 45 Years   (Adult)","Not Applicable","150","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","SFB936 C7","September 1, 2016","July 31, 2019","December 31, 2019","May 11, 2018",,"June 6, 2018","University Clinic Hamburg-Eppendorf, Hamburg, Germany",,"https://ClinicalTrials.gov/show/NCT03522220"
827,"NCT03283748","Detection of Motor Seizures Using WBAN","DMS-WBAN","Unknown status","No Results Available","Seizures, Tonic-Clonic","Device: Wearable sensors","Measurement of Acceleration|Digital Signal processing of the data","Mohawk College|Hamilton Health Sciences Corporation|Ryerson University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","5","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","3596","November 1, 2017","February 25, 2018","December 30, 2018","September 14, 2017",,"May 30, 2018","Mini Thomas, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03283748"
828,"NCT03213613","Double-Blind Randomized Controlled Trial for the Evaluation of a Novel Adaptive Attention Training in Healthy Adolescents",,"Recruiting","No Results Available","Healthy Adolescents","Behavioral: Adaptive Attention Training|Behavioral: Active Control|Behavioral: Low-dose Adaptive Attention Training","Test of Variables of Attention (TOVA), visual form, change from baseline|Delay Discounting task, change from baseline","University of California, San Francisco|Alliance for Decision Education","All","12 Years to 16 Years   (Child)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","P0505751","June 13, 2019","May 31, 2021","May 31, 2021","July 11, 2017",,"September 10, 2019","UCSF Neuroscape, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT03213613"
829,"NCT02613936","Transcranial Direct Current Stimulation for the Treatment of Deficits After Traumatic Brain Injury",,"Recruiting","No Results Available","Traumatic Brain Injury|Post Concussive Symptoms|Depression|Executive Dysfunction","Device: Anodal tDCS|Behavioral: Cognitive training","Change in Examiner Score","University of New Mexico|National Institutes of Health (NIH)|National Institute of General Medical Sciences (NIGMS)","All","18 Years to 55 Years   (Adult)","Not Applicable","36","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","UNM HRRC #15-124|1P20GM109089-01A1","September 2015","August 2020","August 2020","November 25, 2015",,"June 16, 2020","UNM Center for Brain Recovery and Repair, Albuquerque, New Mexico, United States",,"https://ClinicalTrials.gov/show/NCT02613936"
830,"NCT03963245","Project Meaningful Activities and Recovery","MA&R","Recruiting","No Results Available","Mental Illness","Behavioral: Meaningful Activities and Recovery|Behavioral: Standard Care and Treatment","Profiles of occupational engagement in people with severe mental illness (POES-S).|WHODAS 2.0|Manchester Short Assessment of Quality of Life (MANSA).|Questionnaire about Process of Recovery (QPR)","Mental Health Centre Copenhagen","All","18 Years to 80 Years   (Adult, Older Adult)","Not Applicable","128","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","F-61171-15-05","September 19, 2018","February 2021","August 2021","May 24, 2019",,"May 6, 2020","Copenhagen Socialpsychiatry, Copenhagen, Denmark|Copenhagen Mental Health Center, Copenhagen, Denmark|Odense kommunes rehabiliteringsteam (psychiatric rehabilitation team, Odense), Odense, Denmark|Impuls Mødested og Kursuscenter (Drop in centre), Svendborg, Denmark",,"https://ClinicalTrials.gov/show/NCT03963245"
831,"NCT03067506","Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable Technology",,"Completed","Has Results","Major Depressive Disorder","Other: No intervention","Percentage of Days on Which Daily N-back Sessions Were Completed|Percentage of Days on Which Daily Mood Assessment Tests Were Completed|Correlation Coefficient Between Measures of Cognition (N-back Scores) and Performance on the Cambridge Neuropsychological Test Automated Battery (CANTAB) Tests: Spatial Working Memory Between Errors (SWMBE) and Spatial Working Memory Strategy (SWMS)|Correlation Coefficient Between Measures of Cognition (N-back Scores) and Performance on the CANTAB Test: Rapid Visual Information Processing (RVP)","Takeda","All","18 Years to 65 Years   (Adult, Older Adult)",,"30","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","MDD-5003","March 1, 2017","July 3, 2017","July 3, 2017","March 1, 2017","January 10, 2019","January 10, 2019","Takeda Investigative Site, London, United Kingdom","""Study Protocol"", https://ClinicalTrials.gov/ProvidedDocs/06/NCT03067506/Prot_000.pdf|""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/06/NCT03067506/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT03067506"
832,"NCT02697643","A Clinical Decision Support Tool for Electronic Health Records","BHCDS","Completed","No Results Available","Substance Abuse","Behavioral: BHCDS-based recommendations|Behavioral: Non-tailored recommendations","Change in clients' past 30-day substance use and psychosocial functioning at 1 month and 3 months post-baseline as measured by ASI-MV composite scores|Number of client treatment visits|Number of services each client receives or is referred to","Inflexxion, Inc.","All","18 Years and older   (Adult, Older Adult)","Not Applicable","140","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research","19015.13","March 17, 2016","March 31, 2018","March 31, 2018","March 3, 2016",,"August 13, 2018","Stephen Butler, Waltham, Massachusetts, United States","""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/43/NCT02697643/SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02697643"
833,"NCT02721745","Cause and Consequence of Neural Fatigue","Fatstim","Unknown status","No Results Available","Cognitive Fatigue","Behavioral: Natural Fatigue|Device: tDCS|Device: TMS","Proportion of chosen immediate reward in intertemporal questions between an immediate reward smaller than a delayed reward.|Physiological Measures: EEG|Physiological Measures: indirect calorimetry|Physiological Measures:pupillometry","Institut National de la Santé Et de la Recherche Médicale, France","All","20 Years to 39 Years   (Adult)","Not Applicable","216","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","C15-59|2015-A01445-44","May 2016","May 2016","October 2018","March 29, 2016",,"March 8, 2017","ICM, Paris, France",,"https://ClinicalTrials.gov/show/NCT02721745"
834,"NCT03430336","Application for an Electronic Medication Management Support System","AdAM","Unknown status","No Results Available","Polypharmacy","Other: CDSS provides drug-therapy relevant information|Other: Modification of medication|Other: Assessment of medication appropriateness|Other: Medication plan|Other: Guidance in medication process","Combined endpoint of all-cause mortality and all-cause hospital admissions|Change in the appropriateness of prescriptions|Change in all-cause hospital admissions|Change in all-cause mortality","BARMER|Association of Statutory Health Insurance Physicians Westphalia/Lippe|Goethe University|University of Cologne|Ruhr University of Bochum|Bielefeld University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","34400","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","IfA","February 2018","December 2019","December 2019","February 12, 2018",,"February 12, 2018",,,"https://ClinicalTrials.gov/show/NCT03430336"
835,"NCT02674516","The Effect of Repeated Prefrontal Cortex Stimulation on Antisocial and Aggressive Behavior",,"Active, not recruiting","No Results Available","Antisocial Behavior|Aggression","Device: Transcranial direct current stimulation|Device: Sham transcranial direct current stimulation","Change in antisocial behavior inclinations after 24 hours|Change in antisocial behavior inclinations after 48 hours|Number of pins inserted into a virtual voodoo doll after 24 hours|Number of pins inserted into a virtual voodoo doll after 48 hours|Mean reaction time to visual stimuli|Number of attentional lapses in responding to visual stimuli|Number of cards picked from the two ""risky decks"" in the Iowa Gambling Task|Delayed reward discounting rate|Number of balloon pumps in the Balloon Analogue Risk Task|Choice regarding the length of a prison sentence in a hypothetical juror scenario|Sum of self-reported ratings on free will beliefs in Paulhus and Carey's (2011) Free Will and Determinism Plus Scale|The occurrence of a moral or immoral event prior to the final testing session|Decisions to keep or transfer endowments to a fictional player|The amount of money participants would offer and accept from a fictional player in an ultimatum game|Heart rate levels during rest|Skin conductance levels during rest|Change in ratings of positive and negative affect according to the Positive and Negative Affect Schedule (PANAS) at 48 hours|Change in sleep quality at 48 hours|Number of participants with adverse events","University of Pennsylvania","All","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","823967","January 2016","July 2019","December 2020","February 4, 2016",,"March 12, 2020","University of Pennsylvania, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT02674516"
836,"NCT01542528","Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)","IBBS","Completed","Has Results","Attention Deficit Hyperactivity Disorder (ADHD)","Behavioral: IBBS","Improvement in ADHD Severity From Baseline to End of Intervention|Overall Improvement","Yale University|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Hamden Public Schools, Connecticut|C8Sciences|BeCaid China|Peking University|Capital Medical University|Beijing Sport Uninversity","All","5 Years to 10 Years   (Child)","Not Applicable","117","Other|NIH|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","11100009142|R01HD070821","March 2012","July 2016","July 2016","March 2, 2012","September 25, 2017","January 17, 2018","Hamden Public Schools, Hamden, Connecticut, United States|Department of Psychiatry, Yale University, New Haven, Connecticut, United States|Yale Child Study Center, New Haven, Connecticut, United States|Capital Medical University, Beijing, Beijing, China|Peking University, Beijing, Beijing, China",,"https://ClinicalTrials.gov/show/NCT01542528"
837,"NCT00532155","A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer","VITAL","Completed","Has Results","Carcinoma|Non Small Cell Lung","Drug: Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)|Drug: Placebo|Drug: Docetaxel (Taxotere®)|Drug: Dexamethasone (pre- and post-medication for docetaxel)","Overall Survival (OS)|Progression Free Survival (PFS)|Overall Response (OR) Rate as Per Response Evaluation Criteria in Solid Tumours (RECIST) Criteria|Health Related Quality of Life (HRQL) Assessed by the Lung Cancer Symptom Scale (LCSS)|Health Related Quality of Life (HRQL) Assessed by the Average Symptom Burden Index (ASBI)","Sanofi|Regeneron Pharmaceuticals","All","18 Years and older   (Adult, Older Adult)","Phase 3","913","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","EFC10261|EudraCT 2007-000819-29","September 2007","January 2011","October 2011","September 20, 2007","January 1, 2013","June 7, 2016","Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States|Sanofi-Aventis Administrative Office, Buenos Aires, Argentina|sanofi-aventis Australia & New Zealand administrative office, Macquarie Park, New South Wales, Australia|Sanofi-Aventis Administrative Office, Wien, Austria|Sanofi-Aventis Administrative Office, Sao Paulo, Brazil|Sanofi-Aventis Administrative Office, Sofia, Bulgaria|Sanofi-Aventis Administrative Office, Laval, Canada|Sanofi-Aventis Administrative Office, Santiago, Chile|Sanofi-Aventis Administrative Office, Shangai, China|Sanofi-Aventis Administrative Office, Praha, Czech Republic|Sanofi-Aventis Administrative Office, Tallinn, Estonia|Sanofi-Aventis Administrative Office, Helsinki, Finland|Sanofi-Aventis Administrative Office, Paris, France|Sanofi-Aventis Administrative Office, Berlin, Germany|Sanofi-Aventis Administrative Office, Athens, Greece|Sanofi-Aventis Administrative Office, Causeway Bay, Hong Kong|Sanofi-Aventis Administrative Office, Budapest, Hungary|Sanofi-Aventis Administrative Office, Mumbai, India|Sanofi-Aventis Administrative Office, Milano, Italy|Sanofi-Aventis Administrative Office, Seoul, Korea, Republic of|Sanofi-Aventis Administrative Office, Kuala Lumpur, Malaysia|Sanofi-Aventis Administrative Office, Gouda, Netherlands|Sanofi-Aventis Administrative Office, Warszawa, Poland|Sanofi-Aventis Administrative Office, Porto Salvo, Portugal|Sanofi-Aventis Administrative Office, Bucuresti, Romania|Sanofi-Aventis Administrative Office, Moscow, Russian Federation|Sanofi-Aventis Administrative Office, Singapore, Singapore|Sanofi-Aventis Administrative Office, Barcelona, Spain|Sanofi-Aventis Administrative Office, Bromma, Sweden|Sanofi-Aventis Administrative Office, Taipei, Taiwan|Sanofi-Aventis Administraive Office, Istanbul, Turkey|Sanofi-Aventis Admnistrative Office, Guildford Surrey, United Kingdom",,"https://ClinicalTrials.gov/show/NCT00532155"
838,"NCT03575273","The Impact of Methadone Maintenance Therapy on Food Reward Processing in Opioid Dependence",,"Active, not recruiting","No Results Available","Opioid Dependence|Obesity","Behavioral: Sniffin' Sticks Odor Identification and Hedonic Scale|Behavioral: Sucrose Taste Preference Assessment|Behavioral: Food Preferences Task|Behavioral: Progressive Ratio (PR) Task|Procedure: Clinical Electrophysiology|Dietary Supplement: Standardized Meal and Hunger and Satiety Ratings","Event-related potentials measured via BrainVision actiCHamp system|Chemosensory Processing|Food Preferences Task|Progressive Ratio Task","Johns Hopkins University|Mid-Atlantic Nutrition Obesity Research Center|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","All","18 Years to 60 Years   (Adult)","Not Applicable","45","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","IRB00092798|P30DK072488","February 12, 2018","December 1, 2019","December 1, 2020","July 2, 2018",,"December 26, 2019","Broadway Center for Addictions, Baltimore, Maryland, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT03575273"
839,"NCT02553525","Effects of Stimulation Patterns of Deep Brain Stimulation",,"Enrolling by invitation","No Results Available","Parkinson Disease|Essential Tremor|Multiple Sclerosis","Procedure: Therapeutic Stimulation Patterns|Procedure: Symptogenic Stimulation Patterns","Tremor Accelerometry|Bradykinesia Finger Tapping|Neural Activity|Electrode Location","Duke University|National Institute of Neurological Disorders and Stroke (NINDS)|Emory University|University of Florida","All","21 Years to 80 Years   (Adult, Older Adult)","Not Applicable","180","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","Pro00074235|R37NS040894","June 2, 2016","August 2022","August 2022","September 17, 2015",,"July 7, 2020","University of Florida, Gainesville, Florida, United States|Emory University, Atlanta, Georgia, United States|Duke University, Durham, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT02553525"
840,"NCT04412304","Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients",,"Completed","No Results Available","Covid-19|Thromboembolic Events|Bleeding","Drug: Dose of Tinzaparin or Dalteparin","28-days ICU mortality|Incidence of thromboembolic events|Incidence of bleeding events|ICU-free days alive from ICU-admission.","Karolinska Institutet","All","Child, Adult, Older Adult",,"166","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","Anticoagulant therapy Covid-19","March 6, 2020","April 30, 2020","May 28, 2020","June 2, 2020",,"June 22, 2020","South General Hospital, Stockholm, Stockholms Län, Sweden",,"https://ClinicalTrials.gov/show/NCT04412304"
841,"NCT02066116","Kinect-based Upper Limb Rehabilitation System in Stroke Patients",,"Terminated","No Results Available","Stroke|Hemiplegia|Virtual Rehabilitation","Procedure: Kinect-based rehabilitation plus occupational therapy|Other: sham virtual rehabilitation education plus occupational therapy","Change from Baseline in Fugl-Meyer Assessment Scale for upper extremity at 2 weeks|Brunnstrom stage|Modified Barthel Index|Box and Block Test|Number of movement counts during rehabilitation using accelerometer data","Seoul National University Bundang Hospital|Microsoft Research|The Ministry of Science, ICT and Future Planning, Korea","All","20 Years to 80 Years   (Adult, Older Adult)","Not Applicable","23","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","B1401-234-001","November 2014","November 2017","November 2017","February 19, 2014",,"November 6, 2017","Seoul National University Hospital, Seongnam, Gyeonggi-do, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT02066116"
842,"NCT01909349","Web-based Aftercare Intervention for Cardiac Patients","RENATA","Completed","No Results Available","CARDIOVASCULAR DISEASES|HEART DISEASES","Behavioral: self-regulation","Change in dietary and physical activity behavior (self-report)|Body weight|BMI|Days of absence from work|Quality of Life|Dietary and physical activity behavior (self-report)","Jacobs University Bremen gGmbH|Maastricht University|Institute of Physical Education and Sports Sciences|Guangdong Provincial People's Hospital|Hong Kong Baptist University","All","20 Years to 85 Years   (Adult, Older Adult)","Not Applicable","1000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","EK-A-SL-022013","September 2013","September 2015","August 2016","July 26, 2013",,"April 19, 2017","China, Hong Kong, Hong Kong, China|Germany, Bremen, Germany|The Netherlands, Maastricht, LK, Netherlands",,"https://ClinicalTrials.gov/show/NCT01909349"
843,"NCT01861509","BP-C1 in Metastatic Breast Cancer Patients",,"Completed","No Results Available","Metastatic Breast Cancer|Stage IV Breast Cancer","Drug: BP-C1","Single-dose PK: Maximum Observed Serum Concentration (Cmax) for Platinum|Single-dose PK: Time to Reach Maximum Observed Serum Concentration (Tmax) for Platinum|Single-dose PK: Area Under the Curve From Time Zero to Last Quantifiable Concentration (AUC(0-t)) for Platinum|Single-dose PK: Area Under the Curve From Time Zero to Extrapolated Infinite Time (AUC(0-∞))|Single-dose PK: Serum Decay Half-Life (T1/2) for Platinum|Multiple-dose PK: Maximum Observed Serum Concentration at Steady State (Css,max) for Platinum|Multiple-dose PK: Time to Reach Maximum Observed Serum Concentration at steady state (Tss,max) for Platinum|Multiple-dose PK: Minimum Observed Serum Concentration at Steady State (Css,min) for Platinum|Multiple-dose PK: Average Serum concentration at steady state (Css,av) for Platinum|Multiple-dose PK: Area Under the Curve within a dosing interval of tau (=24 hr) at steady state (AUCss,tau) for Platinum|Multiple-dose PK: Serum Decay Half-Life (T1/2) for Platinum|Interleukin Serum levels (Interferon γ and β, Tumour Necrosis Factor (TNF-α), IL-1beta, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-21 and IL-25)|Change (%) in the sum of diameters of target lesions|Number of target lesions|Treatment response","Meabco A/S","Female","18 Years to 80 Years   (Adult, Older Adult)","Phase 1","10","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","BMC2012-4","January 19, 2014","January 20, 2016","January 20, 2016","May 23, 2013",,"October 7, 2019","Oncology Unit. Sheba Medical Centre, Ramat-Gan, Israel|Lampang Cancer Center, Lampang, Thailand",,"https://ClinicalTrials.gov/show/NCT01861509"
844,"NCT00330551","Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia",,"Completed","Has Results","Schizophrenia","Drug: Oral Risperidone|Drug: Risperidone in Long-Acting Injectable Form (Consta)","Medication Adherence|Exacerbation or Relapse of Psychotic Symptoms|Return to Work or School (SAS Work Section)|Maintenance of Work/School Attendance (SAS)|Global Functioning Scale: Role|MATRICS Consensus Cognitive Battery (MCCB) Overall Composite T Score|Emotional Reactivity on Psychophysiological Measures|Retention in Treatment|Awareness of Illness, as Assessed by the Scale to Assess Unawareness of Mental Disorder-Revised (SUMD-R)","University of California, Los Angeles|National Institute of Mental Health (NIMH)|Janssen Scientific Affairs, LLC","All","18 Years to 45 Years   (Adult)","Phase 4","126","Other|NIH|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","P50MH066286|DATR A2-AISZ|Janssen RIS-NAP-4009","March 2006","November 2012","November 2012","May 29, 2006","March 23, 2020","March 23, 2020","Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, California, United States",,"https://ClinicalTrials.gov/show/NCT00330551"
845,"NCT02480582","The Impact of Snacks Which Vary Nutritionally in Their Satiating Potential on Measures of Appetite Control",,"Completed","Has Results","Lack of Satiety|Hyperphagia","Other: Almonds|Other: Cheese Savouries","Test Meal Energy Intake|Food Preference|Appetite Sensations (Hunger)|24 Hour Energy Intake","University of Leeds|Almond Board of California","Female","18 Years to 55 Years   (Adult)","Not Applicable","42","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","LDS-2015-ABC|RG.PSYC.102933","June 2015","November 2015","December 2015","June 24, 2015","March 15, 2017","March 15, 2017",,,"https://ClinicalTrials.gov/show/NCT02480582"
846,"NCT02123901","The Effect of Walking Meditation Training on Glycemic Control and Vascular Function in Patients With Type 2 Diabetes",,"Completed","No Results Available","Type 2 Diabetes","Other: Walking Meditation|Other: Walking|Other: No exercise","Change from baseline in glycemic control|Change from baseline in vascular reactivity|Change from baseline in stress indicators|Change from baseline in physical fitness|Change from baseline in Peripheral arterial stiffness|Change from baseline in ankle-brachial index.|Change from baseline in blood chemistry","Chulalongkorn University","All","40 Years to 75 Years   (Adult, Older Adult)","Not Applicable","33","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","SPSC-1","December 2013","October 2014","February 2015","April 28, 2014",,"September 16, 2015","The Primary Health Promoting Hospital, Prapadang, Samut Prakan, Thailand",,"https://ClinicalTrials.gov/show/NCT02123901"
847,"NCT03489707","The Prevent Anal Cancer Self-Swab Study",,"Suspended","No Results Available","Anal Cancer","Behavioral: Home-based human papillomavirus (HPV) DNA screening|Behavioral: Clinic-based human papillomavirus (HPV) DNA screening","Compliance as assessed by the number of participants who provide specimens for annual anal HPV DNA screening|Factors associated with annual screening compliance as assessed by the Computer-Assisted Self-Interview (CASI) questionnaire (pre-test)|Factors associated with annual screening compliance as assessed by the Computer-Assisted Self-Interview (CASI) questionnaire|Number of participants who agree to have a high resolution anoscopy (HRA)","Medical College of Wisconsin|Baylor College of Medicine|National Cancer Institute (NCI)|The University of Texas Health Science Center, Houston","All","25 Years and older   (Adult, Older Adult)","Not Applicable","400","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening","HSC-MS-17-0635|R01CA215403","March 12, 2019","August 31, 2021","August 31, 2022","April 5, 2018",,"April 3, 2020","Medical College of Wisconsin, Milwaukee, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT03489707"
848,"NCT02146443","Validation and Test-retest Study of the Star-shaped Manual Dexterity Test.",,"Completed","No Results Available","Manual Dexterity","Other: Stretched arm test|Other: Stress|Device: Star shaped manual dexterity test","Completion time of the star shaped manual dexterity test.|Number of errors during the completion of the star shaped manual dexterity test.","Herlev Hospital","All","20 Years to 55 Years   (Adult)","Not Applicable","31","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Investigator)|Primary Purpose: Basic Science","STAR-222","June 2014","September 2014","September 2014","May 23, 2014",,"September 25, 2014","Herlev Hospital, Herlev, Denmark",,"https://ClinicalTrials.gov/show/NCT02146443"
849,"NCT02769936","Glutamate, Learning, and Working Memory",,"Completed","No Results Available","Schizophrenia","Drug: D-cycloserine|Other: Placebo","Performance on Information Integration Learning Task|Performance on Weather Prediction Learning Task|Performance on N-Back Working Memory Task|Change in Visual Evoked Potential Amplitude using Electroencephalograph (EEG)","University of California, Los Angeles","All","18 Years to 50 Years   (Adult)","Phase 1","110","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","13-000409","November 2013","July 2015","December 2015","May 12, 2016",,"May 12, 2016",,,"https://ClinicalTrials.gov/show/NCT02769936"
850,"NCT03004807","Role of Centrum® Silver® in Improving Micronutrient Status in Older Men",,"Recruiting","No Results Available","Vitamin Deficiency|Mineral Deficiency|Aging","Dietary Supplement: Centrum Silver Mens' Formula|Other: Control","Changes in Plasma and Blood Cell Vitamin and Mineral Levels|Lipid Status|High Resolution Respirometry|Cognitive abilities|Spatial memory as assessed by a virtual water maze|Crystallized cognitive abilities","Tory Hagen|Pfizer|Oregon State University","Male","70 Years and older   (Older Adult)","Not Applicable","40","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science","WI211838|7158","July 1, 2018","October 2019","November 2020","December 29, 2016",,"July 17, 2018","Linus Pauling Science Center, Corvallis, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT03004807"
851,"NCT02733861","Evaluation of the Related Factors Influencing the Stability of Dental Implants",,"Unknown status","No Results Available","Teeth Missing",,"Implant stability quotient (ISQ) was tested by Osstell™ Mentor|Measure the bone density of the implant locations by CBCT.|Measure the thickness of the bone around the implant by CBCT.|Measure the crestal bone resorption by X-ray images","Fourth Military Medical University|National Natural Science Foundation of China","All","18 Years to 70 Years   (Adult, Older Adult)",,"1","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IRB-REV-2016012","May 2015","December 2018","December 2018","April 12, 2016",,"June 14, 2018","Dingxin, Xi'an, Shaanxi, China",,"https://ClinicalTrials.gov/show/NCT02733861"
852,"NCT04320914","High Intensity Laser Therapy (Classes IV) and Ibuprofen Gel Phonophoresis for Treating Knee Osteoarthritis",,"Not yet recruiting","No Results Available","Osteo Arthritis Knee","Other: High Intensity LASER Therapy|Other: Ibuprofen gel phonophoresis","Digitalized pain pressure algometer (ALGO-DS-01)|Western Ontario and Mc Master Universities Osteoarthritis Index (WOMAC)|36-Item Short Form Health Survey (SF-36)","Maharishi Markendeswar University (Deemed to be University)|Maharishi Markandeshwar Medical College and Hospital, Kumarhatti, Solan|Himachal Pradesh Council for Science Technology and Environment (HIMCOSTE)","All","45 Years to 70 Years   (Adult, Older Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","MMDU/IEC/140E|U1111-1237-6893","August 2020","October 2021","April 2022","March 25, 2020",,"June 16, 2020",,,"https://ClinicalTrials.gov/show/NCT04320914"
853,"NCT01577277","OPUS School Meal Study - Cross Sectional Analyses From Baseline Investigations",,"Completed","No Results Available","Metabolic Syndrome X",,"Metabolic syndrome score|Body composition|Concentration Performance|Fatty acid composition in whole-blood|Body weight, Body Mass Index (BMI)|Physical activity|Sleep|Cardio-respiratory fitness|Dietary intake|Appetite-regulating hormones|Vitamin D status|Bone Health|Iron status|Attention - other measures|Wellness|Learning|Mathematics proficiency|Reading proficiency|Use of ADHD medicine|Illnesses and use of medicine|Inflammatory markers|Socioeconomic measures|Early Cardiovascular Risk Markers|Pubertal status","Arne Astrup|Technical University of Denmark|University of Aarhus|University Hospital, Gentofte, Copenhagen|University of Copenhagen","All","8 Years to 12 Years   (Child)",,"834","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","D208 baseline|H-1-2010-124","May 2011","December 2011","December 2011","April 13, 2012",,"March 6, 2017","Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen Copenhagen, Denmark, Copenhagen, Denmark",,"https://ClinicalTrials.gov/show/NCT01577277"
854,"NCT02786472","ConnectEd: A Randomized Controlled Trial Connecting Through Educational Training","ConnectEd","Completed","No Results Available","Sexual Violence","Behavioral: Online Bystander Training|Behavioral: Online Substance Abuse Training|Behavioral: In-Person Bystander Training|Behavioral: In-Person Combination Training","Number of Bystander Behaviors|Change in Bystander Behavior Intentions Scale|Change in Bystander Behavior Efficacy Scale|Count of Bystander Behaviors Engagement with Peers|Change in Acceptance of SV/DV Scale|Count of self-reported risky behaviors, sexual and alcohol related","Heather Bush|Centers for Disease Control and Prevention|University of Kentucky","All","17 Years to 24 Years   (Child, Adult)","Not Applicable","3178","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention","CDC R01CE 2690.1","May 2016","December 2019","December 2019","June 1, 2016",,"February 24, 2020","University of Kentucky, Lexington, Kentucky, United States","""Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/72/NCT02786472/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT02786472"
855,"NCT04169646","Prevention and Intervention of Neck Pain in Swiss Office-Workers","NEXpro","Recruiting","No Results Available","Neck Pain|Headache|Musculoskeletal Diseases|Adherence, Patient|Absenteeism|Workplace|Health Promotion|Ergonomics|Efficiency|Presenteeism|Occupational Health|Surveys and Questionnaires|Adult|Exercise Therapy|Work Performance","Other: Multi-component intervention|Other: Control","NP-related productivity loss|Neck pain|Neck Disability Index|Physical activity level|Health related Quality of life|Job-Stress-Index|Health beliefs|Psychosocial workplace factors|Workplace ergonomics|Work implementation|Adherence to intervention|Participants' impression of change|Care seeking|Breaks and Smartphone use|Job satisfaction|Movement control|Mobility of neck and head|Muscle endurance|Muscle strength|Pain pressure threshold|Pain drawings|Headache|Pre-existing headache conditions|Demographic information","Zurich University of Applied Sciences|Swiss National Science Foundation","All","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","32003B_182389","October 28, 2019","December 2021","December 2021","November 20, 2019",,"December 18, 2019","Kanton Aargau, Departement Bau, Verkehr und Umwelt, Aarau, Switzerland|ZHAW, Winterthur, Switzerland",,"https://ClinicalTrials.gov/show/NCT04169646"
856,"NCT02751814","Physical Activity and Screen-Time Regulations in Childcare Centers - Aim 2","Pause and Play","Completed","No Results Available","Childhood Obesity",,"Changes in objective child physical activity|Classroom observation of child screen-time|Parent reports of child screen time|Fundamental motor skills","Pennington Biomedical Research Center|National Institute on Minority Health and Health Disparities (NIMHD)","All","3 Years to 4 Years   (Child)",,"175","Other|NIH","Observational","Observational Model: Case-Only|Time Perspective: Prospective","PBRC 2015-038|U54MD008602-P02UAB|U54MD008602","April 2016","June 2018","June 2018","April 26, 2016",,"May 11, 2020","Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States",,"https://ClinicalTrials.gov/show/NCT02751814"
857,"NCT02104505","Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled LPS","Vitalps","Completed","Has Results","Mild, Allergic Asthma","Drug: Gamma Tocopherol 700 mg capsules,|Drug: Placebo","Comparison of Change in Sputum Percent Neutrophils (PMN)s Following Inhaled Clinical Center Reference Endotoxin (CCRE) Challenge as Affected by Gamma Tocopherol|Chronic Eosinophilic Airway Inflammation as Affected by Gamma Tocopherol|Mucociliary Clearance (MCC) Associated With CCRE Challenge as Affected by Gamma Tocopherol|Mucociliary Clearance as Affected by Gamma Tocopherol","University of North Carolina, Chapel Hill|National Institute of Environmental Health Sciences (NIEHS)|Purdue University","All","18 Years to 50 Years   (Adult)","Phase 1|Phase 2","23","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","13-1605|R01ES023349","November 2015","September 2016","August 2017","April 4, 2014","November 6, 2017","November 6, 2017","Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT02104505"
858,"NCT04161625","Evaluation of Reach, Effects and Cost Effectiveness of a Fall Preventive Intervention Including a mHealth Application",,"Recruiting","No Results Available","Accidental Falls","Behavioral: Digital exercise program with support","Reach|Sociodemographic characteristics age|Sociodemographic characteristics gender|Sociodemographic characteristics living conditions|Functional leg strength|Perceived Exertion|Self-rated balance|Self-rated leg-strength|Falls efficacy|Health related quality of life|Use of the information videos|Experienced positive effects of the exercise intervention|Experienced negative effects of the exercise intervention|Physical activity|Exercise adherence throughout the intervention|Self-rated improvements in balance|Self-rated improvements in leg-strength|Rate of attrition|New exercise routines|Costs related to the interventions|Cost-effectiveness|Participation in technical support sessions|Participation in try-out group exercises|Fall rate|Number of fallers","Umeå University","All","70 Years and older   (Older Adult)","Not Applicable","350","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","SafeStepReach","October 14, 2019","April 2021","April 2021","November 13, 2019",,"November 13, 2019","Caring Science Buildning, Umeå University, Umeå, Sweden",,"https://ClinicalTrials.gov/show/NCT04161625"
859,"NCT03963570","The Effectiveness of a Self-managed Digital Exercise Programme to Prevent Falls in Older Community-dwelling People","SafeStepRCT","Recruiting","No Results Available","Accidental Falls","Behavioral: Safe Step - digital exercise program|Behavioral: Control group","Fall rate|Functional leg strength|Perceived Exertion|Self-rated balance|Self-rated leg-strength|Falls efficacy|Health related quality of life|Use of the information videos|Experienced positive effects of the exercise intervention|Experienced negative effects of the exercise intervention|Physical activity|Number of fallers|Exercise adherence throughout the intervention|Self-rated improvements in balance|Self-rated improvements in leg-strength|Rate of attrition|Sociodemographic characteristics|New exercise routines|Costs related to the interventions|Cost-effectiveness","Umeå University|Glasgow Caledonian University","All","70 Years and older   (Older Adult)","Not Applicable","1400","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","SafeStepRCT","September 27, 2019","September 2021","September 2021","May 24, 2019",,"October 8, 2019","Caring Science Buildning, Umeå University, Umeå, Sweden",,"https://ClinicalTrials.gov/show/NCT03963570"
860,"NCT02312310","Dietary Flavanols and Dentate Gyrus Function",,"Completed","Has Results","Memory Loss","Dietary Supplement: Cocoa Flavanol","Modified Benton Recognition Task (ModBent)|Dentate Gyrus Cerebral Blood Volume|Modified Rey Auditory Verbal Learning Test|NIH Toolbox Cognition Battery (NIHTB-CB): The List Sorting Test","New York State Psychiatric Institute|Mars, Inc.","All","50 Years to 75 Years   (Adult, Older Adult)","Not Applicable","211","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","7034","December 2015","November 2018","April 2020","December 9, 2014","June 11, 2020","June 11, 2020","Columbia University Medical Center, New York, New York, United States","""Study Protocol and Informed Consent Form"", https://ClinicalTrials.gov/ProvidedDocs/10/NCT02312310/Prot_ICF_000.pdf|""Statistical Analysis Plan"", https://ClinicalTrials.gov/ProvidedDocs/10/NCT02312310/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT02312310"
861,"NCT01197339","Hybrid Model of Vocal Inflammation and Tissue Mobilization",,"Completed","No Results Available","Acute Phonotrauma","Behavioral: resonant voice|Behavioral: voice rest|Behavioral: Breathy voice|Behavioral: Relaxation exercise|Behavioral: Resonant voice and relaxation exercise","Biomarker levels in laryngeal secretion","University of Pittsburgh|National Institute on Deafness and Other Communication Disorders (NIDCD)|McGill University|Purdue University","Female","18 Years to 40 Years   (Adult)","Phase 1","45","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science","DC008290|5R01DC008290","September 2010","March 2013","March 2013","September 9, 2010",,"January 25, 2016","Univesity of Pittsburgh, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT01197339"
862,"NCT02122211","Choline Dehydrogenase and Sperm Function: Effects of Betaine",,"Completed","No Results Available","Men Carrying 2 Minor Alleles for Choline Dehydrogenase rs12676|Male Infertility","Drug: Betaine supplement","Change in sperm motility from baseline|Change in sperm count from baseline|Change in sperm mitochondrial function from baseline|Change in sperm ultrastructure from baseline|Change in sperm choline dehydrogenase concentration from baseline|Change in sperm betaine concentration from baseline|Betaine intake|Change in complete blood count from baseline|Change in uric acid concentration from baseline|Change in alkaline phosphatase concentration from baseline|Change in aspartate transaminase concentration from baseline|Change in lactic dehydrogenase concentration from baseline|Change in bilirubin concentration from baseline|Change in blood urea nitrogen concentration from baseline|Change in creatinine concentration from baseline|Change in urinalysis parameters from baseline","University of North Carolina, Chapel Hill","Male","18 Years to 60 Years   (Adult)","Phase 1","6","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","13-2424","April 2014","July 2016","July 2016","April 24, 2014",,"September 8, 2016","UNC Nutrition Research Institute, Kannapolis, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT02122211"
863,"NCT02780557","How Parents Can Help Babies Learn to Talk With Picture Books.",,"Completed","No Results Available","Language Development","Behavioral: Contingent Reading Intervention|Behavioral: Book Provision Control","Change in infant expressive vocabulary|Change in caregiver reported frequency of reading|Infant Real Time Language Understanding: Accuracy|Infant Real Time Language Understanding: Reaction Time","University of Sheffield","All","11 Months to 11 Months   (Child)","Not Applicable","156","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","R/139470-11-1-INFANCY","August 24, 2016","January 30, 2018","March 22, 2018","May 23, 2016",,"May 4, 2018","University of Sheffield, Sheffield, South Yorkshire, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02780557"
864,"NCT03532113","Attentional Control Training in Older Adults: Efficacy, Transfer and Brain Substrates",,"Completed","No Results Available","Inhibition (Psychology)|Updating|General Knowledge|No Training","Behavioral: Updating|Behavioral: Inhibition|Behavioral: General knowledge","Changes on the updating composite measure (Proximal outcome).|Changes on the inhibition composite measure (Proximal outcome).|Transfer to complex working memory measure: the Alpha-span task (Distal outcome).|Transfer to complex working memory measure: the Reading span task (Distal outcome).|Transfer to complex working memory measure: the virtual car ride task (Distal outcome).|Brain structure: Regional gray matter volumes in Prefrontal and lateral temporal cortices, Basal ganglia and Hippocampi.|Brain structure: Cortical thickness in Prefrontal regions and lateral temporal cortices.|Brain function: Updating related activation.|Brain function: Inhibition related activation.","Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal|Natural Sciences and Engineering Research Council, Canada","All","60 Years to 85 Years   (Adult, Older Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care","CRIUGM-005","October 19, 2017","December 20, 2019","December 20, 2019","May 22, 2018",,"January 23, 2020","CRIUGM, Montréal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT03532113"
865,"NCT02005003","Cognitive and Metabolic Effects of a Probiotic Supplement",,"Unknown status","No Results Available","Dietary Supplements|Probiotics|Metabolism|Food Preferences|Microbiota","Behavioral: Inhibitory task|Procedure: Blood samples|Biological: Feces collection|Procedure: Caloric preload|Behavioral: Food selection task|Behavioral: Memory task|Behavioral: Food consumption task","Memory function|Glycometabolic regulation|Food preferences|Inhibitory task|Food consumption task|Sleep patterns|Microbiome changes","Uppsala University","Male","18 Years to 28 Years   (Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","FF8vsPlaceboJC2013","November 2013","December 2015","December 2015","December 9, 2013",,"November 18, 2014","Department of Neuroscience, Uppsala University, Uppsala, Sweden",,"https://ClinicalTrials.gov/show/NCT02005003"
866,"NCT03711084","Effects of Sweetness on Neurocognitive Responses, Glycemia and Food Intake",,"Completed","No Results Available","Obesity","Dietary Supplement: Natural high potency sweetener from leaf extract|Dietary Supplement: Glucose|Dietary Supplement: Sucrose|Dietary Supplement: Maltodextrin|Dietary Supplement: Water","Energy intake|Appetite ratings|Food-cue responses|Blood glucose levels|Hedonic ratings","University of Manchester|Cargill","All","18 Years to 40 Years   (Adult)","Not Applicable","20","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","2310","April 26, 2018","October 15, 2018","November 15, 2018","October 18, 2018",,"February 15, 2019","University of Manchester, Manchester, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03711084"
867,"NCT02983552","Binocular Dig Rush Game Treatment for Amblyopia","ATS20","Active, not recruiting","No Results Available","Amblyopia","Other: iPad®|Other: Spectacle correction","Mean change in amblyopic-eye VA|VA Improvement at 4 Weeks Defined as a Binary Outcome|VA Improvement at 8 Weeks Defined as a Binary Outcome|Stereoacuity|Treatment Compliance with Binocular Therapy|Treatment Compliance with Binocular Therapy at 8 weeks|Fellow-eye Contrast with Binocular Therapy|Fellow-eye Contrast with Binocular Therapy at 8 Weeks|VA in Fellow Eye|VA in Fellow Eye at 8 Weeks|Ocular Alignment|Ocular Alignment at 8 Weeks|Diplopia|Diplopia at 8 Weeks|Adverse Symptoms|Adverse Symptoms at 8 Weeks","Jaeb Center for Health Research|Pediatric Eye Disease Investigator Group|National Eye Institute (NEI)","All","4 Years to 12 Years   (Child)","Not Applicable","320","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","ATS20|2U10EY011751","March 2, 2017","July 2020","August 2020","December 6, 2016",,"June 9, 2020","UAB Pediatric Eye Care; Birmingham Health Care, Birmingham, Alabama, United States|Midwestern University Eye Institute, Glendale, Arizona, United States|University Eye Center at Ketchum Health, Anaheim, California, United States|Loma Linda University Health Care, Dept. of Ophthalmology, Loma Linda, California, United States|Saddleback Eye Medical Associates, Mission Viejo, California, United States|Western University College of Optometry, Pomona, California, United States|Yale University, New Haven, Connecticut, United States|Nova Southeastern University College of Optometry, The Eye Institute, Fort Lauderdale, Florida, United States|University of Florida Shands Hospital, Gainesville, Florida, United States|The Emory Eye Center, Atlanta, Georgia, United States|St Luke's Hospital, Boise, Idaho, United States|Ticho Eye Associates, Chicago Ridge, Illinois, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Illinois College of Optometry, Chicago, Illinois, United States|Progressive Eye Care, Lisle, Illinois, United States|Advanced Vision Center, Schaumburg, Illinois, United States|Pediatric Eye Associates, Wilmette, Illinois, United States|Indiana School of Optometry, Bloomington, Indiana, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|Wolfe Eye Clinic, West Des Moines, Iowa, United States|Greater Baltimore Medical Center, Baltimore, Maryland, United States|Wilmer Eye Institute, Baltimore, Maryland, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Michigan College of Optometry at Ferris State Univ, Big Rapids, Michigan, United States|Helen DeVos Children's Hospital Pediatric Ophthalmology, Grand Rapids, Michigan, United States|Pediatric Ophthalmology, P.C., Grand Rapids, Michigan, United States|University of Minnesota-Minnesota Lions Children's Eye Clinic, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States|Saint Louis University Institute, Saint Louis, Missouri, United States|St. Louis Children's Hospital Eye Center, Saint Louis, Missouri, United States|U of MO St. Louis College of Optometry, Saint Louis, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Concord Ophthalmologic Associates, Concord, New Hampshire, United States|Michael F. Gallaway, O.D., P.C., Marlton, New Jersey, United States|State University of New York, College of Optometry, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Duke University Eye Center, Durham, North Carolina, United States|Cincinnati Children's Hospital, Cincinnati, Ohio, United States|Pediatric Ophthalmology Associates, Inc., Columbus, Ohio, United States|The Ohio State University College of Optometry, Columbus, Ohio, United States|Eye Care Associates, Inc., Poland, Ohio, United States|Dean A. McGee Eye Institute, University of Oklahoma, Oklahoma City, Oklahoma, United States|Pacific University College of Optometry, Portland, Oregon, United States|OHSU Casey Eye Institute, Portland, Oregon, United States|Pediatric Ophthalmology of Erie, Erie, Pennsylvania, United States|Conestoga Eye, Lancaster, Pennsylvania, United States|Pediatric Eye Specialists, Chattanooga, Tennessee, United States|Southern College of Optometry, Memphis, Tennessee, United States|Texas Children's Hospital - Dept. Of Ophthalmology, Houston, Texas, United States|University of Houston College of Optometry, Houston, Texas, United States|Texas Tech University Health Science Center, Lubbock, Texas, United States|San Antonio Eye Center, San Antonio, Texas, United States|Houston Eye Associates, The Woodlands, Texas, United States|Virginia Pediatric Eye Center, Norfolk, Virginia, United States|Seattle Children's Hospital, University of Washington, Seattle, Washington, United States|Northwest Pediatric Ophthalmology, P.S., Spokane, Washington, United States|Spokane Eye Clinical Research, Spokane, Washington, United States|Marshall University, Huntington, West Virginia, United States|University of Wisconsin, University Station, Madison, Wisconsin, United States|Snowy Range Vision Center, Laramie, Wyoming, United States|Alberta Children's Hospital, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT02983552"
868,"NCT02748746","Early Detection of Lymphedema With Bio-Electrical Impedance Analysis in Patients After Breast Cancer Surgery","BIA","Withdrawn","No Results Available","Lymphedema|Breast Cancer","Device: Bio Impedance Analysis Measurement|Device: Tissue Dielectric Constant Measurement","Investigation of early detection of lymphedema after breast cancer surgery with Bio Electrical Impedance Analysis (BIA)|Investigation of symptom related quality of life with LymQoL","Abant Izzet Baysal University|The Scientific and Technological Research Council of Turkey","Female","18 Years to 65 Years   (Adult, Older Adult)","Not Applicable","0","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening","AbantIBU","August 2018","May 2019","November 2019","April 22, 2016",,"June 4, 2020","Abant Izzet Baysal University, Bolu, City Centre, Turkey",,"https://ClinicalTrials.gov/show/NCT02748746"
869,"NCT02642029","Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study",,"Enrolling by invitation","No Results Available","Schizophrenia|Schizoaffective Disorder|Bipolar Disorder","Device: Excitatory TMS|Device: Inhibitory TMS|Device: Sham TMS","Change (Δ) in accuracy of time interval discrimination (Protocol A) pre- and post-TMS|Change (Δ) in accuracy of N-back working memory task (Protocol A) pre- and post-TMS|Change (Δ) in accuracy of repetitive finger tapping task (Protocol B) pre- and post-TMS|Change (Δ) in accuracy of multi-source interference task (Protocol B) pre- and post-TMS|Symptoms (mood and psychosis)","Mclean Hospital|Massachusetts General Hospital","All","18 Years to 50 Years   (Adult)","Not Applicable","200","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science","2015P001833","February 18, 2016","December 2020","December 2020","December 30, 2015",,"January 28, 2020","McLean Hospital, Belmont, Massachusetts, United States|Massachusetts General Hospital, Charlestown, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02642029"
870,"NCT00941304","Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain",,"Completed","Has Results","Dental Pain","Drug: Oxycodone|Drug: Buprenorphine|Drug: Placebo Film|Drug: Placebo Capsule","Sum of Pain Intensity Difference From Baseline to 8 Hours|Total Pain Relief Over 8 Hours|Sum of Pain Relief and Intensity Differences Over 8 Hours|Sum of Pain Relief and Intensity Differences Over 2 Hours|Peak Pain Intensity Difference|Peak Pain Relief|Onset of Analgesia|Duration of Analgesia|Percentage of Participants Reporting a Global Rating of Study Drug as ""Excellent""|Percentage of Participants With ""Excellent"" Investigator Global Rating of Study Drug|Change From Baseline in Cognitive Assessment Using CNS-VS","BioDelivery Sciences International","All","18 Years to 45 Years   (Adult)","Phase 2","153","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","BUP-201","August 2009","November 2009","November 2009","July 17, 2009","February 3, 2016","February 27, 2017","Premier Research Group Limited, Austin, Texas, United States|Donald P. Bandy, DDS, San Marcos, Texas, United States|Premier Research Group Limited, Salt Lake City, Utah, United States",,"https://ClinicalTrials.gov/show/NCT00941304"
